
<html lang="en"     class="pb-page"  data-request-id="71f2ba4e-6a01-4520-bc5c-18d962c6d3a3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2017.60.issue-5;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.6b01594"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses" /></meta><meta name="dc.Creator" content="Dustin  Siegel" /></meta><meta name="dc.Creator" content="Hon C.  Hui" /></meta><meta name="dc.Creator" content="Edward  Doerffler" /></meta><meta name="dc.Creator" content="Michael O.  Clarke" /></meta><meta name="dc.Creator" content="Kwon  Chun" /></meta><meta name="dc.Creator" content="Lijun  Zhang" /></meta><meta name="dc.Creator" content="Sean  Neville" /></meta><meta name="dc.Creator" content="Ernest  Carra" /></meta><meta name="dc.Creator" content="Willard  Lew" /></meta><meta name="dc.Creator" content="Bruce  Ross" /></meta><meta name="dc.Creator" content="Queenie  Wang" /></meta><meta name="dc.Creator" content="Lydia  Wolfe" /></meta><meta name="dc.Creator" content="Robert  Jordan" /></meta><meta name="dc.Creator" content="Veronica  Soloveva" /></meta><meta name="dc.Creator" content="John  Knox" /></meta><meta name="dc.Creator" content="Jason  Perry" /></meta><meta name="dc.Creator" content="Michel  Perron" /></meta><meta name="dc.Creator" content="Kirsten M.  Stray" /></meta><meta name="dc.Creator" content="Ona  Barauskas" /></meta><meta name="dc.Creator" content="Joy Y.  Feng" /></meta><meta name="dc.Creator" content="Yili  Xu" /></meta><meta name="dc.Creator" content="Gary  Lee" /></meta><meta name="dc.Creator" content="Arnold L.  Rheingold" /></meta><meta name="dc.Creator" content="Adrian S.  Ray" /></meta><meta name="dc.Creator" content="Roy  Bannister" /></meta><meta name="dc.Creator" content="Robert  Strickley" /></meta><meta name="dc.Creator" content="Swami  Swaminathan" /></meta><meta name="dc.Creator" content="William A.  Lee" /></meta><meta name="dc.Creator" content="Sina  Bavari" /></meta><meta name="dc.Creator" content="Tomas  Cihlar" /></meta><meta name="dc.Creator" content="Michael K.  Lo" /></meta><meta name="dc.Creator" content="Travis K.  Warren" /></meta><meta name="dc.Creator" content="Richard L.  Mackman" /></meta><meta name="dc.Description" content="The recent Ebola virus (EBOV) outbreak in West Africa was the largest recorded in history with over 28,000 cases, resulting in &gt;11,000 deaths including &gt;500 healthcare workers. A focused screening ..." /></meta><meta name="Description" content="The recent Ebola virus (EBOV) outbreak in West Africa was the largest recorded in history with over 28,000 cases, resulting in &gt;11,000 deaths including &gt;500 healthcare workers. A focused screening ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 26, 2017" /></meta><meta name="dc.Type" content="news" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01594" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2017 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01594" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01594" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01594" /></link>
        
    
    

<title>Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01594" /></meta><meta property="og:title" content="Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0010.jpeg" /></meta><meta property="og:description" content="The recent Ebola virus (EBOV) outbreak in West Africa was the largest recorded in history with over 28,000 cases, resulting in &gt;11,000 deaths including &gt;500 healthcare workers. A focused screening and lead optimization effort identified 4b (GS-5734) with anti-EBOV EC50 = 86 nM in macrophages as the clinical candidate. Structure activity relationships established that the 1′-CN group and C-linked nucleobase were critical for optimal anti-EBOV potency and selectivity against host polymerases. A robust diastereoselective synthesis provided sufficient quantities of 4b to enable preclinical efficacy in a non-human-primate EBOV challenge model. Once-daily 10 mg/kg iv treatment on days 3–14 postinfection had a significant effect on viremia and mortality, resulting in 100% survival of infected treated animals [ Nature 2016, 531, 381−385]. A phase 2 study (PREVAIL IV) is currently enrolling and will evaluate the effect of 4b on viral shedding from sanctuary sites in EBOV survivors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01594"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01594">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01594&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01594&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01594&amp;href=/doi/10.1021/acs.jmedchem.6b01594" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 1648-1661</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01367" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Drug Annotation</span><a href="/doi/10.1021/acs.jmedchem.7b00237" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-<i>f</i>][triazin-4-amino] Adenine <i>C</i>-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Dustin Siegel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dustin Siegel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dustin++Siegel">Dustin Siegel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hon C. Hui</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hon C. Hui</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hon+C.++Hui">Hon C. Hui</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Edward Doerffler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Edward Doerffler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Edward++Doerffler">Edward Doerffler</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael O. Clarke</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael O. Clarke</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+O.++Clarke">Michael O. Clarke</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kwon Chun</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kwon Chun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kwon++Chun">Kwon Chun</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lijun Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lijun Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lijun++Zhang">Lijun Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sean Neville</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sean Neville</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sean++Neville">Sean Neville</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ernest Carra</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ernest Carra</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ernest++Carra">Ernest Carra</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Willard Lew</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Willard Lew</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Willard++Lew">Willard Lew</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bruce Ross</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bruce Ross</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bruce++Ross">Bruce Ross</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Queenie Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Queenie Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Queenie++Wang">Queenie Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lydia Wolfe</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lydia Wolfe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lydia++Wolfe">Lydia Wolfe</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Robert Jordan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert Jordan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Jordan">Robert Jordan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Veronica Soloveva</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Veronica Soloveva</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, Maryland 21702, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Veronica++Soloveva">Veronica Soloveva</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John Knox</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John Knox</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John++Knox">John Knox</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jason Perry</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jason Perry</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jason++Perry">Jason Perry</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michel Perron</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michel Perron</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michel++Perron">Michel Perron</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kirsten M. Stray</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kirsten M. Stray</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kirsten+M.++Stray">Kirsten M. Stray</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ona Barauskas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ona Barauskas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ona++Barauskas">Ona Barauskas</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joy Y. Feng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joy Y. Feng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joy+Y.++Feng">Joy Y. Feng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yili Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yili Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yili++Xu">Yili Xu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gary Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gary Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gary++Lee">Gary Lee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Arnold L. Rheingold</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Arnold L. Rheingold</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">University of California—San Diego, San Diego, California 92093, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Arnold+L.++Rheingold">Arnold L. Rheingold</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Adrian S. Ray</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Adrian S. Ray</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Adrian+S.++Ray">Adrian S. Ray</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Roy Bannister</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Roy Bannister</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Roy++Bannister">Roy Bannister</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Robert Strickley</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert Strickley</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Strickley">Robert Strickley</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Swami Swaminathan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Swami Swaminathan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Swami++Swaminathan">Swami Swaminathan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">William A. Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">William A. Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=William+A.++Lee">William A. Lee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sina Bavari</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sina Bavari</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, Maryland 21702, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sina++Bavari">Sina Bavari</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tomas Cihlar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tomas Cihlar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tomas++Cihlar">Tomas Cihlar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael K. Lo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael K. Lo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centers for Disease Control and Prevention, Atlanta, Georgia 30333, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+K.++Lo">Michael K. Lo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Travis K. Warren</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Travis K. Warren</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, Maryland 21702, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Travis+K.++Warren">Travis K. Warren</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Richard L. Mackman</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard L. Mackman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Gilead Sciences, Inc., Foster City, California 94404, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#a6d4cfc5cec7d4c288cbc7c5cdcbc7c8e6c1cfcac3c7c288c5c9cb"><span class="__cf_email__" data-cfemail="9ceef5fff4fdeef8b2f1fdfff7f1fdf2dcfbf5f0f9fdf8b2fff3f1">[email protected]</span></a>. Tel.: 650 522 5258.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard+L.++Mackman">Richard L. Mackman</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8861-7205" title="Orcid link">http://orcid.org/0000-0001-8861-7205</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01594&amp;href=/doi/10.1021%2Facs.jmedchem.6b01594" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 1648–1661</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 26, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 October 2016</li><li><span class="item_label"><b>Published</b> online</span>26 January 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 March 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01594" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01594</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01594"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">61461</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">254</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01594" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Dustin&quot;,&quot;last_name&quot;:&quot;Siegel&quot;},{&quot;first_name&quot;:&quot;Hon&quot;,&quot;last_name&quot;:&quot;C. Hui&quot;},{&quot;first_name&quot;:&quot;Edward&quot;,&quot;last_name&quot;:&quot;Doerffler&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;O. Clarke&quot;},{&quot;first_name&quot;:&quot;Kwon&quot;,&quot;last_name&quot;:&quot;Chun&quot;},{&quot;first_name&quot;:&quot;Lijun&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Sean&quot;,&quot;last_name&quot;:&quot;Neville&quot;},{&quot;first_name&quot;:&quot;Ernest&quot;,&quot;last_name&quot;:&quot;Carra&quot;},{&quot;first_name&quot;:&quot;Willard&quot;,&quot;last_name&quot;:&quot;Lew&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;Ross&quot;},{&quot;first_name&quot;:&quot;Queenie&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Lydia&quot;,&quot;last_name&quot;:&quot;Wolfe&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Jordan&quot;},{&quot;first_name&quot;:&quot;Veronica&quot;,&quot;last_name&quot;:&quot;Soloveva&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Knox&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;Perry&quot;},{&quot;first_name&quot;:&quot;Michel&quot;,&quot;last_name&quot;:&quot;Perron&quot;},{&quot;first_name&quot;:&quot;Kirsten&quot;,&quot;last_name&quot;:&quot;M. Stray&quot;},{&quot;first_name&quot;:&quot;Ona&quot;,&quot;last_name&quot;:&quot;Barauskas&quot;},{&quot;first_name&quot;:&quot;Joy&quot;,&quot;last_name&quot;:&quot;Y. Feng&quot;},{&quot;first_name&quot;:&quot;Yili&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Arnold&quot;,&quot;last_name&quot;:&quot;L. Rheingold&quot;},{&quot;first_name&quot;:&quot;Adrian&quot;,&quot;last_name&quot;:&quot;S. Ray&quot;},{&quot;first_name&quot;:&quot;Roy&quot;,&quot;last_name&quot;:&quot;Bannister&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Strickley&quot;},{&quot;first_name&quot;:&quot;Swami&quot;,&quot;last_name&quot;:&quot;Swaminathan&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;A. Lee&quot;},{&quot;first_name&quot;:&quot;Sina&quot;,&quot;last_name&quot;:&quot;Bavari&quot;},{&quot;first_name&quot;:&quot;Tomas&quot;,&quot;last_name&quot;:&quot;Cihlar&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;K. Lo&quot;},{&quot;first_name&quot;:&quot;Travis&quot;,&quot;last_name&quot;:&quot;K. Warren&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;L. Mackman&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;26&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;1648-1661&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01594&quot;},&quot;abstract&quot;:&quot;The recent Ebola virus (EBOV) outbreak in West Africa was the largest recorded in history with over 28,000 cases, resulting in &gt;11,000 deaths including &gt;500 healthcare workers. A focused screening and lead optimization effort identified 4b (GS-5734) with anti-EBOV EC50 = 86 nM in macrophages as the clinical candidate. Structure activity relationships established that the 1′-CN group and C-linked nucleobase were critical for optimal anti-EBOV potency and selectivity against host polymerases. A robust diastereoselective synthesis provided sufficient quantities of 4b to enable preclinical efficacy in a non-human-primate EBOV challenge model. Once-daily 10 mg/kg iv treatment on days 3–14 postinfection had a significant effect on viremia and mortality, resulting in 100% survival of infected treated animals [ Nature 2016 , 531 , 381 − 385 ]. A phase 2 study (PREVAIL IV) is currently enrolling and will evaluate the effect of 4b on viral shedding from sanctuary sites in EBOV survivors.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01594&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01594" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01594&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01594" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01594&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01594" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01594&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01594&amp;href=/doi/10.1021/acs.jmedchem.6b01594" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01594" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01594" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01594%26sid%3Dliteratum%253Aachs%26pmid%3D28124907%26genre%3Darticle%26aulast%3DSiegel%26date%3D2017%26atitle%3DDiscovery%2Band%2BSynthesis%2Bof%2Ba%2BPhosphoramidate%2BProdrug%2Bof%2Ba%2BPyrrolo%255B2%252C1-f%255D%255Btriazin-4-amino%255D%2BAdenine%2BC-Nucleoside%2B%2528GS-5734%2529%2Bfor%2Bthe%2BTreatment%2Bof%2BEbola%2Band%2BEmerging%2BViruses%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D5%26spage%3D1648%26epage%3D1661%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (4)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291362" title="Antimicrobial agents">Antimicrobial agents</a>,</li><li><a href="/action/doSearch?ConceptID=291308" title="Nucleic acids">Nucleic acids</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/jmcmar.2017.60.issue-5/20170309/jmcmar.2017.60.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/medium/jm-2016-01594m_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01594&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The recent Ebola virus (EBOV) outbreak in West Africa was the largest recorded in history with over 28,000 cases, resulting in >11,000 deaths including >500 healthcare workers. A focused screening and lead optimization effort identified <b>4b</b> (GS-5734) with anti-EBOV EC<sub>50</sub> = 86 nM in macrophages as the clinical candidate. Structure activity relationships established that the 1′-CN group and <i>C</i>-linked nucleobase were critical for optimal anti-EBOV potency and selectivity against host polymerases. A robust diastereoselective synthesis provided sufficient quantities of <b>4b</b> to enable preclinical efficacy in a non-human-primate EBOV challenge model. Once-daily 10 mg/kg iv treatment on days 3–14 postinfection had a significant effect on viremia and mortality, resulting in 100% survival of infected treated animals [  <cite><i>Nature</i></cite> <span class="NLM_year">2016</span>, <em>531</em>, 381−385]. A phase 2 study (PREVAIL IV) is currently enrolling and will evaluate the effect of <b>4b</b> on viral shedding from sanctuary sites in EBOV survivors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span></span>  Note</h4><p class="first last">This article is made available via the <a href="/page/vi/chemistry_coronavirus_research" class="ext-link">ACS COVID-19 subset</a> for unrestricted RESEARCH re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60621" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60621" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Ebola virus disease (EVD) was first documented 40 years ago during an outbreak of infectious hemorrhagic fever in Northern Zaire (current Democratic Republic of Congo). More than 20 intermittent outbreaks have occurred since then, but the most recent outbreak in West Africa spanning 2013–2016 has been the largest recorded in history and presented an international public health emergency.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Over 28,000 cases were confirmed in Guinea, Liberia, and Sierra Leone resulting in >11,000 deaths including >500 healthcare workers, which severely strained the local medical infrastructure.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In survivors, the Ebola virus (EBOV) can persist in bodily fluids for months after the onset of acute infection potentially leading to EVD-related sequelae and viral recrudescence.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> While rare, secondary transmission has been documented to occur through sexual intercourse implicating persistent virus in genital secretions.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Despite the end of the current outbreak, the potential for equally devastating future outbreaks together with the persistent virus observed in survivors makes the development of a safe, effective, and readily available treatment option for EVD a high priority.</div><div class="NLM_p">EBOV, a member of the <i>Filoviridae</i> family, is a single-stranded, negative-sense, nonsegmented RNA virus that is the causative agent of EVD. Other <i>Filoviridae</i> family members include Marburg, Sudan, and Bundibugyo viruses, which have all been responsible for outbreaks associated with high mortality rates in sub-Saharan Africa.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> Over the course of the recent West African EVD outbreak, several direct acting anti-Ebola agents including monoclonal antibodies (ZMapp),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> interfering-RNAs,<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8−10)</a> and small molecule nucleoside(tide) antivirals such as favipiravir (<b>1</b>),<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a> and brincidofovir (<b>2</b>)<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> have been evaluated in early clinical trials (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). More recently another nucleoside analogue, galidesivir (<b>3</b>, BCX4430<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a>), has entered clinical development. These developments are encouraging, but to date, none of these potential therapeutics have established robust clinical efficacy for the treatment of acute infection or the viral persistence and sequelae. Several vaccines have shown strong promise for preventing EBOV infection, but the breadth and durability of protection they can afford has yet to be established.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/medium/jm-2016-01594m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of antiviral nucleosides and nucleoside phosphonates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01594&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Prior to the Ebola outbreak, we had embarked on a strategic initiative aimed at evaluating the potential of nucleoside analogues for the treatment of selected emerging viruses. A library of ∼1000 diverse nucleoside and nucleoside phosphonate analogues was harnessed from over 2 decades of research across multiple antiviral programs. In collaboration with the Center for Disease Control and Prevention (CDC) and the United States Army Medical Research Institute of Infectious Diseases (USAMRIID), selected compounds from the library were screened against EBOV, leading to the identification of parent <b>4</b> and a potent monophosphate prodrug mixture <b>4a</b> that contained the single <i>S</i>p isomer <b>4b</b> (GS-5734<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a>) that was selected for development. This report describes in detail the structure activity relationships (SAR) of the parent nucleoside, prodrug optimization and selection, and synthesis optimization of the development candidate <b>4b</b>. Candidate compound <b>4b</b> is currently in phase 2 trials to assess the effect on the chronic shedding of virus in EVD survivors following promising efficacy data established in a non-human-primate (NHP) EVD challenge model. These data have been recently reported<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and will be summarized along with the early clinical experience with <b>4b</b>.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64384" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64384" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The assembly of the ∼1000 compound nucleos(t)ide screening library was heavily focused toward ribose analogues that could target RNA viruses since this would encompass many emerging viral infections ranging from respiratory pathogens belonging to the <i>Coronaviridae</i> family such as severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), to mosquito-borne viruses of the <i>Flaviviridae</i> family such as Dengue and Zika. The majority of the library compounds were nucleosides that contained a cyclic modified ribose or “ribose-like” core. These nucleosides were also predominantly <i>N</i>-nucleosides. Less than 10% of the library comprised nucleoside phosphonates or acyclic analogues due to the limited success, to date, in identifying potent RNA virus inhibitors with these types of analogs. A second key factor in the library assembly was that approximately 50% of the library included monophosphate and ester prodrugs to capture analogs that may be missed in cellular screens due to either poor permeability or inefficient metabolism in the respective cell types that the different antiviral assays utilize. Nucleoside analogs require activation by intracellular nucleoside/tide kinases to generate their respective nucleoside triphosphate (NTP) metabolites in order to then compete with endogenous natural nucleotide pools for incorporation into the replicating viral RNA.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The first phosphorylation step to generate the nucleoside monophosphate is often rate limiting, and therefore the application of monophosphate prodrugs, especially phosphoramidates (ProTides), has been extensively explored in nucleoside analogs to bypass this initial phosphorylation step.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> A notable example includes the phosphoramidate prodrug Sofosbuvir (<b>5</b>) for the treatment of HCV (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Nucleoside phosphonate analogs are bioisosteres of the monophosphates but also require prodrugs to enable masking of the charged phosphonate acid thereby allowing more efficient entry into cells. A recent example of an approved drug in this class is the phosphonamidate prodrug tenofovir alafenamide (<b>6</b>) for the treatment of HIV.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In both examples the amidate prodrugs effectively deliver high levels of triphosphate (diphosphophosphonate in the case of nucleoside phosphonates) inside the target cells and demonstrate significant improvements in potency compared to their respective parent nucleos(t)ides when screened in antiviral assays.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a></div><div class="NLM_p">In the original library screening toward a panel of RNA viruses across different viral families, promising leads were identified. Subsequent to the EVD outbreak, some of these analogs were selected for EBOV testing in collaboration with the CDC and USAMRIID in a BSL-4 facility. From this screen nucleoside <b>4</b>,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> a 1′-CN modified adenosine <i>C</i>-nucleoside emerged with sub-micromolar activity toward EBOV in human microvascular endothelial cells (HMVEC-TERT) cells (entry 2, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). In addition, its phosphoramidate prodrug mixture <b>4a</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (entry 3, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) containing ∼1:1 ratio of <i>S</i>p <b>4b</b> and <i>R</i>p <b>4c</b> diastereoisomers (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) was found to be very potent toward EBOV in both HeLa and HMVEC cells. Encouraged by these data, the anti-EBOV activity for a range of nucleoside analogs and their prodrugs was evaluated and the results are reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, along with activity toward respiratory syncytial virus (RSV), from the <i>Pneumoviridae</i> family, and HCV, from the <i>Flaviviridae</i> family.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of Nucleoside Parents and Selected Prodrugs<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/medium/jm-2016-01594m_0008.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">EBOV EC<sub>50</sub> HeLa cells (μM)</th><th class="colsep0 rowsep0" align="center">EBOV EC<sub>50</sub> HMVEC cells<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> (μM)</th><th class="colsep0 rowsep0" align="center">RSV EC<sub>50</sub> HEp-2 cells (μM)</th><th class="colsep0 rowsep0" align="center">HCV 1b EC<sub>50</sub> Huh-7 cells (μM)</th><th class="colsep0 rowsep0" align="center">CC<sub>50</sub> HEp-2 cells (μM)</th><th class="colsep0 rowsep0" align="center">CC<sub>50</sub> Huh-7 cells (μM)</th><th class="colsep0 rowsep0" align="center">CC<sub>50</sub> MT4 cells (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.0035</td><td class="colsep0 rowsep0" align="left">0.038<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left"><0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">0.78</td><td class="colsep0 rowsep0" align="left">0.53</td><td class="colsep0 rowsep0" align="left">4.1</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>88</td><td class="colsep0 rowsep0" align="left">>57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="left">0.17</td><td class="colsep0 rowsep0" align="left">0.12</td><td class="colsep0 rowsep0" align="left">0.027</td><td class="colsep0 rowsep0" align="left">0.023<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">9.2</td><td class="colsep0 rowsep0" align="left">17<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left">0.10</td><td class="colsep0 rowsep0" align="left">0.053</td><td class="colsep0 rowsep0" align="left">0.015</td><td class="colsep0 rowsep0" align="left">0.057</td><td class="colsep0 rowsep0" align="left">6.1</td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">5.5</td><td class="colsep0 rowsep0" align="left">38</td><td class="colsep0 rowsep0" align="left">93</td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>88</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>88</td><td class="colsep0 rowsep0" align="left">120</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">6.9</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>44</td><td class="colsep0 rowsep0" align="left">>32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">56</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>44</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>88</td><td class="colsep0 rowsep0" align="left">>53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">7.3</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>44</td><td class="colsep0 rowsep0" align="left">>57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">63</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>44</td><td class="colsep0 rowsep0" align="left">53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>100<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">>44</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>44</td><td class="colsep0 rowsep0" align="left">32<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>44</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>44</td><td class="colsep0 rowsep0" align="left">>57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left"><b>13a</b></td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">13<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">0.37</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>44</td><td class="colsep0 rowsep0" align="left">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left"><b>13b</b></td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">0.31</td><td class="colsep0 rowsep0" align="left">95</td><td class="colsep0 rowsep0" align="left">51</td><td class="colsep0 rowsep0" align="left">7.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Data reported are at least <i>n</i> ≥ 2 in 384 well assay format unless otherwise noted.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">HMVEC cells = TERT-immortalized human foreskin microvascular endothelial cells (ATCC-4025) cells.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">96 well assay format.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last"><i>n</i> = 1 data only.</p></div></div></div><div class="NLM_p">The presence of the 1′-CN modification in <b>4</b> was found to be critical in providing selectivity toward viral polymerases and avoiding the significant toxicity (CC<sub>50</sub> < 0.01–0.15 μM) associated with the unmodified <i>C</i>-nucleoside <b>7</b> (entry 1, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The MT4 cell line was also used as a sensitive cell line to evaluate cytostatic effects of nucleoside analogs and confirmed the poor selectivity of <b>7</b> observed in both the HEp-2 and Huh-7 cell lines. The prodrug mixture <b>4a</b>, in addition to potent anti-EBOV activity, demonstrated significant activity toward RSV and HCV, with potencies similar to or better than that for EBOV (EC<sub>50</sub> < 120 nM). The broad and potent antiviral activity across all three viruses for <b>4a</b> was further supported by the potent activity of the single <i>S</i>p isomer <b>4b</b> toward the same viruses and also other emerging RNA viruses such as MERS and Junin viruses, and to a lesser extent Lassa.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The antiviral selectivity of <b>4b</b> toward EBOV was 17–32-fold compared to the MT4 cell line CC<sub>50</sub>, and higher in the other cell types reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. Given the anticipated short treatment duration for EVD, this window of in vitro selectivity was considered sufficient for continued interest in <b>4b</b>. The 1′-methyl analogue <b>8</b> (entry 5)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> was less active toward EBOV and also displayed a higher degree of toxicity compared to the 1′-CN analogue <b>4</b> illustrating how small changes in the polarity and size of the 1′ substituent can impact the overall profile. The 1′-ethynyl analogue <b>9</b> (entry 6)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and its corresponding 2-ethylbutyl alanine prodrug <b>9a</b> (entry 7) were both less active when compared to their respective 1′-CN counterparts (<b>4</b> and <b>4a</b>, respectively).</div><div class="NLM_p">Compound <b>4</b> is a <i>C</i>-nucleoside analogue which provides chemical and enzymatic stability toward deglycosylation reactions at the anomeric center. However, alternate base modifications including <i>N</i>-nucleosides were also studied. Interestingly, the corresponding 1′-CN modified adenosine <i>N</i>-analogue <b>10</b> (entry 8)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> was significantly less active toward all viruses, while the 1′-CN modified <i>N</i>-nucleoside pyrimidine <b>11</b> (entry 9) retained weak antiviral activity only for RSV and HCV.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> The phosphoramidate prodrug of 1′-CN cytidine <b>11a</b> (entry 10)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> did not improve the potency toward EBOV (in HeLa cell assay) or the other viruses tested, presumably due to limitations in metabolism beyond the monophosphate. In general, the potency trends of 1′ substitution and nucleobase changes were similar across EBOV, RSV, and HCV, which <named-content content-type="anchor" rid="tbl1" type="simple"></named-content>was in contrast to the trends uncovered with 2′ modifications. The 2′-deoxy-2′-fluorine analogue <b>12</b> (entry 11)<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and the 2′-β-methyl analogue <b>13</b> (entry 12)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> both lacked significant antiviral activity. However, the 2′-β-methyl phosphoramidate prodrugs, analogs <b>13a</b> and <b>13b</b> (entries 13 and 14),<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> respectively, were both potent toward HCV, and only weakly active/inactive toward EBOV and RSV. This result suggests that HCV polymerase is more able to accommodate the 2′-β-methyl group compared to the EBOV and RSV polymerases. Taken together with the 1′ substitution and nucleobase SAR, the EBOV and RSV polymerases demonstrated similar activity trends, while HCV polymerase was differentiated in SAR at the 2′ position.</div><div class="NLM_p">To interrogate the cell based SAR more rigorously the active NTP metabolite <b>4tp</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> was tested toward the viral polymerases (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The triphosphate <b>4tp</b> demonstrated a half-maximal inhibitory concentration (IC<sub>50</sub>) of 1.1 μM against the RSV RdRp and 5.0 μM against HCV RdRp. The Ebola viral polymerase has to date evaded efforts toward its isolation and expression, so the intrinsic activity of the active NTP metabolite cannot be directly evaluated. An alternate method for estimating the inhibitory properties of an NTP for its viral target is to measure the NTP levels inside cells following incubation with the parent or prodrug compound at a given concentration and then calculate the NTP levels at the EC<sub>50</sub> measured in the same cells.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> For example, in a continuous 72 h incubation of 1 μM <b>4a</b>, the <b>4tp</b> levels were measured at 2, 24, 48, and 72 h, and reached a <i>C</i><sub>max</sub> of 300, 110, and 90 pmol/million cells in macrophages, HMVEC, and HeLa cells lines, respectively. The several-fold difference in maximum <b>4tp</b> levels is not unusual and reflects the differences between cells with respect to their ability to break down the prodrug and subsequently metabolize the released monophosphate to the active <b>4tp</b>. The average NTP levels over the 72 h incubation of <b>4a</b> were then used along with an average cell volume of 2 pL<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> to calculate an estimated half-maximal inhibitory concentration of ∼5 μM for the intracellular inhibition of EBOV polymerase. This is comparable in potency toward RSV and HCV polymerases supporting the potent antiviral EC<sub>50</sub> data demonstrated for the prodrug mixture <b>4a</b> across the three viruses when allowing for cell differences (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The selective inhibition of the viral polymerases vs host polymerases is considered a key factor in the development of a safe and effective nucleoside antiviral.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> Therefore, <b>4tp</b> was evaluated toward several host polymerases and was found to be a weak incorporator toward mitochondrial polymerase (POLRMT) and not a substrate for DNA polymerase γ, as would be expected given the presence of the ribose 2′ OH (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Across the host RNA and DNA polymerases evaluated there was no inhibition up to 200 μM (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) demonstrating a high degree of selectivity of <b>4tp</b> toward the viral polymerases compared to representative examples of host polymerases.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibition of RSV Polymerase, HCV Polymerase, and Human Polymerases by <b>4tp</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/medium/jm-2016-01594m_0009.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">enzyme</th><th class="colsep0 rowsep0" align="center"><b>4tp</b> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center"><b>4tp</b> SNI<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> rate (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RSV RdRp</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HCV RdRp</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">POLRMT</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RNA Pol II</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DNA Pol α</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DNA Pol β</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DNA Pol γ</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">SNI = single nucleotide incorporation.</p></div></div></div><div class="NLM_p">Molecular structure information is not available for the EBOV or RSV polymerases, so modeling of the active sites was performed based on the published structures for HIV and HCV polymerases, together with an analysis of the respective sequences.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Within the modeled active site of EBOV polymerase the major difference between EBOV and RSV is Y636 (EBOV) compared to F704 (RSV) and the major difference between EBOV and HCV is E709 (EBOV) compared to S282 (HCV). On docking the triphosphate <b>4tp</b>, the 1′-CN group occupies a pocket formed by residues that are identical between EBOV and RSV, yet very different in HCV (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a). Nevertheless the 1′-CN analogue retains antiviral potency across these viruses and others<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> suggesting that a pocket exists to accommodate the 1′-CN group in many viral polymerases including other filoviruses.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The 2′-β-H of <b>4tp</b> is in close proximity to E709, and replacement of this group with a 2′-β-methyl (<b>13tp</b>) would be anticipated to interfere with E709 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> However, the 2′-β-methyl can be accommodated by the larger pocket afforded by the smaller S282 residue of HCV (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>c). This suggests the lack of activity for 2′-β-methyl analogs toward EBOV and RSV and retained potency toward HCV is likely due to steric constraints in the polymerase active site. Consistent with the model, EBOV and RSV both have the E709 or equivalent residue, and <b>13tp</b> was found to be significantly less active (IC<sub>50</sub> > 30 μM) toward RSV.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/medium/jm-2016-01594m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Compound <b>4tp</b> modeled into the EBOV polymerase active site. Residue Y636 is highlighted in green surface, sits below the ribose, and corresponds to F704 in RSV. Residue E709 is highlighted in red surface, sits in proximity to the 2′-β-H position of the ribose, and corresponds to S282 in HCV. (b) Compound <b>13tp</b> modeled into the EBOV polymerase active site. The 2′-β-methyl overlaps with residue E709 highlighted in red. (c) Compound <b>13tp</b> modeled into the HCV polymerase active site. Residue S282 is highlighted in the yellow surface, and the 2′-β-methyl can be accommodated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01594&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The screening and modeling efforts established <b>4</b> as the best lead for prodrug optimization. The ability to evaluate prodrugs, especially in vivo, required an efficient synthesis route for both the nucleoside <b>4</b> and, preferably, a single prodrug diastereoisomer. Neither was available at the outset, so significant chemistry resources were applied to improve the robustness and scalability of the route along with generation of single prodrug diastereoisomers. The first generation synthesis of <b>4</b> and the single <i>S</i>p phosphoramidate prodrug <b>4b</b> commenced with a glycosylation reaction via metal–halogen exchange of the bromo-base <b>15</b> followed by addition into the ribolactone <b>14</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Two conditions were identified to render this desired C–C bond formation. The first condition (a) proceeded through addition of excess <i>n</i>-BuLi to a mixture of TMSCl and <b>15</b>, which was designed to result in lithium–halogen exchange after removal of the acidic 6N protons by silyl protection. Addition of this in situ generated reagent to the ribolactone <b>14</b> then afforded <b>16</b> in 25% yield.<a onclick="showRef(event, 'ref23 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref23 ref35 ref36">(23,35,36)</a> The alternative conditions (b) employed sodium hydride and 1,2-bis(chlorodimethylsilyl)ethane for the 6N protection step, followed by lithium–halogen exchange, and addition to the lactone to afford <b>16</b> in 60% yield.<a onclick="showRef(event, 'ref22 ref36'); return false;" href="javascript:void(0);" class="ref ref22 ref36">(22,36)</a></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/medium/jm-2016-01594m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. First Generation Synthesis of <b>4b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01594&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, (TMS)Cl, THF, – 78 °C, 25%; (b) 1,2-bis(chlorodimethylsilyl)ethane, NaH, <i>n</i>-BuLi, THF, – 78 °C, 60%; (c) (TMS)CN, BF<sub>3</sub>·Et<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, – 78 °C, 58% (89:11β-<b>17</b>/α); (d) BCl<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, – 78 °C, 74%; (e) <b>19</b>, NMI, OP(OMe)<sub>3</sub>, 21%; (f) OP(OPh)Cl<sub>2</sub>, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 23%.</p></p></figure><div class="NLM_p">The efficiency of both conditions was suboptimal as the yields were capricious and highly dependent on the cryogenic temperatures and the rate of <i>n</i>-BuLi addition required for the transformation. Furthermore, premature quenching and reduction of lithio base was observed, which was rationalized to be a consequence of deprotonation α to the lactone under the highly basic conditions. Compound <b>16</b> was isolated as a mixture of 1′-isomers, which were taken into the subsequent 1′-cyanation reaction to isolate the major product, β-anomer <b>17</b>, by chromatography.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Following removal of the three benzyl protecting groups to afford <b>4</b>, the diastereomeric mixture of the phosphoramidoyl chloridate prodrug moiety <b>19</b> was then coupled to provide <b>4a</b> in 21% yield, as an ∼1:1 diastereomeric mixture.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The two diastereomers were resolved using chiral HPLC to afford the <i>S</i>p isomer <b>4b</b> and <i>R</i>p isomer <b>4c</b>, respectively.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> While this route initially provided quantities of <b>4b</b>, the variability in yields, suboptimal selectivity, frequent use of cryogenic temperatures, and chiral chromatography hindered this route from being suited to larger scales.</div><div class="NLM_p">The second generation route enabled the diastereoselective synthesis of the single <i>S</i>p isomer <b>4b</b> on scales suitable to advance the compound into preclinical efficacy and toxicity studies (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The glycosylation step employed the iodo-base <b>20</b> instead of the bromo base, which enabled a more facile metal–halogen exchange compatible with <i>i</i>-PrMgCl·LiCl complex.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Treatment with PhMgCl and TMSCl provided 6N protection to remove the acidic protons with a higher degree of control, and addition of <i>i</i>-PrMgCl·LiCl followed by the ribolactone <b>14</b> at −20 °C afforded the glycosylation product <b>16</b> in a 40% yield. The milder reagents and temperature enabled large-scale batches to be carried out with consistent yields. Treatment of <b>16</b> with TMSCN, TMSOTf, and TfOH at −78 °C afforded <b>17</b> in 85% yield in >95:5 anomeric ratio. The inclusion of TfOH was key to promote the high yield and high selectivity favoring the desired β-anomer. Benzyl deprotection was effected through treatment with BCl<sub>3</sub>, and <b>4</b> was readily isolated through crystallization. Acetonide protection of the 2′,3′-hydroxyl moieties with 2,2-dimethoxypropane in the presence of H<sub>2</sub>SO<sub>4</sub> afforded <b>21</b> in 90% yield. Utilizing the 2′,3′-acetonide protection was found to be optimal as the yield of the coupling reaction with the <i>p</i>-nitrophenolate 2-ethylbutyl-<span class="smallcaps smallerCapital">l</span>-alaninate prodrug mixture <b>22a</b> was dramatically improved compared to directly coupling to the unprotected nucleoside <b>4</b> (70% vs 40%). In the event, reaction of <b>21</b> with the single <i>S</i>p isomer of the <i>p</i>-nitrophenolate prodrug precursor <b>22b</b> in the presence of MgCl<sub>2</sub> and Hünig’s base efficiently appended the prodrug group in 70% yield as a single <i>S</i>p isomer. Final deprotection of the acetonide with concentrated HCl in THF afforded <b>4b</b> in 69% yield.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/medium/jm-2016-01594m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Second Generation Synthesis of <b>4b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01594&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TMSCl, PhMgCl, <i>i</i>-PrMgCl·LiCl, THF, – 20 °C, 40%; (b) TMSCN, TfOH, TMSOTf, CH<sub>2</sub>Cl<sub>2</sub>, – 78 °C, 85%; (c) BCl<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, – 20 °C, 86%; (d) 2,2-dimethoxypropane, H<sub>2</sub>SO<sub>4</sub>, acetone, rt, 90%; (e) <b>22b</b>, MgCl<sub>2</sub>, (<i>i</i>-Pr)<sub>2</sub>NEt, MeCN, 50 °C, 70%; (f) 37% HCl, THF, rt, 69%; (g) OP(OPh)Cl<sub>2</sub>, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, – 78 °C, then 4-nitrophenol, Et<sub>3</sub>N, 0 °C, 80%; (h) <i>i</i>-Pr<sub>2</sub>O, 39%.</p></p></figure><div class="NLM_p">The single <i>S</i>p isomer <b>22b</b> of the <i>p</i>-nitrophenolate 2-ethylbutyl-<span class="smallcaps smallerCapital">l</span>-alaninate prodrug precursor <b>22a</b> was prepared through a sequence beginning with exposure of 2-ethylbutyl-<span class="smallcaps smallerCapital">l</span>-alanine <b>18a</b> to OP(OPh)Cl<sub>2</sub>, followed by 4-nitrophenol, to afford <b>22a</b> as a diastereomeric mixture at phosphorus. Importantly, the single <i>S</i>p isomer <b>22b</b> was readily resolved from the mixture in 39% yield through crystallization in diisopropyl ether, a discovery that was paramount for the success of the diastereoselective synthesis of the <b>4b</b>.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Thus, utilizing the <i>p</i>-nitrophenolate 2-ethylbutyl-<span class="smallcaps smallerCapital">l</span>-alaninate prodrug coupling partner <b>22b</b> offered a significant advantage over the chloridate <b>19</b> in the first generation sequence. Overall the second generation synthesis of <b>4b</b> offered the following improvements: (1) milder glycosylation conditions at higher temperature to allow for consistent yields and scalability, (2) higher selectivity and yield for the 1′-cyanation reaction, and (3) a highly efficient coupling sequence of a single <i>S</i>p prodrug moiety for the diastereoselective synthesis of <b>4b</b>. Through this second generation route >200 g was rapidly prepared to support preclinical efficacy and toxicity studies.</div><div class="NLM_p">The stereochemistry of the <i>p</i>-nitrophenolate 2-ethylbutyl-<span class="smallcaps smallerCapital">l</span>-alaninate prodrug <b>22b</b> and candidate compound <b>4b</b> were unambiguously assigned by small molecule X-ray crystallography (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). In both cases the <i>S</i>p isomer was established and suggests that the coupling with the nucleoside and reagent follows a S<sub>N</sub>2 type inversion of the phosphorus stereocenter.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/medium/jm-2016-01594m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Thermal ellipsoid representations of (a) <b>22b</b> and (b) <b>4b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01594&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The improved method for preparing <b>4</b> enabled many monophosphoramidate and bisphosphoramide prodrug analogues to be synthesized, the results of which are summarized in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. A number of conditions were identified to affect the coupling of the prodrug moieties to <b>4</b> or the 2′,3′-acetonide protected analogue <b>21</b>. The reactions employing <b>4</b> proceeded under either Brønsted basic conditions utilizing <i>t</i>-BuMgCl or Lewis acidic conditions with MgCl<sub>2</sub> in polar aprotic solvents to afford the desired prodrugs in yields ranging from 10 to 43%. The coupling reaction of the 2′,3′-acetonide protected analogue <b>21</b> under Lewis acidic conditions followed by in situ acetonide deprotection in general afforded much higher yields ranging from 60 to 70% (analogues <b>4b</b> and <b>4n</b>). Both the <i>p</i>-nitrophenol (PNP) and pentafluorophenol (PFP) prodrug electrophiles were compatible in the coupling reactions and typically achieved comparable yields. The reactions utilizing diastereomeric mixtures of the prodrug electrophiles, <b>22a</b>,<b>d</b>–<b>h</b>,<b>j</b>,<b>l</b>,<b>n</b> provided the prodrug products in 1.5–2.6 to 1 diastereomeric ratios (unassigned) at phosphorus. In addition to the monophosphoramidate prodrugs, two bisphosphoramide prodrugs, <b>4o</b> and <b>4p</b>, were synthesized and evaluated since they avoided the preparation of chiral phosphorus reagents.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/medium/jm-2016-01594m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Prodrug Synthesis</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01594&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label"><sup>a</sup></span>Prodrug is an undetermined mixture of diastereoisomers unless otherwise indicated.</p><p><span class="fn-label"><sup>b</sup></span>aa = amino acid, Ala = alanine, Phe = phenylalanine, AIB = 2-aminoisobutyrate, <i>c</i>-Bu = cyclobutyl, <i>c</i>-Pent = cyclopentyl, Pent = pentyl, Neopent = neopentyl, 2-EtBu = 2-ethylbutyl, PNP = <i>p</i>-nitrophenolate, and PFP = pentafluorophenolate.</p><p><span class="fn-label"><sup>c</sup></span>LG = leaving group.</p><p><span class="fn-label"><sup>d</sup></span>Single <i>S</i>p isomer.</p><p><span class="fn-label"><sup>e</sup></span>Reagent was a single unassigned isomer at phosphorus.</p><p class="last"><span class="fn-label"><sup>f</sup></span>NA = not applicable.</p></p></figure><div class="NLM_p">The monophosphate prodrugs can improve the potency of the parent nucleosides substantially by delivering the monophosphate into cells and effectively bypassing a rate limiting first phosphorylation step. The phenol and amino acid esters mask the negative charge of the monophosphate group enabling facile passive penetration into the cell. The prodrug breakdown is initiated by intracellular esterases (e.g., carboxy esterase 1 and cathepsin A) that cleave the ester unraveling the carboxylate moiety, which then continues to breakdown to the monophosphate that serves as the prescursor to synthesis of the intracellular NTP.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">Prodrugs <b>4a</b>–<b>p</b> were evaluated toward EBOV in three cell lines and for human plasma stability (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). In general the antiviral activity trends for EBOV across all three cell lines were similar supporting the efficient conversion of these prodrugs across multiple different cell types. A series of ethyl esters with differing amino acids (entries 2–5) established that the phenylalanine and alanine amino acids were the most promising (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Given the intended route of administration was intravenous, increasing lipophiliity beyond log <i>D</i> ∼ 2 was considered a potential issue due to solubility concerns. Therefore, to improve potency the emphasis was placed on the less lipophilic and more commonly used alanine amino acid, with subsequent modification of the ester. Nonproximally branched esters of alanine with increasing log <i>D</i> ranging from 0.6 to 2.1 (entries 5, 11, and 12) demonstrated increased potency. Esters that contained proximal branching without cyclic motifs e.g. <i>i</i>-Pr, <i>t</i>-Bu, and 3-pentyl (entries 7, 8, and 10, respectively) were generally less active, consistent with the increased steric hindrance that likely slows the cleavage rate by esterases. For example, the proximally branched 3-pentyl ester <b>4l</b> (entry 10) has comparable log <i>D</i> to that of the neopentyl analogue <b>4m</b> (entry 11) yet much lower potency. In contrast, cyclic butyl and pentyl esters (entries 6 and 9, respectively) are more potent than <b>4l</b> despite the proximal branching and lower log <i>D</i>, although the potency in the HeLa cell assay was reduced. The <span class="smallcaps smallerCapital">d</span>-Ala 2-EtBu mixture (entry 15) was less potent that the corresponding <span class="smallcaps smallerCapital">l</span>-Ala analogue mixture (entry 12), and the two bisphosphoramide prodrugs (entries 16 and 17) also had reduced activity compared to their monoamidate counterparts (entries 5 and 12, respectively). Thus, based on antiviral properties across HeLa and HMVEC cells, the most promising monophosphoramidate prodrugs were the neopentyl ester <b>4m</b> (single undefined isomer) and 2-EtBu ester mixture <b>4a</b>. The <i>S</i>p and <i>R</i>p isomers of <b>4a</b> (entries 14 and 13, respectively) were separated and found to be similar in potency, but both were marginally more potent than <b>4m</b>. For the intended iv route of administration, plasma stability was not deemed critical in the selection process provided sufficient stability (<i>t</i><sub>1/2</sub> > 60 min) was maintained to allow loading of target cells harboring the virus during drug infusion. The selection of <b>4b</b> was made based on the high potency across multiple cell lines and the crystalline nature of the <i>S</i>p prodrug reagent <b>22b</b> that allowed rapid scale up for efficacy and IND enabling studies of the single <i>S</i>p isomer <b>4b</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Antiviral Activity of Prodrugs <b>4a</b>–<b>p</b>.<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">ester (R)</th><th class="colsep0 rowsep0" align="center">aa<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">EBOV EC<sub>50</sub> HeLa (nM)</th><th class="colsep0 rowsep0" align="center">EBOV EC<sub>50</sub> HMVEC<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a> (nM)</th><th class="colsep0 rowsep0" align="center">EBOV EC<sub>50</sub> macro<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a> (nM)</th><th class="colsep0 rowsep0" align="center">CC<sub>50</sub> MT4 (μM)</th><th class="colsep0 rowsep0" align="center">human plasma <i>t</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center">log <i>D</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>20000</td><td class="colsep0 rowsep0" align="left">780</td><td class="colsep0 rowsep0" align="left">>20000</td><td class="colsep0 rowsep0" align="left">>57</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left"><b>4d</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left"><span class="smallcaps smallerCapital">l</span>-Phe</td><td class="colsep0 rowsep0" align="left">4380</td><td class="colsep0 rowsep0" align="left">587</td><td class="colsep0 rowsep0" align="left">270</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">1584</td><td class="colsep0 rowsep0" align="left">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left"><b>4e</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left"><span class="smallcaps smallerCapital">l</span>-Val</td><td class="colsep0 rowsep0" align="left">7040</td><td class="colsep0 rowsep0" align="left">3151</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">1584</td><td class="colsep0 rowsep0" align="left">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left"><b>4f</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">AIB</td><td class="colsep0 rowsep0" align="left">8470</td><td class="colsep0 rowsep0" align="left">1585</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">1584</td><td class="colsep0 rowsep0" align="left">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left"><b>4g</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left"><span class="smallcaps smallerCapital">l</span>-Ala</td><td class="colsep0 rowsep0" align="left">2425</td><td class="colsep0 rowsep0" align="left">636</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">1584</td><td class="colsep0 rowsep0" align="left">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left"><b>4h</b></td><td class="colsep0 rowsep0" align="left"><i>c</i>-Bu</td><td class="colsep0 rowsep0" align="left"><span class="smallcaps smallerCapital">l</span>-Ala</td><td class="colsep0 rowsep0" align="left">420</td><td class="colsep0 rowsep0" align="left">88</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">815</td><td class="colsep0 rowsep0" align="left">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left"><b>4i</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left"><span class="smallcaps smallerCapital">l</span>-Ala</td><td class="colsep0 rowsep0" align="left">1845</td><td class="colsep0 rowsep0" align="left">367</td><td class="colsep0 rowsep0" align="left">297</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">1561</td><td class="colsep0 rowsep0" align="left">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left"><b>4j</b></td><td class="colsep0 rowsep0" align="left"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="left"><span class="smallcaps smallerCapital">l</span>-Ala</td><td class="colsep0 rowsep0" align="left">30410</td><td class="colsep0 rowsep0" align="left">3790</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">1584</td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left"><b>4k</b></td><td class="colsep0 rowsep0" align="left"><i>c</i>-Pent</td><td class="colsep0 rowsep0" align="left"><span class="smallcaps smallerCapital">l</span>-Ala</td><td class="colsep0 rowsep0" align="left">633</td><td class="colsep0 rowsep0" align="left">160</td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="left">8.8</td><td class="colsep0 rowsep0" align="left">1578</td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left"><b>4l</b></td><td class="colsep0 rowsep0" align="left">3-Pent</td><td class="colsep0 rowsep0" align="left"><span class="smallcaps smallerCapital">l</span>-Ala</td><td class="colsep0 rowsep0" align="left">1810</td><td class="colsep0 rowsep0" align="left">845</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">860</td><td class="colsep0 rowsep0" align="left">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left"><b>4m</b></td><td class="colsep0 rowsep0" align="left">Neopent</td><td class="colsep0 rowsep0" align="left"><span class="smallcaps smallerCapital">l</span>-Ala</td><td class="colsep0 rowsep0" align="left">168</td><td class="colsep0 rowsep0" align="left">92</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">700</td><td class="colsep0 rowsep0" align="left">1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="left">2-EtBu</td><td class="colsep0 rowsep0" align="left"><span class="smallcaps smallerCapital">l</span>-Ala</td><td class="colsep0 rowsep0" align="left">170</td><td class="colsep0 rowsep0" align="left">121</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">195</td><td class="colsep0 rowsep0" align="left">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left"><b>4c</b></td><td class="colsep0 rowsep0" align="left">2-EtBu</td><td class="colsep0 rowsep0" align="left"><span class="smallcaps smallerCapital">l</span>-Ala</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">53</td><td class="colsep0 rowsep0" align="left">111</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">234</td><td class="colsep0 rowsep0" align="left">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left">2-EtBu</td><td class="colsep0 rowsep0" align="left"><span class="smallcaps smallerCapital">l</span>-Ala</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">53</td><td class="colsep0 rowsep0" align="left">86</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">69</td><td class="colsep0 rowsep0" align="left">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left"><b>4n</b></td><td class="colsep0 rowsep0" align="left">2-EtBu</td><td class="colsep0 rowsep0" align="left"><span class="smallcaps smallerCapital">d</span>-Ala</td><td class="colsep0 rowsep0" align="left">550</td><td class="colsep0 rowsep0" align="left">518</td><td class="colsep0 rowsep0" align="left">729</td><td class="colsep0 rowsep0" align="left">42</td><td class="colsep0 rowsep0" align="left">1584</td><td class="colsep0 rowsep0" align="left">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left"><b>4o</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left"><span class="smallcaps smallerCapital">l</span>-Ala</td><td class="colsep0 rowsep0" align="left">20420</td><td class="colsep0 rowsep0" align="left">9102</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>53</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left"><b>4p</b></td><td class="colsep0 rowsep0" align="left">2-EtBu</td><td class="colsep0 rowsep0" align="left"><span class="smallcaps smallerCapital">l</span>-Ala</td><td class="colsep0 rowsep0" align="left">970</td><td class="colsep0 rowsep0" align="left">678</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">507</td><td class="colsep0 rowsep0" align="left">2.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Data is at least <i>n</i> ≥ 2 unless otherwise reported.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">aa = Amino Acid, Ala = Alanine, Phe = Phenylalanine, AIB = 2-aminoisobutyrate, <i>c</i>-Bu = cyclobutyl, <i>c</i>-Pent = cyclopentyl, Pent = pentyl, 2-EtBu = 2-ethylbutyl.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">HMVEC = TERT-immortalized human foreskin microvascular endothelial cells (ATCC-4025).</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Macro = human macrophages.</p></div></div></div><div class="NLM_p">In vivo efficacy evaluation of <b>4b</b> was conducted in monkeys since this represented the most relevant animal model of EVD with similar pathophysiology to the actual human disease. In addition, phosphoramidate esters are highly prone to plasma metabolism in rodents on account of high expression of plasma carboxylesterases,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> thereby excluding pilot efficacy studies in small animal models. Due to the high first pass hepatic extraction of phosphoramidates, oral administration was also not explored in favor of injectable routes of administration. Moreover, oral delivery in patients acutely infected with EBOV that are demonstrating symptoms of the disease may not be ideal because gastrointestinal symptoms may limit the dose that is effectively absorbed. Intravenous administration of <b>4b</b> in rhesus monkeys demonstrated rapid elimination of prodrug and appearance of parent nucleoside in systemic circulation (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a). However, <b>4b</b> also rapidly distributed to peripheral blood mononuclear cells (PBMCs) and triphosphate levels in PBMCs were elevated to a maximum within 2 h (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>b). A dose of 10 mg/kg resulted in an estimated PBMC triphosphate level at 24 h that was several-fold higher than the estimated IC<sub>50</sub> of 5 μM for EBOV, with a half-life of 14 h similar to that measured in vitro in human macrophages. The long intracellular half-life of <b>4tp</b> supported once-daily iv administration in the rhesus efficacy study and in the clinical program.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/medium/jm-2016-01594m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Concentration–time profiles following 10 mg/kg iv single dose slow bolus administration of <b>4b</b> in Rhesus (mean ± SD, <i>n</i> = 3 per time point). (a) Plasma profile of prodrug <b>4b</b> (black circle) and parent nucleoside <b>4</b> (blue triangle). (b) Intracellular concentration of active metabolite <b>4tp</b> in PBMCs (green diamond) and estimated <b>4tp</b> EBOV IC<sub>50</sub> = 5 μM (dashed black line).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01594&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Preclinical in vivo efficacy for <b>4b</b> was conducted in an EBOV-infected rhesus challenge model. The overall strategy was to determine a maximally efficacious dose of <b>4b</b> that could be safely administered and to understand whether delayed time of treatment would be effective, a property that was considered critical for the successful clinical application of <b>4b</b>. These studies have recently been published in full and will only be summarized here.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The starting dose of 3 mg/kg iv was modeled based on the <b>4tp</b> levels in rhesus PBMCs following 10 mg/kg iv dosing to have the potential for inhibiting Ebola viral replication in vivo. A correlation of the in vitro antiviral activity and intracellular metabolism described earlier suggested the 3 mg/kg dose would produce <b>4tp</b> levels that exceed the estimated IC<sub>50</sub> for most of the dosing interval. Compound <b>4b</b> was dosed iv at 3 mg/kg on day 0 or day 2 relative to EBOV inoculation, and continued once daily for 12 days. Systemic viremia was reduced and survival out to day 28 postinfection was improved. Animals administered 3 mg/kg <b>4b</b>, starting at day 0, had a survival rate of 33% while those initiated on day 3 had a 66% survival at 28 days. These encouraging data were then followed with a second study in which one arm explored dosing initiation on day 3 with 10 mg/kg daily for 12 days to assess whether increased dose compared to the 3 mg/kg result could be more efficacious. Two other arms explored an initial loading dose of 10 mg/kg on day 2 or day 3, followed by 11 3 mg/kg daily maintenance doses. All of the animals in the two arms in which <b>4b</b> treatments were initiated on day 3 (<i>n</i> = 12 total) survived through day 28, the end of study. In the daily 10 mg/kg dosed group the effect on viremia was consistently greater than in any of the other groups and was below the limit of quantitation (8 × 10<sup>4</sup> RNA copies mL<sup>–1</sup>) in four of the six animals on days 5 and 7 relative to the vehicle-treated control in which the geometric mean exceeded 10<sup>9</sup> copies mL<sup>–1</sup> at these time points. These data established the effectiveness of <b>4b</b> in treatment of EVD in NHPs and accelerated its progress into clinical development. In addition to the efficacy studies, distribution studies in cynomolgus monkeys using [<sup>14</sup>C]<b>4b</b> at the same effective dose of 10 mg/kg established the presence of drug-related products in the potential sanctuary sites for the virus including testes, epididymis, eyes, and brain.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> At 4 h postdose, the drug levels in the testes and epididymis exceeded those observed in plasma, and even at 168 h postdose detectable levels of drug-related products were still observed in the testes. Exposure levels in the brain were lower than other tissues, including plasma at 4 h, but were detectable above the plasma levels at 168 h indicating a long half-life of exposure in brain relative to plasma. These data supported the potential that <b>4b</b> treatment may also reduce persistence of virus in these sanctuary sites.</div><div class="NLM_p last">Safety and pharmacokinetics of <b>4b</b> administered as once-daily iv infusion were evaluated in single and multiple dose phase 1 clinical trials. No serious adverse effects of the drug were observed. During the course of the phase 1 studies two requests for a compassionate use of <b>4b</b> were received. The first case involved a healthcare worker who had survived acute infection but had relapsed with symptoms of acute meningoencephalytis.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Ebola virus was detected both systemically in plasma and in cerebrospinal fluid. When treated with monoclonal antibodies, the patient developed adverse reaction and was subsequently treated with supportive therapy and <b>4b</b> for a period of 14 days beginning with a dose of 150 mg and then increasing to 225 mg after two daily infusions. No serious adverse effects related to drug were observed. The patient recovered and cleared the virus from both plasma and CNS although without proper control or natural history data to compare, it is not clear whether the antiviral therapy was effective. The second case involved a newborn infant congenitally infected with EBOV and treated with monoclonal antibodies, blood transfusion, and subsequently <b>4b</b>.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The infant recovered and was eventually declared free of Ebola virus after repeated testing failed to detect viremia. The unprecedented scale of the West African epidemic and the ability to reduce mortality rates through supportive therapy has resulted in many survivors of EVD. The persistence of virus sequelae in survivors in multiple body compartments has now been documented in addition to secondary sexual transmission via virus in genital secretions.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> This has prompted the initiation of a randomized, blinded, placebo-controlled phase 2 study (PREVAIL IV) which plans to enroll at least 60 adult male survivors to receive either 100 mg of <b>4b</b> or placebo once-daily over 5 days to assess the effect of <b>4b</b> therapy on the viral shedding in semen.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The results of this study could provide the first evidence as to the potential of <b>4b</b> to reduce virus replication in humans.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30255" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30255" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The recent EBOV outbreak prompted the urgent need for antiviral therapeutics for the treatment of EVD. We identified a promising nucleotide therapeutic <b>4b</b> through initial screening and subsequent optimization of the prodrug moiety for iv administration. The partnership with government organizations, including CDC and USAMRIID, that generated the screening data and conducted the rhesus efficacy studies was critical to the successful identification of <b>4b</b>. Also of importance was the significant chemistry effort that rapidly identified a more efficient route to the parent compound <b>4</b> and the ability to prepare, through crystallization of a key reagent, the single <i>S</i>p phosphorus diastereoisomer <b>4b</b> for in vivo model studies. The active triphosphate delivered by the prodrug has low micromolar polymerase activity toward EBOV, high selectivity for the viral polymerase compared to host polymerases, and a long intracellular half-life supporting once-daily administration. Parenteral treatment with <b>4b</b> in EBOV infected NHPs at 10 mg/kg over 12 days demonstrated a substantial antiviral effect along with 100% survival. Based on its promising potential, and preliminary safety data from phase 1 studies, regulatory authorities approved the compassionate use of <b>4b</b> in two cases including an newborn infant with EVD. Further clinical data on <b>4b</b> is being collected in the phase 2 PREVAIL IV study that aims to assess the ability of <b>4b</b> to reduce persistence of EBOV in sanctuary sites of survivors.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55184" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55184" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All organic compounds were synthesized at Gilead Sciences, Inc. (Foster City, CA, USA) unless otherwise noted. Commercially available solvents and reagents were used as received without further purification. Nuclear magnetic resonance (NMR) spectra were recorded on a Varian Mercury Plus 400 MHz instrument at room temperature, with tetramethylsilane as an internal standard. Proton nuclear magnetic resonance spectra are reported in parts per million (ppm) on the δ scale and are referenced from the residual protium in the NMR solvent (chloroform-<i>d</i><sub>1</sub>, δ 7.26; methanol-<i>d</i><sub>4</sub>, δ 3.31; DMSO-<i>d</i><sub>6</sub>, δ 2.50). Data are reported as follows: chemical shift [multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, sep = septet, m = multiplet, br = broad, app = apparent); coupling constants (<i>J</i>) in hertz; integration. Carbon-13 nuclear magnetic resonance spectra are reported in parts per million on the δ scale and are referenced from the carbon resonances of the solvent (chloroform-<i>d</i><sub>1</sub>, δ 77.16, methanol-<i>d</i><sub>4</sub>, δ 49.15; DMSO-<i>d</i><sub>6</sub>, δ 39.52). Data are reported as follows: chemical shift. No special nomenclature is used for equivalent carbons. Phosphorus-31 nuclear magnetic resonance spectra are reported in parts per million on the δ scale. Data are reported as follows: chemical shift [multiplicity (s = singlet, d = doublet, t = triplet); coupling constants (<i>J</i>) in hertz. No special nomenclature is used for equivalent phosphorus resonances. Analytical thin-layer chromatography was performed using Merck KGaA silica gel 60 F<sub>254</sub> glass plates with UV visualization. Preparative normal phase silica gel chromatography was carried out using a Teledyne ISCO CombiFlash Companion instrument with silica gel cartridges. Purities of the final compounds were determined by high-performance liquid chromatography (HPLC) and were greater than 95% unless otherwise noted. HPLC conditions to assess purity were as follows: Agilent 1100 Series HPLC, Phenominex Kinetex C18; 2.6 μm,100 Å, 100 × 4.6 mm<sup>2</sup> column, 2–98% gradient of 0.1% trifluoroacetic acid in water, and 0.1% trifluoroacetic acid in acetonitrile; flow rate, 1.5 mL/min; acquisition time, 8.5 min; wavelength, UV 214 and 254 nm. High-resolution mass spectrometry (HRMS) was performed on an Agilent model 6230 accurate mass time of flight mass spectrometer featuring Agilent Jet Stream Thermal Focusing Technology, with an Agilent 1200 Rapid Resolution HPLC. HRMS chromatography was performed using an Agilent Zorbax Eclipse Plus C18 RRHD 1.8 μm, 2.1 × 50 mm<sup>2</sup> column at 30 °C, with a 10–90% gradient of 0.05% trifluoroacetic acid in water and 0.05% trifluoroacetic acid in acetonitrile. LC-MS (MS) was conducted on a Thermo Finnigan MSQ Std. using electrospray positive and negative [<i>M</i> + 1]<sup>+</sup> and [<i>M</i> – 1]<sup>−</sup>, and a Dionex Summit HPLC System (model P680A HPG) equipped with a Gemini 5 μ C18 110A column (30 mm × 4.60 mm), eluting with 0.05% formic acid in 1% acetonitrile/water and 0.05% formic acid in 99% acetonitrile/water. Optical rotations were recorded on a Jasco P-2000 polarimeter.</div><div class="NLM_p">The synthesis, characterization data, and associated references for the following compounds are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01594/suppl_file/jm6b01594_si_004.pdf" class="ext-link">Supporting Information</a>: <b>4</b>, <b>4a</b>, <b>7</b>–<b>11</b>, <b>9a</b>, <b>11a</b>, <b>12</b>–<b>13</b>, <b>13a</b>, <b>13b</b>, <b>4tp</b>, <b>13tp</b>, <b>16</b>–<b>17</b>, <b>18a</b>, <b>19</b>, <b>21</b>, and <b>22a</b>–<b>n</b>.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> (<i>S</i>)-2-Ethylbutyl 2-(((<i>S</i>)-(((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(4-Aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate (<b>4b</b>)</h3><div class="NLM_p last">Compound <b>4b</b> was prepared from <b>4</b> and <b>22b</b> as described previously.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a><sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 7.86 (s, 1H), 7.33–7.26 (m, 2H), 7.21–7.12 (m, 3H), 6.91 (d, <i>J</i> = 4.6 Hz, 1H), 6.87 (d, <i>J</i> = 4.6 Hz, 1H), 4.79 (d, <i>J</i> = 5.4 Hz, 1H), 4.43–4.34 (m, 2H), 4.28 (ddd, <i>J</i> = 10.3, 5.9, 4.2 Hz, 1H), 4.17 (t, <i>J</i> = 5.6 Hz, 1H), 4.02 (dd, <i>J</i> = 10.9, 5.8 Hz, 1H), 3.96–3.85 (m, 2H), 1.49–1.41 (m, 1H), 1.35–1.27 (m, 8H), 0.85 (t, <i>J</i> = 7.4 Hz, 6H). <sup>13</sup>C NMR (100 MHz, methanol-<i>d</i><sub>4</sub>): δ 174.98, 174.92, 157.18, 152.14, 152.07, 148.27, 130.68, 126.04, 125.51, 121.33, 121.28, 117.90, 117.58, 112.29, 102.60, 84.31, 84.22, 81.26, 75.63, 71.63, 68.10, 67.17, 67.12, 51.46, 41.65, 24.19, 20.56, 20.50, 11.33, 11.28. <sup>31</sup>P NMR (162 MHz, methanol-<i>d</i><sub>4</sub>): δ 3.66 (s). HRMS (<i>m</i>/<i>z</i>): [M]<sup>+</sup> calcd for C<sub>27</sub>H<sub>35</sub>N<sub>6</sub>O<sub>8</sub>P, 602.2254; found, 602.2274. [α]<sup>21</sup><sub>D</sub> – 21 (<i>c</i> 1.0, MeOH).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> (<i>S</i>)-2-Ethylbutyl 2-(((<i>R</i>)-(((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(4-Aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate (<b>4c</b>)</h3><div class="NLM_p last">Compound <b>4c</b> was prepared from <b>4a</b> by chiral chromatography. Compound <b>4a</b> was dissolved in acetonitrile. The resulting solution was loaded onto a Lux Cellulose-2 chiral column, equilibrated in acetonitrile, and eluted with isocratic acetonitrile/methanol (95:5 (v/v)). The first eluting compound was the <i>R</i>p diastereomer <b>4c</b>, and the second eluting compound was the <i>S</i>p diastereomer <b>4b.</b><sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.05 (s, 1H), 7.36 (d, <i>J</i> = 4.8 Hz, 1H), 7.29 (br t, <i>J</i> = 7.8 Hz, 2H), 7.19–7.13 (m, 3H), 7.11 (d, <i>J</i> = 4.8 Hz, 1H), 4.73 (d, <i>J</i> = 5.2 Hz, 1H), 4.48–4.38 (m, 2H), 4.37–4.28 (m, 1H), 4.17 (t, <i>J</i> = 5.6 Hz, 1H), 4.08–3.94 (m, 2H), 3.94–3.80 (m, 1H), 1.48 (sep, <i>J</i> = 12.0, 6.1 Hz, 1H), 1.34 (p, <i>J</i> = 7.3 Hz, 4H), 1.29 (d, <i>J</i> = 7.2 Hz, 3H), 0.87 (t, <i>J</i> = 7.4 Hz, 6H). <sup>31</sup>P NMR (162 MHz, methanol-<i>d</i><sub>4</sub>): δ 3.71 (s). MS <i>m</i>/<i>z</i>: 603.1 [<i>M</i> + 1]. [α]<sup>21</sup><sub>D</sub> – 46 (<i>c</i> 1.0, MeOH).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> (2<i>S</i>)-Ethyl-2-(((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(4-aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)-3-phenylpropanoate (<b>4d</b>)</h3><div class="NLM_p last">Compound <b>4</b> (0.030 g, 0.103 mmol) was dissolved in DMF (1 mL), and then THF (0.5 mL) was added. <i>t</i>-BuMgCl (1 M/THF, 154.5 μL, 0.154 μmol) was added to the reaction in a dropwise manner with vigorous stirring. The resulting white slurry was stirred at rt for about 30 min. A solution of compound <b>22d</b> (0.058 g, 0.124 mmol) in THF (1 mL) was added in a dropwise manner to the reaction at rt. The reaction progress was monitored by LC-MS. When the reaction progressed to 50% conversion, the reaction was cooled in an ice bath and quenched with glacial acetic acid (70 μL). The reaction was concentrated and the crude residue was purified by reverse phase preparatory HPLC to afford compound <b>4d</b> (22 mg, 34%, as a 2.6:1 mixture of diastereomers at phosphorus). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.91 (d, <i>J</i> = 4 Hz, 1H), 7.90 (br s, 2H), 7.09–7.30 (m, 8H), 7.01, (t, <i>J</i> = 8.2 Hz, 2H), 6.89 (d, <i>J</i> = 4.4 Hz, 1H), 6.82 (t, <i>J</i> = 4.4 Hz, 1H), 6.27 (m, 1H), 6.14 (m, 1H), 5.34 (m, 1H), 4.62 (t, <i>J</i> = 5.6 Hz, 1H), 4.15 (m, 1H), 4.01−3.78 (m, 6H), 2.92 (m, 1H), 2.78 (m, 1H), 1.04 (m, 3H). <sup>31</sup>P NMR (162 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.69 (s), 3.34 (s). MS <i>m</i>/<i>z</i> = 623.0 [M+1].</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> (2<i>S</i>)-Ethyl 2-(((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(4-Aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)-3-methylbutanoate (<b>4e</b>)</h3><div class="NLM_p last">Compound <b>4</b> (0.040 g, 0.14 mmol) was dissolved in NMP (1.5 mL) and then THF (0.25 mL) was added. This solution was cooled in an ice bath and <i>t</i>-BuMgCl (1M/THF, 425.7 μL, 0.426 μmol) was added in a dropwise manner with vigorous stirring. The ice bath was removed, and the resulting white slurry was stirred at rt for about 15 min. A solution of compound <b>22e</b> (0.081 g, 0.192 mmol) in THF (0.5 mL) was added in a dropwise manner to the reaction at rt. The reaction progress was monitored by LC-MS. When the reaction progressed to 50% conversion, the reaction was cooled in an ice bath and quenched with glacial acetic acid (70 μL). The reaction was concentrated and crude residue was semipurified from the residue by reverse phase HPLC. The semipure material was further purified by silica gel column chromatography (eluent, 100% EtOAc ramping to 10% MeOH in EtOAc) to afford compound <b>4e</b> (0.034 g, 43% as a 1.8:1 mixture of diastereomers). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.91 (d, <i>J</i> = 1.6 Hz, 1H), 7.88 (br s, 2H), 7.32 (m, 2H), 7.15 (m, 3H), 6.90 (t, <i>J</i> = 4.2 Hz, 1H), 6.84 (d, <i>J</i> = 4.8 Hz, 1H), 6.26 (dd, <i>J</i> = 13.4, 6.2 Hz, 1H), 5.87 (q, <i>J</i> = 11.2 Hz, 1H), 5.35 (m, 1H), 4.64 (m, 1H), 4.25 (m, 2H), 4.15−3.93 (m, 4H), 3.45 (m, 1H), 1.87 (m, 1H), 1.16−1.09 (m, 3H), 0.83−0.70 (m, 6H). <sup>31</sup>P NMR (162 MHz, DMSO-<i>d</i><sub>6</sub>): δ 4.59 (s), 4.47 (s). MS <i>m</i>/<i>z</i> = 575.02 [<i>M</i> + 1].</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Ethyl 2-(((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(4-Aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)-2-methylpropanoate (<b>4f</b>)</h3><div class="NLM_p last">Compound <b>4</b> (66 mg, 0.23 mmol) was dissolved in NMP (2.0 mL) and the mixture was cooled to about 0 °C. <i>t</i>-BuMgCl (1.0 M in THF, 0.34 mL, 0.34 mmol) was then added and the resulting mixture was stirred at 0 °C for about 30 min. A solution of compound <b>22f</b> (139 mg, 0.34 mmol) in THF (1.0 mL) was then added, and the reaction mixture was heated to about 50 °C. After about 2 h, the reaction was cooled to rt and quenched with acetic acid and methanol. The resulting mixture was concentrated under reduced pressure and purified by preparatory reverse phase HPLC to afford compound <b>4f</b> (32 mg, 25% as a 1.5:1 mixture of diastereomers). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.89 (m, 3H), 7.31 (q, <i>J</i> = 8.1 Hz, 2H), 7.22–7.05 (m, 3H), 6.87 (d, <i>J</i> = 4.5, 1H), 6.80 (d, <i>J</i> = 4.5 Hz, 1H), 6.27 (d, <i>J</i> = 11.7, 1H), 5.81 (d, <i>J</i> = 9.7, 1H), 5.35 (d, <i>J</i> = 5.6 Hz, 1H), 4.64 (dt, <i>J</i> = 9.0, 5.6 Hz, 1H), 4.24 (m, 2H), 4.11 (m, 1H), 4.04–3.90 (m, 3H), 1.39–1.23 (m, 6H), 1.10 (t, <i>J</i> = 7.1, 3H). <sup>31</sup>P NMR (162 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.45, 2.41. MS <i>m</i>/<i>z</i> = 561.03 [<i>M</i> + 1].</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Ethyl ((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(4-Aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">l</span>-alaninate (<b>4g</b>)</h3><div class="NLM_p last">Compound <b>4</b> (50 mg, 0.17 mmol) was dissolved in NMP–THF (1:1 mL)) and cooled with an ice bath. <i>t</i>-BuMgCl (1.0 M in THF, 0.257 mL, 0.257 mmol) was then added over about 5 min. The resulting mixture was allowed to warm to rt and was stirred for about 30 min. Then a solution of compound <b>22g</b> (74.6 mg, 0.189 mmol) in THF (2 mL) was added. After about 30 min, the reaction mixture was purified by preparatory reverse phase HPLC. Fractions containing the desired product were further purified with silica gel chromatography (eluent: 0–20% methanol in dichloromethane) to afford compound <b>4g</b> (23 mg, 24% as a 2.5:1 mixture of diastereomers). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 7.76 (d, <i>J</i> = 6.0 Hz, 1H), 7.25–7.14 (m, 2H), 7.11–6.99 (m, 3H), 6.87–6.72 (m, 2H), 4.70 (d, <i>J</i> = 5.4 Hz, 1H), 4.39–4.24 (m, 2H), 4.20 (dddd, <i>J</i> = 9.7, 7.9, 5.1, 2.8 Hz, 1H), 4.10 (dt, <i>J</i> = 12.8, 5.5 Hz, 1H), 4.06–3.91 (m, 2H), 3.72 (ddq, <i>J</i> = 14.3, 9.3, 7.1 Hz, 1H), 1.17 (dd, <i>J</i> = 7.1, 1.0 Hz, 1H), 1.14–1.06 (m, 5H). <sup>31</sup>P NMR (162 MHz, methanol-<i>d</i><sub>4</sub>): δ 3.73, 3.68. MS <i>m</i>/<i>z</i> = 547 [<i>M</i> + 1].</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> (2<i>S</i>)-Cyclobutyl 2-(((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(4-Aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate (<b>4h</b>)</h3><div class="NLM_p last">Compound <b>4</b> (58 mg, 0.20 mmol) was mixed with compound <b>22h</b> (101 mg, 0.240 mmol) in 2 mL of anhydrous DMF. Magnesium chloride (42 mg, 0.44 mmol) was added in one portion. The reaction mixture was heated to about 50 °C. <i>N</i>,<i>N</i>-Diisopropylethylamine (87 μL, 0.5 mmol) was added, and the reaction was stirred for about 2 h at about 50 °C. The reaction mixture was cooled to room temperature, was diluted with ethyl acetate, and was washed with 5% aqueous citric acid solution followed by saturated aqueous sodium chloride solution. The organic layer was then dried over anhydrous sodium sulfate and concentrated under reduced pressure. The crude residue was purified with silica gel column (eluent, 0–5% methanol in dichloromethane) to afford compound <b>4h</b> (42 mg, 37% yield, as a 3:2 mixture of diastereomers). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 7.85 (m, 1H), 7.34–7.22 (m, 2H), 7.22–7.08 (m, 3H), 6.94–6.84 (m, 2H), 4.95–4.85 (m, 1H), 4.79 (m, 1H), 4.46–4.34 (m, 2H), 4.34–4.24 (m, 1H), 4.19 (m, 1H), 3.81 (m, 1H), 2.27 (m, 2H), 2.01 (m, 2H), 1.84–1.68 (m, 1H), 1.62 (m, 1H), 1.30–1.16 (m, 3H). <sup>31</sup>P NMR (162 MHz, methanol-<i>d</i><sub>4</sub>): δ 3.70, 3.65. MS <i>m</i>/<i>z</i> = 573.0 [<i>M</i> + 1].</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (<i>S</i>)-Isopropyl 2-(((<i>R</i>)-(((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(4-Aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate (<b>4i</b>)</h3><div class="NLM_p last">Compound <b>4</b> (60.0 mg, 206 μmol) was dissolved in NMP (0.28 mL). THF (0.2 mL) was added followed by <i>tert</i>-butyl magnesium chloride (1.0 M solution in tetrahydrofuran, 0.309 mL) at rt under an argon atmosphere. After 20 min, a solution of compound <b>22i</b> (81 mg, 206 μmol) in THF (0.2 mL) was added, and the resulting mixture was warmed to about 50 °C. After 3 h, the reaction mixture was allowed to cool to rt and was purified directly by preparatory HPLC to afford compound <b>4i</b> (44 mg, 38% as a single diastereomer). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 7.86 (s, 1H), 7.34–7.26 (m, 2H), 7.21–7.12 (m, 3H), 6.91 (d, <i>J</i> = 4.6 Hz, 1H), 6.87 (d, <i>J</i> = 4.6 Hz, 1H), 4.92 (sep, <i>J</i> = 6.3 Hz, 1H), 4.80 (d, <i>J</i> = 5.4 Hz, 1H), 4.43–4.34 (m, 1H), 4.33–4.24 (m, 1H), 4.18 (t, <i>J</i> = 5.6 Hz, 1H), 3.82 (dq, <i>J</i> = 9.7, 7.1 Hz, 2H), 1.27 (dd, <i>J</i> = 7.1, 1.0 Hz, 3H), 1.18 (dd, <i>J</i> = 6.3, 4.8 Hz, 6H). <sup>31</sup>P NMR (162 MHz, methanol-<i>d</i><sub>4</sub>): δ 3.72 (s). MS <i>m</i>/<i>z</i> = 561.11 [<i>M</i> + 1].</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>tert</i>-Butyl ((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(4-Aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">l</span>-alaninate (<b>4j</b>)</h3><div class="NLM_p last">To a mixture of intermediate <b>4</b> (80 mg, 0.28 mmol), intermediate <b>22j</b> (174 mg, 0.41 mmol), and MgCl<sub>2</sub> (39 mg, 0.41 mmol) in DMF (4 mL) was added <i>N</i>,<i>N</i>-diisopropylethylamine (0.12 mL, 0.69 mmol) dropwise at room temperature. The reaction mixture was stirred at 50 °C for 1 h and was cooled to rt. The resulting mixture was concentrated under reduced pressure to approximately 2 mL volume and was purified by reverse phase preparative HPLC. Fractions containing the desired product were combined and further purified by silica gel column chromatography (eluent, 0–20% methanol in methylene chloride) to afford compound <b>4j</b> (51 mg, 32%, 1.5:1 diastereomeric mixture). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 7.86 (s, 0.4H), 7.84 (s, 0.6H), 7.28 (m, 2H), 7.21–7.10 (m, 3H), 6.96–6.83 (m, 2H), 4.79 (m, 1H), 4.46–4.34 (m, 2H), 4.28 (m, 1H), 4.22–4.13 (m, 1H), 3.81–3.64 (m, 1H), 1.40 (m, 9H), 1.22 (m, 3H). <sup>31</sup>P NMR (162 MHz, methanol-<i>d</i><sub>4</sub>): δ 3.79 (s). MS <i>m</i>/<i>z</i> = 575 [<i>M</i> + 1].</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (2<i>S</i>)-Cyclopentyl 2-(((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(4-Aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate (<b>4k</b>)</h3><div class="NLM_p last">Compound <b>4</b> (100 mg, 0.34 mmol) was dissolved in THF (2 mL) and cooled under an ice water bath. Then 1 M <i>t</i>-BuMgCl (0.52 mL, 0.77 mmol) was added dropwise slowly. The resulting mixture was stirred for about 30 min at rt. Then compound <b>22k</b> (247 mg, 0.52 mmol) in THF (2 mL) was added over about 5 min and the resulting mixture was stirred for about 24 h at rt. The resulting mixture was diluted with ethyl acetate, cooled under ice–water bath, treated with aqueous NaHCO<sub>3</sub> (2 mL), washed with brine, dried with sodium sulfate, and concentrated under reduced pressure. The resulting mixture was purified by silica gel column chromatography (eluent, 0–20% methanol in dichloromethane) followed by reverse phase preparatory HPLC to afford compound <b>4k</b> (47 mg, 23% as a 27:1 mixture of diastereomers). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 7.85 (s, 1H), 7.33–7.22 (m, 2H), 7.14 (tdd, <i>J</i> = 7.6, 2.1, 1.1 Hz, 3H), 6.95–6.87 (m, 2H), 5.13–5.00 (m, 1H), 4.78 (d, <i>J</i> = 5.4 Hz, 1H), 4.48–4.35 (m, 2H), 4.30 (ddd, <i>J</i> = 10.6, 5.7, 3.6 Hz, 1H), 4.19 (t, <i>J</i> = 5.4 Hz, 1H), 3.78 (dq, <i>J</i> = 9.2, 7.1 Hz, 1H), 1.81 (dtd, <i>J</i> = 12.5, 5.9, 2.4 Hz, 2H), 1.74–1.49 (m, 6H), 1.21 (dd, <i>J</i> = 7.1, 1.2 Hz, 3H). MS <i>m</i>/<i>z</i> = 587 [<i>M</i> + 1].</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Pentan-3-yl ((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(4-Aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">l</span>-alaninate (<b>4l</b>)</h3><div class="NLM_p last">To a mixture of compound <b>4</b> (80 mg, 0.28 mmol), <b>22l</b> (170 mg, 0.39 mmol), and MgCl<sub>2</sub> (39 mg, 0.41 mmol) in DMF (4 mL) was added <i>N,N</i>-diisopropylethylamine (0.12 mL, 0.69 mmol) dropwise at rt. The resulting mixture was stirred at 50 °C for 1 h, concentrated to approximately 2 mL volume, and purified by reverse phase preparative HPLC to afford compound <b>4l</b> (68 mg, 42%, 1.5:1 diastereomeric mixture). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 7.86 (s, 0.4 H), 7.85 (s, 0.6 H), 7.33–7.23 (m, 2H), 7.21–7.08 (m, 3H), 6.95–6.84 (m, 2H), 4.79 (m, 1H), 4.69 (m, 1H), 4.47–4.34 (m, 2H), 4.34–4.24 (m, 1H), 4.19 (m, 1H), 3.85 (m, 1H), 1.64–1.42 (m, 4H), 1.29 (dd, <i>J</i> = 7.0, 1.1 Hz, 1.1 H), 1.23 (dd, <i>J</i> = 7.2, 1.3 Hz, 1.9H), 0.91–0.76 (m, 6H). <sup>31</sup>P NMR (162 MHz, methanol-<i>d</i><sub>4</sub>): δ 3.71, 3.69. MS <i>m</i>/<i>z</i> = 589 [<i>M</i> + 1].</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (<i>S</i>)-Neopentyl 2-(((<i>S</i>)-(((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(4-Aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate (<b>4m</b>)</h3><div class="NLM_p last">Compound <b>4</b> (100 mg, 0.34 mmol) was dissolved in THF (2 mL) and cooled under ice water bath. Then 1 M <i>t</i>-BuMgCl (0.52 mL, 0.77 mmol) was added dropwise slowly. The resulting mixture was stirred for 30 min at room temperature. Then compound <b>22m</b> (248 mg, 0.52 mmol) was added over 5 min, and the resulting mixture was stirred for 24h at room temperature, diluted with EtOAc, cooled under ice–water bath, treated with aqueous NaHCO<sub>3</sub> (2 mL), washed with brine, dried with sodium sulfate, and concentrated in vacuo. The resulting mixture was purified by silica gel column chromatography (MeOH 0 to 20% in DCM) and prep-HPLC (acetonitrile 10 to 80% in water) to give compound <b>4m</b> (12 mg, 10% as a single diastereomer). 1H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 7.86 (s, 1H), 7.36–7.24 (m, 2H), 7.23–7.10 (m, 3H), 6.96–6.85 (m, 2H), 4.78 (d, <i>J</i> = 5.4 Hz, 1H), 4.38 (tdd, <i>J</i> = 10.0, 4.9, 2.5 Hz, 2H), 4.32–4.24 (m, 1H), 4.17 (t, <i>J</i> = 5.6 Hz, 1H), 3.91 (dq, <i>J</i> = 9.8, 7.1 Hz, 1H), 3.81 (d, <i>J</i> = 10.5 Hz, 1H), 3.69 (d, <i>J</i> = 10.5 Hz, 1H), 1.31 (dd, <i>J</i> = 7.2, 1.1 Hz, 3H), 0.89 (s, 9H). MS <i>m</i>/<i>z</i> = 589 [<i>M</i> + 1]<sup>+</sup></div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2-Ethylbutyl ((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(4-Aminopyrrolo[2,1-<i>f</i>][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">d</span>-alaninate (<b>4n</b>)</h3><div class="NLM_p last">Compound <b>21</b> (50 mg, 0.15 mmol) was dissolved in anhydrous tetrahydrofuran (5 mL) and stirred under atmospheric argon. Compound <b>22n</b> (75 mg, 0.17 mmol) was added followed by magnesium chloride (21 mg, 0.23 mmol), and the reaction was warmed to 50 °C and stirred for 30 min. <i>N</i>,<i>N</i>-diisopropylethylamine (65.0 μL, 0.375 mmol) was added dropwise, and the reaction mixture was stirred for 3 h at 50 °C. The reaction mixture was then cooled in an ice bath, and 12 N HCl(aq) (175 μL) was added dropwise. The ice bath was removed, and the reaction mixture was stirred at rt for 4 h. The reaction mixture was diluted with ethyl acetate (15 mL) and cooled in an ice bath. Aqueous 1 N NaOH  solution was added slowly to give pH of 10. The organic layer was then washed with 5% aqueous sodium carbonate solution and then saturated aqueous sodium chloride solution. The organic layer was then dried over anhydrous sodium sulfate and concentrated under reduced pressure. The crude residue was purified with silica gel column chromatography (eluent, 0–10% methanol in dichloromethane) to afford compound <b>4n</b> (60 mg, 66% yield as a 1.1:1 diastereomeric mixture). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 7.87–7.83 (m, 1H), 7.37–7.22 (m, 2H), 7.22–7.04 (m, 3H), 6.96–6.79 (m, 2H), 4.82–4.75 (m, 1H), 4.45–4.23 (m, 3H), 4.18 (m, 1H), 4.06–3.85 (m, 3H), 1.52–1.38 (m, 1H), 1.38–1.24 (m, 7H), 0.85 (m, 6H). <sup>31</sup>P NMR (162 MHz, methanol-<i>d</i><sub>4</sub>): δ 3.87, 3.55. MS <i>m</i>/<i>z</i> = 603.1 [<i>M</i> + 1].</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (2<i>S</i>,2′<i>S</i>)-Diethyl 2,2′-((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(4-Aminopyrrolo[1,2-<i>f</i>][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)phosphoryl)bis(azanediyl)dipropanoate (<b>4o</b>)</h3><div class="NLM_p last">Compound <b>4</b> (14.6 mg, 0.05 mmol) was dissolved in anhydrous trimethyl phosphate (0.5 mL) and stirred under N<sub>2</sub>(g) at rt. POCl<sub>3</sub> (9.2 μL, 0.1 mmol) was added, and the mixture stirred for about 60 min. Alanine ethyl ester hydrochloride <b>18b</b> (61 mg, 0.4 mmol, Aldrich, CAS No. 1115-59-9), and then Et<sub>3</sub>N (70 μL, 0.5 mmol) was added. The resultant mixture was stirred for about 15 min, and then additional Et<sub>3</sub>N (70 μL, 0.5 mmol) was added to give a solution pH of 9–10. The mixture was stirred for about 2 h and then diluted with ethyl acetate, washed with saturated aqueous NaHCO<sub>3</sub> solution, followed by saturated aqueous NaCl solution. The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by reverse phase preparative HPLC to afford compound <b>4o</b> (5.5 mg, 16%). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.13 (s, 1H), 7.41 (d, <i>J</i> = 4.8 Hz, 1H), 7.18 (d, <i>J</i> = 4.8 Hz, 1H), 4.78 (d, <i>J</i> = 5.6 Hz, 1H), 4.36 (m, 1H), 4.25–4.08 (m, 7H), 3.83 (m, 2H), 1.33–1.23 (m, 12H). <sup>31</sup>P NMR (162 MHz, methanol-<i>d</i><sub>4</sub>): δ 13.8. MS <i>m</i>/<i>z</i> = 570.0 [<i>M</i> + 1].</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (2<i>S</i>,2′<i>S</i>)-Bis(2-ethylbutyl) 2,2′-((((2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(4-Aminopyrrolo[1,2-<i>f</i>][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)phosphoryl)bis(azanediyl)dipropanoate (<b>4p</b>)</h3><div class="NLM_p last">To a suspension of compound <b>4</b> (52 mg, 0.18 mmol) and solid sodium bicarbonate (53 mg) in trimethyl phosphate (1.5 mL) at 0 °C was added POCl<sub>3</sub> (120 mg, 0.783 mmol). The mixture was stirred at 0 °C for 3 h, at which point a solution of <b>18a</b> (790 mg, 4.56 mmol) in MeCN (1 mL) was then added. The reaction mixture was stirred at 0 °C for 0.5 h, then triethylamine (0.1 mL) was added and stirred at rt for 0.5 h. The reaction mixture was diluted with ethyl acetate (10 mL), washed with water (10 mL), and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (eluent, 50–100% ethyl acetate in hexanes gradient followed by 0–10% methanol in ethyl acetate gradient) to afford compound <b>4p</b> (71 mg, 58%). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 7.88 (s, 1H), 6.95 (d, <i>J</i> = 4.8 Hz, 1H), 6.89 (d, <i>J</i> = 4.4 Hz, 1H), 4.85 (d, <i>J</i> = 5.6 Hz, 1H), 4.35−4.32 (m, 1H), 4.26−4.12 (m, 3H), 4.09−4.04 (m, 2H), 3.98−3.94 (m, 2H), 3.89−3.79 (m, 2H), 1.54−1.44 (m, 2H), 1.39−1.27 (m, 14H), 0.89 (t, <i>J</i> = 7.2 Hz, 12H). <sup>31</sup>P NMR (162 MHz, methanol-<i>d</i><sub>4</sub>): δ 13.83. MS <i>m</i>/<i>z</i> = 682.1 [<i>M</i> + 1].</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01594" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53864" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53864" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01594" class="ext-link">10.1021/acs.jmedchem.6b01594</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Homology model of HIV (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RTD">1RTD</a><a onclick="showRef(event, 'cit32b'); return false;" href="javascript:void(0);" class="ref cit32b">(32b)</a>) X-ray structure used to generate the EBOV model for <b>4tp</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01594/suppl_file/jm6b01594_si_001.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Homology model of HCV (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WTG">4WTG</a><a onclick="showRef(event, 'cit32c'); return false;" href="javascript:void(0);" class="ref cit32c">(32c)</a>) X-ray structure used to generate the EBOV model for <b>13tp</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01594/suppl_file/jm6b01594_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01594/suppl_file/jm6b01594_si_003.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Assay methods, molecular modeling with RSV, Marburg and Sudan viruses, compound synthesis, and single crystal X-ray structure information(<a href="/doi/suppl/10.1021/acs.jmedchem.6b01594/suppl_file/jm6b01594_si_004.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01594/suppl_file/jm6b01594_si_001.pdb">jm6b01594_si_001.pdb (326.04 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01594/suppl_file/jm6b01594_si_002.pdb">jm6b01594_si_002.pdb (326.34 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01594/suppl_file/jm6b01594_si_003.csv">jm6b01594_si_003.csv (4.16 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01594/suppl_file/jm6b01594_si_004.pdf">jm6b01594_si_004.pdf (782.06 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The Cambridge Crystallographic Data Center (CCDC) numbers for the X-ray structures of compound <b>22b</b> and <b>4b</b> are 1445315 and 1525480, respectively.</p><div class="testing" data-doi="10.1021/acs.jmedchem.6b01594" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78363" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78363" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard L. Mackman</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8861-7205" title="Orcid link">http://orcid.org/0000-0001-8861-7205</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b9cbd0dad1d8cbdd97d4d8dad2d4d8d7f9ded0d5dcd8dd97dad6d4"><span class="__cf_email__" data-cfemail="b8cad1dbd0d9cadc96d5d9dbd3d5d9d6f8dfd1d4ddd9dc96dbd7d5">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dustin Siegel</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hon C. Hui</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edward Doerffler</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael O. Clarke</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kwon Chun</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lijun Zhang</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sean Neville</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ernest Carra</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Willard Lew</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce Ross</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Queenie Wang</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lydia Wolfe</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Jordan</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Veronica Soloveva</span> - <span class="hlFld-Affiliation affiliation">United
States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, Maryland 21702, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Knox</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason Perry</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michel Perron</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kirsten M. Stray</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ona Barauskas</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joy Y. Feng</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yili Xu</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary Lee</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arnold L. Rheingold</span> - <span class="hlFld-Affiliation affiliation">University
of California—San Diego, San Diego, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adrian S. Ray</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roy Bannister</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Strickley</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Swami Swaminathan</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William A. Lee</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sina Bavari</span> - <span class="hlFld-Affiliation affiliation">United
States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, Maryland 21702, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tomas Cihlar</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., Foster
City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael K. Lo</span> - <span class="hlFld-Affiliation affiliation">Centers
for Disease Control and Prevention, Atlanta, Georgia 30333, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Travis K. Warren</span> - <span class="hlFld-Affiliation affiliation">United
States Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, Maryland 21702, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army, U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Research was conducted under an IACUC approved protocol in compliance with the Animal Welfare Act, PHS Policy, and other Federal statutes and regulations relating to animals and experiments involving animals. The facility where this research was conducted is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care, International and adheres to principles stated in the Guide for the Care and Use of Laboratory Animals, National Research Council, 2011.<br /></br>The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e4607-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34577" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34577" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We acknowledge the contributions of the following individuals at USAMRIID for participation: in vivo studies, J. Wells, K. Stuthman, N. Lackemeyer, S. Van Tongeren, G. Donnelly, J. Steffens, A. Shurtleff, L. Gomba, and J. Benko; scientific input, L. Welch, T. Bocan, A. Duplantier, R. Panchal, C. Kane, and D. Mayers (currently of Cocrystal Pharma, Inc.); and services performed, S Tritsch, C. Retterer, D. Gharaibeh, T. Kenny, B. Eaton, G. Gomba, J. Nuss, and C. Rice. From Gilead Sciences we acknowledge K. Wang, K. Brendza, T. Alfredson, and L. Serafini who assisted with analytical methods, S. Bondy and R. Seemayer procured key raw materials, and L. Heumann, R. Polniaszeck, E. Rueden, A. ChtChemelinine, K. Brak, and B. Hoang contributed to synthesis, Yelena Zherebina to chiral separations, and D. Babusis for DMPK sample analysis data. We also thank Curtis E. Moore from the Rheingold Laboratory, UC San Diego, for assistance in the solving of crystal structures. These studies were in part supported by The Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD) of the Defense Threat Reduction Agency (DTRA) under Plan No. CB10218. CDC core funding supported the work done by M.K.L. at CDC.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used:</td></tr><tr><td class="NLM_term">BSL-4</td><td class="NLM_def"><p class="first last">biosafety level 4</p></td></tr><tr><td class="NLM_term">EBOV</td><td class="NLM_def"><p class="first last">Ebola virus</p></td></tr><tr><td class="NLM_term">EVD</td><td class="NLM_def"><p class="first last">Ebola virus disease</p></td></tr><tr><td class="NLM_term">HEp-2</td><td class="NLM_def"><p class="first last">human epithelial type 2 cell</p></td></tr><tr><td class="NLM_term">HMVEC-TERT</td><td class="NLM_def"><p class="first last">human foreskin microvascular endothelial cells</p></td></tr><tr><td class="NLM_term">Huh-7</td><td class="NLM_def"><p class="first last">hepatocellular carcinoma cell</p></td></tr><tr><td class="NLM_term">IACUC</td><td class="NLM_def"><p class="first last">Institutional Animal Care and Use Committee</p></td></tr><tr><td class="NLM_term">IND</td><td class="NLM_def"><p class="first last">investigational new drug</p></td></tr><tr><td class="NLM_term">LG</td><td class="NLM_def"><p class="first last">leaving group</p></td></tr><tr><td class="NLM_term">log <i>D</i></td><td class="NLM_def"><p class="first last">logarithm of distribution coefficient</p></td></tr><tr><td class="NLM_term">Macro</td><td class="NLM_def"><p class="first last">human macrophage cells</p></td></tr><tr><td class="NLM_term">MERS</td><td class="NLM_def"><p class="first last">Middle East respiratory syndrome</p></td></tr><tr><td class="NLM_term">MT4</td><td class="NLM_def"><p class="first last">human leukemia T-cell</p></td></tr><tr><td class="NLM_term">NHP</td><td class="NLM_def"><p class="first last">non-human primate</p></td></tr><tr><td class="NLM_term">NMI</td><td class="NLM_def"><p class="first last"><i>N</i>-methylimidazole</p></td></tr><tr><td class="NLM_term">NTP</td><td class="NLM_def"><p class="first last">nucleoside triphosphate</p></td></tr><tr><td class="NLM_term">PBMC</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cell</p></td></tr><tr><td class="NLM_term">PFP</td><td class="NLM_def"><p class="first last">pentafluorophenol</p></td></tr><tr><td class="NLM_term">PNP</td><td class="NLM_def"><p class="first last"><i>p</i>-nitrophenol</p></td></tr><tr><td class="NLM_term">Pol</td><td class="NLM_def"><p class="first last">polymerase</p></td></tr><tr><td class="NLM_term">POLRMT</td><td class="NLM_def"><p class="first last">mitochondrial RNA polymerase</p></td></tr><tr><td class="NLM_term">RSV</td><td class="NLM_def"><p class="first last">respiratory syncytial virus</p></td></tr><tr><td class="NLM_term">SARS</td><td class="NLM_def"><p class="first last">severe acute respiratory syndrome</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">SNI</td><td class="NLM_def"><p class="first last">single nucleotide incorporation</p></td></tr><tr><td class="NLM_term">USAMRIID</td><td class="NLM_def"><p class="first last">United States Army Medical Research Institute of Infectious Diseases</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05167" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05167" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 44 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">World
Health Organization</span>.  <i>Ebola Situation Report—10
June 2016</i>. <a href="http://apps.who.int/iris/bitstream/10665/208883/1/ebolasitrep_10Jun2016_eng.pdf?ua=1" class="extLink">http://apps.who.int/iris/bitstream/10665/208883/1/ebolasitrep_10Jun2016_eng.pdf?ua=1</a> (accessed Jul. 22, <span class="NLM_year">2016</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=World%0AHealth+Organization&title=Ebola+Situation+Report%E2%80%9410%0AJune+2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DEbola%2520Situation%2520Report%25E2%2580%259410%250AJune%25202016%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">World Health Organization</span>.  <i>Ebola Data and Statistics—11
May 2016</i>. <a href="http://apps.who.int/gho/data/view.ebola-sitrep.ebola-summary-20160511?lang=en" class="extLink">http://apps.who.int/gho/data/view.ebola-sitrep.ebola-summary-20160511?lang=en</a> (accessed Jul. 22, <span class="NLM_year">2016</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=World+Health+Organization&title=Ebola+Data+and+Statistics%E2%80%9411%0AMay+2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DEbola%2520Data%2520and%2520Statistics%25E2%2580%259411%250AMay%25202016%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vetter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, W. A.,  II</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schibler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bausch, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, L.</span></span> <span> </span><span class="NLM_article-title">Ebola Virus Shedding and Transmission: Review of Current Evidence</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>214</i></span>,  <span class="NLM_fpage">S177</span>– <span class="NLM_lpage">S184</span>, <span class="refDoi"> DOI: 10.1093/infdis/jiw254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1093%2Finfdis%2Fjiw254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=27443613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFCgtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=2016&pages=S177-S184&author=P.+Vetterauthor=W.+A.+Fischerauthor=M.+Schiblerauthor=M.+Jacobsauthor=D.+G.+Bauschauthor=L.+Kaiser&title=Ebola+Virus+Shedding+and+Transmission%3A+Review+of+Current+Evidence&doi=10.1093%2Finfdis%2Fjiw254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Ebola virus shedding and transmission: review of current evidence</span></div><div class="casAuthors">Vetter, Pauline; Fischer, William A., II; Schibler, Manuel; Jacobs, Michael; Bausch, Daniel G.; Kaiser, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">214</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">S177-S184</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background.  The magnitude of the 2013-2016 Ebola virus disease outbreak in West Africa was unprecedented, with >28 500 reported cases and >11 000 deaths.  Understanding the key elements of Ebola virus transmission is necessary to implement adequate infection prevention and control measures to protect healthcare workers and halt transmission in the community.  Methods.  We performed an extensive PubMed literature review encompassing the period from discovery of Ebola virus, in 1976, until 1 June 2016 to evaluate the evidence on modes of Ebola virus shedding and transmission.  Findings.  Ebola virus has been isolated by cell culture from blood, saliva, urine, aq. humor, semen, and breast milk from infected or convalescent patients.  Ebola virus RNA has been noted in the following body fluids days or months after onset of illness: saliva (22 days), conjunctiva/tears (28 days), stool (29 days), vaginal fluid (33 days), sweat (44 days), urine (64 days), amniotic fluid (38 days), aq. humor (101 days), cerebrospinal fluid (9 mo), breast milk (16 mo [preliminary data[), and semen (18 mo).  Nevertheless, the only documented cases of secondary transmission from recovered patients have been through sexual transmission.  We did not find strong evidence supporting respiratory or fomite-assocd. transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4U_4OBKnGRLVg90H21EOLACvtfcHk0lhKnalgSJYsnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFCgtbY%253D&md5=c22cd4bfc16956ed9c17e81b9faead7b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjiw254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjiw254%26sid%3Dliteratum%253Aachs%26aulast%3DVetter%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DW.%2BA.%26aulast%3DSchibler%26aufirst%3DM.%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DBausch%26aufirst%3DD.%2BG.%26aulast%3DKaiser%26aufirst%3DL.%26atitle%3DEbola%2520Virus%2520Shedding%2520and%2520Transmission%253A%2520Review%2520of%2520Current%2520Evidence%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2016%26volume%3D214%26spage%3DS177%26epage%3DS184%26doi%3D10.1093%2Finfdis%2Fjiw254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mate, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugelman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyenswah, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladner, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiley, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordier-Lassalle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroth, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies-Wayne, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieh, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fakoli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taweh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Wit, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Doremalen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munster, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prieto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humrighouse, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ströher, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiClaro, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hensley, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoepp, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safronetz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fair, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackley, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laney, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasasira, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichol, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Formenty, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kateh, F. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cock, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolay, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Lockhart, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacios, G.</span></span> <span> </span><span class="NLM_article-title">Molecular Evidence of Sexual Transmission of Ebola Virus</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>373</i></span>,  <span class="NLM_fpage">2448</span>– <span class="NLM_lpage">2454</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1509773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1056%2FNEJMoa1509773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=26465384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2015&pages=2448-2454&author=S.+E.+Mateauthor=J.+R.+Kugelmanauthor=T.+G.+Nyenswahauthor=J.+T.+Ladnerauthor=M.+R.+Wileyauthor=T.+Cordier-Lassalleauthor=A.+Christieauthor=G.+P.+Schrothauthor=S.+M.+Grossauthor=G.+J.+Davies-Wayneauthor=S.+A.+Shindeauthor=R.+Muruganauthor=S.+B.+Siehauthor=M.+Badioauthor=L.+Fakoliauthor=F.+Tawehauthor=E.+de+Witauthor=N.+van+Doremalenauthor=V.+J.+Munsterauthor=J.+Pettittauthor=K.+Prietoauthor=B.+W.+Humrighouseauthor=U.+Str%C3%B6herauthor=J.+W.+DiClaroauthor=L.+E.+Hensleyauthor=R.+J.+Schoeppauthor=D.+Safronetzauthor=J.+Fairauthor=J.+H.+Kuhnauthor=D.+J.+Blackleyauthor=A.+S.+Laneyauthor=D.+E.+Williamsauthor=T.+Loauthor=A.+Gasasiraauthor=S.+T.+Nicholauthor=P.+Formentyauthor=F.+N.+Katehauthor=K.+M.+De+Cockauthor=F.+Bolayauthor=M.+Sanchez-Lockhartauthor=G.+Palacios&title=Molecular+Evidence+of+Sexual+Transmission+of+Ebola+Virus&doi=10.1056%2FNEJMoa1509773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular evidence of sexual transmission of Ebola virus</span></div><div class="casAuthors">Mate, S. E.; Kugelman, J. R.; Nyenswah, T. G.; Ladner, J. T.; Wiley, M. R.; Cordier-Lassalle, T.; Christie, A.; Schroth, G. P.; Gross, S. M.; Davies-Wayne, G. J.; Shinde, S. A.; Murugan, R.; Sieh, S. B.; Badio, M.; Fakoli, L.; Taweh, F.; de Wit, E.; van Doremalen, N.; Munster, V. J.; Pettitt, J.; Prieto, K.; Humrighouse, B. W.; Stroher, U.; Di Claro, J. W.; Hensley, L. E.; Schoepp, R. J.; Safronetz, D.; Fair, J.; Kuhn, J. H.; Blackley, D. J.; Laney, A. S.; Williams, D. E.; Lo, T.; Gasasira, A.; Nichol, S. T.; Formenty, P.; Kateh, F. N.; De Cock, K. M.; Bolay, F.; Sanchez-Lockhart, M.; Palacios, G.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2448-2454</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A suspected case of sexual transmission from a male survivor of Ebola virus disease (EVD) to his female partner (the patient in this report) occurred in Liberia in March 2015.  Ebola virus (EBOV) genomes assembled from blood samples from the patient and a semen sample from the survivor were consistent with direct transmission.  The genomes shared three substitutions that were absent from all other Western African EBOV sequences and that were distinct from the last documented transmission chain in Liberia before this case.  Combined with epidemiol. data, the genomic anal. provides evidence of sexual transmission of EBOV and evidence of the persistence of infective EBOV in semen for 179 days or more after the onset of EVD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoqT2W0BeuGLVg90H21EOLACvtfcHk0ljReyR_wEmuJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1Y%253D&md5=6b66402a4acc8c9b76ef50bbc0b540ba</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1509773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1509773%26sid%3Dliteratum%253Aachs%26aulast%3DMate%26aufirst%3DS.%2BE.%26aulast%3DKugelman%26aufirst%3DJ.%2BR.%26aulast%3DNyenswah%26aufirst%3DT.%2BG.%26aulast%3DLadner%26aufirst%3DJ.%2BT.%26aulast%3DWiley%26aufirst%3DM.%2BR.%26aulast%3DCordier-Lassalle%26aufirst%3DT.%26aulast%3DChristie%26aufirst%3DA.%26aulast%3DSchroth%26aufirst%3DG.%2BP.%26aulast%3DGross%26aufirst%3DS.%2BM.%26aulast%3DDavies-Wayne%26aufirst%3DG.%2BJ.%26aulast%3DShinde%26aufirst%3DS.%2BA.%26aulast%3DMurugan%26aufirst%3DR.%26aulast%3DSieh%26aufirst%3DS.%2BB.%26aulast%3DBadio%26aufirst%3DM.%26aulast%3DFakoli%26aufirst%3DL.%26aulast%3DTaweh%26aufirst%3DF.%26aulast%3Dde%2BWit%26aufirst%3DE.%26aulast%3Dvan%2BDoremalen%26aufirst%3DN.%26aulast%3DMunster%26aufirst%3DV.%2BJ.%26aulast%3DPettitt%26aufirst%3DJ.%26aulast%3DPrieto%26aufirst%3DK.%26aulast%3DHumrighouse%26aufirst%3DB.%2BW.%26aulast%3DStr%25C3%25B6her%26aufirst%3DU.%26aulast%3DDiClaro%26aufirst%3DJ.%2BW.%26aulast%3DHensley%26aufirst%3DL.%2BE.%26aulast%3DSchoepp%26aufirst%3DR.%2BJ.%26aulast%3DSafronetz%26aufirst%3DD.%26aulast%3DFair%26aufirst%3DJ.%26aulast%3DKuhn%26aufirst%3DJ.%2BH.%26aulast%3DBlackley%26aufirst%3DD.%2BJ.%26aulast%3DLaney%26aufirst%3DA.%2BS.%26aulast%3DWilliams%26aufirst%3DD.%2BE.%26aulast%3DLo%26aufirst%3DT.%26aulast%3DGasasira%26aufirst%3DA.%26aulast%3DNichol%26aufirst%3DS.%2BT.%26aulast%3DFormenty%26aufirst%3DP.%26aulast%3DKateh%26aufirst%3DF.%2BN.%26aulast%3DDe%2BCock%26aufirst%3DK.%2BM.%26aulast%3DBolay%26aufirst%3DF.%26aulast%3DSanchez-Lockhart%26aufirst%3DM.%26aulast%3DPalacios%26aufirst%3DG.%26atitle%3DMolecular%2520Evidence%2520of%2520Sexual%2520Transmission%2520of%2520Ebola%2520Virus%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D373%26spage%3D2448%26epage%3D2454%26doi%3D10.1056%2FNEJMoa1509773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, J. H.</span></span> <i>Filoviruses: A Compendium of 40 Years of Epidemiological, Clinical, and Laboratory Studies</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calisher, C. H.</span></span>, Ed.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Wien, Austria</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+H.+Kuhnauthor=C.+H.+Calisher&title=Filoviruses%3A+A+Compendium+of+40+Years+of+Epidemiological%2C+Clinical%2C+and+Laboratory+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DJ.%2BH.%26btitle%3DFiloviruses%253A%2520A%2520Compendium%2520of%252040%2520Years%2520of%2520Epidemiological%252C%2520Clinical%252C%2520and%2520Laboratory%2520Studies%26aulast%3DCalisher%26aufirst%3DC.%2BH.%26pub%3DSpringer%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rougeron, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grard, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, E. M.</span></span> <span> </span><span class="NLM_article-title">Ebola and Marburg Haemorrhagic Fever</span>. <i>J. Clin. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1016/j.jcv.2015.01.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1016%2Fj.jcv.2015.01.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=25660265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A280%3ADC%252BC2Mrjs12ksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2015&pages=111-119&author=V.+Rougeronauthor=H.+Feldmannauthor=G.+Grardauthor=S.+Beckerauthor=E.+M.+Leroy&title=Ebola+and+Marburg+Haemorrhagic+Fever&doi=10.1016%2Fj.jcv.2015.01.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Ebola and Marburg haemorrhagic fever</span></div><div class="casAuthors">Rougeron V; Feldmann H; Grard G; Becker S; Leroy E M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ebolaviruses and Marburgviruses (family Filoviridae) are among the most virulent pathogens for humans and great apes causing severe haemorrhagic fever and death within a matter of days.  This group of viruses is characterized by a linear, non-segmented, single-stranded RNA genome of negative polarity.  The overall burden of filovirus infections is minimal and negligible compared to the devastation caused by malnutrition and other infectious diseases prevalent in Africa such as malaria, dengue or tuberculosis.  In this paper, we review the knowledge gained on the eco/epidemiology, the pathogenesis and the disease control measures for Marburg and Ebola viruses developed over the last 15 years.  The overall progress is promising given the little attention that these pathogen have achieved in the past; however, more is to come over the next decade given the more recent interest in these pathogens as potential public and animal health concerns.  Licensing of therapeutic and prophylactic options may be achievable over the next 5-10 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcStsM_90lVRZNFxYDaSSP8XfW6udTcc2eYi4VfAM9O0rbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mrjs12ksA%253D%253D&md5=6c530fde87516481a89bb91b307175a9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.jcv.2015.01.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jcv.2015.01.014%26sid%3Dliteratum%253Aachs%26aulast%3DRougeron%26aufirst%3DV.%26aulast%3DFeldmann%26aufirst%3DH.%26aulast%3DGrard%26aufirst%3DG.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DLeroy%26aufirst%3DE.%2BM.%26atitle%3DEbola%2520and%2520Marburg%2520Haemorrhagic%2520Fever%26jtitle%3DJ.%2520Clin.%2520Virol.%26date%3D2015%26volume%3D64%26spage%3D111%26epage%3D119%26doi%3D10.1016%2Fj.jcv.2015.01.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bello, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernando, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alimonti, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fausther-Bovendo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aviles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiatt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swope, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohorov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohorova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauly, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olinger, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whaley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strong, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeitlin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobinger, G. P.</span></span> <span> </span><span class="NLM_article-title">Reversion af Advanced Ebola Virus Disease in Nonhuman Primates with ZMapp</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>514</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1038/nature13777</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1038%2Fnature13777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=25171469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1yhsLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=514&publication_year=2014&pages=47-53&author=X.+Qiuauthor=G.+Wongauthor=J.+Audetauthor=A.+Belloauthor=L.+Fernandoauthor=J.+B.+Alimontiauthor=H.+Fausther-Bovendoauthor=H.+Weiauthor=J.+Avilesauthor=E.+Hiattauthor=A.+Johnsonauthor=J.+Mortonauthor=K.+Swopeauthor=O.+Bohorovauthor=N.+Bohorovaauthor=C.+Goodmanauthor=D.+Kimauthor=M.+H.+Paulyauthor=J.+Velascoauthor=J.+Pettittauthor=G.+G.+Olingerauthor=K.+Whaleyauthor=B.+Xuauthor=J.+E.+Strongauthor=L.+Zeitlinauthor=G.+P.+Kobinger&title=Reversion+af+Advanced+Ebola+Virus+Disease+in+Nonhuman+Primates+with+ZMapp&doi=10.1038%2Fnature13777"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp</span></div><div class="casAuthors">Qiu, Xiangguo; Wong, Gary; Audet, Jonathan; Bello, Alexander; Fernando, Lisa; Alimonti, Judie B.; Fausther-Bovendo, Hugues; Wei, Haiyan; Aviles, Jenna; Hiatt, Ernie; Johnson, Ashley; Morton, Josh; Swope, Kelsi; Bohorov, Ognian; Bohorova, Natasha; Goodman, Charles; Kim, Do; Pauly, Michael H.; Velasco, Jesus; Pettitt, James; Olinger, Gene G.; Whaley, Kevin; Xu, Bianli; Strong, James E.; Zeitlin, Larry; Kobinger, Gary P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">514</span>
        (<span class="NLM_cas:issue">7520</span>),
    <span class="NLM_cas:pages">47-53</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Without an approved vaccine or treatments, Ebola outbreak management has been limited to palliative care and barrier methods to prevent transmission.  These approaches, however, have yet to end the 2014 outbreak of Ebola after its prolonged presence in West Africa.  A combination of monoclonal antibodies (ZMapp), optimized from two previous antibody cocktails, is able to rescue 100% of rhesus macaques when treatment is initiated up to 5 days post-challenge.  High fever, viremia and abnormalities in blood count and blood chem. were evident in many animals before ZMapp intervention.  Advanced disease, as indicated by elevated liver enzymes, mucosal hemorrhages and generalized petechia could be reversed, leading to full recovery.  ELISA and neutralizing antibody assays indicate that ZMapp is cross-reactive with the Guinean variant of Ebola.  ZMapp exceeds the efficacy of any other therapeutics described so far, and results warrant further development of this cocktail for clin. use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkWoT6igrahbVg90H21EOLACvtfcHk0lgg1iwfPTd2Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1yhsLjK&md5=df43cbc42ec5cadaa0119d2b46fd05fe</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature13777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13777%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DG.%26aulast%3DAudet%26aufirst%3DJ.%26aulast%3DBello%26aufirst%3DA.%26aulast%3DFernando%26aufirst%3DL.%26aulast%3DAlimonti%26aufirst%3DJ.%2BB.%26aulast%3DFausther-Bovendo%26aufirst%3DH.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DAviles%26aufirst%3DJ.%26aulast%3DHiatt%26aufirst%3DE.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DMorton%26aufirst%3DJ.%26aulast%3DSwope%26aufirst%3DK.%26aulast%3DBohorov%26aufirst%3DO.%26aulast%3DBohorova%26aufirst%3DN.%26aulast%3DGoodman%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DPauly%26aufirst%3DM.%2BH.%26aulast%3DVelasco%26aufirst%3DJ.%26aulast%3DPettitt%26aufirst%3DJ.%26aulast%3DOlinger%26aufirst%3DG.%2BG.%26aulast%3DWhaley%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DStrong%26aufirst%3DJ.%2BE.%26aulast%3DZeitlin%26aufirst%3DL.%26aulast%3DKobinger%26aufirst%3DG.%2BP.%26atitle%3DReversion%2520af%2520Advanced%2520Ebola%2520Virus%2520Disease%2520in%2520Nonhuman%2520Primates%2520with%2520ZMapp%26jtitle%3DNature%26date%3D2014%26volume%3D514%26spage%3D47%26epage%3D53%26doi%3D10.1038%2Fnature13777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thi, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mire, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisbert, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agans, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snead, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deer, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenton, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLachlan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisbert, T. W.</span></span> <span> </span><span class="NLM_article-title">Lipid Nanoparticles siRNA Treatment of Ebola-Virus-Makona-Infected Nonhuman Primates</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>521</i></span>,  <span class="NLM_fpage">362</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1038/nature14442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1038%2Fnature14442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=25901685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnvFWjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=521&publication_year=2015&pages=362-365&author=E.+P.+Thiauthor=C.+E.+Mireauthor=A.+C.+H.+Leeauthor=J.+B.+Geisbertauthor=J.+Z.+Zhouauthor=K.+N.+Agansauthor=N.+M.+Sneadauthor=D.+J.+Deerauthor=T.+R.+Barnardauthor=K.+A.+Fentonauthor=I.+MacLachlanauthor=T.+W.+Geisbert&title=Lipid+Nanoparticles+siRNA+Treatment+of+Ebola-Virus-Makona-Infected+Nonhuman+Primates&doi=10.1038%2Fnature14442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates</span></div><div class="casAuthors">Thi, Emily P.; Mire, Chad E.; Lee, Amy C. H.; Geisbert, Joan B.; Zhou, Joy Z.; Agans, Krystle N.; Snead, Nicholas M.; Deer, Daniel J.; Barnard, Trisha R.; Fenton, Karla A.; MacLachlan, Ian; Geisbert, Thomas W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">521</span>
        (<span class="NLM_cas:issue">7552</span>),
    <span class="NLM_cas:pages">362-365</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The current outbreak of Ebola virus in West Africa is unprecedented, causing more cases and fatalities than all previous outbreaks combined, and has yet to be controlled.  Several post-exposure interventions have been employed under compassionate use to treat patients repatriated to Europe and the United States.  However, the in vivo efficacy of these interventions against the new outbreak strain of Ebola virus is unknown.  Here we show that lipid-nanoparticle-encapsulated short interfering RNAs (siRNAs) rapidly adapted to target the Makona outbreak strain of Ebola virus are able to protect 100% of rhesus monkeys against lethal challenge when treatment was initiated at 3 days after exposure while animals were viremic and clin. ill.  Although all infected animals showed evidence of advanced disease including abnormal haematol., blood chem. and coagulopathy, siRNA-treated animals had milder clin. features and fully recovered, while the untreated control animals succumbed to the disease.  These results represent the first, to our knowledge, successful demonstration of therapeutic anti-Ebola virus efficacy against the new outbreak strain in nonhuman primates and highlight the rapid development of lipid-nanoparticle-delivered siRNA as a countermeasure against this highly lethal human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor1MQp7Ec-J7Vg90H21EOLACvtfcHk0lgg1iwfPTd2Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnvFWjs7w%253D&md5=fdef84ba281214654cf1abf65af39091</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature14442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14442%26sid%3Dliteratum%253Aachs%26aulast%3DThi%26aufirst%3DE.%2BP.%26aulast%3DMire%26aufirst%3DC.%2BE.%26aulast%3DLee%26aufirst%3DA.%2BC.%2BH.%26aulast%3DGeisbert%26aufirst%3DJ.%2BB.%26aulast%3DZhou%26aufirst%3DJ.%2BZ.%26aulast%3DAgans%26aufirst%3DK.%2BN.%26aulast%3DSnead%26aufirst%3DN.%2BM.%26aulast%3DDeer%26aufirst%3DD.%2BJ.%26aulast%3DBarnard%26aufirst%3DT.%2BR.%26aulast%3DFenton%26aufirst%3DK.%2BA.%26aulast%3DMacLachlan%26aufirst%3DI.%26aulast%3DGeisbert%26aufirst%3DT.%2BW.%26atitle%3DLipid%2520Nanoparticles%2520siRNA%2520Treatment%2520of%2520Ebola-Virus-Makona-Infected%2520Nonhuman%2520Primates%26jtitle%3DNature%26date%3D2015%26volume%3D521%26spage%3D362%26epage%3D365%26doi%3D10.1038%2Fnature14442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Tekmira Pharmaceuticals Corp</span>.  <i>Tekmira Provides Update
on TKM-Ebola-Guinea</i>. <a href="http://www.sec.gov/Archives/edgar/data/1447028/000117184315003522/newsrelease.htm" class="extLink">http://www.sec.gov/Archives/edgar/data/1447028/000117184315003522/newsrelease.htm</a>, <span class="NLM_year">2015</span> (accessed Jul. 22, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Tekmira+Pharmaceuticals+Corp&title=Tekmira+Provides+Update%0Aon+TKM-Ebola-Guinea"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DTekmira%2520Provides%2520Update%250Aon%2520TKM-Ebola-Guinea%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iversen, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garza, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mourich, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panchal, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavari, S.</span></span> <span> </span><span class="NLM_article-title">Discovery and Early Development of AVI-7537 and AVI-7288 For the Treatment of Ebola Virus and Marburg Virus Infections</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2806</span>– <span class="NLM_lpage">2830</span>, <span class="refDoi"> DOI: 10.3390/v4112806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.3390%2Fv4112806" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=23202506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSrtrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=2806-2830&author=P.+L.+Iversenauthor=T.+K.+Warrenauthor=J.+B.+Wellsauthor=N.+L.+Garzaauthor=D.+V.+Mourichauthor=L.+S.+Welchauthor=R.+G.+Panchalauthor=S.+Bavari&title=Discovery+and+Early+Development+of+AVI-7537+and+AVI-7288+For+the+Treatment+of+Ebola+Virus+and+Marburg+Virus+Infections&doi=10.3390%2Fv4112806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections</span></div><div class="casAuthors">Iversen, Patrick L.; Warren, Travis K.; Wells, Jay B.; Garza, Nicole L.; Mourich, Dan V.; Welch, Lisa S.; Panchal, Rekha G.; Bavari, Sina</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2806-2830</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">There are no currently approved treatments for filovirus infections.  In this study we report the discovery process which led to the development of antisense Phosphorodiamidate Morpholino Oligomers (PMOs) AVI-6002 (composed of AVI-7357 and AVI-7539) and AVI-6003 (composed of AVI-7287 and AVI-7288) targeting Ebola virus and Marburg virus resp.  The discovery process involved identification of optimal transcript binding sites for PMO based RNA-therapeutics followed by screening for effective viral gene target in mouse and guinea pig models utilizing adapted viral isolates.  An evolution of chem. modifications were tested, beginning with simple Phosphorodiamidate Morpholino Oligomers (PMO) transitioning to cell penetrating peptide conjugated PMOs (PPMO) and ending with PMOplus contg. a limited no. of pos. charged linkages in the PMO structure.  The initial lead compds. were combinations of two agents targeting sep. genes.  In the final anal., a single agent for treatment of each virus was selected, AVI-7537 targeting the VP24 gene of Ebola virus and AVI-7288 targeting NP of Marburg virus and are now progressing into late stage clin. development as the optimal therapeutic candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowvQAjvU0VXLVg90H21EOLACvtfcHk0lgg1iwfPTd2Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSrtrvL&md5=08933874fba7c4e1866783fa380dd05a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3390%2Fv4112806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv4112806%26sid%3Dliteratum%253Aachs%26aulast%3DIversen%26aufirst%3DP.%2BL.%26aulast%3DWarren%26aufirst%3DT.%2BK.%26aulast%3DWells%26aufirst%3DJ.%2BB.%26aulast%3DGarza%26aufirst%3DN.%2BL.%26aulast%3DMourich%26aufirst%3DD.%2BV.%26aulast%3DWelch%26aufirst%3DL.%2BS.%26aulast%3DPanchal%26aufirst%3DR.%2BG.%26aulast%3DBavari%26aufirst%3DS.%26atitle%3DDiscovery%2520and%2520Early%2520Development%2520of%2520AVI-7537%2520and%2520AVI-7288%2520For%2520the%2520Treatment%2520of%2520Ebola%2520Virus%2520and%2520Marburg%2520Virus%2520Infections%26jtitle%3DViruses%26date%3D2012%26volume%3D4%26spage%3D2806%26epage%3D2830%26doi%3D10.3390%2Fv4112806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oestereich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lüdtke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rieger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Fontela, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Günther, S.</span></span> <span> </span><span class="NLM_article-title">Successful Treatment of Advanced Ebola Virus Infection With T-705 (favipiravir) in a Small Animal Model</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2014.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1016%2Fj.antiviral.2014.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=24583123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVKrtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2014&pages=17-21&author=L.+Oestereichauthor=A.+L%C3%BCdtkeauthor=S.+Wurrauthor=T.+Riegerauthor=C.+Mu%C3%B1oz-Fontelaauthor=S.+G%C3%BCnther&title=Successful+Treatment+of+Advanced+Ebola+Virus+Infection+With+T-705+%28favipiravir%29+in+a+Small+Animal+Model&doi=10.1016%2Fj.antiviral.2014.02.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model</span></div><div class="casAuthors">Oestereich, Lisa; Ludtke, Anja; Wurr, Stephanie; Rieger, Toni; Munoz-Fontela, Cesar; Gunther, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17-21</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Outbreaks of Ebola hemorrhagic fever in sub-Saharan Africa are assocd. with case fatality rates of up to 90%.  Currently, neither a vaccine nor an effective antiviral treatment is available for use in humans.  Here, we evaluated the efficacy of the pyrazinecarboxamide deriv. T-705 (favipiravir) against Zaire Ebola virus (EBOV) in vitro and in vivo.  T-705 suppressed replication of Zaire EBOV in cell culture by 4 log units with an IC90 of 110 μM.  Mice lacking the type I interferon receptor (IFNAR-/-) were used as in vivo model for Zaire EBOV-induced disease.  Initiation of T-705 administration at day 6 post infection induced rapid virus clearance, reduced biochem. parameters of disease severity, and prevented a lethal outcome in 100% of the animals.  The findings suggest that T-705 is a candidate for treatment of Ebola hemorrhagic fever.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvuc7NJjAwqrVg90H21EOLACvtfcHk0lg4wrPgxLzs2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVKrtbg%253D&md5=faeb7e30254ebd9ebc4a4d0458349077</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2014.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2014.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DOestereich%26aufirst%3DL.%26aulast%3DL%25C3%25BCdtke%26aufirst%3DA.%26aulast%3DWurr%26aufirst%3DS.%26aulast%3DRieger%26aufirst%3DT.%26aulast%3DMu%25C3%25B1oz-Fontela%26aufirst%3DC.%26aulast%3DG%25C3%25BCnther%26aufirst%3DS.%26atitle%3DSuccessful%2520Treatment%2520of%2520Advanced%2520Ebola%2520Virus%2520Infection%2520With%2520T-705%2520%2528favipiravir%2529%2520in%2520a%2520Small%2520Animal%2520Model%26jtitle%3DAntiviral%2520Res.%26date%3D2014%26volume%3D105%26spage%3D17%26epage%3D21%26doi%3D10.1016%2Fj.antiviral.2014.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smither, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastaugh, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steward, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenk, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lever, M. S.</span></span> <span> </span><span class="NLM_article-title">Post-exposure Efficacy of Oral T-705 (Favipiravir) Against Inhalational Ebola Virus Infection in a Mouse Model</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">155</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2014.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1016%2Fj.antiviral.2014.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=24462697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVOjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2014&pages=153-155&author=S.+J.+Smitherauthor=L.+S.+Eastaughauthor=J.+A.+Stewardauthor=M.+Nelsonauthor=R.+P.+Lenkauthor=M.+S.+Lever&title=Post-exposure+Efficacy+of+Oral+T-705+%28Favipiravir%29+Against+Inhalational+Ebola+Virus+Infection+in+a+Mouse+Model&doi=10.1016%2Fj.antiviral.2014.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Post-exposure efficacy of Oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model</span></div><div class="casAuthors">Smither, Sophie J.; Eastaugh, Lin S.; Steward, Jackie A.; Nelson, Michelle; Lenk, Robert P.; Lever, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">153-155</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Filoviruses cause disease with high case fatality rates and are considered biol. threat agents.  Licensed post-exposure therapies that can be administered by the oral route are desired for safe and rapid distribution and uptake in the event of exposure or outbreaks.  Favipiravir or T-705 has broad antiviral activity and has already undergone phase II and is undergoing phase III clin. trials for influenza.  Here we report the first use of T-705 against Ebola virus.  T-705 gave 100% protection against aerosol Ebola virus E718 infection; protection was shown in immune-deficient mice after 14 days of twice-daily dosing.  T-705 was also shown to inhibit Ebola virus infection in cell culture.  T-705 is likely to be licensed for use against influenza in the near future and could also be used with a new indication for filovirus infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4fn813ywvgLVg90H21EOLACvtfcHk0lg4wrPgxLzs2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVOjt7s%253D&md5=ed50722557680051ddef5684978f24bc</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2014.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2014.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DSmither%26aufirst%3DS.%2BJ.%26aulast%3DEastaugh%26aufirst%3DL.%2BS.%26aulast%3DSteward%26aufirst%3DJ.%2BA.%26aulast%3DNelson%26aufirst%3DM.%26aulast%3DLenk%26aufirst%3DR.%2BP.%26aulast%3DLever%26aufirst%3DM.%2BS.%26atitle%3DPost-exposure%2520Efficacy%2520of%2520Oral%2520T-705%2520%2528Favipiravir%2529%2520Against%2520Inhalational%2520Ebola%2520Virus%2520Infection%2520in%2520a%2520Mouse%2520Model%26jtitle%3DAntiviral%2520Res.%26date%3D2014%26volume%3D104%26spage%3D153%26epage%3D155%26doi%3D10.1016%2Fj.antiviral.2014.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sissoko, D.</span>; <span class="NLM_string-name">Folkesson, E.</span>; <span class="NLM_string-name">Abdoul, M.</span>; <span class="NLM_string-name">Beavogui, A. H.</span>; <span class="NLM_string-name">Gunther, S.</span>; <span class="NLM_string-name">Shepherd, S.</span>; <span class="NLM_string-name">Danel, C.</span>; <span class="NLM_string-name">Mentre, F.</span>; <span class="NLM_string-name">Anglaret, X.</span>; <span class="NLM_string-name">Malvy, D.</span></span> <span> </span><span class="NLM_article-title">Favipiravir in Patients With Ebola Virus Disease: Early Results of the JIKI Trial in Guinea</span>.  <i>Conference on Retroviruses and Opportunistic Infections</i>, Seattle, WA, USA, Feb. 23–26, 2015, Abstract 103-ALB; <span class="NLM_publisher-name">CROI Foundation/IAS-USA</span>: <span class="NLM_publisher-loc">San Francisco, CA, USA</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=D.+Sissoko&author=E.+Folkesson&author=M.+Abdoul&author=A.+H.+Beavogui&author=S.+Gunther&author=S.+Shepherd&author=C.+Danel&author=F.+Mentre&author=X.+Anglaret&author=D.+Malvy&title=Favipiravir+in+Patients+With+Ebola+Virus+Disease%3A+Early+Results+of+the+JIKI+Trial+in+Guinea"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DSissoko%26aufirst%3DD.%26atitle%3DFavipiravir%2520in%2520Patients%2520With%2520Ebola%2520Virus%2520Disease%253A%2520Early%2520Results%2520of%2520the%2520JIKI%2520Trial%2520in%2520Guinea%26jtitle%3DConference%2520on%2520Retroviruses%2520and%2520Opportunistic%2520Infections%26pub%3DCROI%2520Foundation%252FIAS-USA%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McMullan, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flint, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albariño, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olinger, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethna, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hensley, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichol, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanier, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiropoulou, C. F.</span></span> <span> </span><span class="NLM_article-title">The Lipid Moiety of Brincidofovir is Required For In Vitro Antiviral Activity Against Ebola Virus</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">78</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2015.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1016%2Fj.antiviral.2015.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=26526586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVyqurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2016&pages=71-78&author=L.+K.+McMullanauthor=M.+Flintauthor=J.+Dyallauthor=C.+Albari%C3%B1oauthor=G.+G.+Olingerauthor=S.+Fosterauthor=P.+Sethnaauthor=L.+E.+Hensleyauthor=S.+T.+Nicholauthor=E.+R.+Lanierauthor=C.+F.+Spiropoulou&title=The+Lipid+Moiety+of+Brincidofovir+is+Required+For+In+Vitro+Antiviral+Activity+Against+Ebola+Virus&doi=10.1016%2Fj.antiviral.2015.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus</span></div><div class="casAuthors">McMullan, Laura K.; Flint, Mike; Dyall, Julie; Albarino, Cesar; Olinger, Gene G.; Foster, Scott; Sethna, Phiroze; Hensley, Lisa E.; Nichol, Stuart T.; Lanier, E. Randall; Spiropoulou, Christina F.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">71-78</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Brincidofovir (BCV) is the 3-hexadecyloxy-1-propanol (HDP) lipid conjugate of the acyclic nucleoside phosphonate cidofovir (CDV).  BCV has established broad-spectrum activity against double-stranded DNA (dsDNA) viruses; however, its activity against RNA viruses has been less thoroughly evaluated.  Here, we report that BCV inhibited infection of Ebola virus in multiple human cell lines.  Unlike the mechanism of action for BCV against cytomegalovirus and other dsDNA viruses, phosphorylation of CDV to the diphosphate form appeared unnecessary.  Instead, antiviral activity required the lipid moiety and in vitro activity against EBOV was obsd. for several HDP-nucleotide conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL5O09ZNdpmrVg90H21EOLACvtfcHk0lg4wrPgxLzs2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVyqurjI&md5=3b771401ef41f83a9b6f0d0ec4712f81</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2015.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2015.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DMcMullan%26aufirst%3DL.%2BK.%26aulast%3DFlint%26aufirst%3DM.%26aulast%3DDyall%26aufirst%3DJ.%26aulast%3DAlbari%25C3%25B1o%26aufirst%3DC.%26aulast%3DOlinger%26aufirst%3DG.%2BG.%26aulast%3DFoster%26aufirst%3DS.%26aulast%3DSethna%26aufirst%3DP.%26aulast%3DHensley%26aufirst%3DL.%2BE.%26aulast%3DNichol%26aufirst%3DS.%2BT.%26aulast%3DLanier%26aufirst%3DE.%2BR.%26aulast%3DSpiropoulou%26aufirst%3DC.%2BF.%26atitle%3DThe%2520Lipid%2520Moiety%2520of%2520Brincidofovir%2520is%2520Required%2520For%2520In%2520Vitro%2520Antiviral%2520Activity%2520Against%2520Ebola%2520Virus%26jtitle%3DAntiviral%2520Res.%26date%3D2016%26volume%3D125%26spage%3D71%26epage%3D78%26doi%3D10.1016%2Fj.antiviral.2015.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warren, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panchal, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuthman, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garza, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Tongeren, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Retterer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pegoraro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honnold, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotian, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taubenheim, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minning, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheridan, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavari, S.</span></span> <span> </span><span class="NLM_article-title">Protection Against Filovirus Disease by a Novel Broad-Spectrum Nucleoside Analogue BCX4430</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>508</i></span>,  <span class="NLM_fpage">402</span>– <span class="NLM_lpage">405</span>, <span class="refDoi"> DOI: 10.1038/nature13027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1038%2Fnature13027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=24590073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtlWhu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=508&publication_year=2014&pages=402-405&author=T.+K.+Warrenauthor=J.+Wellsauthor=R.+G.+Panchalauthor=K.+S.+Stuthmanauthor=N.+L.+Garzaauthor=S.+A.+Van+Tongerenauthor=L.+Dongauthor=C.+J.+Rettererauthor=B.+P.+Eatonauthor=G.+Pegoraroauthor=S.+Honnoldauthor=S.+Bantiaauthor=P.+Kotianauthor=X.+Chenauthor=B.+R.+Taubenheimauthor=L.+S.+Welchauthor=D.+M.+Minningauthor=Y.+S.+Babuauthor=W.+P.+Sheridanauthor=S.+Bavari&title=Protection+Against+Filovirus+Disease+by+a+Novel+Broad-Spectrum+Nucleoside+Analogue+BCX4430&doi=10.1038%2Fnature13027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430</span></div><div class="casAuthors">Warren, Travis K.; Wells, Jay; Panchal, Rekha G.; Stuthman, Kelly S.; Garza, Nicole L.; Van Tongeren, Sean A.; Dong, Lian; Retterer, Cary J.; Eaton, Brett P.; Pegoraro, Gianluca; Honnold, Shelley; Bantia, Shanta; Kotian, Pravin; Chen, Xilin; Taubenheim, Brian R.; Welch, Lisa S.; Minning, Dena M.; Babu, Yarlagadda S.; Sheridan, William P.; Bavari, Sina</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">508</span>
        (<span class="NLM_cas:issue">7496</span>),
    <span class="NLM_cas:pages">402-405</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Filoviruses are emerging pathogens and causative agents of viral haemorrhagic fever.  Case fatality rates of filovirus disease outbreaks are among the highest reported for any human pathogen, exceeding 90% (ref. 1).  Licensed therapeutic or vaccine products are not available to treat filovirus diseases.  Candidate therapeutics previously shown to be efficacious in non-human primate disease models are based on virus-specific designs and have limited broad-spectrum antiviral potential.  Here we show that BCX4430, a novel synthetic adenosine analog, inhibits infection of distinct filoviruses in human cells.  Biochem., reporter-based and primer-extension assays indicate that BCX4430 inhibits viral RNA polymerase function, acting as a non-obligate RNA chain terminator.  Post-exposure i.m. administration of BCX4430 protects against Ebola virus and Marburg virus disease in rodent models.  Most importantly, BCX4430 completely protects cynomolgus macaques from Marburg virus infection when administered as late as 48 h after infection.  In addn., BCX4430 exhibits broad-spectrum antiviral activity against numerous viruses, including bunyaviruses, arenaviruses, paramyxoviruses, coronaviruses and flaviviruses.  This is the first report, to our knowledge, of non-human primate protection from filovirus disease by a synthetic drug-like small mol.  We provide addnl. pharmacol. characterizations supporting the potential development of BCX4430 as a countermeasure against human filovirus diseases and other viral diseases representing major public health threats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpev8c7g-X43rVg90H21EOLACvtfcHk0lilQUsTbA7p7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtlWhu7w%253D&md5=dc7d390055ecf253e4b21c95b4e9e1a2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature13027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13027%26sid%3Dliteratum%253Aachs%26aulast%3DWarren%26aufirst%3DT.%2BK.%26aulast%3DWells%26aufirst%3DJ.%26aulast%3DPanchal%26aufirst%3DR.%2BG.%26aulast%3DStuthman%26aufirst%3DK.%2BS.%26aulast%3DGarza%26aufirst%3DN.%2BL.%26aulast%3DVan%2BTongeren%26aufirst%3DS.%2BA.%26aulast%3DDong%26aufirst%3DL.%26aulast%3DRetterer%26aufirst%3DC.%2BJ.%26aulast%3DEaton%26aufirst%3DB.%2BP.%26aulast%3DPegoraro%26aufirst%3DG.%26aulast%3DHonnold%26aufirst%3DS.%26aulast%3DBantia%26aufirst%3DS.%26aulast%3DKotian%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DTaubenheim%26aufirst%3DB.%2BR.%26aulast%3DWelch%26aufirst%3DL.%2BS.%26aulast%3DMinning%26aufirst%3DD.%2BM.%26aulast%3DBabu%26aufirst%3DY.%2BS.%26aulast%3DSheridan%26aufirst%3DW.%2BP.%26aulast%3DBavari%26aufirst%3DS.%26atitle%3DProtection%2520Against%2520Filovirus%2520Disease%2520by%2520a%2520Novel%2520Broad-Spectrum%2520Nucleoside%2520Analogue%2520BCX4430%26jtitle%3DNature%26date%3D2014%26volume%3D508%26spage%3D402%26epage%3D405%26doi%3D10.1038%2Fnature13027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Henao-Restrepo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longini, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmunds, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camacho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doumbia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draguez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duraffour, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enwere, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hossmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondé, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuisma, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norheim, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riveros, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soumah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trelle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicari, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kéïta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieny, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Røttingen, J.-A.</span></span> <span> </span><span class="NLM_article-title">Efficacy and Effectiveness of an rVSV-Vectored Vaccine Expressing Ebola, Surface Glycoprotein: Interim Results From the Guinea Ring Vaccination Cluster-Randomised Trial</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>386</i></span>,  <span class="NLM_fpage">857</span>– <span class="NLM_lpage">866</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(15)61117-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1016%2FS0140-6736%2815%2961117-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=26248676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1yjsrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=386&publication_year=2015&pages=857-866&author=A.+M.+Henao-Restrepoauthor=I.+M.+Longiniauthor=M.+Eggerauthor=N.+E.+Deanauthor=W.+J.+Edmundsauthor=A.+Camachoauthor=M.+W.+Carrollauthor=M.+Doumbiaauthor=B.+Draguezauthor=S.+Duraffourauthor=G.+Enwereauthor=R.+Graisauthor=S.+Guntherauthor=S.+Hossmannauthor=M.+K.+Kond%C3%A9author=S.+Koneauthor=E.+Kuismaauthor=M.+M.+Levineauthor=S.+Mandalauthor=G.+Norheimauthor=X.+Riverosauthor=A.+Soumahauthor=S.+Trelleauthor=A.+S.+Vicariauthor=C.+H.+Watsonauthor=S.+K%C3%A9%C3%AFtaauthor=M.+P.+Kienyauthor=J.-A.+R%C3%B8ttingen&title=Efficacy+and+Effectiveness+of+an+rVSV-Vectored+Vaccine+Expressing+Ebola%2C+Surface+Glycoprotein%3A+Interim+Results+From+the+Guinea+Ring+Vaccination+Cluster-Randomised+Trial&doi=10.1016%2FS0140-6736%2815%2961117-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial</span></div><div class="casAuthors">Henao-Restrepo, Ana Maria; Longini, Ira M.; Egger, Matthias; Dean, Natalie E.; Edmunds, W. John; Camacho, Anton; Carroll, Miles W.; Doumbia, Moussa; Draguez, Bertrand; Duraffour, Sophie; Enwere, Godwin; Grais, Rebecca; Gunther, Stephan; Hossmann, Stefanie; Konde, Mandy Kader; Kone, Souleymane; Kuisma, Eeva; Levine, Myron M.; Mandal, Sema; Norheim, Gunnstein; Riveros, Ximena; Soumah, Aboubacar; Trelle, Sven; Vicari, Andrea S.; Watson, Conall H.; Keita, Sakoba; Kieny, Marie Paule; Roettingen, John-Arne</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">386</span>
        (<span class="NLM_cas:issue">9996</span>),
    <span class="NLM_cas:pages">857-866</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A recombinant, replication-competent vesicular stomatitis virus-based vaccine expressing a surface glycoprotein of Zaire Ebolavirus (rVSV-ZEBOV) is a promising Ebola vaccine candidate.  We report the results of an interim anal. of a trial of rVSV-ZEBOV in Guinea, west Africa.  For this open-label, cluster-randomised ring vaccination trial, suspected cases of Ebola virus disease (Guinea, west Africa) were independently ascertained by Ebola response teams as part of a national surveillance system.  After lab. confirmation of a new case, clusters of all contacts and contacts of contacts were defined and randomly allocated 1:1 to immediate vaccination or delayed (21 days later) vaccination with rVSV-ZEBOV (one dose of 2 × 107 plaque-forming units, administered i.m. in the deltoid muscle).  Adults (age ≥18 years) who were not pregnant or breastfeeding were eligible for vaccination.  Block randomisation was used, with randomly varying blocks, stratified by location (urban vs rural) and size of rings (≤20 vs >20 individuals).  The study is open label and masking of participants and field teams to the time of vaccination is not possible, but Ebola response teams and lab. workers were unaware of allocation to immediate or delayed vaccination.  Taking into account the incubation period of the virus of about 10 days, the prespecified primary outcome was lab.-confirmed Ebola virus disease with onset of symptoms at least 10 days after randomisation.  The primary anal. was per protocol and compared the incidence of Ebola virus disease in eligible and vaccinated individuals in immediate vaccination clusters with the incidence in eligible individuals in delayed vaccination clusters.  This trial is registered with the Pan African Clin. Trials Registry, no. PACTR201503001057193.  Between Apr. 1, 2015, and July 20, 2015, 90 clusters, with a total population of 7651 people were included in the planned interim anal. 48 of these clusters (4123 people) were randomly assigned to immediate vaccination with rVSV-ZEBOV, and 42 clusters (3528 people) were randomly assigned to delayed vaccination with rVSV-ZEBOV.  In the immediate vaccination group, there were no cases of Ebola virus disease with symptom onset at least 10 days after randomisation, whereas in the delayed vaccination group there were 16 cases of Ebola virus disease from seven clusters, showing a vaccine efficacy of 100% (95% CI 74·7-100·0; p=0·0036).  No new cases of Ebola virus disease were diagnosed in vaccinees from the immediate or delayed groups from 6 days post-vaccination.  At the cluster level, with the inclusion of all eligible adults, vaccine effectiveness was 75·1% (95% CI -7·1 to 94·2; p=0·1791), and 76·3% (95% CI -15·5 to 95·1; p=0·3351) with the inclusion of everyone (eligible or not eligible for vaccination). 43 serious adverse events were reported; one serious adverse event was judged to be causally related to vaccination (a febrile episode in a vaccinated participant, which resolved without sequelae).  Assessment of serious adverse events is ongoing.  The results of this interim anal. indicate that rVSV-ZEBOV might be highly efficacious and safe in preventing Ebola virus disease, and is most likely effective at the population level when delivered during an Ebola virus disease outbreak via a ring vaccination strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW0EdaKSJSF7Vg90H21EOLACvtfcHk0lilQUsTbA7p7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1yjsrzM&md5=26bdabce63d3b06a7bbe2ba63b7de984</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2815%2961117-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252815%252961117-5%26sid%3Dliteratum%253Aachs%26aulast%3DHenao-Restrepo%26aufirst%3DA.%2BM.%26aulast%3DLongini%26aufirst%3DI.%2BM.%26aulast%3DEgger%26aufirst%3DM.%26aulast%3DDean%26aufirst%3DN.%2BE.%26aulast%3DEdmunds%26aufirst%3DW.%2BJ.%26aulast%3DCamacho%26aufirst%3DA.%26aulast%3DCarroll%26aufirst%3DM.%2BW.%26aulast%3DDoumbia%26aufirst%3DM.%26aulast%3DDraguez%26aufirst%3DB.%26aulast%3DDuraffour%26aufirst%3DS.%26aulast%3DEnwere%26aufirst%3DG.%26aulast%3DGrais%26aufirst%3DR.%26aulast%3DGunther%26aufirst%3DS.%26aulast%3DHossmann%26aufirst%3DS.%26aulast%3DKond%25C3%25A9%26aufirst%3DM.%2BK.%26aulast%3DKone%26aufirst%3DS.%26aulast%3DKuisma%26aufirst%3DE.%26aulast%3DLevine%26aufirst%3DM.%2BM.%26aulast%3DMandal%26aufirst%3DS.%26aulast%3DNorheim%26aufirst%3DG.%26aulast%3DRiveros%26aufirst%3DX.%26aulast%3DSoumah%26aufirst%3DA.%26aulast%3DTrelle%26aufirst%3DS.%26aulast%3DVicari%26aufirst%3DA.%2BS.%26aulast%3DWatson%26aufirst%3DC.%2BH.%26aulast%3DK%25C3%25A9%25C3%25AFta%26aufirst%3DS.%26aulast%3DKieny%26aufirst%3DM.%2BP.%26aulast%3DR%25C3%25B8ttingen%26aufirst%3DJ.-A.%26atitle%3DEfficacy%2520and%2520Effectiveness%2520of%2520an%2520rVSV-Vectored%2520Vaccine%2520Expressing%2520Ebola%252C%2520Surface%2520Glycoprotein%253A%2520Interim%2520Results%2520From%2520the%2520Guinea%2520Ring%2520Vaccination%2520Cluster-Randomised%2520Trial%26jtitle%3DLancet%26date%3D2015%26volume%3D386%26spage%3D857%26epage%3D866%26doi%3D10.1016%2FS0140-6736%2815%2961117-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warren, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloveva, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuthman, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Tongeren, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garza, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shurtleff, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Retterer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharaibeh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomba, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelmsen, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuss, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugelman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacios, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerffler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neville, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carra, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lew, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babusis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stray, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trancheva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barauskas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flint, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMullan, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fearns, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayers, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiropoulou, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichol, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavari, S.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Efficacy of The Small Molecule GS-5734 Against Ebola Virus in Rhesus Monkeys</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>531</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">385</span>, <span class="refDoi"> DOI: 10.1038/nature17180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1038%2Fnature17180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=26934220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC28XjvVGnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=531&publication_year=2016&pages=381-385&author=T.+K.+Warrenauthor=R.+Jordanauthor=M.+K.+Loauthor=A.+S.+Rayauthor=R.+L.+Mackmanauthor=V.+Solovevaauthor=D.+Siegelauthor=M.+Perronauthor=R.+Bannisterauthor=H.+C.+Huiauthor=N.+Larsonauthor=R.+Strickleyauthor=J.+Wellsauthor=K.+S.+Stuthmanauthor=S.+A.+Van+Tongerenauthor=N.+L.+Garzaauthor=G.+Donnellyauthor=A.+C.+Shurtleffauthor=C.+J.+Rettererauthor=D.+Gharaibehauthor=R.+Zamaniauthor=T.+Kennyauthor=B.+P.+Eatonauthor=E.+Grimesauthor=L.+S.+Welchauthor=L.+Gombaauthor=C.+L.+Wilhelmsenauthor=D.+K.+Nicholsauthor=J.+E.+Nussauthor=E.+R.+Nagleauthor=J.+R.+Kugelmanauthor=G.+Palaciosauthor=E.+Doerfflerauthor=S.+Nevilleauthor=E.+Carraauthor=M.+O.+Clarkeauthor=L.+Zhangauthor=W.+Lewauthor=B.+Rossauthor=Q.+Wangauthor=K.+Chunauthor=L.+Wolfeauthor=D.+Babusisauthor=Y.+Parkauthor=K.+M.+Strayauthor=I.+Tranchevaauthor=J.+Y.+Fengauthor=O.+Barauskasauthor=Y.+Xuauthor=P.+Wongauthor=M.+R.+Braunauthor=M.+Flintauthor=L.+K.+McMullanauthor=S.+S.+Chenauthor=R.+Fearnsauthor=S.+Swaminathanauthor=D.+L.+Mayersauthor=C.+F.+Spiropoulouauthor=W.+A.+Leeauthor=S.+T.+Nicholauthor=T.+Cihlarauthor=S.+Bavari&title=Therapeutic+Efficacy+of+The+Small+Molecule+GS-5734+Against+Ebola+Virus+in+Rhesus+Monkeys&doi=10.1038%2Fnature17180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys</span></div><div class="casAuthors">Warren, Travis K.; Jordan, Robert; Lo, Michael K.; Ray, Adrian S.; Mackman, Richard L.; Soloveva, Veronica; Siegel, Dustin; Perron, Michel; Bannister, Roy; Hui, Hon C.; Larson, Nate; Strickley, Robert; Wells, Jay; Stuthman, Kelly S.; Van Tongeren, Sean A.; Garza, Nicole L.; Donnelly, Ginger; Shurtleff, Amy C.; Retterer, Cary J.; Gharaibeh, Dima; Zamani, Rouzbeh; Kenny, Tara; Eaton, Brett P.; Grimes, Elizabeth; Welch, Lisa S.; Gomba, Laura; Wilhelmsen, Catherine L.; Nichols, Donald K.; Nuss, Jonathan E.; Nagle, Elyse R.; Kugelman, Jeffrey R.; Palacios, Gustavo; Doerffler, Edward; Neville, Sean; Carra, Ernest; Clarke, Michael O.; Zhang, Lijun; Lew, Willard; Ross, Bruce; Wang, Queenie; Chun, Kwon; Wolfe, Lydia; Babusis, Darius; Park, Yeojin; Stray, Kirsten M.; Trancheva, Iva; Feng, Joy Y.; Barauskas, Ona; Xu, Yili; Wong, Pamela; Braun, Molly R.; Flint, Mike; McMullan, Laura K.; Chen, Shan-Shan; Fearns, Rachel; Swaminathan, Swami; Mayers, Douglas L.; Spiropoulou, Christina F.; Lee, William A.; Nichol, Stuart T.; Cihlar, Tomas; Bavari, Sina</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">531</span>
        (<span class="NLM_cas:issue">7594</span>),
    <span class="NLM_cas:pages">381-385</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The most recent Ebola virus outbreak in West Africa, which was unprecedented in the no. of cases and fatalities, geog. distribution, and no. of nations affected, highlights the need for safe, effective, and readily available antiviral agents for treatment and prevention of acute Ebola virus (EBOV) disease (EVD) or sequelae.  No antiviral therapeutics have yet received regulatory approval or demonstrated clin. efficacy.  Here we report the discovery of a novel small mol. GS-5734, a monophosphoramidate prodrug of an adenosine analog, with antiviral activity against EBOV.  GS-5734 exhibits antiviral activity against multiple variants of EBOV and other filoviruses in cell-based assays.  The pharmacol. active nucleoside triphosphate (NTP) is efficiently formed in multiple human cell types incubated with GS-5734 in vitro, and the NTP acts as an alternative substrate and RNA-chain terminator in primer-extension assays using a surrogate respiratory syncytial virus RNA polymerase.  I.v. administration of GS-5734 to nonhuman primates resulted in persistent NTP levels in peripheral blood mononuclear cells (half-life, 14 h) and distribution to sanctuary sites for viral replication including testes, eyes, and brain.  In a rhesus monkey model of EVD, once-daily i.v. administration of 10 mg kg-1 GS-5734 for 12 days resulted in profound suppression of EBOV replication and protected 100% of EBOV-infected animals against lethal disease, ameliorating clin. disease signs and pathophysiol. markers, even when treatments were initiated three days after virus exposure when systemic viral RNA was detected in two out of six treated animals.  These results show the first substantive post-exposure protection by a small-mol. antiviral compd. against EBOV in nonhuman primates.  The broad-spectrum antiviral activity of GS-5734 in vitro against other pathogenic RNA viruses, including filoviruses, arenaviruses, and coronaviruses, suggests the potential for wider medical use.  GS-5734 is amenable to large-scale manufg., and clin. studies investigating the drug safety and pharmacokinetics are ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX4QsyLVjgHLVg90H21EOLACvtfcHk0liuzlJtNHhw3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjvVGnu70%253D&md5=ab121d827ac0a40cc1fed3dd1df905b6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnature17180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17180%26sid%3Dliteratum%253Aachs%26aulast%3DWarren%26aufirst%3DT.%2BK.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DLo%26aufirst%3DM.%2BK.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DSoloveva%26aufirst%3DV.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DPerron%26aufirst%3DM.%26aulast%3DBannister%26aufirst%3DR.%26aulast%3DHui%26aufirst%3DH.%2BC.%26aulast%3DLarson%26aufirst%3DN.%26aulast%3DStrickley%26aufirst%3DR.%26aulast%3DWells%26aufirst%3DJ.%26aulast%3DStuthman%26aufirst%3DK.%2BS.%26aulast%3DVan%2BTongeren%26aufirst%3DS.%2BA.%26aulast%3DGarza%26aufirst%3DN.%2BL.%26aulast%3DDonnelly%26aufirst%3DG.%26aulast%3DShurtleff%26aufirst%3DA.%2BC.%26aulast%3DRetterer%26aufirst%3DC.%2BJ.%26aulast%3DGharaibeh%26aufirst%3DD.%26aulast%3DZamani%26aufirst%3DR.%26aulast%3DKenny%26aufirst%3DT.%26aulast%3DEaton%26aufirst%3DB.%2BP.%26aulast%3DGrimes%26aufirst%3DE.%26aulast%3DWelch%26aufirst%3DL.%2BS.%26aulast%3DGomba%26aufirst%3DL.%26aulast%3DWilhelmsen%26aufirst%3DC.%2BL.%26aulast%3DNichols%26aufirst%3DD.%2BK.%26aulast%3DNuss%26aufirst%3DJ.%2BE.%26aulast%3DNagle%26aufirst%3DE.%2BR.%26aulast%3DKugelman%26aufirst%3DJ.%2BR.%26aulast%3DPalacios%26aufirst%3DG.%26aulast%3DDoerffler%26aufirst%3DE.%26aulast%3DNeville%26aufirst%3DS.%26aulast%3DCarra%26aufirst%3DE.%26aulast%3DClarke%26aufirst%3DM.%2BO.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLew%26aufirst%3DW.%26aulast%3DRoss%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DChun%26aufirst%3DK.%26aulast%3DWolfe%26aufirst%3DL.%26aulast%3DBabusis%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DStray%26aufirst%3DK.%2BM.%26aulast%3DTrancheva%26aufirst%3DI.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DBarauskas%26aufirst%3DO.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DWong%26aufirst%3DP.%26aulast%3DBraun%26aufirst%3DM.%2BR.%26aulast%3DFlint%26aufirst%3DM.%26aulast%3DMcMullan%26aufirst%3DL.%2BK.%26aulast%3DChen%26aufirst%3DS.%2BS.%26aulast%3DFearns%26aufirst%3DR.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DMayers%26aufirst%3DD.%2BL.%26aulast%3DSpiropoulou%26aufirst%3DC.%2BF.%26aulast%3DLee%26aufirst%3DW.%2BA.%26aulast%3DNichol%26aufirst%3DS.%2BT.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DBavari%26aufirst%3DS.%26atitle%3DTherapeutic%2520Efficacy%2520of%2520The%2520Small%2520Molecule%2520GS-5734%2520Against%2520Ebola%2520Virus%2520in%2520Rhesus%2520Monkeys%26jtitle%3DNature%26date%3D2016%26volume%3D531%26spage%3D381%26epage%3D385%26doi%3D10.1038%2Fnature17180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mehellou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuigan, C.</span></span> <span> </span><span class="NLM_article-title">Aryloxy Phosphoramidate Triesters: A Technology For Delivering Monophosphorylated Nucleosides and Sugars Into Cells</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1779</span>– <span class="NLM_lpage">1791</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200900289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1002%2Fcmdc.200900289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=19760699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlagurbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1779-1791&author=Y.+Mehellouauthor=J.+Balzariniauthor=C.+McGuigan&title=Aryloxy+Phosphoramidate+Triesters%3A+A+Technology+For+Delivering+Monophosphorylated+Nucleosides+and+Sugars+Into+Cells&doi=10.1002%2Fcmdc.200900289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Aryloxy Phosphoramidate Triesters: a Technology for Delivering Monophosphorylated Nucleosides and Sugars into Cells</span></div><div class="casAuthors">Mehellou, Youcef; Balzarini, Jan; McGuigan, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1779-1791</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Prodrug technologies aimed at delivering nucleoside monophosphates into cells (protides) have proved to be effective in improving the therapeutic potential of antiviral and anticancer nucleosides.  In these cases, the nucleoside monophosphates are delivered into the cell, where they may then be further converted (phosphorylated) to their active species.  Herein, we describe one of these technologies developed in our labs., known as the phosphoramidate protide method.  In this approach, the charges of the phosphate group are fully masked to provide efficient passive cell-membrane penetration.  Upon entering the cell, the masking groups are enzymically cleaved to release the phosphorylated biomol.  The application of this technol. to various therapeutic nucleosides has resulted in improved antiviral and anticancer activities, and in some cases it has transformed inactive nucleosides to active ones.  Addnl., the phosphoramidate technol. has also been applied to numerous antiviral nucleoside phosphonates, and has resulted in at least three phosphoramidate-based nucleotides progressing to clin. investigations.  Furthermore, the phosphoramidate technol. has been recently applied to sugars (mainly glucosamine) in order to improve their therapeutic potential.  The development of the phosphoramidate technol., mechanism of action and the application of the technol. to various monophosphorylated nucleosides and sugars will be reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzsccB6GOugbVg90H21EOLACvtfcHk0liuzlJtNHhw3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlagurbI&md5=ccffcc4d9db89b5f1d0aa13e6daf2100</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900289%26sid%3Dliteratum%253Aachs%26aulast%3DMehellou%26aufirst%3DY.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DMcGuigan%26aufirst%3DC.%26atitle%3DAryloxy%2520Phosphoramidate%2520Triesters%253A%2520A%2520Technology%2520For%2520Delivering%2520Monophosphorylated%2520Nucleosides%2520and%2520Sugars%2520Into%2520Cells%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1779%26epage%3D1791%26doi%3D10.1002%2Fcmdc.200900289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sofia, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagarathnam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rachakonda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espiritu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keilman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steuer, H. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furman, P. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of a β-D-2′-Deoxy-2′-α-Fluoro-2′-β-<i>C</i>-Methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7202</span>– <span class="NLM_lpage">7218</span>, <span class="refDoi"> DOI: 10.1021/jm100863x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100863x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7202-7218&author=M.+J.+Sofiaauthor=D.+Baoauthor=W.+Changauthor=J.+Duauthor=D.+Nagarathnamauthor=S.+Rachakondaauthor=P.+G.+Reddyauthor=B.+S.+Rossauthor=P.+Wangauthor=H.-R.+Zhangauthor=S.+Bansalauthor=C.+Espirituauthor=M.+Keilmanauthor=A.+M.+Lamauthor=H.+M.+M.+Steuerauthor=C.+Niuauthor=M.+J.+Ottoauthor=P.+A.+Furman&title=Discovery+of+a+%CE%B2-D-2%E2%80%B2-Deoxy-2%E2%80%B2-%CE%B1-Fluoro-2%E2%80%B2-%CE%B2-C-Methyluridine+Nucleotide+Prodrug+%28PSI-7977%29+for+the+Treatment+of+Hepatitis+C+Virus&doi=10.1021%2Fjm100863x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a β-D-2'-Deoxy-2'-α-fluoro-2'-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus</span></div><div class="casAuthors">Sofia, Michael J.; Bao, Donghui; Chang, Wonsuk; Du, Jinfa; Nagarathnam, Dhanapalan; Rachakonda, Suguna; Reddy, P. Ganapati; Ross, Bruce S.; Wang, Peiyuan; Zhang, Hai-Ren; Bansal, Shalini; Espiritu, Christine; Keilman, Meg; Lam, Angela M.; Steuer, Holly M. Micolochick; Niu, Congrong; Otto, Michael J.; Furman, Phillip A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7202-7218</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) is a global health problem requiring novel approaches for effective treatment of this disease.  The HCV NS5B polymerase has been demonstrated to be a viable target for the development of HCV therapies.  β-D-2'-Deoxy-2'-α-fluoro-2'-β-C-Me nucleosides are selective inhibitors of the HCV NS5B polymerase and have demonstrated potent activity in the clinic.  Phosphoramidate prodrugs of the 5'-phosphate deriv. of the β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine nucleoside were prepd. and showed significant potency in the HCV subgenomic replicon assay (<1 μM) and produced high levels of triphosphate 6 in primary hepatocytes and in the livers of rats, dogs, and monkeys when administered in vivo.  The single diastereomer 51 of diastereomeric mixt. 14 was crystd., and an X-ray structure was detd. establishing the phosphoramidate stereochem. as Sp, thus correlating for the first time the stereochem. of a phosphoramidate prodrug with biol. activity.  51 (PSI-7977) was selected as a clin. development candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWAkLi9-odWbVg90H21EOLACvtfcHk0ljqsyQRng3azw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtb%252FO&md5=33d371e557e9d70562a326f97798f45c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm100863x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100863x%26sid%3Dliteratum%253Aachs%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DBao%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DNagarathnam%26aufirst%3DD.%26aulast%3DRachakonda%26aufirst%3DS.%26aulast%3DReddy%26aufirst%3DP.%2BG.%26aulast%3DRoss%26aufirst%3DB.%2BS.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DH.-R.%26aulast%3DBansal%26aufirst%3DS.%26aulast%3DEspiritu%26aufirst%3DC.%26aulast%3DKeilman%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DSteuer%26aufirst%3DH.%2BM.%2BM.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DDiscovery%2520of%2520a%2520%25CE%25B2-D-2%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-%25CE%25B1-Fluoro-2%25E2%2580%25B2-%25CE%25B2-C-Methyluridine%2520Nucleotide%2520Prodrug%2520%2528PSI-7977%2529%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C%2520Virus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7202%26epage%3D7218%26doi%3D10.1021%2Fjm100863x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, G.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cundy, K. C.</span></span> <span> </span><span class="NLM_article-title">Selective Intracellular Activation of a Novel Prodrug of the Human Immunodeficiency Virus Reverse Transcriptase Inhibitor Tenofovir Leads to Preferential Distribution and Accumulation in Lymphatic Tissue</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1898</span>– <span class="NLM_lpage">1906</span>, <span class="refDoi"> DOI: 10.1128/AAC.49.5.1898-1906.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1128%2FAAC.49.5.1898-1906.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=15855512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFSntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=1898-1906&author=A.+W.+Leeauthor=G.-X.+Heauthor=E.+Eisenbergauthor=T.+Cihlarauthor=S.+Swaminathanauthor=A.+Mulatoauthor=K.+C.+Cundy&title=Selective+Intracellular+Activation+of+a+Novel+Prodrug+of+the+Human+Immunodeficiency+Virus+Reverse+Transcriptase+Inhibitor+Tenofovir+Leads+to+Preferential+Distribution+and+Accumulation+in+Lymphatic+Tissue&doi=10.1128%2FAAC.49.5.1898-1906.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue</span></div><div class="casAuthors">Lee, William A.; He, Gong-Xin; Eisenberg, Eugene; Cihlar, Tomas; Swaminathan, Swami; Mulato, Andrew; Cundy, Kenneth C.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1898-1906</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">An isopropylalaninyl monoamidate Ph monoester prodrug of tenofovir (GS 7340) was prepd., and its in vitro antiviral activity, metab., and pharmacokinetics in dogs were detd.  The 50% effective concn. (EC50) of GS 7340 against human immunodeficiency virus type 1 in MT-2 cells was 0.005 μM compared to an EC50 of 5 μM for the parent drug, tenofovir.  The (L)-alaninyl analog (GS 7340) was >1000-fold more active than the (D)-alaninyl analog.  GS 7340 has a half-life of 90 min in human plasma at 37° and a half-life of 28.3 min in an MT-2 cell ext. at 37°.  The antiviral activity (>10× the EC50) and the metabolic stability in MT-2 cell exts. (>35×) and plasma (>2.5×) were also sensitive to the stereochem. at the phosphorus.  After a single oral dose of GS 7340 (10 mg-eq/kg tenofovir) to male beagle dogs, the plasma bioavailability of tenofovir compared to an i.v. dose of tenofovir was 17%.  The total intracellular concn. of all tenofovir species in isolated peripheral blood mononuclear cells at 24 h was 63 μg-eq/mL compared to 0.2 μg-eq/mL in plasma.  A radiolabeled distribution study with dogs resulted in an increased distribution of tenofovir to tissues of lymphatic origin compared to the com. available prodrug tenofovir DF (Viread).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbOoU4rGP0xrVg90H21EOLACvtfcHk0ljqsyQRng3azw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFSntL0%253D&md5=b5e724620a1cafa4b473a84aea841282</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1128%2FAAC.49.5.1898-1906.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.49.5.1898-1906.2005%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DA.%2BW.%26aulast%3DHe%26aufirst%3DG.-X.%26aulast%3DEisenberg%26aufirst%3DE.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DMulato%26aufirst%3DA.%26aulast%3DCundy%26aufirst%3DK.%2BC.%26atitle%3DSelective%2520Intracellular%2520Activation%2520of%2520a%2520Novel%2520Prodrug%2520of%2520the%2520Human%2520Immunodeficiency%2520Virus%2520Reverse%2520Transcriptase%2520Inhibitor%2520Tenofovir%2520Leads%2520to%2520Preferential%2520Distribution%2520and%2520Accumulation%2520in%2520Lymphatic%2520Tissue%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26volume%3D49%26spage%3D1898%26epage%3D1906%26doi%3D10.1128%2FAAC.49.5.1898-1906.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steuer, H. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitaker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sofia, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furman, P. A.</span></span> <span> </span><span class="NLM_article-title">The Mechanism of Action of β-D-2′-Deoxy-2′-Fluoro-2′-<i>C</i>-Methylcytidine Involves a Second Metabolic Pathway Leading to β-D-2′-Deoxy-2′-Fluoro-2′-<i>C</i>-Methyluridine 5′-Triphosphate, A Potent Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">458</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1128/AAC.01184-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1128%2FAAC.01184-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=17999967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=458-464&author=E.+Murakamiauthor=C.+Niuauthor=H.+Baoauthor=H.+M.+M.+Steuerauthor=T.+Whitakerauthor=T.+Nachmanauthor=M.+A.+Sofiaauthor=P.+Wangauthor=M.+J.+Ottoauthor=P.+A.+Furman&title=The+Mechanism+of+Action+of+%CE%B2-D-2%E2%80%B2-Deoxy-2%E2%80%B2-Fluoro-2%E2%80%B2-C-Methylcytidine+Involves+a+Second+Metabolic+Pathway+Leading+to+%CE%B2-D-2%E2%80%B2-Deoxy-2%E2%80%B2-Fluoro-2%E2%80%B2-C-Methyluridine+5%E2%80%B2-Triphosphate%2C+A+Potent+Inhibitor+of+the+Hepatitis+C+Virus+RNA-Dependent+RNA+Polymerase&doi=10.1128%2FAAC.01184-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanism of action of β-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine involves a second metabolic pathway leading to β-D-2'-deoxy-2'-fluoro-2'-C-methyluridine 5'-triphosphate, a potent inhibitor of the hepatitis C virus RNA-dependent RNA polymerase</span></div><div class="casAuthors">Murakami, Eisuke; Niu, Congrong; Bao, Haiying; Micolochick Steuer, Holly M.; Whitaker, Tony; Nachman, Tammy; Sofia, Michael A.; Wang, Peiyuan; Otto, Michael J.; Furman, Phillip A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">458-464</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">β-D-2'-Deoxy-2'-fluoro-2'-C-methylcytidine (PSI-6130) is a potent inhibitor of hepatitis C virus (HCV) RNA replication in an HCV replicon assay.  The 5'-triphosphate of PSI-6130 is a competitive inhibitor of the HCV RNA-dependent RNA polymerase (RdRp) and acts as a nonobligate chain terminator.  Recently, it has been shown that the metab. of PSI-6130 also results in the formation of the 5'-triphosphate of the uridine congener, β-D-2'-deoxy-2'-fluoro-2'-C-methyluridine (PSI-6206; RO2433).  Here we show that the formation of the 5'-triphosphate of RO2433 (RO2433-TP) requires the deamination of PSI-6130 monophosphate and that RO2433 monophosphate is subsequently phosphorylated to the corresponding di- and triphosphates by cellular UMP-CMP kinase and nucleoside diphosphate kinase, resp.  RO2433-TP is a potent inhibitor of the HCV RdRp; however, both enzymic and cell-based assays show that PSI-6130 triphosphate is a more potent inhibitor of the HCV RdRp than RO2433-TP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdrOmmMbGQNrVg90H21EOLACvtfcHk0lj1f_jmlTdunA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSqtbc%253D&md5=9215a7a0363bc79295269f560d2597ef</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1128%2FAAC.01184-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01184-07%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DE.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DBao%26aufirst%3DH.%26aulast%3DSteuer%26aufirst%3DH.%2BM.%2BM.%26aulast%3DWhitaker%26aufirst%3DT.%26aulast%3DNachman%26aufirst%3DT.%26aulast%3DSofia%26aufirst%3DM.%2BA.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DThe%2520Mechanism%2520of%2520Action%2520of%2520%25CE%25B2-D-2%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-Fluoro-2%25E2%2580%25B2-C-Methylcytidine%2520Involves%2520a%2520Second%2520Metabolic%2520Pathway%2520Leading%2520to%2520%25CE%25B2-D-2%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-Fluoro-2%25E2%2580%25B2-C-Methyluridine%25205%25E2%2580%25B2-Triphosphate%252C%2520A%2520Potent%2520Inhibitor%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520RNA-Dependent%2520RNA%2520Polymerase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D458%26epage%3D464%26doi%3D10.1128%2FAAC.01184-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, O. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. U.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Antiviral Activity of a Series of 1′-Substituted 4-Aza-7,9-Dideazaadenosine <i>C</i>-Nucleosides</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2705</span>– <span class="NLM_lpage">2707</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1016%2Fj.bmcl.2012.02.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=22446091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVGqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2705-2707&author=A.+Choauthor=O.+L.+Saundersauthor=T.+Butlerauthor=L.+Zhangauthor=J.+Xuauthor=J.+E.+Velaauthor=J.+Y.+Fengauthor=A.+S.+Rayauthor=C.+U.+Kim&title=Synthesis+and+Antiviral+Activity+of+a+Series+of+1%E2%80%B2-Substituted+4-Aza-7%2C9-Dideazaadenosine+C-Nucleosides&doi=10.1016%2Fj.bmcl.2012.02.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides</span></div><div class="casAuthors">Cho, Aesop; Saunders, Oliver L.; Butler, Thomas; Zhang, Lijun; Xu, Jie; Vela, Jennifer E.; Feng, Joy Y.; Ray, Adrian S.; Kim, Choung U.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2705-2707</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 1'-substituted analogs of 4-aza-7,9-dideazaadenosine C-nucleoside, e.g. I, were prepd. and evaluated for the potential as antiviral agents.  These compds. showed a broad range of inhibitory activity against various RNA viruses.  In particular, the whole cell potency against HCV when R = CN was attributed to inhibition of HCV NS5B polymerase and intracellular concn. of the corresponding nucleoside triphosphate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAj_ComFGJ9LVg90H21EOLACvtfcHk0lj1f_jmlTdunA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVGqt7Y%253D&md5=b7576da7b34ae7b3862d80b52645465a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.105%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DA.%26aulast%3DSaunders%26aufirst%3DO.%2BL.%26aulast%3DButler%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DVela%26aufirst%3DJ.%2BE.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DKim%26aufirst%3DC.%2BU.%26atitle%3DSynthesis%2520and%2520Antiviral%2520Activity%2520of%2520a%2520Series%2520of%25201%25E2%2580%25B2-Substituted%25204-Aza-7%252C9-Dideazaadenosine%2520C-Nucleosides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2705%26epage%3D2707%26doi%3D10.1016%2Fj.bmcl.2012.02.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span>; <span class="NLM_string-name">Parrish, J. P.</span>; <span class="NLM_string-name">Ray, A. S.</span>; <span class="NLM_string-name">Theodore, D. A.</span></span> <span> </span><span class="NLM_article-title">Methods and Compounds for Treating Paramyxoviridae Virus Infections</span>. U.S. Patent <span class="NLM_patent">2011045102</span> July, 22, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=R.+L.+Mackman&author=J.+P.+Parrish&author=A.+S.+Ray&author=D.+A.+Theodore&title=Methods+and+Compounds+for+Treating+Paramyxoviridae+Virus+Infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMackman%26aufirst%3DR.%2BL.%26atitle%3DMethods%2520and%2520Compounds%2520for%2520Treating%2520Paramyxoviridae%2520Virus%2520Infections%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patil, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otter, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R. S.</span></span> <span> </span><span class="NLM_article-title">4-Aza-7,9-Dideazaadenosine, A New Cytotoxic Synthetic <i>C</i>-Nucleoside Analogue of Adenosine</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">5339</span>– <span class="NLM_lpage">5342</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)73494-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1016%2FS0040-4039%2800%2973494-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADyaK2cXmtlWht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1994&pages=5339-5342&author=S.+A.+Patilauthor=P.+B.+Otterauthor=R.+S.+Klein&title=4-Aza-7%2C9-Dideazaadenosine%2C+A+New+Cytotoxic+Synthetic+C-Nucleoside+Analogue+of+Adenosine&doi=10.1016%2FS0040-4039%2800%2973494-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">4-Aza-7,9-dideazaadenosine, a new cytotoxic synthetic C-nucleoside analog of adenosine</span></div><div class="casAuthors">Patil, Shirish A.; Otter, Brian A.; Klein, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">5339-42</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">The first synthesis of I, the pyrrolo[2,1-f]triazine C-nucleoside congener of adenosine is described.  The key intermediate ribofuranosyl pyrrole is obtained by the direct C-ribosylation of pyrrolemagnesium bromide followed by an acid-catalyzed dehydration, Vilsmeier formylation, and N-amination.  In vitro growth inhibitory activities of I against leukemic cell lines (0.8-15 nM) are comparable to those of 9-deazaadenosine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1bQfZLO2B8bVg90H21EOLACvtfcHk0lhWficyKAw7lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmtlWht7o%253D&md5=5331a09cb66b387fd153ad1d8f69d6c7</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2973494-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252973494-0%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DS.%2BA.%26aulast%3DOtter%26aufirst%3DP.%2BB.%26aulast%3DKlein%26aufirst%3DR.%2BS.%26atitle%3D4-Aza-7%252C9-Dideazaadenosine%252C%2520A%2520New%2520Cytotoxic%2520Synthetic%2520C-Nucleoside%2520Analogue%2520of%2520Adenosine%26jtitle%3DTetrahedron%2520Lett.%26date%3D1994%26volume%3D35%26spage%3D5339%26epage%3D5342%26doi%3D10.1016%2FS0040-4039%2800%2973494-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lou, Z.</span>; <span class="NLM_string-name">Chen, G.</span>; <span class="NLM_string-name">Xie, Y.</span></span> <span> </span><span class="NLM_article-title">Cyanoribofuranoside Compound and a Preparation Method Thereof</span>. Chinese Patent <span class="NLM_patent">CN 1137132 C</span> Feb., 4, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=Z.+Lou&author=G.+Chen&author=Y.+Xie&title=Cyanoribofuranoside+Compound+and+a+Preparation+Method+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLou%26aufirst%3DZ.%26atitle%3DCyanoribofuranoside%2520Compound%2520and%2520a%2520Preparation%2520Method%2520Thereof%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kano, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashida, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haraguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyasaka, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of 1′-<i>C</i>-Cyano-Pyrimidine Nucleosides</span>. <i>Nucleosides, Nucleotides Nucleic Acids</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">324</span>, <span class="refDoi"> DOI: 10.1080/07328319608002386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1080%2F07328319608002386" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1996&pages=305-324&author=Y.+Yoshimuraauthor=F.+Kanoauthor=S.+Miyazakiauthor=N.+Ashidaauthor=S.+Sakataauthor=K.+Haraguchiauthor=Y.+Itohauthor=H.+Tanakaauthor=T.+Miyasaka&title=Synthesis+and+Biological+Evaluation+of+1%E2%80%B2-C-Cyano-Pyrimidine+Nucleosides&doi=10.1080%2F07328319608002386"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1080%2F07328319608002386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07328319608002386%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimura%26aufirst%3DY.%26aulast%3DKano%26aufirst%3DF.%26aulast%3DMiyazaki%26aufirst%3DS.%26aulast%3DAshida%26aufirst%3DN.%26aulast%3DSakata%26aufirst%3DS.%26aulast%3DHaraguchi%26aufirst%3DK.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DMiyasaka%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%25201%25E2%2580%25B2-C-Cyano-Pyrimidine%2520Nucleosides%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D1996%26volume%3D15%26spage%3D305%26epage%3D324%26doi%3D10.1080%2F07328319608002386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kirschberg, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squires, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zonte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aktoudianakis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metobo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. U.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 1′-<i>C</i>-Cyano Pyrimidine Nucleosides and Characterization as HCV Polymerase Inhibitors</span>. <i>Nucleosides, Nucleotides Nucleic Acids</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">763</span>– <span class="NLM_lpage">785</span>, <span class="refDoi"> DOI: 10.1080/15257770.2015.1075550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1080%2F15257770.2015.1075550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=26398773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFKhsrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=763-785&author=T.+A.+Kirschbergauthor=M.+Mishauthor=N.+H.+Squiresauthor=S.+Zonteauthor=E.+Aktoudianakisauthor=S.+Metoboauthor=T.+Butlerauthor=X.+Juauthor=A.+Choauthor=A.+S.+Rayauthor=C.+U.+Kim&title=Synthesis+of+1%E2%80%B2-C-Cyano+Pyrimidine+Nucleosides+and+Characterization+as+HCV+Polymerase+Inhibitors&doi=10.1080%2F15257770.2015.1075550"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 1'-C-Cyano Pyrimidine Nucleosides and Characterization as HCV Polymerase Inhibitors</span></div><div class="casAuthors">Kirschberg, Thorsten A.; Mish, Michael; Squires, Neil H.; Zonte, Sebastian; Aktoudianakis, Evangelos; Metobo, Sammy; Butler, Thomas; Ju, Xie; Cho, Aesop; Ray, Adrian S.; Kim, Choung U.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">763-785</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Ribose modified 1'-C-cyano pyrimidine nucleosides were synthesized.  A silver triflate mediated Vorbruggen reaction was used to generate the nucleoside scaffold and follow-up chem. provided specific ribose modified analogs.  Nucleosides and phosphoramidate prodrugs were tested for their anti-HCV activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo25OTpf7cL67Vg90H21EOLACvtfcHk0lhWficyKAw7lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFKhsrfI&md5=172176a9fd3b10fdc4d64a8630b68763</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1080%2F15257770.2015.1075550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15257770.2015.1075550%26sid%3Dliteratum%253Aachs%26aulast%3DKirschberg%26aufirst%3DT.%2BA.%26aulast%3DMish%26aufirst%3DM.%26aulast%3DSquires%26aufirst%3DN.%2BH.%26aulast%3DZonte%26aufirst%3DS.%26aulast%3DAktoudianakis%26aufirst%3DE.%26aulast%3DMetobo%26aufirst%3DS.%26aulast%3DButler%26aufirst%3DT.%26aulast%3DJu%26aufirst%3DX.%26aulast%3DCho%26aufirst%3DA.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DKim%26aufirst%3DC.%2BU.%26atitle%3DSynthesis%2520of%25201%25E2%2580%25B2-C-Cyano%2520Pyrimidine%2520Nucleosides%2520and%2520Characterization%2520as%2520HCV%2520Polymerase%2520Inhibitors%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2015%26volume%3D34%26spage%3D763%26epage%3D785%26doi%3D10.1080%2F15257770.2015.1075550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metobo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aktoudianakis, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lew, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerffler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babusis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carey, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">German, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenaux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHutchison, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. U.</span></span> <span> </span><span class="NLM_article-title">Discovery of the First <i>C</i>-nucleoside HCV Polymerase Inhibitor (GS-6620) with Demonstrated Antiviral Response in HCV Infected Patients</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1812</span>– <span class="NLM_lpage">1825</span>, <span class="refDoi"> DOI: 10.1021/jm400201a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400201a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2nt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1812-1825&author=A.+Choauthor=L.+Zhangauthor=J.+Xuauthor=R.+Leeauthor=T.+Butlerauthor=S.+Metoboauthor=V.+Aktoudianakisauthor=W.+Lewauthor=H.+Yeauthor=M.+Clarkeauthor=E.+Doerfflerauthor=D.+Byunauthor=T.+Wangauthor=D.+Babusisauthor=A.+C.+Careyauthor=P.+Germanauthor=D.+Sauerauthor=W.+Zhongauthor=S.+Rossiauthor=M.+Fenauxauthor=J.+G.+McHutchisonauthor=J.+Perryauthor=J.+Fengauthor=A.+S.+Rayauthor=C.+U.+Kim&title=Discovery+of+the+First+C-nucleoside+HCV+Polymerase+Inhibitor+%28GS-6620%29+with+Demonstrated+Antiviral+Response+in+HCV+Infected+Patients&doi=10.1021%2Fjm400201a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the First C-Nucleoside HCV Polymerase Inhibitor (GS-6620) with Demonstrated Antiviral Response in HCV Infected Patients</span></div><div class="casAuthors">Cho, Aesop; Zhang, Lijun; Xu, Jie; Lee, Rick; Butler, Thomas; Metobo, Sammy; Aktoudianakis, Vangelis; Lew, Willard; Ye, Hong; Clarke, Michael; Doerffler, Edward; Byun, Daniel; Wang, Ting; Babusis, Darius; Carey, Anne C.; German, Polina; Sauer, Dorothea; Zhong, Weidong; Rossi, Stephen; Fenaux, Martijn; McHutchison, John G.; Perry, Jason; Feng, Joy; Ray, Adrian S.; Kim, Choung U.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1812-1825</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection presents an unmet medical need requiring more effective treatment options.  Nucleoside inhibitors (NI) of HCV polymerase (NS5B) have demonstrated pan-genotypic activity and durable antiviral response in the clinic, and they are likely to become a key component of future treatment regimens.  NI candidates that have entered clin. development thus far have all been N-nucleoside derivs.  Herein, we report the discovery of a C-nucleoside class of NS5B inhibitors.  Exploration of adenosine analogs in this class identified 1'-cyano-2'-C-Me 4-aza-7,9-dideaza adenosine as a potent and selective inhibitor of NS5B.  A monophosphate prodrug approach afforded a series of compds. showing submicromolar activity in HCV replicon assays.  Further pharmacokinetic optimization for sufficient oral absorption and liver triphosphate loading led to identification of a clin. development candidate GS-6620 (I).  In a phase I clin. study, the potential for potent activity was demonstrated but with high intra- and interpatient pharmacokinetic and pharmacodynamic variability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro0DWejYRAB7Vg90H21EOLACvtfcHk0lhWficyKAw7lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2nt7c%253D&md5=60cb14dcd3d500933bcf4e55e9257fc6</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm400201a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400201a%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DR.%26aulast%3DButler%26aufirst%3DT.%26aulast%3DMetobo%26aufirst%3DS.%26aulast%3DAktoudianakis%26aufirst%3DV.%26aulast%3DLew%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DClarke%26aufirst%3DM.%26aulast%3DDoerffler%26aufirst%3DE.%26aulast%3DByun%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DBabusis%26aufirst%3DD.%26aulast%3DCarey%26aufirst%3DA.%2BC.%26aulast%3DGerman%26aufirst%3DP.%26aulast%3DSauer%26aufirst%3DD.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DRossi%26aufirst%3DS.%26aulast%3DFenaux%26aufirst%3DM.%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DKim%26aufirst%3DC.%2BU.%26atitle%3DDiscovery%2520of%2520the%2520First%2520C-nucleoside%2520HCV%2520Polymerase%2520Inhibitor%2520%2528GS-6620%2529%2520with%2520Demonstrated%2520Antiviral%2520Response%2520in%2520HCV%2520Infected%2520Patients%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1812%26epage%3D1825%26doi%3D10.1021%2Fjm400201a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkin, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichert, W. M.</span></span> <span> </span><span class="NLM_article-title">Directed Cell Migration on Fibronectin Gradients: Effect of Gradient Slope</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>312</i></span>,  <span class="NLM_fpage">2424</span>– <span class="NLM_lpage">2432</span>, <span class="refDoi"> DOI: 10.1016/j.yexcr.2006.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1016%2Fj.yexcr.2006.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=16730349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmsl2ju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2006&pages=2424-2432&author=J.+T.+Smithauthor=J.+T.+Elkinauthor=W.+M.+Reichert&title=Directed+Cell+Migration+on+Fibronectin+Gradients%3A+Effect+of+Gradient+Slope&doi=10.1016%2Fj.yexcr.2006.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">Directed cell migration on fibronectin gradients: Effect of gradient slope</span></div><div class="casAuthors">Smith, Jason T.; Elkin, James T.; Reichert, W. Monty</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">312</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2424-2432</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The migration of human microvascular endothelial cells (hMEC) was measured on a range of fibronectin gradient slopes. hMEC drift speed increased with increasing gradient slope with no concurrent change in cellular persistence time or random cell speed.  The frequency of discrete cellular motion in the gradient direction increased with gradient slope.  Morphol. polarization of cells on the gradients is also characterized and correlated with cellular drift speed.  These expts. present the first demonstration of cellular response to changing haptotactic gradient slope using an in vitro system for the quant. study of cell migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2O0Yz433V77Vg90H21EOLACvtfcHk0lhOXdXIXS3w6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xmsl2ju70%253D&md5=8bb11aee1a1b2ec1f34f116ee2ba94d4</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2006.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2006.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DJ.%2BT.%26aulast%3DElkin%26aufirst%3DJ.%2BT.%26aulast%3DReichert%26aufirst%3DW.%2BM.%26atitle%3DDirected%2520Cell%2520Migration%2520on%2520Fibronectin%2520Gradients%253A%2520Effect%2520of%2520Gradient%2520Slope%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2006%26volume%3D312%26spage%3D2424%26epage%3D2432%26doi%3D10.1016%2Fj.yexcr.2006.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroenke, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piwnica-Worms, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackerman, J. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neil, J. J.</span></span> <span> </span><span class="NLM_article-title">Intracellular Water Specific MR of Microbead-Adherent Cells: The HeLa Cell Intracellular Water Exchange Lifetime</span>. <i>NMR Biomed.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1002/nbm.1173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1002%2Fnbm.1173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=17461436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkt1Sku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=159-164&author=L.+Zhaoauthor=C.+D.+Kroenkeauthor=J.+Songauthor=D.+Piwnica-Wormsauthor=J.+J.+H.+Ackermanauthor=J.+J.+Neil&title=Intracellular+Water+Specific+MR+of+Microbead-Adherent+Cells%3A+The+HeLa+Cell+Intracellular+Water+Exchange+Lifetime&doi=10.1002%2Fnbm.1173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular water-specific MR of microbead-adherent cells: the HeLa cell intracellular water exchange lifetime</span></div><div class="casAuthors">Zhao, L.; Kroenke, C. D.; Song, J.; Piwnica-Worms, D.; Ackerman, J. J. H.; Neil, J. J.</div><div class="citationInfo"><span class="NLM_cas:title">NMR in Biomedicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-164</span>CODEN:
                <span class="NLM_cas:coden">NMRBEF</span>;
        ISSN:<span class="NLM_cas:issn">0952-3480</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Quant. characterization of the intracellular water 1H MR signal from cultured cells will provide crit. biophys. insight into the MR signal from tissues in vivo.  Microbeads provide a robust immobilization substrate for the m any mammalian cell lines that adhere to surfaces and also provide sufficient cell d. for observation of the intracellular water MR signal.  However, selective observation of the intracellular water MR signal from perfused, microbead-adherent mammalian cells requires highly effective suppression of the extracellular water MR signal.  We describe how high-velocity perfusion of microbead-adherent cells results in short apparent 1H MR longitudinal and transverse relaxation times for the extracellular water in a thin slice selected orthogonal to the direction of flow.  When combined with a spin-echo pulse sequence, this phenomenon provides highly effective suppression of the extracellular water MR signal.  This new method is exploited here to quantify the kinetics of water exchange from the intracellular to extracellular spaces of HeLa cells.  The time const. describing water exchange from intracellular to extracellular spaces, also known as the exchange lifetime for intracellular water, is 119 ± 14 ms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRk0icA4x2Z7Vg90H21EOLACvtfcHk0lhOXdXIXS3w6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkt1Sku7s%253D&md5=b2c8be705f1dede292ae732c61cd85f4</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1002%2Fnbm.1173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fnbm.1173%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DKroenke%26aufirst%3DC.%2BD.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DPiwnica-Worms%26aufirst%3DD.%26aulast%3DAckerman%26aufirst%3DJ.%2BJ.%2BH.%26aulast%3DNeil%26aufirst%3DJ.%2BJ.%26atitle%3DIntracellular%2520Water%2520Specific%2520MR%2520of%2520Microbead-Adherent%2520Cells%253A%2520The%2520HeLa%2520Cell%2520Intracellular%2520Water%2520Exchange%2520Lifetime%26jtitle%3DNMR%2520Biomed.%26date%3D2008%26volume%3D21%26spage%3D159%26epage%3D164%26doi%3D10.1002%2Fnbm.1173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barauskas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkus, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, B.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerffler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W.</span></span> <span> </span><span class="NLM_article-title">Discovery of β-D-2′-α-Fluoro-4′-α-Cyano-5-Aza-7,9-Dideaza Adenosine as a Potent Nucleoside Inhibitor of Respiratory Syncytial Virus With Excellent Selectivity Over Mitochondrial RNA and DNA Polymerases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2484</span>– <span class="NLM_lpage">2487</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.04.073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1016%2Fj.bmcl.2015.04.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=25978965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsFyisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2484-2487&author=M.+O.+Clarkeauthor=R.+Mackmanauthor=D.+Byunauthor=H.+Huiauthor=O.+Barauskasauthor=G.+Birkusauthor=B.-K.+Chunauthor=E.+Doerfflerauthor=J.+Fengauthor=K.+Karkiauthor=G.+Leeauthor=M.+Perronauthor=D.+Siegelauthor=S.+Swaminathanauthor=W.+Lee&title=Discovery+of+%CE%B2-D-2%E2%80%B2-%CE%B1-Fluoro-4%E2%80%B2-%CE%B1-Cyano-5-Aza-7%2C9-Dideaza+Adenosine+as+a+Potent+Nucleoside+Inhibitor+of+Respiratory+Syncytial+Virus+With+Excellent+Selectivity+Over+Mitochondrial+RNA+and+DNA+Polymerases&doi=10.1016%2Fj.bmcl.2015.04.073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of β-D-2'-deoxy-2'-α-fluoro-4'-α-cyano-5-aza-7,9-dideaza adenosine as a potent nucleoside inhibitor of respiratory syncytial virus with excellent selectivity over mitochondrial RNA and DNA polymerases</span></div><div class="casAuthors">Clarke, Michael O.; Mackman, Richard; Byun, Daniel; Hui, Hon; Barauskas, Ona; Birkus, Gabriel; Chun, Byoung-Kwon; Doerffler, Edward; Feng, Joy; Karki, Kapil; Lee, Gary; Perron, Michel; Siegel, Dustin; Swaminathan, Swami; Lee, William</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2484-2487</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Novel 4'-substituted β-D-2'-deoxy-2'-α-fluoro (2'd2'F) nucleoside inhibitors of respiratory syncytial virus (RSV) are reported.  The introduction of 4'-substitution onto 2'd2'F nucleoside analogs resulted in compds. demonstrating potent cell based RSV inhibition, improved inhibition of the RSV polymerase by the nucleoside triphosphate metabolites, and enhanced selectivity over incorporation by mitochondrial RNA and DNA polymerases.  Selectivity over the mitochondrial polymerases was found to be extremely sensitive to the specific 4'-substitution and not readily predictable.  Combining the most potent and selective 4'-groups from N-nucleoside analogs onto a 2'd2'F C-nucleoside analog resulted in the identification of I as a promising nucleoside lead for RSV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkr67PvLBml7Vg90H21EOLACvtfcHk0lhOXdXIXS3w6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnsFyisr0%253D&md5=744a3a2680ef899fcd84258c386471d2</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.073%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DM.%2BO.%26aulast%3DMackman%26aufirst%3DR.%26aulast%3DByun%26aufirst%3DD.%26aulast%3DHui%26aufirst%3DH.%26aulast%3DBarauskas%26aufirst%3DO.%26aulast%3DBirkus%26aufirst%3DG.%26aulast%3DChun%26aufirst%3DB.-K.%26aulast%3DDoerffler%26aufirst%3DE.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DPerron%26aufirst%3DM.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520%25CE%25B2-D-2%25E2%2580%25B2-%25CE%25B1-Fluoro-4%25E2%2580%25B2-%25CE%25B1-Cyano-5-Aza-7%252C9-Dideaza%2520Adenosine%2520as%2520a%2520Potent%2520Nucleoside%2520Inhibitor%2520of%2520Respiratory%2520Syncytial%2520Virus%2520With%2520Excellent%2520Selectivity%2520Over%2520Mitochondrial%2520RNA%2520and%2520DNA%2520Polymerases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2484%26epage%3D2487%26doi%3D10.1016%2Fj.bmcl.2015.04.073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barauskas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmadyar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babusis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCutcheon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakowicz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span> <span> </span><span class="NLM_article-title">Role of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C Virus</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">806</span>– <span class="NLM_lpage">817</span>, <span class="refDoi"> DOI: 10.1128/AAC.01922-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1128%2FAAC.01922-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=26596942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsFKit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=806-817&author=J.+Fengauthor=Y.+Xuauthor=O.+Barauskasauthor=J.+K.+Perryauthor=S.+Ahmadyarauthor=G.+Stepanauthor=H.+Yuauthor=D.+Babusisauthor=Y.+Parkauthor=K.+McCutcheonauthor=M.+Perronauthor=B.+E.+Schultzauthor=R.+Sakowiczauthor=A.+S.+Ray&title=Role+of+Mitochondrial+RNA+Polymerase+in+the+Toxicity+of+Nucleotide+Inhibitors+of+Hepatitis+C+Virus&doi=10.1128%2FAAC.01922-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Role of mitochondrial RNA polymerase in the toxicity of nucleotide inhibitors of hepatitis C virus</span></div><div class="casAuthors">Feng, Joy Y.; Xu, Yili; Barauskas, Ona; Perry, Jason K.; Ahmadyar, Shekeba; Stepan, George; Yu, Helen; Babusis, Darius; Park, Yeojin; McCutcheon, Krista; Perron, Michel; Schultz, Brian E.; Sakowicz, Roman; Ray, Adrian S.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">806-817</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Toxicity has emerged during the clin. development of many but not all nucleotide inhibitors (NI) of hepatitis C virus (HCV).  To better understand the mechanism for adverse events, clin. relevant HCV NI were characterized in biochem. and cellular assays, including assays of decreased viability in multiple cell lines and primary cells, interaction with human DNA and RNA polymerases, and inhibition of mitochondrial protein synthesis and respiration.  NI that were incorporated by the mitochondrial RNA polymerase (PolRMT) inhibited mitochondrial protein synthesis and showed a corresponding decrease in mitochondrial oxygen consumption in cells.  The nucleoside released by the prodrug balapiravir (R1626), 4'-azido cytidine, was a highly selective inhibitor of mitochondrial RNA transcription.  The nucleotide prodrug of 2'-C-Me guanosine, BMS-986094, showed a primary effect on mitochondrial function at submicromolar concns., followed by general cytotoxicity.  In contrast, NI contg. multiple ribose modifications, including the active forms of mericitabine and sofosbuvir, were poor substrates for PolRMT and did not show mitochondrial toxicity in cells.  In general, these studies identified the prostate cell line PC-3 as more than an order of magnitude more sensitive to mitochondrial toxicity than the commonly used HepG2 cells.  In conclusion, analogous to the role of mitochondrial DNA polymerase gamma in toxicity caused by some 2'-deoxynucleotide analogs, there is an assocn. between HCV NI that interact with PolRMT and the observation of adverse events.  More broadly applied, the sensitive methods for detecting mitochondrial toxicity described here may help in the identification of mitochondrial toxicity prior to clin. testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJLNn7rQbeOrVg90H21EOLACvtfcHk0lhDRJia8NaReg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsFKit70%253D&md5=7cc35537b70729a9de882d2ac4b18a98</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1128%2FAAC.01922-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01922-15%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DBarauskas%26aufirst%3DO.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DAhmadyar%26aufirst%3DS.%26aulast%3DStepan%26aufirst%3DG.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DBabusis%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DMcCutcheon%26aufirst%3DK.%26aulast%3DPerron%26aufirst%3DM.%26aulast%3DSchultz%26aufirst%3DB.%2BE.%26aulast%3DSakowicz%26aufirst%3DR.%26aulast%3DRay%26aufirst%3DA.%2BS.%26atitle%3DRole%2520of%2520Mitochondrial%2520RNA%2520Polymerase%2520in%2520the%2520Toxicity%2520of%2520Nucleotide%2520Inhibitors%2520of%2520Hepatitis%2520C%2520Virus%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D806%26epage%3D817%26doi%3D10.1128%2FAAC.01922-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poch, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delarue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, D. H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouloy, M.</span></span> <span> </span><span class="NLM_article-title">Rift Valley Fever Virus L Segment: Correction of the Sequence and Possible Functional Role of Newly Identified Regions Conserved in RNA-Dependent Polymerases</span>. <i>J. Gen. Virol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">1345</span>– <span class="NLM_lpage">1352</span>, <span class="refDoi"> DOI: 10.1099/0022-1317-75-6-1345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1099%2F0022-1317-75-6-1345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=7515937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADyaK2cXlt1Kmsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1994&pages=1345-1352&author=R.+M%C3%BCllerauthor=O.+Pochauthor=M.+Delarueauthor=D.+H.+L.+Bishopauthor=M.+Bouloy&title=Rift+Valley+Fever+Virus+L+Segment%3A+Correction+of+the+Sequence+and+Possible+Functional+Role+of+Newly+Identified+Regions+Conserved+in+RNA-Dependent+Polymerases&doi=10.1099%2F0022-1317-75-6-1345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">Rift valley fever virus L segment: correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases</span></div><div class="casAuthors">Mueller, R.; Poch, O.; Delarue, M.; Bishop, D. H. L.; Bouloy, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1345-52</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    </div><div class="casAbstract">The sequence of Rift Valley fever virus L segment that the authors published in a previous paper was erroneous in the 3'-terminal region of the antigenomic RNA mol.  Here, the authors have shown that the L segment is in fact 6404 nucleotides long and encodes a polypeptide of 237.7 K in the viral complementary sense.  Sequence comparisons performed between the RNA-dependent RNA polymerases of 22 neg.-stranded RNA viruses revealed the existence of two novel regions located at the amino termini of the proteins and conserved only in the polymerases of bunya- and arenaviruses.  In the region conserved in all RNA-dependent polymerases, corresponding to the so-called polymerase module, the authors identified a new motif, designated premotif A, common to all RNA-dependent polymerases, as well as amino acids located in the region between motifs preA and A which are strictly conserved for segmented neg.-stranded RNA viruses.  Using the recently released coordinates of human immunodeficiency virus reverse transcriptase and the alignment between all RNA-dependent polymerases in the polymerase module, the authors have detd. the position of the conserved residues in these polymerases and discuss their possible functions in light of the variable structural information.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq518GlOdLiaLVg90H21EOLACvtfcHk0lhDRJia8NaReg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlt1Kmsb0%253D&md5=9c15f982bafd2de7fbae61e347c8d967</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1099%2F0022-1317-75-6-1345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252F0022-1317-75-6-1345%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DR.%26aulast%3DPoch%26aufirst%3DO.%26aulast%3DDelarue%26aufirst%3DM.%26aulast%3DBishop%26aufirst%3DD.%2BH.%2BL.%26aulast%3DBouloy%26aufirst%3DM.%26atitle%3DRift%2520Valley%2520Fever%2520Virus%2520L%2520Segment%253A%2520Correction%2520of%2520the%2520Sequence%2520and%2520Possible%2520Functional%2520Role%2520of%2520Newly%2520Identified%2520Regions%2520Conserved%2520in%2520RNA-Dependent%2520Polymerases%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D1994%26volume%3D75%26spage%3D1345%26epage%3D1352%26doi%3D10.1099%2F0022-1317-75-6-1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chopra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdine, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, S. C.</span></span> <span> </span><span class="NLM_article-title">Structure of a Covalently Trapped Catalytic Complex of HIV-1 Reverse Transcriptase: Implications for Drug Resistance</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">1669</span>– <span class="NLM_lpage">1675</span>, <span class="refDoi"> DOI: 10.1126/science.282.5394.1669</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1126%2Fscience.282.5394.1669" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=9831551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADyaK1cXnslGhtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1998&pages=1669-1675&author=H.+Huangauthor=R.+Chopraauthor=G.+L.+Verdineauthor=S.+C.+Harrison&title=Structure+of+a+Covalently+Trapped+Catalytic+Complex+of+HIV-1+Reverse+Transcriptase%3A+Implications+for+Drug+Resistance&doi=10.1126%2Fscience.282.5394.1669"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance</span></div><div class="casAuthors">Huang, Huifang; Chopra, Rajiv; Verdine, Gregory L.; Harrison, Stephen C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">5394</span>),
    <span class="NLM_cas:pages">1669-1675</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A combinatorial disulfide crosslinking strategy was used to prep. a stalled complex of human immunodeficiency virus-type 1 (HIV-1) reverse transcriptase with a DNA template:primer and a deoxynucleoside triphosphate (dNTP), and the crystal structure of the complex was detd. at a resoln. of 3.2 angstroms.  The presence of a dideoxynucleotide at the 3'-primer terminus allows capture of a state in which the substrates are poised for attack on the dNTP.  Conformational changes that accompany formation of the catalytic complex produce distinct clusters of the residues that are altered in viruses resistant to nucleoside analog drugs.  The positioning of these residues in the neighborhood of the dNTP helps to resolve some long-standing puzzles about the mol. basis of resistance.  The resistance mutations are likely to influence binding or reactivity of the inhibitors, relative to normal dNTPs, and the clustering of the mutations correlates with the chem. structure of the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV_rP3C5B_N7Vg90H21EOLACvtfcHk0lhDRJia8NaReg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnslGhtr4%253D&md5=e97c3a69e2aa084beff2ec8dd88af3b4</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1126%2Fscience.282.5394.1669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.282.5394.1669%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DVerdine%26aufirst%3DG.%2BL.%26aulast%3DHarrison%26aufirst%3DS.%2BC.%26atitle%3DStructure%2520of%2520a%2520Covalently%2520Trapped%2520Catalytic%2520Complex%2520of%2520HIV-1%2520Reverse%2520Transcriptase%253A%2520Implications%2520for%2520Drug%2520Resistance%26jtitle%3DScience%26date%3D1998%26volume%3D282%26spage%3D1669%26epage%3D1675%26doi%3D10.1126%2Fscience.282.5394.1669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit32c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Appleby, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barauskas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetmore, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sofia, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, T. E.</span></span> <span> </span><span class="NLM_article-title">Structural Basis For RNA Replication by the Hepatitis C Virus Polymerase</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">771</span>– <span class="NLM_lpage">775</span>, <span class="refDoi"> DOI: 10.1126/science.1259210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1126%2Fscience.1259210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=25678663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitlKktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2015&pages=771-775&author=T.+C.+Applebyauthor=J.+K.+Perryauthor=E.+Murakamiauthor=O.+Barauskasauthor=J.+Fengauthor=A.+Choauthor=D.+Foxauthor=D.+R.+Wetmoreauthor=M.+E.+McGrathauthor=A.+S.+Rayauthor=M.+J.+Sofiaauthor=S.+Swaminathanauthor=T.+E.+Edwards&title=Structural+Basis+For+RNA+Replication+by+the+Hepatitis+C+Virus+Polymerase&doi=10.1126%2Fscience.1259210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32cR"><div class="casContent"><span class="casTitleNuber">32c</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for RNA replication by the hepatitis C virus polymerase</span></div><div class="casAuthors">Appleby, Todd C.; Perry, Jason K.; Murakami, Eisuke; Barauskas, Ona; Feng, Joy; Cho, Aesop; Fox, David, III; Wetmore, Diana R.; McGrath, Mary E.; Ray, Adrian S.; Sofia, Michael J.; Swaminathan, S.; Edwards, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6223</span>),
    <span class="NLM_cas:pages">771-775</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Nucleotide analog inhibitors have shown clin. success in the treatment of hepatitis C virus (HCV) infection, despite an incomplete mechanistic understanding of NS5B, the viral RNA-dependent RNA polymerase.  Here we study the details of HCV RNA replication by detg. crystal structures of stalled polymerase ternary complexes with enzymes, RNA templates, RNA primers, incoming nucleotides, and catalytic metal ions during both primed initiation and elongation of RNA synthesis.  Our anal. revealed that highly conserved active-site residues in NS5B position the primer for in-line attack on the incoming nucleotide.  A β loop and a C-terminal membrane-anchoring linker occlude the active-site cavity in the apo state, retract in the primed initiation assembly to enforce replication of the HCV genome from the 3' terminus, and vacate the active-site cavity during elongation.  We investigated the incorporation of nucleotide analog inhibitors, including the clin. active metabolite formed by sofosbuvir, to elucidate key mol. interactions in the active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvMC7Wt9bjr7Vg90H21EOLACvtfcHk0lhvG2GHnr2dXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitlKktrk%253D&md5=aeebcacedf36a44ae80c972100c80c24</span></div><a href="/servlet/linkout?suffix=cit32c&amp;dbid=16384&amp;doi=10.1126%2Fscience.1259210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1259210%26sid%3Dliteratum%253Aachs%26aulast%3DAppleby%26aufirst%3DT.%2BC.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DMurakami%26aufirst%3DE.%26aulast%3DBarauskas%26aufirst%3DO.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DCho%26aufirst%3DA.%26aulast%3DFox%26aufirst%3DD.%26aulast%3DWetmore%26aufirst%3DD.%2BR.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DEdwards%26aufirst%3DT.%2BE.%26atitle%3DStructural%2520Basis%2520For%2520RNA%2520Replication%2520by%2520the%2520Hepatitis%2520C%2520Virus%2520Polymerase%26jtitle%3DScience%26date%3D2015%26volume%3D347%26spage%3D771%26epage%3D775%26doi%3D10.1126%2Fscience.1259210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="note"><p class="first last">For active site models of other filovirus polymerases see the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01594/suppl_file/jm6b01594_si_001.pdb" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barauskas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenaux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirunagari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagpacan, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ku, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitrinos, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkus, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Hepatitis C Virus Replication by GS-6620, a Potent <i>C</i>-Nucleoside Monophosphate Prodrug</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1930</span>– <span class="NLM_lpage">1942</span>, <span class="refDoi"> DOI: 10.1128/AAC.02351-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1128%2FAAC.02351-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=24419349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVSlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=1930-1942&author=J.+Y.+Fengauthor=G.+Chengauthor=J.+Perryauthor=O.+Barauskasauthor=Y.+Xuauthor=M.+Fenauxauthor=S.+Engauthor=N.+Tirunagariauthor=B.+Pengauthor=M.+Yuauthor=Y.+Tianauthor=Y.-J.+Leeauthor=G.+Stepanauthor=L.+L.+Lagpacanauthor=D.+Jinauthor=M.+Hungauthor=K.+S.+Kuauthor=B.+Hanauthor=K.+Kitrinosauthor=M.+Perronauthor=G.+Birkusauthor=K.+A.+Wongauthor=W.+Zhongauthor=C.+U.+Kimauthor=A.+Careyauthor=A.+Choauthor=A.+S.+Ray&title=Inhibition+of+Hepatitis+C+Virus+Replication+by+GS-6620%2C+a+Potent+C-Nucleoside+Monophosphate+Prodrug&doi=10.1128%2FAAC.02351-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of hepatitis C virus replication by GS-6620, a potent C-nucleoside monophosphate prodrug</span></div><div class="casAuthors">Feng, Joy Y.; Cheng, Guofeng; Perry, Jason; Barauskas, Ona; Xu, Yili; Fenaux, Martijn; Eng, Stacey; Tirunagari, Neeraj; Peng, Betty; Yu, Mei; Tian, Yang; Lee, Yu-Jen; Stepan, George; Lagpacan, Leanna L.; Jin, Debi; Hung, Magdeleine; Ku, Karin S.; Han, Bin; Kitrinos, Kathryn; Perron, Michel; Birkus, Gabriel; Wong, Kelly A.; Zhong, Weidong; Kim, Choung U.; Carey, Anne; Cho, Aesop; Ray, Adrian S.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1930-1942, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">As a class, nucleotide inhibitors (NIs) of the hepatitis C virus (HCV) nonstructural protein 5B (NS5B) RNA-dependent RNA polymerase offer advantages over other direct-acting antivirals, including properties, such as pangenotype activity, a high barrier to resistance, and reduced potential for drug-drug interactions.  We studied the in vitro pharmacol. of a novel C-nucleoside adenosine analog monophosphate prodrug, GS-6620.  It was found to be a potent and selective HCV inhibitor against HCV replicons of genotypes 1 to 6 and against an infectious genotype 2a virus (50% effective concn. [EC50], 0.048 to 0.68 μM).  GS-6620 showed limited activities against other viruses, maintaining only some of its activity against the closely related bovine viral diarrhea virus (EC50, 1.5 μM).  The active 5'-triphosphate metabolite of GS-6620 is a chain terminator of viral RNA synthesis and a competitive inhibitor of NS5B-catalyzed ATP incorporation, with Ki/Km values of 0.23 and 0.18 for HCV NS5B genotypes 1b and 2a, resp.  With its unique dual substitutions of 1'-CN and 2'-C-Me on the ribose ring, the active triphosphate metabolite was found to have enhanced selectivity for the HCV NS5B polymerase over host RNA polymerases.  GS-6620 demonstrated a high barrier to resistance in vitro.  Prolonged passaging resulted in the selection of the S282T mutation in NS5B that was found to be resistant in both cellular and enzymic assays (>30-fold).  Consistent with its in vitro profile, GS-6620 exhibited the potential for potent anti-HCV activity in a proof-of-concept clin. trial, but its utility was limited by the requirement of high dose levels and pharmacokinetic and pharmacodynamic variability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvNp6xp0zrdrVg90H21EOLACvtfcHk0lhvG2GHnr2dXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVSlsLs%253D&md5=43e83867f11918c5499dd6a993386260</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1128%2FAAC.02351-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02351-13%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DBarauskas%26aufirst%3DO.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DFenaux%26aufirst%3DM.%26aulast%3DEng%26aufirst%3DS.%26aulast%3DTirunagari%26aufirst%3DN.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DY.-J.%26aulast%3DStepan%26aufirst%3DG.%26aulast%3DLagpacan%26aufirst%3DL.%2BL.%26aulast%3DJin%26aufirst%3DD.%26aulast%3DHung%26aufirst%3DM.%26aulast%3DKu%26aufirst%3DK.%2BS.%26aulast%3DHan%26aufirst%3DB.%26aulast%3DKitrinos%26aufirst%3DK.%26aulast%3DPerron%26aufirst%3DM.%26aulast%3DBirkus%26aufirst%3DG.%26aulast%3DWong%26aufirst%3DK.%2BA.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DKim%26aufirst%3DC.%2BU.%26aulast%3DCarey%26aufirst%3DA.%26aulast%3DCho%26aufirst%3DA.%26aulast%3DRay%26aufirst%3DA.%2BS.%26atitle%3DInhibition%2520of%2520Hepatitis%2520C%2520Virus%2520Replication%2520by%2520GS-6620%252C%2520a%2520Potent%2520C-Nucleoside%2520Monophosphate%2520Prodrug%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D1930%26epage%3D1942%26doi%3D10.1128%2FAAC.02351-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T.</span>; <span class="NLM_string-name">Cho, A.</span>; <span class="NLM_string-name">Kim, C. U.</span>; <span class="NLM_string-name">Saunders, O. L.</span>; <span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">1′-Substituted Carba-Nucleoside Analogs for Antiviral Treatment</span>. U.S. Patent <span class="NLM_patent">2009041447</span> Apr., 22, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=T.+Butler&author=A.+Cho&author=C.+U.+Kim&author=O.+L.+Saunders&author=L.+Zhang&title=1%E2%80%B2-Substituted+Carba-Nucleoside+Analogs+for+Antiviral+Treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DT.%26atitle%3D1%25E2%2580%25B2-Substituted%2520Carba-Nucleoside%2520Analogs%2520for%2520Antiviral%2520Treatment%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T.</span>; <span class="NLM_string-name">Cho, A.</span>; <span class="NLM_string-name">Graetz, B. R.</span>; <span class="NLM_string-name">Kim, C. U.</span>; <span class="NLM_string-name">Metobo, S. E.</span>; <span class="NLM_string-name">Saunders, O. L.</span>; <span class="NLM_string-name">Waltman, A. W.</span>; <span class="NLM_string-name">Xu, J.</span>; <span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">Processes and Intermediates for the Preparation of 1′-Substituted Carba-Nucleoside Analogs</span>. U.S. Patent<span class="NLM_patent">20100459508</span> Sep., 20, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+Butler&author=A.+Cho&author=B.+R.+Graetz&author=C.+U.+Kim&author=S.+E.+Metobo&author=O.+L.+Saunders&author=A.+W.+Waltman&author=J.+Xu&author=L.+Zhang&title=Processes+and+Intermediates+for+the+Preparation+of+1%E2%80%B2-Substituted+Carba-Nucleoside+Analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DT.%26atitle%3DProcesses%2520and%2520Intermediates%2520for%2520the%2520Preparation%2520of%25201%25E2%2580%25B2-Substituted%2520Carba-Nucleoside%2520Analogs%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Metobo, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, O. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aktoudianakis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. U.</span></span> <span> </span><span class="NLM_article-title">Practical Synthesis of 1′-Substituted Tubercidin <i>C</i>-Nucleoside Analogs</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2011.11.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1016%2Fj.tetlet.2011.11.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Ols7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=484-486&author=S.+E.+Metoboauthor=J.+Xuauthor=O.+L.+Saundersauthor=T.+Butlerauthor=E.+Aktoudianakisauthor=A.+Choauthor=C.+U.+Kim&title=Practical+Synthesis+of+1%E2%80%B2-Substituted+Tubercidin+C-Nucleoside+Analogs&doi=10.1016%2Fj.tetlet.2011.11.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Practical synthesis of 1'-substituted Tubercidin C-nucleoside analogs</span></div><div class="casAuthors">Metobo, Sammy E.; Xu, Jie; Saunders, Oliver L.; Butler, Thomas; Aktoudianakis, Evangelos; Cho, Aesop; Kim, Choung U.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">484-486</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Several 1'-substituted analogs of Tubercidin C-nucleosides were prepd. using a highly convergent synthesis.  Good to high diastereoselectivity was achieved using a variety of nucleophiles targeting the 1'-position.  The source for this stereoselectivity is herein proposed.  It is thought to be attributed to a temp.-dependent chelation of the incoming nucleophile to either the 2'- or 3'-benzyloxy ether of the ribose core.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzYtnu5F19ibVg90H21EOLACvtfcHk0lgYAX0Y5r213A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Ols7fN&md5=14adad9cdf925cecfa238f7ef2330902</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2011.11.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2011.11.055%26sid%3Dliteratum%253Aachs%26aulast%3DMetobo%26aufirst%3DS.%2BE.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DSaunders%26aufirst%3DO.%2BL.%26aulast%3DButler%26aufirst%3DT.%26aulast%3DAktoudianakis%26aufirst%3DE.%26aulast%3DCho%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DC.%2BU.%26atitle%3DPractical%2520Synthesis%2520of%25201%25E2%2580%25B2-Substituted%2520Tubercidin%2520C-Nucleoside%2520Analogs%26jtitle%3DTetrahedron%2520Lett.%26date%3D2012%26volume%3D53%26spage%3D484%26epage%3D486%26doi%3D10.1016%2Fj.tetlet.2011.11.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Axt, S. D.</span>; <span class="NLM_string-name">Badalov, P. R.</span>; <span class="NLM_string-name">Brak, K.</span>; <span class="NLM_string-name">Campagna, S.</span>; <span class="NLM_string-name">Chtchemelinine, A.</span>; <span class="NLM_string-name">Chun, B. K.</span>; <span class="NLM_string-name">Clarke, M. O. H.</span>; <span class="NLM_string-name">Doerffler, E.</span>; <span class="NLM_string-name">Frick, M. M.</span>; <span class="NLM_string-name">Gao, D.</span>; <span class="NLM_string-name">Heumann, L. V.</span>; <span class="NLM_string-name">Hoang, B.</span>; <span class="NLM_string-name">Hui, H. C.</span>; <span class="NLM_string-name">Jordan, R.</span>; <span class="NLM_string-name">Lew, W.</span>; <span class="NLM_string-name">Mackman, R. L.</span>; <span class="NLM_string-name">Milburn, R. R.</span>; <span class="NLM_string-name">Neville, S. T.</span>; <span class="NLM_string-name">Parrish, J. P.</span>; <span class="NLM_string-name">Ray, A. S.</span>; <span class="NLM_string-name">Ross, B.</span>; <span class="NLM_string-name">Rueden, E.</span>; <span class="NLM_string-name">Scott, R. W.</span>; <span class="NLM_string-name">Siegel, D.</span>; <span class="NLM_string-name">Stevens, A. C.</span>; <span class="NLM_string-name">Tadeus, C.</span>; <span class="NLM_string-name">Vieira, T.</span>; <span class="NLM_string-name">Waltman, A. W.</span>; <span class="NLM_string-name">Wang, X.</span>; <span class="NLM_string-name">Whitcomb, M. C.</span>; <span class="NLM_string-name">Wolfe, L.</span>; <span class="NLM_string-name">Yu, C.-Y.</span></span> <span> </span><span class="NLM_article-title">Methods For Treating Filoviridae Virus Infections</span>. U.S. Patent <span class="NLM_patent">2015017934</span>, Oct. 29, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+D.+Axt&author=P.+R.+Badalov&author=K.+Brak&author=S.+Campagna&author=A.+Chtchemelinine&author=B.+K.+Chun&author=M.+O.+H.+Clarke&author=E.+Doerffler&author=M.+M.+Frick&author=D.+Gao&author=L.+V.+Heumann&author=B.+Hoang&author=H.+C.+Hui&author=R.+Jordan&author=W.+Lew&author=R.+L.+Mackman&author=R.+R.+Milburn&author=S.+T.+Neville&author=J.+P.+Parrish&author=A.+S.+Ray&author=B.+Ross&author=E.+Rueden&author=R.+W.+Scott&author=D.+Siegel&author=A.+C.+Stevens&author=C.+Tadeus&author=T.+Vieira&author=A.+W.+Waltman&author=X.+Wang&author=M.+C.+Whitcomb&author=L.+Wolfe&author=C.-Y.+Yu&title=Methods+For+Treating+Filoviridae+Virus+Infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAxt%26aufirst%3DS.%2BD.%26atitle%3DMethods%2520For%2520Treating%2520Filoviridae%2520Virus%2520Infections%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krasovskiy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knochel, P.</span></span> <span> </span><span class="NLM_article-title">A LiCl-Mediated Br/Mg Exchange Reaction For the Preparation of Functionalized Aryl- and Heteroarylmagnesium Compounds From Organic Bromides</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">3333</span>– <span class="NLM_lpage">3336</span>, <span class="refDoi"> DOI: 10.1002/anie.200454084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1002%2Fanie.200454084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsF2gu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=3333-3336&author=A.+Krasovskiyauthor=P.+Knochel&title=A+LiCl-Mediated+Br%2FMg+Exchange+Reaction+For+the+Preparation+of+Functionalized+Aryl-+and+Heteroarylmagnesium+Compounds+From+Organic+Bromides&doi=10.1002%2Fanie.200454084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A LiCl-mediated Br/Mg exchange reaction for the preparation of functionalized aryl- and heteroarylmagnesium compounds from organic bromides</span></div><div class="casAuthors">Krasovskiy, Arkady; Knochel, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3333-3336</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A wide range of aryl and heteroaryl bromides, which are usually sluggish in exchange reactions, are readily converted into the corresponding Grignard reagents by means of a Br/Mg exchange reaction triggered by iPrMgCl·LiCl.  These Grignard intermediates react with electrophiles in good yields.  For example, 4-MeOC6H4MgCl·LiCl was prepd. from iPrMgCl·LiCl and 4-MeOC6H4Br and reacted with PhCHO giving 4-MeOC6H4CH(OH)Ph (70% yield).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPoDY5Id67ErVg90H21EOLACvtfcHk0lgYAX0Y5r213A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsF2gu7s%253D&md5=aabf3ff877c31da0dd84f3a5be883580</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fanie.200454084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200454084%26sid%3Dliteratum%253Aachs%26aulast%3DKrasovskiy%26aufirst%3DA.%26aulast%3DKnochel%26aufirst%3DP.%26atitle%3DA%2520LiCl-Mediated%2520Br%252FMg%2520Exchange%2520Reaction%2520For%2520the%2520Preparation%2520of%2520Functionalized%2520Aryl-%2520and%2520Heteroarylmagnesium%2520Compounds%2520From%2520Organic%2520Bromides%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2004%26volume%3D43%26spage%3D3333%26epage%3D3336%26doi%3D10.1002%2Fanie.200454084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span>For a separate account
describing the crystallization induced resolution of <i>p</i>-nitrophenolate 2-ethylbutyl-L-alaninate phosphoramidate see: <span class="NLM_contrib-group"><span class="NLM_string-name">Klasson, B.</span>; <span class="NLM_string-name">Eneroth, A.</span>; <span class="NLM_string-name">Nilson, M.</span>; <span class="NLM_string-name">Pinho, P.</span>; <span class="NLM_string-name">Samuelsson, B.</span>; <span class="NLM_string-name">Sund, C.</span></span> <span> </span><span class="NLM_article-title">HCV Polymerase Inhibitors</span>. European Patent <span class="NLM_patent">IB2012056994</span> Dec. 5, <span class="NLM_year">2012</span>. The conditions in this patent were identified independently/concurrently with this report.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=B.+Klasson&author=A.+Eneroth&author=M.+Nilson&author=P.+Pinho&author=B.+Samuelsson&author=C.+Sund&title=HCV+Polymerase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKlasson%26aufirst%3DB.%26atitle%3DHCV%2520Polymerase%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bahar, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogihara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, T.</span></span> <span> </span><span class="NLM_article-title">Species Difference of Esterase Expression and Hydrolase Activity in Plasma</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">3979</span>– <span class="NLM_lpage">3988</span>, <span class="refDoi"> DOI: 10.1002/jps.23258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1002%2Fjps.23258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=22833171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVyksb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2012&pages=3979-3988&author=F.+G.+Baharauthor=K.+Ohuraauthor=T.+Ogiharaauthor=T.+Imai&title=Species+Difference+of+Esterase+Expression+and+Hydrolase+Activity+in+Plasma&doi=10.1002%2Fjps.23258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Species difference of esterase expression and hydrolase activity in plasma</span></div><div class="casAuthors">Bahar, Fatma Goksin; Ohura, Kayoko; Ogihara, Takuo; Imai, Teruko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3979-3988</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Differences in esterase expression among human, rhesus monkey, cynomolgus monkey, dog, minipig, rabbit, rat, and mouse plasma were identified using native polyacrylamide gel electrophoresis.  Paraoxonase (PON) and butyrylcholinesterase (BChE) were ubiquitous in all species, but were highly expressed in primates and dogs, whereas carboxylesterase (CES) was only abundant in rabbits, mice, and rats.  Several unknown esterases were obsd. in minipig and mouse plasma.  These differences in plasma esterases and their expression levels result in species differences with respect to hydrolase activity.  These differences were characterized using several different substrates.  In contrast to the high hydrolase activity found for p-nitrophenylacetate (PNPA), a substrate of several hydrolase enzymes, irinotecan, a carbamate compd., was resistant to all plasma esterases.  Oseltamivir, temocapril, and propranolol (PL) derivs. were rapidly hydrolyzed in mouse and rat plasma by their highly active CES enzyme, but rabbit plasma CES hydrolyzed only the PL derivs.  Interestingly, PL derivs. were highly hydrolyzed by monkey plasma BChE, whereas BChE from human, dog, and minipig plasma showed negligible activity.  In conclusion, the esterase expression and hydrolyzing pattern of dog plasma were found to be closest to that of human plasma.  These differences should be considered when selecting model animals for preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIjepKzp5aYLVg90H21EOLACvtfcHk0lgYAX0Y5r213A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVyksb7L&md5=6ec3b10b30a3ab7071a426eadb993a11</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fjps.23258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23258%26sid%3Dliteratum%253Aachs%26aulast%3DBahar%26aufirst%3DF.%2BG.%26aulast%3DOhura%26aufirst%3DK.%26aulast%3DOgihara%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DT.%26atitle%3DSpecies%2520Difference%2520of%2520Esterase%2520Expression%2520and%2520Hydrolase%2520Activity%2520in%2520Plasma%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D101%26spage%3D3979%26epage%3D3988%26doi%3D10.1002%2Fjps.23258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhagani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cropley, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filipe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gifford, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabeen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannessen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karageorgopoulos, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lackenby, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lester, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R. S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacConnachie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahungu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mepham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmarini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seaton, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sreenu, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Templeton, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkie, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, E. C.</span></span> <span> </span><span class="NLM_article-title">Late Ebola Virus Relapse Causing Meningoencephalitis: A Case Report</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>388</i></span>,  <span class="NLM_fpage">498</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(16)30386-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1016%2FS0140-6736%2816%2930386-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=27209148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FitV2ksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2016&pages=498-503&author=M.+Jacobsauthor=A.+Rodgerauthor=D.+D.+Bellauthor=S.+Bhaganiauthor=I.+Cropleyauthor=A.+Filipeauthor=R.+J.+Giffordauthor=S.+Hopkinsauthor=J.+Hughesauthor=F.+Jabeenauthor=I.+Johannessenauthor=D.+Karageorgopoulosauthor=A.+Lackenbyauthor=R.+Lesterauthor=R.+S.+N.+Liuauthor=A.+MacConnachieauthor=T.+Mahunguauthor=D.+Martinauthor=N.+Marshallauthor=S.+Mephamauthor=R.+Ortonauthor=M.+Palmariniauthor=M.+Patelauthor=C.+Perryauthor=S.+E.+Petersauthor=D.+Porterauthor=D.+Ritchieauthor=N.+D.+Ritchieauthor=R.+A.+Seatonauthor=V.+B.+Sreenuauthor=K.+Templetonauthor=S.+Warrenauthor=G.+S.+Wilkieauthor=M.+Zambonauthor=R.+Gopalauthor=E.+C.+Thomson&title=Late+Ebola+Virus+Relapse+Causing+Meningoencephalitis%3A+A+Case+Report&doi=10.1016%2FS0140-6736%2816%2930386-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Late Ebola virus relapse causing meningoencephalitis: a case report</span></div><div class="casAuthors">Jacobs Michael; Rodger Alison; Bell David J; MacConnachie Alisdair; Perry Colin; Peters S Erica; Porter Duncan; Ritchie David; Ritchie Neil D; Seaton R Andrew; Bhagani Sanjay; Cropley Ian; Hopkins Susan; Karageorgopoulos Drosos; Lester Rebecca; Mahungu Tabitha; Mepham Stephen; Warren Simon; Filipe Ana; Gifford Robert J; Hughes Joseph; Orton Richard; Palmarini Massimo; Sreenu Vattipally B; Wilkie Gavin S; Jabeen Farrah; Johannessen Ingolfur; Templeton Kate; Lackenby Angie; Zambon Maria; Liu Rebecca S N; Martin Daniel; Marshall Neal; Patel Monika; Gopal Robin; Thomson Emma C</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">10043</span>),
    <span class="NLM_cas:pages">498-503</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  There are thousands of survivors of the 2014 Ebola outbreak in west Africa.  Ebola virus can persist in survivors for months in immune-privileged sites; however, viral relapse causing life-threatening and potentially transmissible disease has not been described.  We report a case of late relapse in a patient who had been treated for severe Ebola virus disease with high viral load (peak cycle threshold value 13.2).  METHODS:  A 39-year-old female nurse from Scotland, who had assisted the humanitarian effort in Sierra Leone, had received intensive supportive treatment and experimental antiviral therapies, and had been discharged with undetectable Ebola virus RNA in peripheral blood.  The patient was readmitted to hospital 9 months after discharge with symptoms of acute meningitis, and was found to have Ebola virus in cerebrospinal fluid (CSF).  She was treated with supportive therapy and experimental antiviral drug GS-5734 (Gilead Sciences, San Francisco, Foster City, CA, USA).  We monitored Ebola virus RNA in CSF and plasma, and sequenced the viral genome using an unbiased metagenomic approach.  FINDINGS:  On admission, reverse transcriptase PCR identified Ebola virus RNA at a higher level in CSF (cycle threshold value 23.7) than plasma (31.3); infectious virus was only recovered from CSF.  The patient developed progressive meningoencephalitis with cranial neuropathies and radiculopathy.  Clinical recovery was associated with addition of high-dose corticosteroids during GS-5734 treatment.  CSF Ebola virus RNA slowly declined and was undetectable following 14 days of treatment with GS-5734.  Sequencing of plasma and CSF viral genome revealed only two non-coding changes compared with the original infecting virus.  INTERPRETATION:  Our report shows that previously unanticipated, late, severe relapses of Ebola virus can occur, in this case in the CNS.  This finding fundamentally redefines what is known about the natural history of Ebola virus infection.  Vigilance should be maintained in the thousands of Ebola survivors for cases of relapsed infection.  The potential for these cases to initiate new transmission chains is a serious public health concern.  FUNDING:  Royal Free London NHS Foundation Trust.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRYRsrOSKHcwJQHPYJuLg8TfW6udTcc2eYHPQGwFIg83Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FitV2ksg%253D%253D&md5=c2cb4099c19a6603874e120d53a7c8b4</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2816%2930386-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252816%252930386-5%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DRodger%26aufirst%3DA.%26aulast%3DBell%26aufirst%3DD.%2BD.%26aulast%3DBhagani%26aufirst%3DS.%26aulast%3DCropley%26aufirst%3DI.%26aulast%3DFilipe%26aufirst%3DA.%26aulast%3DGifford%26aufirst%3DR.%2BJ.%26aulast%3DHopkins%26aufirst%3DS.%26aulast%3DHughes%26aufirst%3DJ.%26aulast%3DJabeen%26aufirst%3DF.%26aulast%3DJohannessen%26aufirst%3DI.%26aulast%3DKarageorgopoulos%26aufirst%3DD.%26aulast%3DLackenby%26aufirst%3DA.%26aulast%3DLester%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DR.%2BS.%2BN.%26aulast%3DMacConnachie%26aufirst%3DA.%26aulast%3DMahungu%26aufirst%3DT.%26aulast%3DMartin%26aufirst%3DD.%26aulast%3DMarshall%26aufirst%3DN.%26aulast%3DMepham%26aufirst%3DS.%26aulast%3DOrton%26aufirst%3DR.%26aulast%3DPalmarini%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DC.%26aulast%3DPeters%26aufirst%3DS.%2BE.%26aulast%3DPorter%26aufirst%3DD.%26aulast%3DRitchie%26aufirst%3DD.%26aulast%3DRitchie%26aufirst%3DN.%2BD.%26aulast%3DSeaton%26aufirst%3DR.%2BA.%26aulast%3DSreenu%26aufirst%3DV.%2BB.%26aulast%3DTempleton%26aufirst%3DK.%26aulast%3DWarren%26aufirst%3DS.%26aulast%3DWilkie%26aufirst%3DG.%2BS.%26aulast%3DZambon%26aufirst%3DM.%26aulast%3DGopal%26aufirst%3DR.%26aulast%3DThomson%26aufirst%3DE.%2BC.%26atitle%3DLate%2520Ebola%2520Virus%2520Relapse%2520Causing%2520Meningoencephalitis%253A%2520A%2520Case%2520Report%26jtitle%3DLancet%26date%3D2016%26volume%3D388%26spage%3D498%26epage%3D503%26doi%3D10.1016%2FS0140-6736%2816%2930386-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schnirring, L.</span></span> <span> </span><span class="NLM_article-title">Youngest Ebola Survivor Leaves Guinea Hospital</span>; <span class="NLM_publisher-name">Center For Infectious Disease Research and Policy</span>, <span class="NLM_publisher-loc">Minneapolis, MN, USA</span>, Nov. 30, <span class="NLM_year">2015</span>; <a href="http://www.cidrap.umn.edu/news-perspective/2015/11/youngest-ebola-survivor-leaves-guinea-hospital" class="extLink">http://www.cidrap.umn.edu/news-perspective/2015/11/youngest-ebola-survivor-leaves-guinea-hospital</a> (accessed Jul. 22, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=L.+Schnirring&title=Youngest+Ebola+Survivor+Leaves+Guinea+Hospital"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DSchnirring%26aufirst%3DL.%26atitle%3DYoungest%2520Ebola%2520Survivor%2520Leaves%2520Guinea%2520Hospital%26pub%3DCenter%2520For%2520Infectious%2520Disease%2520Research%2520and%2520Policy%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">National Institues of Health</span>. <span> </span><span class="NLM_article-title">PREVAIL Treatment
Trial For Men With Persistent Ebola Viral RNA in Semen Opens in Liberia</span>, Jul. 5, <span class="NLM_year">2016</span>; <a href="https://www.nih.gov/news-events/news-releases/prevail-treatment-trial-men-persistent-ebola-viral-rna-semen-opens-liberia" class="extLink">https://www.nih.gov/news-events/news-releases/prevail-treatment-trial-men-persistent-ebola-viral-rna-semen-opens-liberia</a> (accessed, Jul., 22, <span class="NLM_year">2016</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=National+Institues+of+Health&title=PREVAIL+Treatment%0ATrial+For+Men+With+Persistent+Ebola+Viral+RNA+in+Semen+Opens+in+Liberia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DPREVAIL%2520Treatment%250ATrial%2520For%2520Men%2520With%2520Persistent%2520Ebola%2520Viral%2520RNA%2520in%2520Semen%2520Opens%2520in%2520Liberia%26date%3D2016%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29a','cit29b'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32a','cit32b','cit32c'],'ref33':[],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 254 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Didier F. Vargas, Enrique L. Larghi, <span class="NLM_string-name hlFld-ContribAuthor">Teodoro S. Kaufman</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of the Synthesis of Remdesivir. Classical Approaches and Most Recent Advances. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2021,</strong> <em>6 </em>
                                    (30)
                                     , 19356-19363. <a href="https://doi.org/10.1021/acsomega.1c03082" title="DOI URL">https://doi.org/10.1021/acsomega.1c03082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.1c03082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.1c03082%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DEvolution%252Bof%252Bthe%252BSynthesis%252Bof%252BRemdesivir.%252BClassical%252BApproaches%252Band%252BMost%252BRecent%252BAdvances%26aulast%3DVargas%26aufirst%3DDidier%2BF.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D11062021%26date%3D14072021%26date%3D23072021%26volume%3D6%26issue%3D30%26spage%3D19356%26epage%3D19363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Violaine Desgens-Martin, <span class="NLM_string-name hlFld-ContribAuthor">Arturo A. Keller</span>. </span><span class="cited-content_cbyCitation_article-title">COVID-19 Treatment Agents: Do They Pose an Environmental Risk?. </span><span class="cited-content_cbyCitation_journal-name">ACS ES&T Water</span><span> <strong>2021,</strong> <em>1 </em>
                                    (7)
                                     , 1555-1565. <a href="https://doi.org/10.1021/acsestwater.1c00059" title="DOI URL">https://doi.org/10.1021/acsestwater.1c00059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsestwater.1c00059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsestwater.1c00059%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520ES%2526T%2520Water%26atitle%3DCOVID-19%252BTreatment%252BAgents%25253A%252BDo%252BThey%252BPose%252Ban%252BEnvironmental%252BRisk%25253F%26aulast%3DDesgens-Martin%26aufirst%3DViolaine%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D17022021%26date%3D26052021%26date%3D21052021%26date%3D09062021%26volume%3D1%26issue%3D7%26spage%3D1555%26epage%3D1565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">David L. Hughes</span>. </span><span class="cited-content_cbyCitation_article-title">Quest for a Cure: Potential Small-Molecule Treatments for COVID-19, Part 2. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2021,</strong> <em>25 </em>
                                    (5)
                                     , 1089-1111. <a href="https://doi.org/10.1021/acs.oprd.1c00100" title="DOI URL">https://doi.org/10.1021/acs.oprd.1c00100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.1c00100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.1c00100%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DQuest%252Bfor%252Ba%252BCure%25253A%252BPotential%252BSmall-Molecule%252BTreatments%252Bfor%252BCOVID-19%25252C%252BPart%252B2%26aulast%3DHughes%26aufirst%3DDavid%2BL.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D23032021%26date%3D19042021%26volume%3D25%26issue%3D5%26spage%3D1089%26epage%3D1111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Richard L. Mackman, Hon C. Hui, Michel Perron, Eisuke Murakami, Christopher Palmiotti, Gary Lee, Kirsten Stray, Lijun Zhang, Bindu Goyal, Kwon Chun, Daniel Byun, Dustin Siegel, Scott Simonovich, Venice Du Pont, Jared Pitts, Darius Babusis, Arya Vijjapurapu, Xianghan Lu, Cynthia Kim, Xiaofeng Zhao, Julie Chan, Bin Ma, Diane Lye, Adelle Vandersteen, Sarah Wortman, Kimberly T. Barrett, Maria Toteva, Robert Jordan, Raju Subramanian, John P. Bilello, <span class="NLM_string-name hlFld-ContribAuthor">Tomas Cihlar</span>. </span><span class="cited-content_cbyCitation_article-title">Prodrugs of a 1′-CN-4-Aza-7,9-dideazaadenosine C-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 5001-5017. <a href="https://doi.org/10.1021/acs.jmedchem.1c00071" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00071%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProdrugs%252Bof%252Ba%252B1%2525E2%252580%2525B2-CN-4-Aza-7%25252C9-dideazaadenosine%252BC-Nucleoside%252BLeading%252Bto%252Bthe%252BDiscovery%252Bof%252BRemdesivir%252B%252528GS-5734%252529%252Bas%252Ba%252BPotent%252BInhibitor%252Bof%252BRespiratory%252BSyncytial%252BVirus%252Bwith%252BEfficacy%252Bin%252Bthe%252BAfrican%252BGreen%252BMonkey%252BModel%252Bof%252BRSV%26aulast%3DMackman%26aufirst%3DRichard%2BL.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D15012021%26date%3D09042021%26volume%3D64%26issue%3D8%26spage%3D5001%26epage%3D5017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Timo von Keutz, Jason D. Williams, <span class="NLM_string-name hlFld-ContribAuthor">C. Oliver Kappe</span>. </span><span class="cited-content_cbyCitation_article-title">Flash Chemistry Approach to Organometallic C-Glycosylation for the Synthesis of Remdesivir. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2021,</strong> <em>25 </em>
                                    (4)
                                     , 1015-1021. <a href="https://doi.org/10.1021/acs.oprd.1c00024" title="DOI URL">https://doi.org/10.1021/acs.oprd.1c00024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.1c00024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.1c00024%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DFlash%252BChemistry%252BApproach%252Bto%252BOrganometallic%252BC-Glycosylation%252Bfor%252Bthe%252BSynthesis%252Bof%252BRemdesivir%26aulast%3Dvon%2BKeutz%26aufirst%3DTimo%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D21012021%26date%3D22022021%26volume%3D25%26issue%3D4%26spage%3D1015%26epage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ting Chen, Cheng-Yin Fei, Yi-Ping Chen, Karen Sargsyan, Chun-Ping Chang, Hanna S. Yuan, <span class="NLM_string-name hlFld-ContribAuthor">Carmay Lim</span>. </span><span class="cited-content_cbyCitation_article-title">Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2021,</strong> <em>4 </em>
                                    (2)
                                     , 898-907. <a href="https://doi.org/10.1021/acsptsci.1c00022" title="DOI URL">https://doi.org/10.1021/acsptsci.1c00022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.1c00022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.1c00022%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DSynergistic%252BInhibition%252Bof%252BSARS-CoV-2%252BReplication%252BUsing%252BDisulfiram%25252FEbselen%252Band%252BRemdesivir%26aulast%3DChen%26aufirst%3DTing%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D15012021%26date%3D26032021%26volume%3D4%26issue%3D2%26spage%3D898%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jiapeng Li, Shuhan Liu, Jian Shi, Xinwen Wang, Yanling Xue, <span class="NLM_string-name hlFld-ContribAuthor">Hao-Jie Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Tissue-Specific Proteomics Analysis of Anti-COVID-19 Nucleoside and Nucleotide Prodrug-Activating Enzymes Provides Insights into the Optimization of Prodrug Design and Pharmacotherapy Strategy. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2021,</strong> <em>4 </em>
                                    (2)
                                     , 870-887. <a href="https://doi.org/10.1021/acsptsci.1c00016" title="DOI URL">https://doi.org/10.1021/acsptsci.1c00016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.1c00016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.1c00016%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DTissue-Specific%252BProteomics%252BAnalysis%252Bof%252BAnti-COVID-19%252BNucleoside%252Band%252BNucleotide%252BProdrug-Activating%252BEnzymes%252BProvides%252BInsights%252Binto%252Bthe%252BOptimization%252Bof%252BProdrug%252BDesign%252Band%252BPharmacotherapy%252BStrategy%26aulast%3DLi%26aufirst%3DJiapeng%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D08012021%26date%3D01042021%26volume%3D4%26issue%3D2%26spage%3D870%26epage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ei-ichi Ami, <span class="NLM_string-name hlFld-ContribAuthor">Hiroshi Ohrui</span>. </span><span class="cited-content_cbyCitation_article-title">Intriguing Antiviral Modified Nucleosides: A Retrospective View into the Future Treatment of COVID-19. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (4)
                                     , 510-517. <a href="https://doi.org/10.1021/acsmedchemlett.1c00070" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.1c00070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.1c00070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.1c00070%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIntriguing%252BAntiviral%252BModified%252BNucleosides%25253A%252BA%252BRetrospective%252BView%252Binto%252Bthe%252BFuture%252BTreatment%252Bof%252BCOVID-19%26aulast%3DAmi%26aufirst%3DEi-ichi%26date%3D2021%26date%3D2021%26date%3D29032021%26volume%3D12%26issue%3D4%26spage%3D510%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yuanchao Xie, Tianwen Hu, Yan Zhang, Daibao Wei, Wei Zheng, Fuqiang Zhu, Guanghui Tian, Haji A. Aisa, <span class="NLM_string-name hlFld-ContribAuthor">Jingshan Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Weinreb Amide Approach to the Practical Synthesis of a Key Remdesivir Intermediate. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (7)
                                     , 5065-5072. <a href="https://doi.org/10.1021/acs.joc.0c02986" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02986</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02986%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DWeinreb%252BAmide%252BApproach%252Bto%252Bthe%252BPractical%252BSynthesis%252Bof%252Ba%252BKey%252BRemdesivir%252BIntermediate%26aulast%3DXie%26aufirst%3DYuanchao%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D20122020%26date%3D18032021%26volume%3D86%26issue%3D7%26spage%3D5065%26epage%3D5072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Veeranjaneyulu Gannedi, Bharath Kumar Villuri, Sivakumar N. Reddy, Chiao-Chu Ku, Chi-Huey Wong, <span class="NLM_string-name hlFld-ContribAuthor">Shang-Cheng Hung</span>. </span><span class="cited-content_cbyCitation_article-title">Practical Remdesivir Synthesis through One-Pot Organocatalyzed Asymmetric (S)-P-Phosphoramidation. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (7)
                                     , 4977-4985. <a href="https://doi.org/10.1021/acs.joc.0c02888" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02888</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02888%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPractical%252BRemdesivir%252BSynthesis%252Bthrough%252BOne-Pot%252BOrganocatalyzed%252BAsymmetric%252B%252528S%252529-P-Phosphoramidation%26aulast%3DGannedi%26aufirst%3DVeeranjaneyulu%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D04122020%26date%3D26022021%26volume%3D86%26issue%3D7%26spage%3D4977%26epage%3D4985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Andrew J. Prussia, <span class="NLM_string-name hlFld-ContribAuthor">Spandan Chennamadhavuni</span>. </span><span class="cited-content_cbyCitation_article-title">Biostructural Models for the Binding of Nucleoside Analogs to SARS-CoV-2 RNA-Dependent RNA Polymerase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2021,</strong> <em>61 </em>
                                    (3)
                                     , 1402-1411. <a href="https://doi.org/10.1021/acs.jcim.0c01277" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c01277</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c01277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c01277%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DBiostructural%252BModels%252Bfor%252Bthe%252BBinding%252Bof%252BNucleoside%252BAnalogs%252Bto%252BSARS-CoV-2%252BRNA-Dependent%252BRNA%252BPolymerase%26aulast%3DPrussia%26aufirst%3DAndrew%2BJ.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D02112020%26date%3D03032021%26volume%3D61%26issue%3D3%26spage%3D1402%26epage%3D1411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nemanja Milisavljevic, Eva Konkolová, Jaroslav Kozák, Jan Hodek, Lucia Veselovská, Veronika Sýkorová, Karel Čížek, Radek Pohl, Luděk Eyer, Pavel Svoboda, Daniel Růžek, Jan Weber, Radim Nencka, Evžen Bouřa, <span class="NLM_string-name hlFld-ContribAuthor">Michal Hocek</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral Activity of 7-Substituted 7-Deazapurine Ribonucleosides, Monophosphate Prodrugs, and Triphoshates against Emerging RNA Viruses. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2021,</strong> <em>7 </em>
                                    (2)
                                     , 471-478. <a href="https://doi.org/10.1021/acsinfecdis.0c00829" title="DOI URL">https://doi.org/10.1021/acsinfecdis.0c00829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.0c00829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.0c00829%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DAntiviral%252BActivity%252Bof%252B7-Substituted%252B7-Deazapurine%252BRibonucleosides%25252C%252BMonophosphate%252BProdrugs%25252C%252Band%252BTriphoshates%252Bagainst%252BEmerging%252BRNA%252BViruses%26aulast%3DMilisavljevic%26aufirst%3DNemanja%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D25112020%26date%3D04012021%26volume%3D7%26issue%3D2%26spage%3D471%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yingjun Li, Liu Cao, Ge Li, Feng Cong, Yunfeng Li, Jing Sun, Yinzhu Luo, Guijiang Chen, Guanguan Li, Ping Wang, Fan Xing, Yanxi Ji, Jincun Zhao, Yu Zhang, Deyin Guo, <span class="NLM_string-name hlFld-ContribAuthor">Xumu Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mouse Models. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01929%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRemdesivir%252BMetabolite%252BGS-441524%252BEffectively%252BInhibits%252BSARS-CoV-2%252BInfection%252Bin%252BMouse%252BModels%26aulast%3DLi%26aufirst%3DYingjun%26date%3D2021%26date%3D2020%26date%3D07112020%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yi Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Liang V. Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of Targets and Potential Drugs of SARS-CoV-2 According to the Viral Replication. </span><span class="cited-content_cbyCitation_journal-name">Journal of Proteome Research</span><span> <strong>2021,</strong> <em>20 </em>
                                    (1)
                                     , 49-59. <a href="https://doi.org/10.1021/acs.jproteome.0c00526" title="DOI URL">https://doi.org/10.1021/acs.jproteome.0c00526</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jproteome.0c00526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jproteome.0c00526%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Proteome%2520Research%26atitle%3DOverview%252Bof%252BTargets%252Band%252BPotential%252BDrugs%252Bof%252BSARS-CoV-2%252BAccording%252Bto%252Bthe%252BViral%252BReplication%26aulast%3DZhang%26aufirst%3DYi%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D11072020%26date%3D21122020%26volume%3D20%26issue%3D1%26spage%3D49%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Sara S.    Rocks    </span><span class="hlFld-ContribAuthor "> Robert A.    Stockland    ,    Jr. </span>. </span><span class="cited-content_cbyCitation_article-title">Heteronuclear NMR Spectroscopy in the Undergraduate Curriculum: Direct and Indirect Effects. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 191-208. <a href="https://doi.org/10.1021/bk-2021-1376.ch013" title="DOI URL">https://doi.org/10.1021/bk-2021-1376.ch013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2021-1376.ch013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2021-1376.ch013%26sid%3Dliteratum%253Aachs%26atitle%3DHeteronuclear%252BNMR%252BSpectroscopy%252Bin%252Bthe%252BUndergraduate%252BCurriculum%25253A%252BDirect%252Band%252BIndirect%252BEffects%26aulast%3DRocks%26aufirst%3DSara%2BS.%26date%3D2021%26date%3D2021%26spage%3D191%26epage%3D208%26atitle%3DNMR%252BSpectroscopy%252Bin%252Bthe%252BUndergraduate%252BCurriculum%25252C%252BVolume%252B4%25253A%252BIn-Person%252Band%252BDistance%252BLearning%252BApproaches%26aulast%3DSoulsby%26aufirst%3DDavid%26date%3D2021%26date%3D2021%26volume%3D1376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Eugene Mamontov, Yongqiang Cheng, Luke L. Daemen, Alexander I. Kolesnikov, Anibal J. Ramirez-Cuesta, Matthew R. Ryder, <span class="NLM_string-name hlFld-ContribAuthor">Matthew B. Stone</span>. </span><span class="cited-content_cbyCitation_article-title">Hydration-Induced Disorder Lowers the Energy Barriers for Methyl Rotation in Drug Molecules. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (23)
                                     , 10256-10261. <a href="https://doi.org/10.1021/acs.jpclett.0c02642" title="DOI URL">https://doi.org/10.1021/acs.jpclett.0c02642</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpclett.0c02642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpclett.0c02642%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520Letters%26atitle%3DHydration-Induced%252BDisorder%252BLowers%252Bthe%252BEnergy%252BBarriers%252Bfor%252BMethyl%252BRotation%252Bin%252BDrug%252BMolecules%26aulast%3DMamontov%26aufirst%3DEugene%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28082020%26date%3D27102020%26date%3D19112020%26volume%3D11%26issue%3D23%26spage%3D10256%26epage%3D10261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Padmaja D. Wakchaure, Shibaji Ghosh, <span class="NLM_string-name hlFld-ContribAuthor">Bishwajit Ganguly</span>. </span><span class="cited-content_cbyCitation_article-title">Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry B</span><span> <strong>2020,</strong> <em>124 </em>
                                    (47)
                                     , 10641-10652. <a href="https://doi.org/10.1021/acs.jpcb.0c06747" title="DOI URL">https://doi.org/10.1021/acs.jpcb.0c06747</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpcb.0c06747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpcb.0c06747%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520B%26atitle%3DRevealing%252Bthe%252BInhibition%252BMechanism%252Bof%252BRNA-Dependent%252BRNA%252BPolymerase%252B%252528RdRp%252529%252Bof%252BSARS-CoV-2%252Bby%252BRemdesivir%252Band%252BNucleotide%252BAnalogues%25253A%252BA%252BMolecular%252BDynamics%252BSimulation%252BStudy%26aulast%3DWakchaure%26aufirst%3DPadmaja%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D23072020%26date%3D23102020%26date%3D15112020%26volume%3D124%26issue%3D47%26spage%3D10641%26epage%3D10652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rolando Cannalire, Carmen Cerchia, Andrea R. Beccari, Francesco Saverio Di Leva, <span class="NLM_string-name hlFld-ContribAuthor">Vincenzo Summa</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01140%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BSARS-CoV-2%252BProteases%252Band%252BPolymerase%252Bfor%252BCOVID-19%252BTreatment%25253A%252BState%252Bof%252Bthe%252BArt%252Band%252BFuture%252BOpportunities%26aulast%3DCannalire%26aufirst%3DRolando%26date%3D2020%26date%3D2020%26date%3D02072020%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Marwa O. Mikati, Justin J. Miller, Damon M. Osbourn, Yasaman Barekatain, Naomi Ghebremichael, Ishaan T. Shah, Carey-Ann D. Burnham, Kenneth M. Heidel, Victoria C. Yan, Florian L. Muller, Cynthia S. Dowd, Rachel L. Edwards, <span class="NLM_string-name hlFld-ContribAuthor">Audrey R. Odom John</span>. </span><span class="cited-content_cbyCitation_article-title">Antimicrobial Prodrug Activation by the Staphylococcal Glyoxalase GloB. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2020,</strong> <em>6 </em>
                                    (11)
                                     , 3064-3075. <a href="https://doi.org/10.1021/acsinfecdis.0c00582" title="DOI URL">https://doi.org/10.1021/acsinfecdis.0c00582</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.0c00582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.0c00582%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DAntimicrobial%252BProdrug%252BActivation%252Bby%252Bthe%252BStaphylococcal%252BGlyoxalase%252BGloB%26aulast%3DMikati%26aufirst%3DMarwa%2BO.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14082020%26date%3D29102020%26volume%3D6%26issue%3D11%26spage%3D3064%26epage%3D3075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rachel R. Knapp, Veronica Tona, Taku Okada, Richmond Sarpong, <span class="NLM_string-name hlFld-ContribAuthor">Neil K. Garg</span>. </span><span class="cited-content_cbyCitation_article-title">Cyanoamidine Cyclization Approach to Remdesivir’s Nucleobase. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (21)
                                     , 8430-8435. <a href="https://doi.org/10.1021/acs.orglett.0c03052" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03052%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCyanoamidine%252BCyclization%252BApproach%252Bto%252BRemdesivir%2525E2%252580%252599s%252BNucleobase%26aulast%3DKnapp%26aufirst%3DRachel%2BR.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D12092020%26date%3D21102020%26volume%3D22%26issue%3D21%26spage%3D8430%26epage%3D8435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiao Jia, Stefan Weber, Dominique Schols, <span class="NLM_string-name hlFld-ContribAuthor">Chris Meier</span>. </span><span class="cited-content_cbyCitation_article-title">Membrane Permeable, Bioreversibly Modified Prodrugs of Nucleoside Diphosphate-γ-Phosphonates. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11990-12007. <a href="https://doi.org/10.1021/acs.jmedchem.0c01294" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01294</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01294%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMembrane%252BPermeable%25252C%252BBioreversibly%252BModified%252BProdrugs%252Bof%252BNucleoside%252BDiphosphate-%2525CE%2525B3-Phosphonates%26aulast%3DJia%26aufirst%3DXiao%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D24072020%26date%3D14102020%26date%3D29092020%26volume%3D63%26issue%3D20%26spage%3D11990%26epage%3D12007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tiago Vieira, Andrew C. Stevens, Andrei Chtchemelinine, Detian Gao, Pavel Badalov, <span class="NLM_string-name hlFld-ContribAuthor">Lars Heumann</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a Large-Scale Cyanation Process Using Continuous Flow Chemistry En Route to the Synthesis of Remdesivir. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2020,</strong> <em>24 </em>
                                    (10)
                                     , 2113-2121. <a href="https://doi.org/10.1021/acs.oprd.0c00172" title="DOI URL">https://doi.org/10.1021/acs.oprd.0c00172</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.0c00172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.0c00172%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DDevelopment%252Bof%252Ba%252BLarge-Scale%252BCyanation%252BProcess%252BUsing%252BContinuous%252BFlow%252BChemistry%252BEn%252BRoute%252Bto%252Bthe%252BSynthesis%252Bof%252BRemdesivir%26aulast%3DVieira%26aufirst%3DTiago%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09042020%26date%3D10062020%26date%3D21052020%26volume%3D24%26issue%3D10%26spage%3D2113%26epage%3D2121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Timo von Keutz, Jason D. Williams, <span class="NLM_string-name hlFld-ContribAuthor">C. Oliver Kappe</span>. </span><span class="cited-content_cbyCitation_article-title">Continuous Flow C-Glycosylation via Metal–Halogen Exchange: Process Understanding and Improvements toward Efficient Manufacturing of Remdesivir. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2020,</strong> <em>24 </em>
                                    (10)
                                     , 2362-2368. <a href="https://doi.org/10.1021/acs.oprd.0c00370" title="DOI URL">https://doi.org/10.1021/acs.oprd.0c00370</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.0c00370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.0c00370%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DContinuous%252BFlow%252BC-Glycosylation%252Bvia%252BMetal%2525E2%252580%252593Halogen%252BExchange%25253A%252BProcess%252BUnderstanding%252Band%252BImprovements%252Btoward%252BEfficient%252BManufacturing%252Bof%252BRemdesivir%26aulast%3Dvon%2BKeutz%26aufirst%3DTimo%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15082020%26date%3D24092020%26volume%3D24%26issue%3D10%26spage%3D2362%26epage%3D2368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Matthew D. Lloyd</span>. </span><span class="cited-content_cbyCitation_article-title">High-Throughput Screening for the Discovery of Enzyme Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10742-10772. <a href="https://doi.org/10.1021/acs.jmedchem.0c00523" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00523%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHigh-Throughput%252BScreening%252Bfor%252Bthe%252BDiscovery%252Bof%252BEnzyme%252BInhibitors%26aulast%3DLloyd%26aufirst%3DMatthew%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30032020%26date%3D10062020%26date%3D20052020%26volume%3D63%26issue%3D19%26spage%3D10742%26epage%3D10772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dinesh J. Paymode, Flavio S. P. Cardoso, Toolika Agrawal, John W. Tomlin, Daniel W. Cook, Justina M. Burns, Rodger W. Stringham, Joshua D. Sieber, B. Frank Gupton, <span class="NLM_string-name hlFld-ContribAuthor">David R. Snead</span>. </span><span class="cited-content_cbyCitation_article-title">Expanding Access to Remdesivir via an Improved Pyrrolotriazine Synthesis: Supply Centered Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (19)
                                     , 7656-7661. <a href="https://doi.org/10.1021/acs.orglett.0c02848" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c02848</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c02848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c02848%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DExpanding%252BAccess%252Bto%252BRemdesivir%252Bvia%252Ban%252BImproved%252BPyrrolotriazine%252BSynthesis%25253A%252BSupply%252BCentered%252BSynthesis%26aulast%3DPaymode%26aufirst%3DDinesh%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D25082020%26date%3D15092020%26volume%3D22%26issue%3D19%26spage%3D7656%26epage%3D7661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Ilya G. Shenderovich</span>. </span><span class="cited-content_cbyCitation_article-title">For Whom a Puddle Is the Sea? Adsorption of Organic Guests on Hydrated MCM-41 Silica. </span><span class="cited-content_cbyCitation_journal-name">Langmuir</span><span> <strong>2020,</strong> <em>36 </em>
                                    (38)
                                     , 11383-11392. <a href="https://doi.org/10.1021/acs.langmuir.0c02327" title="DOI URL">https://doi.org/10.1021/acs.langmuir.0c02327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.langmuir.0c02327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.langmuir.0c02327%26sid%3Dliteratum%253Aachs%26jtitle%3DLangmuir%26atitle%3DFor%252BWhom%252Ba%252BPuddle%252BIs%252Bthe%252BSea%25253F%252BAdsorption%252Bof%252BOrganic%252BGuests%252Bon%252BHydrated%252BMCM-41%252BSilica%26aulast%3DShenderovich%26aufirst%3DIlya%2BG.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07082020%26date%3D08092020%26date%3D15092020%26date%3D08092020%26volume%3D36%26issue%3D38%26spage%3D11383%26epage%3D11392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fei Xue, Xinbo Zhou, Ruijie Zhou, Xiaohan Zhou, Dian Xiao, Eric Gu, Xiaowen Guo, Ji Xiang, Ke Wang, Likai Yang, Wu Zhong, <span class="NLM_string-name hlFld-ContribAuthor">Yong Qin</span>. </span><span class="cited-content_cbyCitation_article-title">Improvement of the C-glycosylation Step for the Synthesis of Remdesivir. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2020,</strong> <em>24 </em>
                                    (9)
                                     , 1772-1777. <a href="https://doi.org/10.1021/acs.oprd.0c00310" title="DOI URL">https://doi.org/10.1021/acs.oprd.0c00310</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.0c00310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.0c00310%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DImprovement%252Bof%252Bthe%252BC-glycosylation%252BStep%252Bfor%252Bthe%252BSynthesis%252Bof%252BRemdesivir%26aulast%3DXue%26aufirst%3DFei%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D01072020%26date%3D17082020%26date%3D05082020%26volume%3D24%26issue%3D9%26spage%3D1772%26epage%3D1777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Andrew N. Bigley, Tamari Narindoshvili, <span class="NLM_string-name hlFld-ContribAuthor">Frank M. Raushel</span>. </span><span class="cited-content_cbyCitation_article-title">A Chemoenzymatic Synthesis of the (RP)-Isomer of the Antiviral Prodrug Remdesivir. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2020,</strong> <em>59 </em>
                                    (33)
                                     , 3038-3043. <a href="https://doi.org/10.1021/acs.biochem.0c00591" title="DOI URL">https://doi.org/10.1021/acs.biochem.0c00591</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.0c00591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.0c00591%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DA%252BChemoenzymatic%252BSynthesis%252Bof%252Bthe%252B%252528RP%252529-Isomer%252Bof%252Bthe%252BAntiviral%252BProdrug%252BRemdesivir%26aulast%3DBigley%26aufirst%3DAndrew%2BN.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17072020%26date%3D04082020%26date%3D10082020%26date%3D04082020%26volume%3D59%26issue%3D33%26spage%3D3038%26epage%3D3043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Andrew J. Wiemer</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic Efficacy of Phosphate Prodrugs and the Remdesivir Paradigm. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2020,</strong> <em>3 </em>
                                    (4)
                                     , 613-626. <a href="https://doi.org/10.1021/acsptsci.0c00076" title="DOI URL">https://doi.org/10.1021/acsptsci.0c00076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.0c00076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.0c00076%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DMetabolic%252BEfficacy%252Bof%252BPhosphate%252BProdrugs%252Band%252Bthe%252BRemdesivir%252BParadigm%26aulast%3DWiemer%26aufirst%3DAndrew%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29062020%26date%3D05082020%26date%3D24072020%26volume%3D3%26issue%3D4%26spage%3D613%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Qingfeng Li, Elisabetta Groaz, Leentje Persoons, Dirk Daelemans, <span class="NLM_string-name hlFld-ContribAuthor">Piet Herdewijn</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Antitumor Activity of C-7-Alkynylated and Arylated Pyrrolotriazine C-Ribonucleosides. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (8)
                                     , 1605-1610. <a href="https://doi.org/10.1021/acsmedchemlett.0c00269" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00269</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00269%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BAntitumor%252BActivity%252Bof%252BC-7-Alkynylated%252Band%252BArylated%252BPyrrolotriazine%252BC-Ribonucleosides%26aulast%3DLi%26aufirst%3DQingfeng%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D20052020%26date%3D09072020%26date%3D13072020%26date%3D09072020%26volume%3D11%26issue%3D8%26spage%3D1605%26epage%3D1610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Melissa A. Hardy, Brandon A. Wright, J. Logan Bachman, Timothy B. Boit, Hannah M. S. Haley, Rachel R. Knapp, Robert F. Lusi, Taku Okada, Veronica Tona, Neil K. Garg, <span class="NLM_string-name hlFld-ContribAuthor">Richmond Sarpong</span>. </span><span class="cited-content_cbyCitation_article-title">Treating a Global Health Crisis with a Dose of Synthetic Chemistry. </span><span class="cited-content_cbyCitation_journal-name">ACS Central Science</span><span> <strong>2020,</strong> <em>6 </em>
                                    (7)
                                     , 1017-1030. <a href="https://doi.org/10.1021/acscentsci.0c00637" title="DOI URL">https://doi.org/10.1021/acscentsci.0c00637</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscentsci.0c00637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscentsci.0c00637%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Central%2520Science%26atitle%3DTreating%252Ba%252BGlobal%252BHealth%252BCrisis%252Bwith%252Ba%252BDose%252Bof%252BSynthetic%252BChemistry%26aulast%3DHardy%26aufirst%3DMelissa%2BA.%26date%3D2020%26date%3D2020%26date%3D30062020%26volume%3D6%26issue%3D7%26spage%3D1017%26epage%3D1030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wen-Biao Wu, Jin-Sheng Yu, <span class="NLM_string-name hlFld-ContribAuthor">Jian Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Enantioselective Cyanation: Recent Advances and Perspectives. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (14)
                                     , 7668-7690. <a href="https://doi.org/10.1021/acscatal.0c01918" title="DOI URL">https://doi.org/10.1021/acscatal.0c01918</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.0c01918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.0c01918%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DCatalytic%252BEnantioselective%252BCyanation%25253A%252BRecent%252BAdvances%252Band%252BPerspectives%26aulast%3DWu%26aufirst%3DWen-Biao%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29042020%26date%3D12062020%26date%3D28062020%26date%3D12062020%26volume%3D10%26issue%3D14%26spage%3D7668%26epage%3D7690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Peter Finkbeiner, Jörg P. Hehn, <span class="NLM_string-name hlFld-ContribAuthor">Christian Gnamm</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphine Oxides from a Medicinal Chemist’s Perspective: Physicochemical and in Vitro Parameters Relevant for Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (13)
                                     , 7081-7107. <a href="https://doi.org/10.1021/acs.jmedchem.0c00407" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00407</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00407%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPhosphine%252BOxides%252Bfrom%252Ba%252BMedicinal%252BChemist%2525E2%252580%252599s%252BPerspective%25253A%252BPhysicochemical%252Band%252Bin%252BVitro%252BParameters%252BRelevant%252Bfor%252BDrug%252BDiscovery%26aulast%3DFinkbeiner%26aufirst%3DPeter%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10032020%26date%3D17062020%26date%3D01062020%26volume%3D63%26issue%3D13%26spage%3D7081%26epage%3D7107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Victoria C. Yan, <span class="NLM_string-name hlFld-ContribAuthor">Florian L. Muller</span>. </span><span class="cited-content_cbyCitation_article-title">Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (7)
                                     , 1361-1366. <a href="https://doi.org/10.1021/acsmedchemlett.0c00316" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00316</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00316%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAdvantages%252Bof%252Bthe%252BParent%252BNucleoside%252BGS-441524%252Bover%252BRemdesivir%252Bfor%252BCovid-19%252BTreatment%26aulast%3DYan%26aufirst%3DVictoria%2BC.%26date%3D2020%26date%3D2020%26date%3D23062020%26volume%3D11%26issue%3D7%26spage%3D1361%26epage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chris De Savi, David L. Hughes, <span class="NLM_string-name hlFld-ContribAuthor">Lisbet Kvaerno</span>. </span><span class="cited-content_cbyCitation_article-title">Quest for a COVID-19 Cure by Repurposing Small-Molecule Drugs: Mechanism of Action, Clinical Development, Synthesis at Scale, and Outlook for Supply. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2020,</strong> <em>24 </em>
                                    (6)
                                     , 940-976. <a href="https://doi.org/10.1021/acs.oprd.0c00233" title="DOI URL">https://doi.org/10.1021/acs.oprd.0c00233</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.0c00233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.0c00233%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DQuest%252Bfor%252Ba%252BCOVID-19%252BCure%252Bby%252BRepurposing%252BSmall-Molecule%252BDrugs%25253A%252BMechanism%252Bof%252BAction%25252C%252BClinical%252BDevelopment%25252C%252BSynthesis%252Bat%252BScale%25252C%252Band%252BOutlook%252Bfor%252BSupply%26aulast%3DDe%2BSavi%26aufirst%3DChris%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17052020%26date%3D08062020%26date%3D02062020%26volume%3D24%26issue%3D6%26spage%3D940%26epage%3D976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiao Jia, Dominique Schols, <span class="NLM_string-name hlFld-ContribAuthor">Chris Meier</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-HIV-Active Nucleoside Triphosphate Prodrugs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 6003-6027. <a href="https://doi.org/10.1021/acs.jmedchem.0c00271" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00271</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00271%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAnti-HIV-Active%252BNucleoside%252BTriphosphate%252BProdrugs%26aulast%3DJia%26aufirst%3DXiao%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14022020%26date%3D03062020%26date%3D18052020%26volume%3D63%26issue%3D11%26spage%3D6003%26epage%3D6027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Richard T. Eastman, Jacob S. Roth, Kyle R. Brimacombe, Anton Simeonov, Min Shen, Samarjit Patnaik, <span class="NLM_string-name hlFld-ContribAuthor">Matthew D. Hall</span>. </span><span class="cited-content_cbyCitation_article-title">Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19. </span><span class="cited-content_cbyCitation_journal-name">ACS Central Science</span><span> <strong>2020,</strong> <em>6 </em>
                                    (5)
                                     , 672-683. <a href="https://doi.org/10.1021/acscentsci.0c00489" title="DOI URL">https://doi.org/10.1021/acscentsci.0c00489</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscentsci.0c00489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscentsci.0c00489%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Central%2520Science%26atitle%3DRemdesivir%25253A%252BA%252BReview%252Bof%252BIts%252BDiscovery%252Band%252BDevelopment%252BLeading%252Bto%252BEmergency%252BUse%252BAuthorization%252Bfor%252BTreatment%252Bof%252BCOVID-19%26aulast%3DEastman%26aufirst%3DRichard%2BT.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21042020%26date%3D04052020%26volume%3D6%26issue%3D5%26spage%3D672%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Haidi Li, Jie Chao, Jaafar Hasan, Guang Tian, Yatao Jin, Zixin Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Chuanguang Qin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Tri(4-formylphenyl) Phosphonate Derivatives as Recyclable Triple-Equivalent Supports of Peptide Synthesis. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (10)
                                     , 6271-6280. <a href="https://doi.org/10.1021/acs.joc.9b03023" title="DOI URL">https://doi.org/10.1021/acs.joc.9b03023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b03023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b03023%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BTri%2525284-formylphenyl%252529%252BPhosphonate%252BDerivatives%252Bas%252BRecyclable%252BTriple-Equivalent%252BSupports%252Bof%252BPeptide%252BSynthesis%26aulast%3DLi%26aufirst%3DHaidi%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D07112019%26date%3D01052020%26date%3D22042020%26volume%3D85%26issue%3D10%26spage%3D6271%26epage%3D6280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dean G. Brown, <span class="NLM_string-name hlFld-ContribAuthor">Jonas Boström</span>. </span><span class="cited-content_cbyCitation_article-title">Where Do Recent Small Molecule Clinical Development Candidates Come From?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (21)
                                     , 9442-9468. <a href="https://doi.org/10.1021/acs.jmedchem.8b00675" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00675%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWhere%252BDo%252BRecent%252BSmall%252BMolecule%252BClinical%252BDevelopment%252BCandidates%252BCome%252BFrom%25253F%26aulast%3DBrown%26aufirst%3DDean%2BG.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27042018%26date%3D09072018%26date%3D19062018%26volume%3D61%26issue%3D21%26spage%3D9442%26epage%3D9468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ke-Xin  Huang</span>, <span class="hlFld-ContribAuthor ">Ming-Sheng  Xie</span>, <span class="hlFld-ContribAuthor ">Qi-Ying  Zhang</span>, <span class="hlFld-ContribAuthor ">Gui-Rong  Qu</span>, and <span class="hlFld-ContribAuthor ">Hai-Ming  Guo</span>  . </span><span class="cited-content_cbyCitation_article-title">Enantioselective Synthesis of Carbocyclic Nucleosides via Asymmetric [3 + 2] Annulation of α-Purine-Substituted Acrylates with MBH Carbonates. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (2)
                                     , 389-392. <a href="https://doi.org/10.1021/acs.orglett.7b03625" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b03625</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b03625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b03625%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DEnantioselective%252BSynthesis%252Bof%252BCarbocyclic%252BNucleosides%252Bvia%252BAsymmetric%252B%25255B3%252B%25252B%252B2%25255D%252BAnnulation%252Bof%252B%2525CE%2525B1-Purine-Substituted%252BAcrylates%252Bwith%252BMBH%252BCarbonates%26aulast%3DHuang%26aufirst%3DKe-Xin%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D27112017%26date%3D05012018%26date%3D19012018%26volume%3D20%26issue%3D2%26spage%3D389%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wanqing  Wu</span>, <span class="hlFld-ContribAuthor ">Zhiming  Lin</span>, <span class="hlFld-ContribAuthor ">Chuanle  Zhu</span>, <span class="hlFld-ContribAuthor ">Pengquan  Chen</span>, <span class="hlFld-ContribAuthor ">Jiawei  Li</span>, and <span class="hlFld-ContribAuthor ">Huanfeng  Jiang</span>  . </span><span class="cited-content_cbyCitation_article-title">Transition-Metal-Free [3+2] Cycloaddition of Dehydroaminophosphonates and N-Tosylhydrazones: Access to Aminocyclopropanephosphonates with Adjacent Quaternary-Tetrasubstituted Carbon Centers. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (23)
                                     , 12746-12756. <a href="https://doi.org/10.1021/acs.joc.7b01862" title="DOI URL">https://doi.org/10.1021/acs.joc.7b01862</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b01862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b01862%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTransition-Metal-Free%252B%25255B3%25252B2%25255D%252BCycloaddition%252Bof%252BDehydroaminophosphonates%252Band%252BN-Tosylhydrazones%25253A%252BAccess%252Bto%252BAminocyclopropanephosphonates%252Bwith%252BAdjacent%252BQuaternary-Tetrasubstituted%252BCarbon%252BCenters%26aulast%3DWu%26aufirst%3DWanqing%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D25072017%26date%3D26102017%26date%3D01122017%26date%3D01092017%26volume%3D82%26issue%3D23%26spage%3D12746%26epage%3D12756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hubert  Hřebabecký</span>, <span class="hlFld-ContribAuthor ">Martin  Dračínský</span>, <span class="hlFld-ContribAuthor ">Eliška  Procházková</span>, <span class="hlFld-ContribAuthor ">Michal  Šála</span>, <span class="hlFld-ContribAuthor ">Richard  Mackman</span>, and <span class="hlFld-ContribAuthor ">Radim  Nencka</span>  . </span><span class="cited-content_cbyCitation_article-title">Control of α/β Anomer Formation by a 2′,5′ Bridge: Toward Nucleoside Derivatives Locked in the South Conformation. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (21)
                                     , 11337-11347. <a href="https://doi.org/10.1021/acs.joc.7b01000" title="DOI URL">https://doi.org/10.1021/acs.joc.7b01000</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b01000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b01000%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DControl%252Bof%252B%2525CE%2525B1%25252F%2525CE%2525B2%252BAnomer%252BFormation%252Bby%252Ba%252B2%2525E2%252580%2525B2%25252C5%2525E2%252580%2525B2%252BBridge%25253A%252BToward%252BNucleoside%252BDerivatives%252BLocked%252Bin%252Bthe%252BSouth%252BConformation%26aulast%3DH%25C5%2599ebabeck%25C3%25BD%26aufirst%3DHubert%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D11052017%26date%3D24102017%26date%3D03112017%26date%3D03102017%26volume%3D82%26issue%3D21%26spage%3D11337%26epage%3D11347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ilaria  Vicenti</span>, <span class="hlFld-ContribAuthor ">Maria Grazia  Martina</span>, <span class="hlFld-ContribAuthor ">Adele  Boccuto</span>, <span class="hlFld-ContribAuthor ">Marta  De Angelis</span>, <span class="hlFld-ContribAuthor ">Giorgia  Giavarini</span>, <span class="hlFld-ContribAuthor ">Filippo  Dragoni</span>, <span class="hlFld-ContribAuthor ">Serena  Marchi</span>, <span class="hlFld-ContribAuthor ">Claudia Maria  Trombetta</span>, <span class="hlFld-ContribAuthor ">Emmanuele  Crespan</span>, <span class="hlFld-ContribAuthor ">Giovanni  Maga</span>, <span class="hlFld-ContribAuthor ">Cecilia  Eydoux</span>, <span class="hlFld-ContribAuthor ">Etienne  Decroly</span>, <span class="hlFld-ContribAuthor ">Emanuele  Montomoli</span>, <span class="hlFld-ContribAuthor ">Lucia  Nencioni</span>, <span class="hlFld-ContribAuthor ">Maurizio  Zazzi</span>, <span class="hlFld-ContribAuthor ">Marco  Radi</span>. </span><span class="cited-content_cbyCitation_article-title">System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>224 </em>, 113683. <a href="https://doi.org/10.1016/j.ejmech.2021.113683" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113683</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113683%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSystem-oriented%252Boptimization%252Bof%252Bmulti-target%252B2%25252C6-diaminopurine%252Bderivatives%25253A%252BEasily%252Baccessible%252Bbroad-spectrum%252Bantivirals%252Bactive%252Bagainst%252Bflaviviruses%25252C%252Binfluenza%252Bvirus%252Band%252BSARS-CoV-2%26aulast%3DVicenti%26aufirst%3DIlaria%26date%3D2021%26volume%3D224%26spage%3D113683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jayanta  Dowarah</span>, <span class="hlFld-ContribAuthor ">Brilliant N.  Marak</span>, <span class="hlFld-ContribAuthor ">Umesh Chand Singh  Yadav</span>, <span class="hlFld-ContribAuthor ">Ved Prakash  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Potential drug development and therapeutic approaches for clinical intervention in COVID-19. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>114 </em>, 105016. <a href="https://doi.org/10.1016/j.bioorg.2021.105016" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DPotential%252Bdrug%252Bdevelopment%252Band%252Btherapeutic%252Bapproaches%252Bfor%252Bclinical%252Bintervention%252Bin%252BCOVID-19%26aulast%3DDowarah%26aufirst%3DJayanta%26date%3D2021%26volume%3D114%26spage%3D105016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eugene  Mamontov</span>, <span class="hlFld-ContribAuthor ">Yongqiang  Cheng</span>, <span class="hlFld-ContribAuthor ">Luke L.  Daemen</span>, <span class="hlFld-ContribAuthor ">Alexander I.  Kolesnikov</span>, <span class="hlFld-ContribAuthor ">Anibal J.  Ramirez-Cuesta</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Ryder</span>, <span class="hlFld-ContribAuthor ">Matthew B.  Stone</span>. </span><span class="cited-content_cbyCitation_article-title">Low rotational barriers for the most dynamically active methyl groups in the proposed antiviral drugs for treatment of SARS-CoV-2, apilimod and tetrandrine. </span><span class="cited-content_cbyCitation_journal-name">Chemical Physics Letters</span><span> <strong>2021,</strong> <em>777 </em>, 138727. <a href="https://doi.org/10.1016/j.cplett.2021.138727" title="DOI URL">https://doi.org/10.1016/j.cplett.2021.138727</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cplett.2021.138727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cplett.2021.138727%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Physics%2520Letters%26atitle%3DLow%252Brotational%252Bbarriers%252Bfor%252Bthe%252Bmost%252Bdynamically%252Bactive%252Bmethyl%252Bgroups%252Bin%252Bthe%252Bproposed%252Bantiviral%252Bdrugs%252Bfor%252Btreatment%252Bof%252BSARS-CoV-2%25252C%252Bapilimod%252Band%252Btetrandrine%26aulast%3DMamontov%26aufirst%3DEugene%26date%3D2021%26volume%3D777%26spage%3D138727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianlin  Han</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Konno</span>, <span class="hlFld-ContribAuthor ">Tatsunori  Sato</span>, <span class="hlFld-ContribAuthor ">Vadim A.  Soloshonok</span>, <span class="hlFld-ContribAuthor ">Kunisuke  Izawa</span>. </span><span class="cited-content_cbyCitation_article-title">Tailor-made amino acids in the design of small-molecule blockbuster drugs. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>220 </em>, 113448. <a href="https://doi.org/10.1016/j.ejmech.2021.113448" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113448</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113448%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTailor-made%252Bamino%252Bacids%252Bin%252Bthe%252Bdesign%252Bof%252Bsmall-molecule%252Bblockbuster%252Bdrugs%26aulast%3DHan%26aufirst%3DJianlin%26date%3D2021%26volume%3D220%26spage%3D113448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Zhao</span>, <span class="hlFld-ContribAuthor ">Jing  Sun</span>, <span class="hlFld-ContribAuthor ">Yunfei  Li</span>, <span class="hlFld-ContribAuthor ">Zhengxuan  Li</span>, <span class="hlFld-ContribAuthor ">Yu  Xie</span>, <span class="hlFld-ContribAuthor ">Ruoqing  Feng</span>, <span class="hlFld-ContribAuthor ">Jincun  Zhao</span>, <span class="hlFld-ContribAuthor ">Yuhui  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">The strand-biased transcription of SARS-CoV-2 and unbalanced inhibition by remdesivir. </span><span class="cited-content_cbyCitation_journal-name">iScience</span><span> <strong>2021,</strong> <em>24 </em>
                                    (8)
                                     , 102857. <a href="https://doi.org/10.1016/j.isci.2021.102857" title="DOI URL">https://doi.org/10.1016/j.isci.2021.102857</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.isci.2021.102857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.isci.2021.102857%26sid%3Dliteratum%253Aachs%26jtitle%3DiScience%26atitle%3DThe%252Bstrand-biased%252Btranscription%252Bof%252BSARS-CoV-2%252Band%252Bunbalanced%252Binhibition%252Bby%252Bremdesivir%26aulast%3DZhao%26aufirst%3DYan%26date%3D2021%26volume%3D24%26issue%3D8%26spage%3D102857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaiming  Tao</span>, <span class="hlFld-ContribAuthor ">Philip L.  Tzou</span>, <span class="hlFld-ContribAuthor ">Janin  Nouhin</span>, <span class="hlFld-ContribAuthor ">Hector  Bonilla</span>, <span class="hlFld-ContribAuthor ">Prasanna  Jagannathan</span>, <span class="hlFld-ContribAuthor ">Robert W.  Shafer</span>. </span><span class="cited-content_cbyCitation_article-title">SARS-CoV-2 Antiviral Therapy. </span><span class="cited-content_cbyCitation_journal-name">Clinical Microbiology Reviews</span><span> <strong>2021,</strong> <em>7 </em><a href="https://doi.org/10.1128/CMR.00109-21" title="DOI URL">https://doi.org/10.1128/CMR.00109-21</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/CMR.00109-21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FCMR.00109-21%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Microbiology%2520Reviews%26atitle%3DSARS-CoV-2%252BAntiviral%252BTherapy%26aulast%3DTao%26aufirst%3DKaiming%26date%3D2021%26date%3D2021%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sinthyia  Ahmed</span>, <span class="hlFld-ContribAuthor ">Rumana  Mahtarin</span>, <span class="hlFld-ContribAuthor ">Md. Shamiul  Islam</span>, <span class="hlFld-ContribAuthor ">Susmita  Das</span>, <span class="hlFld-ContribAuthor ">Abdulla  Al Mamun</span>, <span class="hlFld-ContribAuthor ">Sayeda Samina  Ahmed</span>, <span class="hlFld-ContribAuthor ">Md Ackas  Ali</span>. </span><span class="cited-content_cbyCitation_article-title">Remdesivir analogs against SARS-CoV-2 RNA-dependent RNA polymerase . </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>0 </em>, 1-14. <a href="https://doi.org/10.1080/07391102.2021.1955743" title="DOI URL">https://doi.org/10.1080/07391102.2021.1955743</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1955743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1955743%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DRemdesivir%252Banalogs%252Bagainst%252BSARS-CoV-2%252BRNA-dependent%252BRNA%252Bpolymerase%2525C2%2525A0%26aulast%3DAhmed%26aufirst%3DSinthyia%26date%3D2021%26date%3D2021%26volume%3D0%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José J.  García-Trejo</span>, <span class="hlFld-ContribAuthor ">Raquel  Ortega</span>, <span class="hlFld-ContribAuthor ">Mariel  Zarco-Zavala</span>. </span><span class="cited-content_cbyCitation_article-title">Putative Repurposing of Lamivudine, a Nucleoside/Nucleotide Analogue and Antiretroviral to Improve the Outcome of Cancer and COVID-19 Patients. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fonc.2021.664794" title="DOI URL">https://doi.org/10.3389/fonc.2021.664794</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2021.664794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2021.664794%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DPutative%252BRepurposing%252Bof%252BLamivudine%25252C%252Ba%252BNucleoside%25252FNucleotide%252BAnalogue%252Band%252BAntiretroviral%252Bto%252BImprove%252Bthe%252BOutcome%252Bof%252BCancer%252Band%252BCOVID-19%252BPatients%26aulast%3DGarc%25C3%25ADa-Trejo%26aufirst%3DJos%25C3%25A9%2BJ.%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aluru  Rammohan</span>, <span class="hlFld-ContribAuthor ">Grigory V.  Zyryanov</span>. </span><span class="cited-content_cbyCitation_article-title">Minireview: Remdesivir, A Prominent Nucleotide/Nucleoside Antiviral Drug. </span><span class="cited-content_cbyCitation_journal-name">Polycyclic Aromatic Compounds</span><span> <strong>2021,</strong> <em>10 </em>, 1-8. <a href="https://doi.org/10.1080/10406638.2021.1947331" title="DOI URL">https://doi.org/10.1080/10406638.2021.1947331</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10406638.2021.1947331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10406638.2021.1947331%26sid%3Dliteratum%253Aachs%26jtitle%3DPolycyclic%2520Aromatic%2520Compounds%26atitle%3DMinireview%25253A%252BRemdesivir%25252C%252BA%252BProminent%252BNucleotide%25252FNucleoside%252BAntiviral%252BDrug%26aulast%3DRammohan%26aufirst%3DAluru%26date%3D2021%26date%3D2021%26volume%3D10%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdul  Aleem</span>, <span class="hlFld-ContribAuthor ">Guruprasad  Mahadevaiah</span>, <span class="hlFld-ContribAuthor ">Nasir  Shariff</span>, <span class="hlFld-ContribAuthor ">Jiten P.  Kothadia</span>. </span><span class="cited-content_cbyCitation_article-title">Hepatic manifestations of COVID-19 and effect of remdesivir on liver function in patients with COVID-19 illness. </span><span class="cited-content_cbyCitation_journal-name">Baylor University Medical Center Proceedings</span><span> <strong>2021,</strong> <em>34 </em>
                                    (4)
                                     , 473-477. <a href="https://doi.org/10.1080/08998280.2021.1885289" title="DOI URL">https://doi.org/10.1080/08998280.2021.1885289</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/08998280.2021.1885289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F08998280.2021.1885289%26sid%3Dliteratum%253Aachs%26jtitle%3DBaylor%2520University%2520Medical%2520Center%2520Proceedings%26atitle%3DHepatic%252Bmanifestations%252Bof%252BCOVID-19%252Band%252Beffect%252Bof%252Bremdesivir%252Bon%252Bliver%252Bfunction%252Bin%252Bpatients%252Bwith%252BCOVID-19%252Billness%26aulast%3DAleem%26aufirst%3DAbdul%26date%3D2021%26date%3D2021%26volume%3D34%26issue%3D4%26spage%3D473%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed A.  Hendaus</span>. </span><span class="cited-content_cbyCitation_article-title">Remdesivir in the treatment of coronavirus disease 2019 (COVID-19): a simplified summary. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>39 </em>
                                    (10)
                                     , 3787-3792. <a href="https://doi.org/10.1080/07391102.2020.1767691" title="DOI URL">https://doi.org/10.1080/07391102.2020.1767691</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1767691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1767691%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DRemdesivir%252Bin%252Bthe%252Btreatment%252Bof%252Bcoronavirus%252Bdisease%252B2019%252B%252528COVID-19%252529%25253A%252Ba%252Bsimplified%252Bsummary%26aulast%3DHendaus%26aufirst%3DMohamed%2BA.%26date%3D2021%26date%3D2020%26volume%3D39%26issue%3D10%26spage%3D3787%26epage%3D3792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad Mahdi Nejadi  Babadaei</span>, <span class="hlFld-ContribAuthor ">Anwarul  Hasan</span>, <span class="hlFld-ContribAuthor ">Yasaman  Vahdani</span>, <span class="hlFld-ContribAuthor ">Samir Haj  Bloukh</span>, <span class="hlFld-ContribAuthor ">Majid  Sharifi</span>, <span class="hlFld-ContribAuthor ">Ehsan  Kachooei</span>, <span class="hlFld-ContribAuthor ">Setareh  Haghighat</span>, <span class="hlFld-ContribAuthor ">Mojtaba  Falahati</span>. </span><span class="cited-content_cbyCitation_article-title">Development of remdesivir repositioning as a nucleotide analog against COVID-19 RNA dependent RNA polymerase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>39 </em>
                                    (10)
                                     , 3771-3779. <a href="https://doi.org/10.1080/07391102.2020.1767210" title="DOI URL">https://doi.org/10.1080/07391102.2020.1767210</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1767210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1767210%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DDevelopment%252Bof%252Bremdesivir%252Brepositioning%252Bas%252Ba%252Bnucleotide%252Banalog%252Bagainst%252BCOVID-19%252BRNA%252Bdependent%252BRNA%252Bpolymerase%26aulast%3DBabadaei%26aufirst%3DMohammad%2BMahdi%2BNejadi%26date%3D2021%26date%3D2020%26volume%3D39%26issue%3D10%26spage%3D3771%26epage%3D3779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lajos  Szente</span>, <span class="hlFld-ContribAuthor ">István  Puskás</span>, <span class="hlFld-ContribAuthor ">Tamás  Sohajda</span>, <span class="hlFld-ContribAuthor ">Erzsébet  Varga</span>, <span class="hlFld-ContribAuthor ">Panna  Vass</span>, <span class="hlFld-ContribAuthor ">Zsombor Kristóf  Nagy</span>, <span class="hlFld-ContribAuthor ">Attila  Farkas</span>, <span class="hlFld-ContribAuthor ">Bianka  Várnai</span>, <span class="hlFld-ContribAuthor ">Szabolcs  Béni</span>, <span class="hlFld-ContribAuthor ">Eszter  Hazai</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfobutylether-beta-cyclodextrin-enabled antiviral remdesivir: Characterization of electrospun- and lyophilized formulations. </span><span class="cited-content_cbyCitation_journal-name">Carbohydrate Polymers</span><span> <strong>2021,</strong> <em>264 </em>, 118011. <a href="https://doi.org/10.1016/j.carbpol.2021.118011" title="DOI URL">https://doi.org/10.1016/j.carbpol.2021.118011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.carbpol.2021.118011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.carbpol.2021.118011%26sid%3Dliteratum%253Aachs%26jtitle%3DCarbohydrate%2520Polymers%26atitle%3DSulfobutylether-beta-cyclodextrin-enabled%252Bantiviral%252Bremdesivir%25253A%252BCharacterization%252Bof%252Belectrospun-%252Band%252Blyophilized%252Bformulations%26aulast%3DSzente%26aufirst%3DLajos%26date%3D2021%26volume%3D264%26spage%3D118011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-juan  Hu</span>, <span class="hlFld-ContribAuthor ">Lu  Chang</span>, <span class="hlFld-ContribAuthor ">Ying  Yang</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Yuan-chao  Xie</span>, <span class="hlFld-ContribAuthor ">Jing-shan  Shen</span>, <span class="hlFld-ContribAuthor ">Bo  Tan</span>, <span class="hlFld-ContribAuthor ">Jia  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics and tissue distribution of remdesivir and its metabolites nucleotide monophosphate, nucleotide triphosphate, and nucleoside in mice. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2021,</strong> <em>42 </em>
                                    (7)
                                     , 1195-1200. <a href="https://doi.org/10.1038/s41401-020-00537-9" title="DOI URL">https://doi.org/10.1038/s41401-020-00537-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-020-00537-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-020-00537-9%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DPharmacokinetics%252Band%252Btissue%252Bdistribution%252Bof%252Bremdesivir%252Band%252Bits%252Bmetabolites%252Bnucleotide%252Bmonophosphate%25252C%252Bnucleotide%252Btriphosphate%25252C%252Band%252Bnucleoside%252Bin%252Bmice%26aulast%3DHu%26aufirst%3DWen-juan%26date%3D2021%26date%3D2020%26volume%3D42%26issue%3D7%26spage%3D1195%26epage%3D1200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Genichiro  Tsuji</span>, <span class="hlFld-ContribAuthor ">Kenzo  Yonemitsu</span>, <span class="hlFld-ContribAuthor ">Takahito  Ito</span>, <span class="hlFld-ContribAuthor ">Yuta  Yanase</span>, <span class="hlFld-ContribAuthor ">Masashi  Uema</span>, <span class="hlFld-ContribAuthor ">Nobumichi  Ohoka</span>, <span class="hlFld-ContribAuthor ">Takao  Inoue</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Asakura</span>, <span class="hlFld-ContribAuthor ">Yosuke  Demizu</span>. </span><span class="cited-content_cbyCitation_article-title">Development of ciclesonide analogues that block SARS-CoV-2 RNA replication. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>43 </em>, 128052. <a href="https://doi.org/10.1016/j.bmcl.2021.128052" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128052%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252Bciclesonide%252Banalogues%252Bthat%252Bblock%252BSARS-CoV-2%252BRNA%252Breplication%26aulast%3DTsuji%26aufirst%3DGenichiro%26date%3D2021%26volume%3D43%26spage%3D128052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anwar  Mohammad</span>, <span class="hlFld-ContribAuthor ">Fahd  Al-Mulla</span>, <span class="hlFld-ContribAuthor ">Dong-Qing  Wei</span>, <span class="hlFld-ContribAuthor ">Jehad  Abubaker</span>. </span><span class="cited-content_cbyCitation_article-title">Remdesivir MD Simulations Suggest a More Favourable Binding to SARS-CoV-2 RNA Dependent RNA Polymerase Mutant P323L Than Wild-Type. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (7)
                                     , 919. <a href="https://doi.org/10.3390/biom11070919" title="DOI URL">https://doi.org/10.3390/biom11070919</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11070919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11070919%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DRemdesivir%252BMD%252BSimulations%252BSuggest%252Ba%252BMore%252BFavourable%252BBinding%252Bto%252BSARS-CoV-2%252BRNA%252BDependent%252BRNA%252BPolymerase%252BMutant%252BP323L%252BThan%252BWild-Type%26aulast%3DMohammad%26aufirst%3DAnwar%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D7%26spage%3D919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manasi P  Jogalekar</span>, <span class="hlFld-ContribAuthor ">Anurag  Veerabathini</span>, <span class="hlFld-ContribAuthor ">Ankit B  Patel</span>. </span><span class="cited-content_cbyCitation_article-title">COVID-19: Antiviral agents and enzyme inhibitors/receptor blockers in development. </span><span class="cited-content_cbyCitation_journal-name">Experimental Biology and Medicine</span><span> <strong>2021,</strong> <em>246 </em>
                                    (13)
                                     , 1533-1540. <a href="https://doi.org/10.1177/1535370221999989" title="DOI URL">https://doi.org/10.1177/1535370221999989</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1535370221999989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1535370221999989%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520Biology%2520and%2520Medicine%26atitle%3DCOVID-19%25253A%252BAntiviral%252Bagents%252Band%252Benzyme%252Binhibitors%25252Freceptor%252Bblockers%252Bin%252Bdevelopment%26aulast%3DJogalekar%26aufirst%3DManasi%2BP%26date%3D2021%26date%3D2021%26volume%3D246%26issue%3D13%26spage%3D1533%26epage%3D1540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prem Prakash  Sharma</span>, <span class="hlFld-ContribAuthor ">Sumit  Kumar</span>, <span class="hlFld-ContribAuthor ">Sukrit  Srivastava</span>, <span class="hlFld-ContribAuthor ">Mitul  Srivastava</span>, <span class="hlFld-ContribAuthor ">Babban  Jee</span>, <span class="hlFld-ContribAuthor ">Nikolay Yu.  Gorobets</span>, <span class="hlFld-ContribAuthor ">Dhruv  Kumar</span>, <span class="hlFld-ContribAuthor ">Mukesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Shailendra  Asthana</span>, <span class="hlFld-ContribAuthor ">Peng  Zhang</span>, <span class="hlFld-ContribAuthor ">Poonam</span>, <span class="hlFld-ContribAuthor ">Martin  Zoltner</span>, <span class="hlFld-ContribAuthor ">Brijesh  Rathi</span>. </span><span class="cited-content_cbyCitation_article-title">Computational study of novel inhibitory molecule, 1-(4-((2
              S
              ,3
              S
              )-3-amino-2-hydroxy-4-phenylbutyl)piperazin-1-yl)-3-phenylurea, with high potential to competitively block ATP binding to the RNA dependent RNA polymerase of SARS-CoV-2 virus. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>11 </em>, 1-19. <a href="https://doi.org/10.1080/07391102.2021.1940281" title="DOI URL">https://doi.org/10.1080/07391102.2021.1940281</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1940281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1940281%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DComputational%252Bstudy%252Bof%252Bnovel%252Binhibitory%252Bmolecule%25252C%252B1-%2525284-%252528%2525282%252BS%252B%25252C3%252BS%252B%252529-3-amino-2-hydroxy-4-phenylbutyl%252529piperazin-1-yl%252529-3-phenylurea%25252C%252Bwith%252Bhigh%252Bpotential%252Bto%252Bcompetitively%252Bblock%252BATP%252Bbinding%252Bto%252Bthe%252BRNA%252Bdependent%252BRNA%252Bpolymerase%252Bof%252BSARS-CoV-2%252Bvirus%26aulast%3DSharma%26aufirst%3DPrem%2BPrakash%26date%3D2021%26date%3D2021%26volume%3D11%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heba  Elmansi</span>, <span class="hlFld-ContribAuthor ">Adel Ehab  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Ibraam E.  Mikhail</span>, <span class="hlFld-ContribAuthor ">Fathalla  Belal</span>. </span><span class="cited-content_cbyCitation_article-title">Green and sensitive spectrofluorimetric determination of Remdesivir, an FDA approved SARS-CoV-2 candidate antiviral; application in pharmaceutical dosage forms and spiked human plasma. </span><span class="cited-content_cbyCitation_journal-name">Analytical Methods</span><span> <strong>2021,</strong> <em>13 </em>
                                    (23)
                                     , 2596-2602. <a href="https://doi.org/10.1039/D1AY00469G" title="DOI URL">https://doi.org/10.1039/D1AY00469G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1AY00469G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1AY00469G%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Methods%26atitle%3DGreen%252Band%252Bsensitive%252Bspectrofluorimetric%252Bdetermination%252Bof%252BRemdesivir%25252C%252Ban%252BFDA%252Bapproved%252BSARS-CoV-2%252Bcandidate%252Bantiviral%25253B%252Bapplication%252Bin%252Bpharmaceutical%252Bdosage%252Bforms%252Band%252Bspiked%252Bhuman%252Bplasma%26aulast%3DElmansi%26aufirst%3DHeba%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D23%26spage%3D2596%26epage%3D2602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jung-Hyun  Won</span>, <span class="hlFld-ContribAuthor ">Howard  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Can the COVID-19 Pandemic Disrupt the Current Drug Development Practices?. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (11)
                                     , 5457. <a href="https://doi.org/10.3390/ijms22115457" title="DOI URL">https://doi.org/10.3390/ijms22115457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22115457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22115457%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DCan%252Bthe%252BCOVID-19%252BPandemic%252BDisrupt%252Bthe%252BCurrent%252BDrug%252BDevelopment%252BPractices%25253F%26aulast%3DWon%26aufirst%3DJung-Hyun%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D11%26spage%3D5457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. Mohammed  Idhrees</span>, <span class="hlFld-ContribAuthor ">Prasanna Karthik  Suthakaran</span>, <span class="hlFld-ContribAuthor ">George Jose  Valooran</span>, <span class="hlFld-ContribAuthor ">Mohamad  Bashir</span>. </span><span class="cited-content_cbyCitation_article-title">Will Remdesivir Reshape Cardiovascular Practice in COVID 19 Era?. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Angiology</span><span> <strong>2021,</strong> <em>30 </em>
                                    (02)
                                     , 155-159. <a href="https://doi.org/10.1055/s-0040-1721403" title="DOI URL">https://doi.org/10.1055/s-0040-1721403</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1055/s-0040-1721403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1055%2Fs-0040-1721403%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Angiology%26atitle%3DWill%252BRemdesivir%252BReshape%252BCardiovascular%252BPractice%252Bin%252BCOVID%252B19%252BEra%25253F%26aulast%3DIdhrees%26aufirst%3DA.%2BMohammed%26date%3D2021%26date%3D2020%26volume%3D30%26issue%3D02%26spage%3D155%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessio Danilo  Inchingolo</span>, <span class="hlFld-ContribAuthor ">Gianna  Dipalma</span>, <span class="hlFld-ContribAuthor ">Angelo Michele  Inchingolo</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Malcangi</span>, <span class="hlFld-ContribAuthor ">Luigi  Santacroce</span>, <span class="hlFld-ContribAuthor ">Maria Teresa  D’Oria</span>, <span class="hlFld-ContribAuthor ">Ciro Gargiulo  Isacco</span>, <span class="hlFld-ContribAuthor ">Ioana Roxana  Bordea</span>, <span class="hlFld-ContribAuthor ">Sebastian  Candrea</span>, <span class="hlFld-ContribAuthor ">Antonio  Scarano</span>, <span class="hlFld-ContribAuthor ">Benedetta  Morandi</span>, <span class="hlFld-ContribAuthor ">Massimo  Del Fabbro</span>, <span class="hlFld-ContribAuthor ">Marco  Farronato</span>, <span class="hlFld-ContribAuthor ">Gianluca Martino  Tartaglia</span>, <span class="hlFld-ContribAuthor ">Mario Giosuè  Balzanelli</span>, <span class="hlFld-ContribAuthor ">Andrea  Ballini</span>, <span class="hlFld-ContribAuthor ">Ludovica  Nucci</span>, <span class="hlFld-ContribAuthor ">Felice  Lorusso</span>, <span class="hlFld-ContribAuthor ">Silvio  Taschieri</span>, <span class="hlFld-ContribAuthor ">Francesco  Inchingolo</span>. </span><span class="cited-content_cbyCitation_article-title">The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants</span><span> <strong>2021,</strong> <em>10 </em>
                                    (6)
                                     , 881. <a href="https://doi.org/10.3390/antiox10060881" title="DOI URL">https://doi.org/10.3390/antiox10060881</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antiox10060881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantiox10060881%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%26atitle%3DThe%252B15-Months%252BClinical%252BExperience%252Bof%252BSARS-CoV-2%25253A%252BA%252BLiterature%252BReview%252Bof%252BTherapies%252Band%252BAdjuvants%26aulast%3DInchingolo%26aufirst%3DAlessio%2BDanilo%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D6%26spage%3D881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chong-Hyun  Shin</span>, <span class="hlFld-ContribAuthor ">Ki-Hye  Kim</span>, <span class="hlFld-ContribAuthor ">Subbiah  Jeeva</span>, <span class="hlFld-ContribAuthor ">Sang-Moo  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic Syndrome. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2021,</strong> <em>10 </em>
                                    (6)
                                     , 1412. <a href="https://doi.org/10.3390/cells10061412" title="DOI URL">https://doi.org/10.3390/cells10061412</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells10061412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells10061412%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DTowards%252BGoals%252Bto%252BRefine%252BProphylactic%252Band%252BTherapeutic%252BStrategies%252BAgainst%252BCOVID-19%252BLinked%252Bto%252BAging%252Band%252BMetabolic%252BSyndrome%26aulast%3DShin%26aufirst%3DChong-Hyun%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D6%26spage%3D1412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Young-Hee  Jin</span>, <span class="hlFld-ContribAuthor ">Jung Sun  Min</span>, <span class="hlFld-ContribAuthor ">Sangeun  Jeon</span>, <span class="hlFld-ContribAuthor ">Jihye  Lee</span>, <span class="hlFld-ContribAuthor ">Seungtaek  Kim</span>, <span class="hlFld-ContribAuthor ">Tamina  Park</span>, <span class="hlFld-ContribAuthor ">Daeui  Park</span>, <span class="hlFld-ContribAuthor ">Min Seong  Jang</span>, <span class="hlFld-ContribAuthor ">Chul Min  Park</span>, <span class="hlFld-ContribAuthor ">Jong Hwan  Song</span>, <span class="hlFld-ContribAuthor ">Hyoung Rae  Kim</span>, <span class="hlFld-ContribAuthor ">Sunoh  Kwon</span>. </span><span class="cited-content_cbyCitation_article-title">Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections. </span><span class="cited-content_cbyCitation_journal-name">Phytomedicine</span><span> <strong>2021,</strong> <em>86 </em>, 153440. <a href="https://doi.org/10.1016/j.phymed.2020.153440" title="DOI URL">https://doi.org/10.1016/j.phymed.2020.153440</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phymed.2020.153440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phymed.2020.153440%26sid%3Dliteratum%253Aachs%26jtitle%3DPhytomedicine%26atitle%3DLycorine%25252C%252Ba%252Bnon-nucleoside%252BRNA%252Bdependent%252BRNA%252Bpolymerase%252Binhibitor%25252C%252Bas%252Bpotential%252Btreatment%252Bfor%252Bemerging%252Bcoronavirus%252Binfections%26aulast%3DJin%26aufirst%3DYoung-Hee%26date%3D2021%26volume%3D86%26spage%3D153440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiashu  Xie</span>, <span class="hlFld-ContribAuthor ">Zhengqiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (6)
                                     , 1607-1616. <a href="https://doi.org/10.1016/j.apsb.2021.03.028" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.03.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.03.028%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DCan%252Bremdesivir%252Band%252Bits%252Bparent%252Bnucleoside%252BGS-441524%252Bbe%252Bpotential%252Boral%252Bdrugs%25253F%252BAn%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%252BDMPK%252Bassessment%26aulast%3DXie%26aufirst%3DJiashu%26date%3D2021%26volume%3D11%26issue%3D6%26spage%3D1607%26epage%3D1616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mona Sadat  Mirtaleb</span>, <span class="hlFld-ContribAuthor ">Amir Hossein  Mirtaleb</span>, <span class="hlFld-ContribAuthor ">Hassan  Nosrati</span>, <span class="hlFld-ContribAuthor ">Jalal  Heshmatnia</span>, <span class="hlFld-ContribAuthor ">Reza  Falak</span>, <span class="hlFld-ContribAuthor ">Reza  Zolfaghari Emameh</span>. </span><span class="cited-content_cbyCitation_article-title">Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2021,</strong> <em>138 </em>, 111518. <a href="https://doi.org/10.1016/j.biopha.2021.111518" title="DOI URL">https://doi.org/10.1016/j.biopha.2021.111518</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2021.111518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2021.111518%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DPotential%252Btherapeutic%252Bagents%252Bto%252BCOVID-19%25253A%252BAn%252Bupdate%252Breview%252Bon%252Bantiviral%252Btherapy%25252C%252Bimmunotherapy%25252C%252Band%252Bcell%252Btherapy%26aulast%3DMirtaleb%26aufirst%3DMona%2BSadat%26date%3D2021%26volume%3D138%26spage%3D111518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marzuq A.  Ungogo</span>, <span class="hlFld-ContribAuthor ">Mustapha  Mohammed</span>, <span class="hlFld-ContribAuthor ">Bala N.  Umar</span>, <span class="hlFld-ContribAuthor ">Auwal A.  Bala</span>, <span class="hlFld-ContribAuthor ">Garba M.  Khalid</span>. </span><span class="cited-content_cbyCitation_article-title">Review of pharmacologic and immunologic agents in the management of COVID-19. </span><span class="cited-content_cbyCitation_journal-name">Biosafety and Health</span><span> <strong>2021,</strong> <em>3 </em>
                                    (3)
                                     , 148-155. <a href="https://doi.org/10.1016/j.bsheal.2021.01.001" title="DOI URL">https://doi.org/10.1016/j.bsheal.2021.01.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bsheal.2021.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bsheal.2021.01.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBiosafety%2520and%2520Health%26atitle%3DReview%252Bof%252Bpharmacologic%252Band%252Bimmunologic%252Bagents%252Bin%252Bthe%252Bmanagement%252Bof%252BCOVID-19%26aulast%3DUngogo%26aufirst%3DMarzuq%2BA.%26date%3D2021%26volume%3D3%26issue%3D3%26spage%3D148%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chih-Cheng  Lai</span>, <span class="hlFld-ContribAuthor ">Chien-Ming  Chao</span>, <span class="hlFld-ContribAuthor ">Po-Ren  Hsueh</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical efficacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials. </span><span class="cited-content_cbyCitation_journal-name">Journal of Microbiology, Immunology and Infection</span><span> <strong>2021,</strong> <em>55 </em><a href="https://doi.org/10.1016/j.jmii.2021.05.011" title="DOI URL">https://doi.org/10.1016/j.jmii.2021.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmii.2021.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmii.2021.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Microbiology%252C%2520Immunology%2520and%2520Infection%26atitle%3DClinical%252Befficacy%252Bof%252Bantiviral%252Bagents%252Bagainst%252Bcoronavirus%252Bdisease%252B2019%25253A%252BA%252Bsystematic%252Breview%252Bof%252Brandomized%252Bcontrolled%252Btrials%26aulast%3DLai%26aufirst%3DChih-Cheng%26date%3D2021%26volume%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taibi  Ben Hadda</span>, <span class="hlFld-ContribAuthor ">Malika  Berredjem</span>, <span class="hlFld-ContribAuthor ">Faisal A.  Almalki</span>, <span class="hlFld-ContribAuthor ">Vesna  Rastija</span>, <span class="hlFld-ContribAuthor ">Joazaizulfazli  Jamalis</span>, <span class="hlFld-ContribAuthor ">Talha Bin  Emran</span>, <span class="hlFld-ContribAuthor ">Tareq  Abu-Izneid</span>, <span class="hlFld-ContribAuthor ">Eman  Esharkawy</span>, <span class="hlFld-ContribAuthor ">Luis Cruz  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Ali M.  Alqahtani</span>. </span><span class="cited-content_cbyCitation_article-title">How to face COVID-19: proposed treatments based on remdesivir and hydroxychloroquine in the presence of zinc sulfate. Docking/DFT/POM structural analysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>16 </em>, 1-14. <a href="https://doi.org/10.1080/07391102.2021.1930161" title="DOI URL">https://doi.org/10.1080/07391102.2021.1930161</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1930161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1930161%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DHow%252Bto%252Bface%252BCOVID-19%25253A%252Bproposed%252Btreatments%252Bbased%252Bon%252Bremdesivir%252Band%252Bhydroxychloroquine%252Bin%252Bthe%252Bpresence%252Bof%252Bzinc%252Bsulfate.%252BDocking%25252FDFT%25252FPOM%252Bstructural%252Banalysis%26aulast%3DBen%2BHadda%26aufirst%3DTaibi%26date%3D2021%26date%3D2021%26volume%3D16%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michaela  Serpi</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Pertusati</span>. </span><span class="cited-content_cbyCitation_article-title">An overview of ProTide technology and its implications to drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2021,</strong> <em>87 </em>, 1-13. <a href="https://doi.org/10.1080/17460441.2021.1922385" title="DOI URL">https://doi.org/10.1080/17460441.2021.1922385</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2021.1922385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2021.1922385%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DAn%252Boverview%252Bof%252BProTide%252Btechnology%252Band%252Bits%252Bimplications%252Bto%252Bdrug%252Bdiscovery%26aulast%3DSerpi%26aufirst%3DMichaela%26date%3D2021%26date%3D2021%26volume%3D87%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazuhiro  Okamoto</span>, <span class="hlFld-ContribAuthor ">Mizuki  Tsutsui</span>, <span class="hlFld-ContribAuthor ">Haruka  Morizumi</span>, <span class="hlFld-ContribAuthor ">Yoshikazu  Kitano</span>, <span class="hlFld-ContribAuthor ">Kazuhiro  Chiba</span>. </span><span class="cited-content_cbyCitation_article-title">Electrochemical Synthesis of Imino‐
              C
              ‐Nucleosides by “Reactivity Switching” Methodology for
              in situ
              Generated Glycoside Donors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>2021 </em>
                                    (17)
                                     , 2479-2484. <a href="https://doi.org/10.1002/ejoc.202100106" title="DOI URL">https://doi.org/10.1002/ejoc.202100106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202100106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202100106%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DElectrochemical%252BSynthesis%252Bof%252BImino%2525E2%252580%252590%252BC%252B%2525E2%252580%252590Nucleosides%252Bby%252B%2525E2%252580%25259CReactivity%252BSwitching%2525E2%252580%25259D%252BMethodology%252Bfor%252Bin%2525E2%252580%252585situ%252BGenerated%252BGlycoside%252BDonors%26aulast%3DOkamoto%26aufirst%3DKazuhiro%26date%3D2021%26date%3D2021%26volume%3D2021%26issue%3D17%26spage%3D2479%26epage%3D2484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Hui-Xia  Zhang</span>, <span class="hlFld-ContribAuthor ">Wen-Di  Luo</span>, <span class="hlFld-ContribAuthor ">Christopher Wai Kei  Lam</span>, <span class="hlFld-ContribAuthor ">Cai-Yun  Wang</span>, <span class="hlFld-ContribAuthor ">Li-Ping  Bai</span>, <span class="hlFld-ContribAuthor ">Vincent Kam Wai  Wong</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-Hong  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Profiling Ribonucleotide and Deoxyribonucleotide Pools Perturbed by Remdesivir in Human Bronchial Epithelial Cells. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fphar.2021.647280" title="DOI URL">https://doi.org/10.3389/fphar.2021.647280</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2021.647280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2021.647280%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DProfiling%252BRibonucleotide%252Band%252BDeoxyribonucleotide%252BPools%252BPerturbed%252Bby%252BRemdesivir%252Bin%252BHuman%252BBronchial%252BEpithelial%252BCells%26aulast%3DLi%26aufirst%3DYan%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eleni  Pitsillou</span>, <span class="hlFld-ContribAuthor ">Julia  Liang</span>, <span class="hlFld-ContribAuthor ">Katherine  Ververis</span>, <span class="hlFld-ContribAuthor ">Andrew  Hung</span>, <span class="hlFld-ContribAuthor ">Tom C.  Karagiannis</span>. </span><span class="cited-content_cbyCitation_article-title">Interaction of small molecules with the SARS-CoV-2 papain-like protease: In silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2021,</strong> <em>104 </em>, 107851. <a href="https://doi.org/10.1016/j.jmgm.2021.107851" title="DOI URL">https://doi.org/10.1016/j.jmgm.2021.107851</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2021.107851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2021.107851%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DInteraction%252Bof%252Bsmall%252Bmolecules%252Bwith%252Bthe%252BSARS-CoV-2%252Bpapain-like%252Bprotease%25253A%252BIn%252Bsilico%252Bstudies%252Band%252Bin%2525C2%2525A0vitro%252Bvalidation%252Bof%252Bprotease%252Bactivity%252Binhibition%252Busing%252Ban%252Benzymatic%252Binhibition%252Bassay%26aulast%3DPitsillou%26aufirst%3DEleni%26date%3D2021%26volume%3D104%26spage%3D107851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Saqrane</span>, <span class="hlFld-ContribAuthor ">M.A.  El Mhammedi</span>, <span class="hlFld-ContribAuthor ">S.  Lahrich</span>, <span class="hlFld-ContribAuthor ">F.  Laghrib</span>, <span class="hlFld-ContribAuthor ">Y.  El Bouabi</span>, <span class="hlFld-ContribAuthor ">A.  Farahi</span>, <span class="hlFld-ContribAuthor ">M.  Bakasse</span>. </span><span class="cited-content_cbyCitation_article-title">Recent knowledge in favor of remdesivir (GS-5734) as a therapeutic option for the COVID-19 infections. </span><span class="cited-content_cbyCitation_journal-name">Journal of Infection and Public Health</span><span> <strong>2021,</strong> <em>14 </em>
                                    (5)
                                     , 655-660. <a href="https://doi.org/10.1016/j.jiph.2021.02.006" title="DOI URL">https://doi.org/10.1016/j.jiph.2021.02.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jiph.2021.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jiph.2021.02.006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Infection%2520and%2520Public%2520Health%26atitle%3DRecent%252Bknowledge%252Bin%252Bfavor%252Bof%252Bremdesivir%252B%252528GS-5734%252529%252Bas%252Ba%252Btherapeutic%252Boption%252Bfor%252Bthe%252BCOVID-19%252Binfections%26aulast%3DSaqrane%26aufirst%3DS.%26date%3D2021%26volume%3D14%26issue%3D5%26spage%3D655%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jimin  Xu</span>, <span class="hlFld-ContribAuthor ">Yu  Xue</span>, <span class="hlFld-ContribAuthor ">Richard  Zhou</span>, <span class="hlFld-ContribAuthor ">Pei‐Yong  Shi</span>, <span class="hlFld-ContribAuthor ">Hongmin  Li</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Drug repurposing approach to combating coronavirus: Potential drugs and drug targets. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2021,</strong> <em>41 </em>
                                    (3)
                                     , 1375-1426. <a href="https://doi.org/10.1002/med.21763" title="DOI URL">https://doi.org/10.1002/med.21763</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21763%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DDrug%252Brepurposing%252Bapproach%252Bto%252Bcombating%252Bcoronavirus%25253A%252BPotential%252Bdrugs%252Band%252Bdrug%252Btargets%26aulast%3DXu%26aufirst%3DJimin%26date%3D2021%26date%3D2020%26volume%3D41%26issue%3D3%26spage%3D1375%26epage%3D1426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaxi  Yu</span>, <span class="hlFld-ContribAuthor ">Shuai  Chen</span>, <span class="hlFld-ContribAuthor ">Chander  Amgoth</span>, <span class="hlFld-ContribAuthor ">Guping  Tang</span>, <span class="hlFld-ContribAuthor ">Hongzhen  Bai</span>, <span class="hlFld-ContribAuthor ">Xiurong  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Two polymorphs of remdesivir: crystal structure, solubility, and pharmacokinetic study. </span><span class="cited-content_cbyCitation_journal-name">CrystEngComm</span><span> <strong>2021,</strong> <em>23 </em>
                                    (16)
                                     , 2923-2927. <a href="https://doi.org/10.1039/D1CE00175B" title="DOI URL">https://doi.org/10.1039/D1CE00175B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1CE00175B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1CE00175B%26sid%3Dliteratum%253Aachs%26jtitle%3DCrystEngComm%26atitle%3DTwo%252Bpolymorphs%252Bof%252Bremdesivir%25253A%252Bcrystal%252Bstructure%25252C%252Bsolubility%25252C%252Band%252Bpharmacokinetic%252Bstudy%26aulast%3DYu%26aufirst%3DKaxi%26date%3D2021%26date%3D2021%26volume%3D23%26issue%3D16%26spage%3D2923%26epage%3D2927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hailei  Su</span>, <span class="hlFld-ContribAuthor ">Feng  Zhou</span>, <span class="hlFld-ContribAuthor ">Ziru  Huang</span>, <span class="hlFld-ContribAuthor ">Xiaohua  Ma</span>, <span class="hlFld-ContribAuthor ">Kathiresan  Natarajan</span>, <span class="hlFld-ContribAuthor ">Minchuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Yong  Huang</span>, <span class="hlFld-ContribAuthor ">Haibin  Su</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Insights into Small‐Molecule Drug Discovery for SARS‐CoV‐2. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>133 </em>
                                    (18)
                                     , 9873-9886. <a href="https://doi.org/10.1002/ange.202008835" title="DOI URL">https://doi.org/10.1002/ange.202008835</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202008835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202008835%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DMolecular%252BInsights%252Binto%252BSmall%2525E2%252580%252590Molecule%252BDrug%252BDiscovery%252Bfor%252BSARS%2525E2%252580%252590CoV%2525E2%252580%2525902%26aulast%3DSu%26aufirst%3DHailei%26date%3D2021%26date%3D2021%26volume%3D133%26issue%3D18%26spage%3D9873%26epage%3D9886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hailei  Su</span>, <span class="hlFld-ContribAuthor ">Feng  Zhou</span>, <span class="hlFld-ContribAuthor ">Ziru  Huang</span>, <span class="hlFld-ContribAuthor ">Xiaohua  Ma</span>, <span class="hlFld-ContribAuthor ">Kathiresan  Natarajan</span>, <span class="hlFld-ContribAuthor ">Minchuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Yong  Huang</span>, <span class="hlFld-ContribAuthor ">Haibin  Su</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Insights into Small‐Molecule Drug Discovery for SARS‐CoV‐2. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>60 </em>
                                    (18)
                                     , 9789-9802. <a href="https://doi.org/10.1002/anie.202008835" title="DOI URL">https://doi.org/10.1002/anie.202008835</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202008835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202008835%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DMolecular%252BInsights%252Binto%252BSmall%2525E2%252580%252590Molecule%252BDrug%252BDiscovery%252Bfor%252BSARS%2525E2%252580%252590CoV%2525E2%252580%2525902%26aulast%3DSu%26aufirst%3DHailei%26date%3D2021%26date%3D2021%26volume%3D60%26issue%3D18%26spage%3D9789%26epage%3D9802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zemene Demelash  Kifle</span>, <span class="hlFld-ContribAuthor ">Akeberegn Gorems  Ayele</span>, <span class="hlFld-ContribAuthor ">Engidaw Fentahun  Enyew</span>, . </span><span class="cited-content_cbyCitation_article-title">Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment. </span><span class="cited-content_cbyCitation_journal-name">Journal of Environmental and Public Health</span><span> <strong>2021,</strong> <em>2021 </em>, 1-11. <a href="https://doi.org/10.1155/2021/6631721" title="DOI URL">https://doi.org/10.1155/2021/6631721</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2021/6631721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2021%2F6631721%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Environmental%2520and%2520Public%2520Health%26atitle%3DDrug%252BRepurposing%252BApproach%25252C%252BPotential%252BDrugs%25252C%252Band%252BNovel%252BDrug%252BTargets%252Bfor%252BCOVID-19%252BTreatment%26aulast%3DKifle%26aufirst%3DZemene%2BDemelash%26date%3D2021%26volume%3D2021%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H. M. Nasrullah  Faisal</span>, <span class="hlFld-ContribAuthor ">Kalpana S.  Katti</span>, <span class="hlFld-ContribAuthor ">Dinesh R.  Katti</span>. </span><span class="cited-content_cbyCitation_article-title">Differences in Interactions Within Viral Replication Complexes of SARS-CoV-2 (COVID-19) and SARS-CoV Coronaviruses Control RNA Replication Ability. </span><span class="cited-content_cbyCitation_journal-name">JOM</span><span> <strong>2021,</strong> <em>8 </em><a href="https://doi.org/10.1007/s11837-021-04662-6" title="DOI URL">https://doi.org/10.1007/s11837-021-04662-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11837-021-04662-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11837-021-04662-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJOM%26atitle%3DDifferences%252Bin%252BInteractions%252BWithin%252BViral%252BReplication%252BComplexes%252Bof%252BSARS-CoV-2%252B%252528COVID-19%252529%252Band%252BSARS-CoV%252BCoronaviruses%252BControl%252BRNA%252BReplication%252BAbility%26aulast%3DFaisal%26aufirst%3DH.%2BM.%2BNasrullah%26date%3D2021%26date%3D2021%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atieh  Yaghoubi</span>, <span class="hlFld-ContribAuthor ">Saeid  Amel Jamehdar</span>, <span class="hlFld-ContribAuthor ">Aref  Movaqar</span>, <span class="hlFld-ContribAuthor ">Nasrin  Milani</span>, <span class="hlFld-ContribAuthor ">Saman  Soleimanpour</span>. </span><span class="cited-content_cbyCitation_article-title">An effective drug against COVID-19: reality or dream?. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Respiratory Medicine</span><span> <strong>2021,</strong> <em>15 </em>
                                    (4)
                                     , 505-518. <a href="https://doi.org/10.1080/17476348.2021.1854092" title="DOI URL">https://doi.org/10.1080/17476348.2021.1854092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17476348.2021.1854092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17476348.2021.1854092%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Respiratory%2520Medicine%26atitle%3DAn%252Beffective%252Bdrug%252Bagainst%252BCOVID-19%25253A%252Breality%252Bor%252Bdream%25253F%26aulast%3DYaghoubi%26aufirst%3DAtieh%26date%3D2021%26date%3D2020%26volume%3D15%26issue%3D4%26spage%3D505%26epage%3D518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ilaria  Vicenti</span>, <span class="hlFld-ContribAuthor ">Maurizio  Zazzi</span>, <span class="hlFld-ContribAuthor ">Francesco  Saladini</span>. </span><span class="cited-content_cbyCitation_article-title">SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (4)
                                     , 325-337. <a href="https://doi.org/10.1080/13543776.2021.1880568" title="DOI URL">https://doi.org/10.1080/13543776.2021.1880568</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1880568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1880568%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSARS-CoV-2%252BRNA-dependent%252BRNA%252Bpolymerase%252Bas%252Ba%252Btherapeutic%252Btarget%252Bfor%252BCOVID-19%26aulast%3DVicenti%26aufirst%3DIlaria%26date%3D2021%26date%3D2021%26volume%3D31%26issue%3D4%26spage%3D325%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rohitash  Yadav</span>, <span class="hlFld-ContribAuthor ">Jitendra Kumar  Chaudhary</span>, <span class="hlFld-ContribAuthor ">Neeraj  Jain</span>, <span class="hlFld-ContribAuthor ">Pankaj Kumar  Chaudhary</span>, <span class="hlFld-ContribAuthor ">Supriya  Khanra</span>, <span class="hlFld-ContribAuthor ">Puneet  Dhamija</span>, <span class="hlFld-ContribAuthor ">Ambika  Sharma</span>, <span class="hlFld-ContribAuthor ">Ashish  Kumar</span>, <span class="hlFld-ContribAuthor ">Shailendra  Handu</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2021,</strong> <em>10 </em>
                                    (4)
                                     , 821. <a href="https://doi.org/10.3390/cells10040821" title="DOI URL">https://doi.org/10.3390/cells10040821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells10040821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells10040821%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DRole%252Bof%252BStructural%252Band%252BNon-Structural%252BProteins%252Band%252BTherapeutic%252BTargets%252Bof%252BSARS-CoV-2%252Bfor%252BCOVID-19%26aulast%3DYadav%26aufirst%3DRohitash%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D4%26spage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert J.  Geraghty</span>, <span class="hlFld-ContribAuthor ">Matthew T.  Aliota</span>, <span class="hlFld-ContribAuthor ">Laurent F.  Bonnac</span>. </span><span class="cited-content_cbyCitation_article-title">Broad-Spectrum Antiviral Strategies and Nucleoside Analogues. </span><span class="cited-content_cbyCitation_journal-name">Viruses</span><span> <strong>2021,</strong> <em>13 </em>
                                    (4)
                                     , 667. <a href="https://doi.org/10.3390/v13040667" title="DOI URL">https://doi.org/10.3390/v13040667</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/v13040667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fv13040667%26sid%3Dliteratum%253Aachs%26jtitle%3DViruses%26atitle%3DBroad-Spectrum%252BAntiviral%252BStrategies%252Band%252BNucleoside%252BAnalogues%26aulast%3DGeraghty%26aufirst%3DRobert%2BJ.%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D4%26spage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jatin  Machhi</span>, <span class="hlFld-ContribAuthor ">Farah  Shahjin</span>, <span class="hlFld-ContribAuthor ">Srijanee  Das</span>, <span class="hlFld-ContribAuthor ">Milankumar  Patel</span>, <span class="hlFld-ContribAuthor ">Mai Mohamed  Abdelmoaty</span>, <span class="hlFld-ContribAuthor ">Jacob D.  Cohen</span>, <span class="hlFld-ContribAuthor ">Preet Amol  Singh</span>, <span class="hlFld-ContribAuthor ">Ashish  Baldi</span>, <span class="hlFld-ContribAuthor ">Neha  Bajwa</span>, <span class="hlFld-ContribAuthor ">Raj  Kumar</span>, <span class="hlFld-ContribAuthor ">Lalit K.  Vora</span>, <span class="hlFld-ContribAuthor ">Tapan A.  Patel</span>, <span class="hlFld-ContribAuthor ">Maxim D.  Oleynikov</span>, <span class="hlFld-ContribAuthor ">Dhruvkumar  Soni</span>, <span class="hlFld-ContribAuthor ">Pravin  Yeapuri</span>, <span class="hlFld-ContribAuthor ">Insiya  Mukadam</span>, <span class="hlFld-ContribAuthor ">Rajashree  Chakraborty</span>, <span class="hlFld-ContribAuthor ">Caroline G.  Saksena</span>, <span class="hlFld-ContribAuthor ">Jonathan  Herskovitz</span>, <span class="hlFld-ContribAuthor ">Mahmudul  Hasan</span>, <span class="hlFld-ContribAuthor ">David  Oupicky</span>, <span class="hlFld-ContribAuthor ">Suvarthi  Das</span>, <span class="hlFld-ContribAuthor ">Ryan F.  Donnelly</span>, <span class="hlFld-ContribAuthor ">Kenneth S.  Hettie</span>, <span class="hlFld-ContribAuthor ">Linda  Chang</span>, <span class="hlFld-ContribAuthor ">Howard E.  Gendelman</span>, <span class="hlFld-ContribAuthor ">Bhavesh D.  Kevadiya</span>. </span><span class="cited-content_cbyCitation_article-title">Nanocarrier vaccines for SARS-CoV-2. </span><span class="cited-content_cbyCitation_journal-name">Advanced Drug Delivery Reviews</span><span> <strong>2021,</strong> <em>171 </em>, 215-239. <a href="https://doi.org/10.1016/j.addr.2021.01.002" title="DOI URL">https://doi.org/10.1016/j.addr.2021.01.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.addr.2021.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.addr.2021.01.002%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Drug%2520Delivery%2520Reviews%26atitle%3DNanocarrier%252Bvaccines%252Bfor%252BSARS-CoV-2%26aulast%3DMachhi%26aufirst%3DJatin%26date%3D2021%26volume%3D171%26spage%3D215%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vladimir E.  Kataev</span>, <span class="hlFld-ContribAuthor ">Bulat F.  Garifullin</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral nucleoside analogs. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2021,</strong> <em>57 </em>
                                    (4)
                                     , 326-341. <a href="https://doi.org/10.1007/s10593-021-02912-8" title="DOI URL">https://doi.org/10.1007/s10593-021-02912-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-021-02912-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-021-02912-8%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DAntiviral%252Bnucleoside%252Banalogs%26aulast%3DKataev%26aufirst%3DVladimir%2BE.%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D4%26spage%3D326%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donata  Pluskota-Karwatka</span>, <span class="hlFld-ContribAuthor ">Marcin  Hoffmann</span>, <span class="hlFld-ContribAuthor ">Jan  Barciszewski</span>. </span><span class="cited-content_cbyCitation_article-title">Reducing SARS-CoV-2 pathological protein activity with small molecules. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical Analysis</span><span> <strong>2021,</strong> <em>76 </em><a href="https://doi.org/10.1016/j.jpha.2021.03.012" title="DOI URL">https://doi.org/10.1016/j.jpha.2021.03.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpha.2021.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpha.2021.03.012%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520Analysis%26atitle%3DReducing%252BSARS-CoV-2%252Bpathological%252Bprotein%252Bactivity%252Bwith%252Bsmall%252Bmolecules%26aulast%3DPluskota-Karwatka%26aufirst%3DDonata%26date%3D2021%26volume%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Catherine S.  Adamson</span>, <span class="hlFld-ContribAuthor ">Kelly  Chibale</span>, <span class="hlFld-ContribAuthor ">Rebecca J. M.  Goss</span>, <span class="hlFld-ContribAuthor ">Marcel  Jaspars</span>, <span class="hlFld-ContribAuthor ">David J.  Newman</span>, <span class="hlFld-ContribAuthor ">Rosemary A.  Dorrington</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral drug discovery: preparing for the next pandemic. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2021,</strong> <em>50 </em>
                                    (6)
                                     , 3647-3655. <a href="https://doi.org/10.1039/D0CS01118E" title="DOI URL">https://doi.org/10.1039/D0CS01118E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CS01118E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CS01118E%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DAntiviral%252Bdrug%252Bdiscovery%25253A%252Bpreparing%252Bfor%252Bthe%252Bnext%252Bpandemic%26aulast%3DAdamson%26aufirst%3DCatherine%2BS.%26date%3D2021%26date%3D2021%26volume%3D50%26issue%3D6%26spage%3D3647%26epage%3D3655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanchao  Xie</span>, <span class="hlFld-ContribAuthor ">Xiaozhen  Guo</span>, <span class="hlFld-ContribAuthor ">Tianwen  Hu</span>, <span class="hlFld-ContribAuthor ">Daibao  Wei</span>, <span class="hlFld-ContribAuthor ">Xiuli  Ma</span>, <span class="hlFld-ContribAuthor ">Jiaqiang  Wu</span>, <span class="hlFld-ContribAuthor ">Bing  Huang</span>, <span class="hlFld-ContribAuthor ">Jingshan  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Significant Inhibition of Porcine Epidemic Diarrhea Virus In Vitro by Remdesivir, Its Parent Nucleoside and β-d-N4-hydroxycytidine. </span><span class="cited-content_cbyCitation_journal-name">Virologica Sinica</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.1007/s12250-021-00362-2" title="DOI URL">https://doi.org/10.1007/s12250-021-00362-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12250-021-00362-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12250-021-00362-2%26sid%3Dliteratum%253Aachs%26jtitle%3DVirologica%2520Sinica%26atitle%3DSignificant%252BInhibition%252Bof%252BPorcine%252BEpidemic%252BDiarrhea%252BVirus%252BIn%252BVitro%252Bby%252BRemdesivir%25252C%252BIts%252BParent%252BNucleoside%252Band%252B%2525CE%2525B2-d-N4-hydroxycytidine%26aulast%3DXie%26aufirst%3DYuanchao%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Obireddy  Sreekanth Reddy</span>, <span class="hlFld-ContribAuthor ">Wing‐Fu  Lai</span>. </span><span class="cited-content_cbyCitation_article-title">Tackling COVID‐19 Using Remdesivir and Favipiravir as Therapeutic Options. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2021,</strong> <em>22 </em>
                                    (6)
                                     , 939-948. <a href="https://doi.org/10.1002/cbic.202000595" title="DOI URL">https://doi.org/10.1002/cbic.202000595</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.202000595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.202000595%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DTackling%252BCOVID%2525E2%252580%25259019%252BUsing%252BRemdesivir%252Band%252BFavipiravir%252Bas%252BTherapeutic%252BOptions%26aulast%3DSreekanth%2BReddy%26aufirst%3DObireddy%26date%3D2021%26date%3D2020%26volume%3D22%26issue%3D6%26spage%3D939%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaohui  Ju</span>, <span class="hlFld-ContribAuthor ">Yunkai  Zhu</span>, <span class="hlFld-ContribAuthor ">Yuyan  Wang</span>, <span class="hlFld-ContribAuthor ">Jingrui  Li</span>, <span class="hlFld-ContribAuthor ">Jiaxing  Zhang</span>, <span class="hlFld-ContribAuthor ">Mingli  Gong</span>, <span class="hlFld-ContribAuthor ">Wenlin  Ren</span>, <span class="hlFld-ContribAuthor ">Sai  Li</span>, <span class="hlFld-ContribAuthor ">Jin  Zhong</span>, <span class="hlFld-ContribAuthor ">Linqi  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiangfeng Cliff  Zhang</span>, <span class="hlFld-ContribAuthor ">Rong  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiang  Ding</span>, . </span><span class="cited-content_cbyCitation_article-title">A novel cell culture system modeling the SARS-CoV-2 life cycle. </span><span class="cited-content_cbyCitation_journal-name">PLOS Pathogens</span><span> <strong>2021,</strong> <em>17 </em>
                                    (3)
                                     , e1009439. <a href="https://doi.org/10.1371/journal.ppat.1009439" title="DOI URL">https://doi.org/10.1371/journal.ppat.1009439</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.ppat.1009439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.ppat.1009439%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Pathogens%26atitle%3DA%252Bnovel%252Bcell%252Bculture%252Bsystem%252Bmodeling%252Bthe%252BSARS-CoV-2%252Blife%252Bcycle%26aulast%3DJu%26aufirst%3DXiaohui%26date%3D2021%26date%3D2021%26volume%3D17%26issue%3D3%26spage%3De1009439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bimalendu  Adhikari</span>, <span class="hlFld-ContribAuthor ">Nihar  Sahu</span>. </span><span class="cited-content_cbyCitation_article-title">COVID‐19 into Chemical Science Perspective: Chemical Preventive Measures and Drug Development. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (9)
                                     , 2010-2028. <a href="https://doi.org/10.1002/slct.202100127" title="DOI URL">https://doi.org/10.1002/slct.202100127</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202100127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202100127%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DCOVID%2525E2%252580%25259019%252Binto%252BChemical%252BScience%252BPerspective%25253A%252BChemical%252BPreventive%252BMeasures%252Band%252BDrug%252BDevelopment%26aulast%3DAdhikari%26aufirst%3DBimalendu%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D9%26spage%3D2010%26epage%3D2028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederick  Hansen</span>, <span class="hlFld-ContribAuthor ">Heinz  Feldmann</span>, <span class="hlFld-ContribAuthor ">Michael A  Jarvis</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Ebola virus replication through pharmaceutical intervention. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2021,</strong> <em>30 </em>
                                    (3)
                                     , 201-226. <a href="https://doi.org/10.1080/13543784.2021.1881061" title="DOI URL">https://doi.org/10.1080/13543784.2021.1881061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2021.1881061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2021.1881061%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DTargeting%252BEbola%252Bvirus%252Breplication%252Bthrough%252Bpharmaceutical%252Bintervention%26aulast%3DHansen%26aufirst%3DFrederick%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D3%26spage%3D201%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuki  Yoshida</span>, <span class="hlFld-ContribAuthor ">Masakazu  Honma</span>, <span class="hlFld-ContribAuthor ">Yasuaki  Kimura</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Abe</span>. </span><span class="cited-content_cbyCitation_article-title">Structure, Synthesis and Inhibition Mechanism of Nucleoside Analogues as HIV‐1 Reverse Transcriptase Inhibitors (NRTIs). </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (5)
                                     , 743-766. <a href="https://doi.org/10.1002/cmdc.202000695" title="DOI URL">https://doi.org/10.1002/cmdc.202000695</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000695%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DStructure%25252C%252BSynthesis%252Band%252BInhibition%252BMechanism%252Bof%252BNucleoside%252BAnalogues%252Bas%252BHIV%2525E2%252580%2525901%252BReverse%252BTranscriptase%252BInhibitors%252B%252528NRTIs%252529%26aulast%3DYoshida%26aufirst%3DYuki%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D5%26spage%3D743%26epage%3D766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ingrid  Fricke-Galindo</span>, <span class="hlFld-ContribAuthor ">Ramcés  Falfán-Valencia</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacogenetics Approach for the Improvement of COVID-19 Treatment. </span><span class="cited-content_cbyCitation_journal-name">Viruses</span><span> <strong>2021,</strong> <em>13 </em>
                                    (3)
                                     , 413. <a href="https://doi.org/10.3390/v13030413" title="DOI URL">https://doi.org/10.3390/v13030413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/v13030413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fv13030413%26sid%3Dliteratum%253Aachs%26jtitle%3DViruses%26atitle%3DPharmacogenetics%252BApproach%252Bfor%252Bthe%252BImprovement%252Bof%252BCOVID-19%252BTreatment%26aulast%3DFricke-Galindo%26aufirst%3DIngrid%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D3%26spage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anish  Nag</span>, <span class="hlFld-ContribAuthor ">Ritesh  Banerjee</span>, <span class="hlFld-ContribAuthor ">Rajshree Roy  Chowdhury</span>, <span class="hlFld-ContribAuthor ">Chandana  Krishnapura Venkatesh</span>. </span><span class="cited-content_cbyCitation_article-title">Phytochemicals as potential drug candidates for targeting SARS CoV 2 proteins, an in silico study. </span><span class="cited-content_cbyCitation_journal-name">VirusDisease</span><span> <strong>2021,</strong> <em>32 </em>
                                    (1)
                                     , 98-107. <a href="https://doi.org/10.1007/s13337-021-00654-x" title="DOI URL">https://doi.org/10.1007/s13337-021-00654-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13337-021-00654-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13337-021-00654-x%26sid%3Dliteratum%253Aachs%26jtitle%3DVirusDisease%26atitle%3DPhytochemicals%252Bas%252Bpotential%252Bdrug%252Bcandidates%252Bfor%252Btargeting%252BSARS%252BCoV%252B2%252Bproteins%25252C%252Ban%252Bin%252Bsilico%252Bstudy%26aulast%3DNag%26aufirst%3DAnish%26date%3D2021%26date%3D2021%26volume%3D32%26issue%3D1%26spage%3D98%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark A.  Vanden Avond</span>, <span class="hlFld-ContribAuthor ">Hui  Meng</span>, <span class="hlFld-ContribAuthor ">Margaret J.  Beatka</span>, <span class="hlFld-ContribAuthor ">Daniel C.  Helbling</span>, <span class="hlFld-ContribAuthor ">Mariah J.  Prom</span>, <span class="hlFld-ContribAuthor ">Jessica L.  Sutton</span>, <span class="hlFld-ContribAuthor ">Rebecca A.  Slick</span>, <span class="hlFld-ContribAuthor ">David P.  Dimmock</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Pertusati</span>, <span class="hlFld-ContribAuthor ">Michaela  Serpi</span>, <span class="hlFld-ContribAuthor ">Elisa  Pileggi</span>, <span class="hlFld-ContribAuthor ">Patrick  Crutcher</span>, <span class="hlFld-ContribAuthor ">Stephen  Thomas</span>, <span class="hlFld-ContribAuthor ">Michael W.  Lawlor</span>. </span><span class="cited-content_cbyCitation_article-title">The nucleotide prodrug
              CERC
              ‐913 improves
              mtDNA
              content in primary hepatocytes from
              DGUOK‐deficient
              rats. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inherited Metabolic Disease</span><span> <strong>2021,</strong> <em>44 </em>
                                    (2)
                                     , 492-501. <a href="https://doi.org/10.1002/jimd.12354" title="DOI URL">https://doi.org/10.1002/jimd.12354</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jimd.12354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjimd.12354%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inherited%2520Metabolic%2520Disease%26atitle%3DThe%252Bnucleotide%252Bprodrug%252BCERC%252B%2525E2%252580%252590913%252Bimproves%252BmtDNA%252Bcontent%252Bin%252Bprimary%252Bhepatocytes%252Bfrom%252BDGUOK%2525E2%252580%252590deficient%252Brats%26aulast%3DVanden%2BAvond%26aufirst%3DMark%2BA.%26date%3D2021%26date%3D2021%26volume%3D44%26issue%3D2%26spage%3D492%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priyanka  Dash</span>, <span class="hlFld-ContribAuthor ">Subhashree  Mohapatra</span>, <span class="hlFld-ContribAuthor ">Sayantan  Ghosh</span>, <span class="hlFld-ContribAuthor ">Bismita  Nayak</span>. </span><span class="cited-content_cbyCitation_article-title">A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.590154" title="DOI URL">https://doi.org/10.3389/fphar.2020.590154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.590154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.590154%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DA%252BScoping%252BInsight%252Bon%252BPotential%252BProphylactics%25252C%252BVaccines%252Band%252BTherapeutic%252BWeaponry%252Bfor%252Bthe%252BOngoing%252BNovel%252BCoronavirus%252B%252528COVID-19%252529%252BPandemic-%252BA%252BComprehensive%252BReview%26aulast%3DDash%26aufirst%3DPriyanka%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Facs.jmedchem.6b01594&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-5%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01594&amp;citedByCount=254&amp;pagesCount=3&amp;pageNumber=2" title="Load more citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load more citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/medium/jm-2016-01594m_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01594&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/medium/jm-2016-01594m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of antiviral nucleosides and nucleoside phosphonates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01594&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/medium/jm-2016-01594m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Compound <b>4tp</b> modeled into the EBOV polymerase active site. Residue Y636 is highlighted in green surface, sits below the ribose, and corresponds to F704 in RSV. Residue E709 is highlighted in red surface, sits in proximity to the 2′-β-H position of the ribose, and corresponds to S282 in HCV. (b) Compound <b>13tp</b> modeled into the EBOV polymerase active site. The 2′-β-methyl overlaps with residue E709 highlighted in red. (c) Compound <b>13tp</b> modeled into the HCV polymerase active site. Residue S282 is highlighted in the yellow surface, and the 2′-β-methyl can be accommodated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01594&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/medium/jm-2016-01594m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. First Generation Synthesis of <b>4b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01594&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, (TMS)Cl, THF, – 78 °C, 25%; (b) 1,2-bis(chlorodimethylsilyl)ethane, NaH, <i>n</i>-BuLi, THF, – 78 °C, 60%; (c) (TMS)CN, BF<sub>3</sub>·Et<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, – 78 °C, 58% (89:11β-<b>17</b>/α); (d) BCl<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, – 78 °C, 74%; (e) <b>19</b>, NMI, OP(OMe)<sub>3</sub>, 21%; (f) OP(OPh)Cl<sub>2</sub>, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 23%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/medium/jm-2016-01594m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Second Generation Synthesis of <b>4b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01594&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TMSCl, PhMgCl, <i>i</i>-PrMgCl·LiCl, THF, – 20 °C, 40%; (b) TMSCN, TfOH, TMSOTf, CH<sub>2</sub>Cl<sub>2</sub>, – 78 °C, 85%; (c) BCl<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, – 20 °C, 86%; (d) 2,2-dimethoxypropane, H<sub>2</sub>SO<sub>4</sub>, acetone, rt, 90%; (e) <b>22b</b>, MgCl<sub>2</sub>, (<i>i</i>-Pr)<sub>2</sub>NEt, MeCN, 50 °C, 70%; (f) 37% HCl, THF, rt, 69%; (g) OP(OPh)Cl<sub>2</sub>, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, – 78 °C, then 4-nitrophenol, Et<sub>3</sub>N, 0 °C, 80%; (h) <i>i</i>-Pr<sub>2</sub>O, 39%.</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/medium/jm-2016-01594m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Thermal ellipsoid representations of (a) <b>22b</b> and (b) <b>4b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01594&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/medium/jm-2016-01594m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Prodrug Synthesis</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01594&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label"><sup>a</sup></span>Prodrug is an undetermined mixture of diastereoisomers unless otherwise indicated.</p><p><span class="fn-label"><sup>b</sup></span>aa = amino acid, Ala = alanine, Phe = phenylalanine, AIB = 2-aminoisobutyrate, <i>c</i>-Bu = cyclobutyl, <i>c</i>-Pent = cyclopentyl, Pent = pentyl, Neopent = neopentyl, 2-EtBu = 2-ethylbutyl, PNP = <i>p</i>-nitrophenolate, and PFP = pentafluorophenolate.</p><p><span class="fn-label"><sup>c</sup></span>LG = leaving group.</p><p><span class="fn-label"><sup>d</sup></span>Single <i>S</i>p isomer.</p><p><span class="fn-label"><sup>e</sup></span>Reagent was a single unassigned isomer at phosphorus.</p><p class="last"><span class="fn-label"><sup>f</sup></span>NA = not applicable.</p></p></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/medium/jm-2016-01594m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Concentration–time profiles following 10 mg/kg iv single dose slow bolus administration of <b>4b</b> in Rhesus (mean ± SD, <i>n</i> = 3 per time point). (a) Plasma profile of prodrug <b>4b</b> (black circle) and parent nucleoside <b>4</b> (blue triangle). (b) Intracellular concentration of active metabolite <b>4tp</b> in PBMCs (green diamond) and estimated <b>4tp</b> EBOV IC<sub>50</sub> = 5 μM (dashed black line).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01594/20201113-01/images/large/jm-2016-01594m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01594&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i31">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67616" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67616" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 44 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">World
Health Organization</span>.  <i>Ebola Situation Report—10
June 2016</i>. <a href="http://apps.who.int/iris/bitstream/10665/208883/1/ebolasitrep_10Jun2016_eng.pdf?ua=1" class="extLink">http://apps.who.int/iris/bitstream/10665/208883/1/ebolasitrep_10Jun2016_eng.pdf?ua=1</a> (accessed Jul. 22, <span class="NLM_year">2016</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=World%0AHealth+Organization&title=Ebola+Situation+Report%E2%80%9410%0AJune+2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DEbola%2520Situation%2520Report%25E2%2580%259410%250AJune%25202016%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">World Health Organization</span>.  <i>Ebola Data and Statistics—11
May 2016</i>. <a href="http://apps.who.int/gho/data/view.ebola-sitrep.ebola-summary-20160511?lang=en" class="extLink">http://apps.who.int/gho/data/view.ebola-sitrep.ebola-summary-20160511?lang=en</a> (accessed Jul. 22, <span class="NLM_year">2016</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=World+Health+Organization&title=Ebola+Data+and+Statistics%E2%80%9411%0AMay+2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DEbola%2520Data%2520and%2520Statistics%25E2%2580%259411%250AMay%25202016%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vetter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, W. A.,  II</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schibler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bausch, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, L.</span></span> <span> </span><span class="NLM_article-title">Ebola Virus Shedding and Transmission: Review of Current Evidence</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>214</i></span>,  <span class="NLM_fpage">S177</span>– <span class="NLM_lpage">S184</span>, <span class="refDoi"> DOI: 10.1093/infdis/jiw254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1093%2Finfdis%2Fjiw254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=27443613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFCgtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=2016&pages=S177-S184&author=P.+Vetterauthor=W.+A.+Fischerauthor=M.+Schiblerauthor=M.+Jacobsauthor=D.+G.+Bauschauthor=L.+Kaiser&title=Ebola+Virus+Shedding+and+Transmission%3A+Review+of+Current+Evidence&doi=10.1093%2Finfdis%2Fjiw254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Ebola virus shedding and transmission: review of current evidence</span></div><div class="casAuthors">Vetter, Pauline; Fischer, William A., II; Schibler, Manuel; Jacobs, Michael; Bausch, Daniel G.; Kaiser, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">214</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">S177-S184</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background.  The magnitude of the 2013-2016 Ebola virus disease outbreak in West Africa was unprecedented, with >28 500 reported cases and >11 000 deaths.  Understanding the key elements of Ebola virus transmission is necessary to implement adequate infection prevention and control measures to protect healthcare workers and halt transmission in the community.  Methods.  We performed an extensive PubMed literature review encompassing the period from discovery of Ebola virus, in 1976, until 1 June 2016 to evaluate the evidence on modes of Ebola virus shedding and transmission.  Findings.  Ebola virus has been isolated by cell culture from blood, saliva, urine, aq. humor, semen, and breast milk from infected or convalescent patients.  Ebola virus RNA has been noted in the following body fluids days or months after onset of illness: saliva (22 days), conjunctiva/tears (28 days), stool (29 days), vaginal fluid (33 days), sweat (44 days), urine (64 days), amniotic fluid (38 days), aq. humor (101 days), cerebrospinal fluid (9 mo), breast milk (16 mo [preliminary data[), and semen (18 mo).  Nevertheless, the only documented cases of secondary transmission from recovered patients have been through sexual transmission.  We did not find strong evidence supporting respiratory or fomite-assocd. transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4U_4OBKnGRLVg90H21EOLACvtfcHk0lh70QHce9y_eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFCgtbY%253D&md5=c22cd4bfc16956ed9c17e81b9faead7b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjiw254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjiw254%26sid%3Dliteratum%253Aachs%26aulast%3DVetter%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DW.%2BA.%26aulast%3DSchibler%26aufirst%3DM.%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DBausch%26aufirst%3DD.%2BG.%26aulast%3DKaiser%26aufirst%3DL.%26atitle%3DEbola%2520Virus%2520Shedding%2520and%2520Transmission%253A%2520Review%2520of%2520Current%2520Evidence%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2016%26volume%3D214%26spage%3DS177%26epage%3DS184%26doi%3D10.1093%2Finfdis%2Fjiw254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mate, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugelman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyenswah, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladner, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiley, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordier-Lassalle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroth, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies-Wayne, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieh, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fakoli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taweh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Wit, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Doremalen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munster, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prieto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humrighouse, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ströher, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiClaro, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hensley, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoepp, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safronetz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fair, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackley, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laney, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasasira, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichol, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Formenty, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kateh, F. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cock, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolay, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Lockhart, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacios, G.</span></span> <span> </span><span class="NLM_article-title">Molecular Evidence of Sexual Transmission of Ebola Virus</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>373</i></span>,  <span class="NLM_fpage">2448</span>– <span class="NLM_lpage">2454</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1509773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1056%2FNEJMoa1509773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=26465384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2015&pages=2448-2454&author=S.+E.+Mateauthor=J.+R.+Kugelmanauthor=T.+G.+Nyenswahauthor=J.+T.+Ladnerauthor=M.+R.+Wileyauthor=T.+Cordier-Lassalleauthor=A.+Christieauthor=G.+P.+Schrothauthor=S.+M.+Grossauthor=G.+J.+Davies-Wayneauthor=S.+A.+Shindeauthor=R.+Muruganauthor=S.+B.+Siehauthor=M.+Badioauthor=L.+Fakoliauthor=F.+Tawehauthor=E.+de+Witauthor=N.+van+Doremalenauthor=V.+J.+Munsterauthor=J.+Pettittauthor=K.+Prietoauthor=B.+W.+Humrighouseauthor=U.+Str%C3%B6herauthor=J.+W.+DiClaroauthor=L.+E.+Hensleyauthor=R.+J.+Schoeppauthor=D.+Safronetzauthor=J.+Fairauthor=J.+H.+Kuhnauthor=D.+J.+Blackleyauthor=A.+S.+Laneyauthor=D.+E.+Williamsauthor=T.+Loauthor=A.+Gasasiraauthor=S.+T.+Nicholauthor=P.+Formentyauthor=F.+N.+Katehauthor=K.+M.+De+Cockauthor=F.+Bolayauthor=M.+Sanchez-Lockhartauthor=G.+Palacios&title=Molecular+Evidence+of+Sexual+Transmission+of+Ebola+Virus&doi=10.1056%2FNEJMoa1509773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular evidence of sexual transmission of Ebola virus</span></div><div class="casAuthors">Mate, S. E.; Kugelman, J. R.; Nyenswah, T. G.; Ladner, J. T.; Wiley, M. R.; Cordier-Lassalle, T.; Christie, A.; Schroth, G. P.; Gross, S. M.; Davies-Wayne, G. J.; Shinde, S. A.; Murugan, R.; Sieh, S. B.; Badio, M.; Fakoli, L.; Taweh, F.; de Wit, E.; van Doremalen, N.; Munster, V. J.; Pettitt, J.; Prieto, K.; Humrighouse, B. W.; Stroher, U.; Di Claro, J. W.; Hensley, L. E.; Schoepp, R. J.; Safronetz, D.; Fair, J.; Kuhn, J. H.; Blackley, D. J.; Laney, A. S.; Williams, D. E.; Lo, T.; Gasasira, A.; Nichol, S. T.; Formenty, P.; Kateh, F. N.; De Cock, K. M.; Bolay, F.; Sanchez-Lockhart, M.; Palacios, G.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2448-2454</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A suspected case of sexual transmission from a male survivor of Ebola virus disease (EVD) to his female partner (the patient in this report) occurred in Liberia in March 2015.  Ebola virus (EBOV) genomes assembled from blood samples from the patient and a semen sample from the survivor were consistent with direct transmission.  The genomes shared three substitutions that were absent from all other Western African EBOV sequences and that were distinct from the last documented transmission chain in Liberia before this case.  Combined with epidemiol. data, the genomic anal. provides evidence of sexual transmission of EBOV and evidence of the persistence of infective EBOV in semen for 179 days or more after the onset of EVD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoqT2W0BeuGLVg90H21EOLACvtfcHk0lh5bvwG54a2mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1Y%253D&md5=6b66402a4acc8c9b76ef50bbc0b540ba</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1509773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1509773%26sid%3Dliteratum%253Aachs%26aulast%3DMate%26aufirst%3DS.%2BE.%26aulast%3DKugelman%26aufirst%3DJ.%2BR.%26aulast%3DNyenswah%26aufirst%3DT.%2BG.%26aulast%3DLadner%26aufirst%3DJ.%2BT.%26aulast%3DWiley%26aufirst%3DM.%2BR.%26aulast%3DCordier-Lassalle%26aufirst%3DT.%26aulast%3DChristie%26aufirst%3DA.%26aulast%3DSchroth%26aufirst%3DG.%2BP.%26aulast%3DGross%26aufirst%3DS.%2BM.%26aulast%3DDavies-Wayne%26aufirst%3DG.%2BJ.%26aulast%3DShinde%26aufirst%3DS.%2BA.%26aulast%3DMurugan%26aufirst%3DR.%26aulast%3DSieh%26aufirst%3DS.%2BB.%26aulast%3DBadio%26aufirst%3DM.%26aulast%3DFakoli%26aufirst%3DL.%26aulast%3DTaweh%26aufirst%3DF.%26aulast%3Dde%2BWit%26aufirst%3DE.%26aulast%3Dvan%2BDoremalen%26aufirst%3DN.%26aulast%3DMunster%26aufirst%3DV.%2BJ.%26aulast%3DPettitt%26aufirst%3DJ.%26aulast%3DPrieto%26aufirst%3DK.%26aulast%3DHumrighouse%26aufirst%3DB.%2BW.%26aulast%3DStr%25C3%25B6her%26aufirst%3DU.%26aulast%3DDiClaro%26aufirst%3DJ.%2BW.%26aulast%3DHensley%26aufirst%3DL.%2BE.%26aulast%3DSchoepp%26aufirst%3DR.%2BJ.%26aulast%3DSafronetz%26aufirst%3DD.%26aulast%3DFair%26aufirst%3DJ.%26aulast%3DKuhn%26aufirst%3DJ.%2BH.%26aulast%3DBlackley%26aufirst%3DD.%2BJ.%26aulast%3DLaney%26aufirst%3DA.%2BS.%26aulast%3DWilliams%26aufirst%3DD.%2BE.%26aulast%3DLo%26aufirst%3DT.%26aulast%3DGasasira%26aufirst%3DA.%26aulast%3DNichol%26aufirst%3DS.%2BT.%26aulast%3DFormenty%26aufirst%3DP.%26aulast%3DKateh%26aufirst%3DF.%2BN.%26aulast%3DDe%2BCock%26aufirst%3DK.%2BM.%26aulast%3DBolay%26aufirst%3DF.%26aulast%3DSanchez-Lockhart%26aufirst%3DM.%26aulast%3DPalacios%26aufirst%3DG.%26atitle%3DMolecular%2520Evidence%2520of%2520Sexual%2520Transmission%2520of%2520Ebola%2520Virus%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D373%26spage%3D2448%26epage%3D2454%26doi%3D10.1056%2FNEJMoa1509773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, J. H.</span></span> <i>Filoviruses: A Compendium of 40 Years of Epidemiological, Clinical, and Laboratory Studies</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calisher, C. H.</span></span>, Ed.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Wien, Austria</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+H.+Kuhnauthor=C.+H.+Calisher&title=Filoviruses%3A+A+Compendium+of+40+Years+of+Epidemiological%2C+Clinical%2C+and+Laboratory+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DJ.%2BH.%26btitle%3DFiloviruses%253A%2520A%2520Compendium%2520of%252040%2520Years%2520of%2520Epidemiological%252C%2520Clinical%252C%2520and%2520Laboratory%2520Studies%26aulast%3DCalisher%26aufirst%3DC.%2BH.%26pub%3DSpringer%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rougeron, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grard, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, E. M.</span></span> <span> </span><span class="NLM_article-title">Ebola and Marburg Haemorrhagic Fever</span>. <i>J. Clin. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1016/j.jcv.2015.01.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1016%2Fj.jcv.2015.01.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=25660265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A280%3ADC%252BC2Mrjs12ksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2015&pages=111-119&author=V.+Rougeronauthor=H.+Feldmannauthor=G.+Grardauthor=S.+Beckerauthor=E.+M.+Leroy&title=Ebola+and+Marburg+Haemorrhagic+Fever&doi=10.1016%2Fj.jcv.2015.01.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Ebola and Marburg haemorrhagic fever</span></div><div class="casAuthors">Rougeron V; Feldmann H; Grard G; Becker S; Leroy E M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ebolaviruses and Marburgviruses (family Filoviridae) are among the most virulent pathogens for humans and great apes causing severe haemorrhagic fever and death within a matter of days.  This group of viruses is characterized by a linear, non-segmented, single-stranded RNA genome of negative polarity.  The overall burden of filovirus infections is minimal and negligible compared to the devastation caused by malnutrition and other infectious diseases prevalent in Africa such as malaria, dengue or tuberculosis.  In this paper, we review the knowledge gained on the eco/epidemiology, the pathogenesis and the disease control measures for Marburg and Ebola viruses developed over the last 15 years.  The overall progress is promising given the little attention that these pathogen have achieved in the past; however, more is to come over the next decade given the more recent interest in these pathogens as potential public and animal health concerns.  Licensing of therapeutic and prophylactic options may be achievable over the next 5-10 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcStsM_90lVRZNFxYDaSSP8XfW6udTcc2eb-jlpp6GG6Qrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mrjs12ksA%253D%253D&md5=6c530fde87516481a89bb91b307175a9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.jcv.2015.01.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jcv.2015.01.014%26sid%3Dliteratum%253Aachs%26aulast%3DRougeron%26aufirst%3DV.%26aulast%3DFeldmann%26aufirst%3DH.%26aulast%3DGrard%26aufirst%3DG.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DLeroy%26aufirst%3DE.%2BM.%26atitle%3DEbola%2520and%2520Marburg%2520Haemorrhagic%2520Fever%26jtitle%3DJ.%2520Clin.%2520Virol.%26date%3D2015%26volume%3D64%26spage%3D111%26epage%3D119%26doi%3D10.1016%2Fj.jcv.2015.01.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bello, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernando, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alimonti, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fausther-Bovendo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aviles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiatt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swope, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohorov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohorova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauly, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olinger, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whaley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strong, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeitlin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobinger, G. P.</span></span> <span> </span><span class="NLM_article-title">Reversion af Advanced Ebola Virus Disease in Nonhuman Primates with ZMapp</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>514</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1038/nature13777</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1038%2Fnature13777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=25171469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1yhsLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=514&publication_year=2014&pages=47-53&author=X.+Qiuauthor=G.+Wongauthor=J.+Audetauthor=A.+Belloauthor=L.+Fernandoauthor=J.+B.+Alimontiauthor=H.+Fausther-Bovendoauthor=H.+Weiauthor=J.+Avilesauthor=E.+Hiattauthor=A.+Johnsonauthor=J.+Mortonauthor=K.+Swopeauthor=O.+Bohorovauthor=N.+Bohorovaauthor=C.+Goodmanauthor=D.+Kimauthor=M.+H.+Paulyauthor=J.+Velascoauthor=J.+Pettittauthor=G.+G.+Olingerauthor=K.+Whaleyauthor=B.+Xuauthor=J.+E.+Strongauthor=L.+Zeitlinauthor=G.+P.+Kobinger&title=Reversion+af+Advanced+Ebola+Virus+Disease+in+Nonhuman+Primates+with+ZMapp&doi=10.1038%2Fnature13777"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp</span></div><div class="casAuthors">Qiu, Xiangguo; Wong, Gary; Audet, Jonathan; Bello, Alexander; Fernando, Lisa; Alimonti, Judie B.; Fausther-Bovendo, Hugues; Wei, Haiyan; Aviles, Jenna; Hiatt, Ernie; Johnson, Ashley; Morton, Josh; Swope, Kelsi; Bohorov, Ognian; Bohorova, Natasha; Goodman, Charles; Kim, Do; Pauly, Michael H.; Velasco, Jesus; Pettitt, James; Olinger, Gene G.; Whaley, Kevin; Xu, Bianli; Strong, James E.; Zeitlin, Larry; Kobinger, Gary P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">514</span>
        (<span class="NLM_cas:issue">7520</span>),
    <span class="NLM_cas:pages">47-53</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Without an approved vaccine or treatments, Ebola outbreak management has been limited to palliative care and barrier methods to prevent transmission.  These approaches, however, have yet to end the 2014 outbreak of Ebola after its prolonged presence in West Africa.  A combination of monoclonal antibodies (ZMapp), optimized from two previous antibody cocktails, is able to rescue 100% of rhesus macaques when treatment is initiated up to 5 days post-challenge.  High fever, viremia and abnormalities in blood count and blood chem. were evident in many animals before ZMapp intervention.  Advanced disease, as indicated by elevated liver enzymes, mucosal hemorrhages and generalized petechia could be reversed, leading to full recovery.  ELISA and neutralizing antibody assays indicate that ZMapp is cross-reactive with the Guinean variant of Ebola.  ZMapp exceeds the efficacy of any other therapeutics described so far, and results warrant further development of this cocktail for clin. use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkWoT6igrahbVg90H21EOLACvtfcHk0lgA9rXYXGzWYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1yhsLjK&md5=df43cbc42ec5cadaa0119d2b46fd05fe</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature13777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13777%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DG.%26aulast%3DAudet%26aufirst%3DJ.%26aulast%3DBello%26aufirst%3DA.%26aulast%3DFernando%26aufirst%3DL.%26aulast%3DAlimonti%26aufirst%3DJ.%2BB.%26aulast%3DFausther-Bovendo%26aufirst%3DH.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DAviles%26aufirst%3DJ.%26aulast%3DHiatt%26aufirst%3DE.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DMorton%26aufirst%3DJ.%26aulast%3DSwope%26aufirst%3DK.%26aulast%3DBohorov%26aufirst%3DO.%26aulast%3DBohorova%26aufirst%3DN.%26aulast%3DGoodman%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DPauly%26aufirst%3DM.%2BH.%26aulast%3DVelasco%26aufirst%3DJ.%26aulast%3DPettitt%26aufirst%3DJ.%26aulast%3DOlinger%26aufirst%3DG.%2BG.%26aulast%3DWhaley%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DStrong%26aufirst%3DJ.%2BE.%26aulast%3DZeitlin%26aufirst%3DL.%26aulast%3DKobinger%26aufirst%3DG.%2BP.%26atitle%3DReversion%2520af%2520Advanced%2520Ebola%2520Virus%2520Disease%2520in%2520Nonhuman%2520Primates%2520with%2520ZMapp%26jtitle%3DNature%26date%3D2014%26volume%3D514%26spage%3D47%26epage%3D53%26doi%3D10.1038%2Fnature13777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thi, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mire, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisbert, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agans, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snead, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deer, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenton, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLachlan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisbert, T. W.</span></span> <span> </span><span class="NLM_article-title">Lipid Nanoparticles siRNA Treatment of Ebola-Virus-Makona-Infected Nonhuman Primates</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>521</i></span>,  <span class="NLM_fpage">362</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1038/nature14442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1038%2Fnature14442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=25901685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnvFWjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=521&publication_year=2015&pages=362-365&author=E.+P.+Thiauthor=C.+E.+Mireauthor=A.+C.+H.+Leeauthor=J.+B.+Geisbertauthor=J.+Z.+Zhouauthor=K.+N.+Agansauthor=N.+M.+Sneadauthor=D.+J.+Deerauthor=T.+R.+Barnardauthor=K.+A.+Fentonauthor=I.+MacLachlanauthor=T.+W.+Geisbert&title=Lipid+Nanoparticles+siRNA+Treatment+of+Ebola-Virus-Makona-Infected+Nonhuman+Primates&doi=10.1038%2Fnature14442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates</span></div><div class="casAuthors">Thi, Emily P.; Mire, Chad E.; Lee, Amy C. H.; Geisbert, Joan B.; Zhou, Joy Z.; Agans, Krystle N.; Snead, Nicholas M.; Deer, Daniel J.; Barnard, Trisha R.; Fenton, Karla A.; MacLachlan, Ian; Geisbert, Thomas W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">521</span>
        (<span class="NLM_cas:issue">7552</span>),
    <span class="NLM_cas:pages">362-365</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The current outbreak of Ebola virus in West Africa is unprecedented, causing more cases and fatalities than all previous outbreaks combined, and has yet to be controlled.  Several post-exposure interventions have been employed under compassionate use to treat patients repatriated to Europe and the United States.  However, the in vivo efficacy of these interventions against the new outbreak strain of Ebola virus is unknown.  Here we show that lipid-nanoparticle-encapsulated short interfering RNAs (siRNAs) rapidly adapted to target the Makona outbreak strain of Ebola virus are able to protect 100% of rhesus monkeys against lethal challenge when treatment was initiated at 3 days after exposure while animals were viremic and clin. ill.  Although all infected animals showed evidence of advanced disease including abnormal haematol., blood chem. and coagulopathy, siRNA-treated animals had milder clin. features and fully recovered, while the untreated control animals succumbed to the disease.  These results represent the first, to our knowledge, successful demonstration of therapeutic anti-Ebola virus efficacy against the new outbreak strain in nonhuman primates and highlight the rapid development of lipid-nanoparticle-delivered siRNA as a countermeasure against this highly lethal human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor1MQp7Ec-J7Vg90H21EOLACvtfcHk0lgA9rXYXGzWYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnvFWjs7w%253D&md5=fdef84ba281214654cf1abf65af39091</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature14442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14442%26sid%3Dliteratum%253Aachs%26aulast%3DThi%26aufirst%3DE.%2BP.%26aulast%3DMire%26aufirst%3DC.%2BE.%26aulast%3DLee%26aufirst%3DA.%2BC.%2BH.%26aulast%3DGeisbert%26aufirst%3DJ.%2BB.%26aulast%3DZhou%26aufirst%3DJ.%2BZ.%26aulast%3DAgans%26aufirst%3DK.%2BN.%26aulast%3DSnead%26aufirst%3DN.%2BM.%26aulast%3DDeer%26aufirst%3DD.%2BJ.%26aulast%3DBarnard%26aufirst%3DT.%2BR.%26aulast%3DFenton%26aufirst%3DK.%2BA.%26aulast%3DMacLachlan%26aufirst%3DI.%26aulast%3DGeisbert%26aufirst%3DT.%2BW.%26atitle%3DLipid%2520Nanoparticles%2520siRNA%2520Treatment%2520of%2520Ebola-Virus-Makona-Infected%2520Nonhuman%2520Primates%26jtitle%3DNature%26date%3D2015%26volume%3D521%26spage%3D362%26epage%3D365%26doi%3D10.1038%2Fnature14442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Tekmira Pharmaceuticals Corp</span>.  <i>Tekmira Provides Update
on TKM-Ebola-Guinea</i>. <a href="http://www.sec.gov/Archives/edgar/data/1447028/000117184315003522/newsrelease.htm" class="extLink">http://www.sec.gov/Archives/edgar/data/1447028/000117184315003522/newsrelease.htm</a>, <span class="NLM_year">2015</span> (accessed Jul. 22, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Tekmira+Pharmaceuticals+Corp&title=Tekmira+Provides+Update%0Aon+TKM-Ebola-Guinea"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DTekmira%2520Provides%2520Update%250Aon%2520TKM-Ebola-Guinea%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iversen, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garza, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mourich, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panchal, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavari, S.</span></span> <span> </span><span class="NLM_article-title">Discovery and Early Development of AVI-7537 and AVI-7288 For the Treatment of Ebola Virus and Marburg Virus Infections</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2806</span>– <span class="NLM_lpage">2830</span>, <span class="refDoi"> DOI: 10.3390/v4112806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.3390%2Fv4112806" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=23202506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSrtrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=2806-2830&author=P.+L.+Iversenauthor=T.+K.+Warrenauthor=J.+B.+Wellsauthor=N.+L.+Garzaauthor=D.+V.+Mourichauthor=L.+S.+Welchauthor=R.+G.+Panchalauthor=S.+Bavari&title=Discovery+and+Early+Development+of+AVI-7537+and+AVI-7288+For+the+Treatment+of+Ebola+Virus+and+Marburg+Virus+Infections&doi=10.3390%2Fv4112806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections</span></div><div class="casAuthors">Iversen, Patrick L.; Warren, Travis K.; Wells, Jay B.; Garza, Nicole L.; Mourich, Dan V.; Welch, Lisa S.; Panchal, Rekha G.; Bavari, Sina</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2806-2830</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">There are no currently approved treatments for filovirus infections.  In this study we report the discovery process which led to the development of antisense Phosphorodiamidate Morpholino Oligomers (PMOs) AVI-6002 (composed of AVI-7357 and AVI-7539) and AVI-6003 (composed of AVI-7287 and AVI-7288) targeting Ebola virus and Marburg virus resp.  The discovery process involved identification of optimal transcript binding sites for PMO based RNA-therapeutics followed by screening for effective viral gene target in mouse and guinea pig models utilizing adapted viral isolates.  An evolution of chem. modifications were tested, beginning with simple Phosphorodiamidate Morpholino Oligomers (PMO) transitioning to cell penetrating peptide conjugated PMOs (PPMO) and ending with PMOplus contg. a limited no. of pos. charged linkages in the PMO structure.  The initial lead compds. were combinations of two agents targeting sep. genes.  In the final anal., a single agent for treatment of each virus was selected, AVI-7537 targeting the VP24 gene of Ebola virus and AVI-7288 targeting NP of Marburg virus and are now progressing into late stage clin. development as the optimal therapeutic candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowvQAjvU0VXLVg90H21EOLACvtfcHk0lgA9rXYXGzWYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSrtrvL&md5=08933874fba7c4e1866783fa380dd05a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3390%2Fv4112806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv4112806%26sid%3Dliteratum%253Aachs%26aulast%3DIversen%26aufirst%3DP.%2BL.%26aulast%3DWarren%26aufirst%3DT.%2BK.%26aulast%3DWells%26aufirst%3DJ.%2BB.%26aulast%3DGarza%26aufirst%3DN.%2BL.%26aulast%3DMourich%26aufirst%3DD.%2BV.%26aulast%3DWelch%26aufirst%3DL.%2BS.%26aulast%3DPanchal%26aufirst%3DR.%2BG.%26aulast%3DBavari%26aufirst%3DS.%26atitle%3DDiscovery%2520and%2520Early%2520Development%2520of%2520AVI-7537%2520and%2520AVI-7288%2520For%2520the%2520Treatment%2520of%2520Ebola%2520Virus%2520and%2520Marburg%2520Virus%2520Infections%26jtitle%3DViruses%26date%3D2012%26volume%3D4%26spage%3D2806%26epage%3D2830%26doi%3D10.3390%2Fv4112806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oestereich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lüdtke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rieger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Fontela, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Günther, S.</span></span> <span> </span><span class="NLM_article-title">Successful Treatment of Advanced Ebola Virus Infection With T-705 (favipiravir) in a Small Animal Model</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2014.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1016%2Fj.antiviral.2014.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=24583123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVKrtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2014&pages=17-21&author=L.+Oestereichauthor=A.+L%C3%BCdtkeauthor=S.+Wurrauthor=T.+Riegerauthor=C.+Mu%C3%B1oz-Fontelaauthor=S.+G%C3%BCnther&title=Successful+Treatment+of+Advanced+Ebola+Virus+Infection+With+T-705+%28favipiravir%29+in+a+Small+Animal+Model&doi=10.1016%2Fj.antiviral.2014.02.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model</span></div><div class="casAuthors">Oestereich, Lisa; Ludtke, Anja; Wurr, Stephanie; Rieger, Toni; Munoz-Fontela, Cesar; Gunther, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17-21</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Outbreaks of Ebola hemorrhagic fever in sub-Saharan Africa are assocd. with case fatality rates of up to 90%.  Currently, neither a vaccine nor an effective antiviral treatment is available for use in humans.  Here, we evaluated the efficacy of the pyrazinecarboxamide deriv. T-705 (favipiravir) against Zaire Ebola virus (EBOV) in vitro and in vivo.  T-705 suppressed replication of Zaire EBOV in cell culture by 4 log units with an IC90 of 110 μM.  Mice lacking the type I interferon receptor (IFNAR-/-) were used as in vivo model for Zaire EBOV-induced disease.  Initiation of T-705 administration at day 6 post infection induced rapid virus clearance, reduced biochem. parameters of disease severity, and prevented a lethal outcome in 100% of the animals.  The findings suggest that T-705 is a candidate for treatment of Ebola hemorrhagic fever.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvuc7NJjAwqrVg90H21EOLACvtfcHk0liuiO3I3LeC9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVKrtbg%253D&md5=faeb7e30254ebd9ebc4a4d0458349077</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2014.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2014.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DOestereich%26aufirst%3DL.%26aulast%3DL%25C3%25BCdtke%26aufirst%3DA.%26aulast%3DWurr%26aufirst%3DS.%26aulast%3DRieger%26aufirst%3DT.%26aulast%3DMu%25C3%25B1oz-Fontela%26aufirst%3DC.%26aulast%3DG%25C3%25BCnther%26aufirst%3DS.%26atitle%3DSuccessful%2520Treatment%2520of%2520Advanced%2520Ebola%2520Virus%2520Infection%2520With%2520T-705%2520%2528favipiravir%2529%2520in%2520a%2520Small%2520Animal%2520Model%26jtitle%3DAntiviral%2520Res.%26date%3D2014%26volume%3D105%26spage%3D17%26epage%3D21%26doi%3D10.1016%2Fj.antiviral.2014.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smither, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastaugh, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steward, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenk, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lever, M. S.</span></span> <span> </span><span class="NLM_article-title">Post-exposure Efficacy of Oral T-705 (Favipiravir) Against Inhalational Ebola Virus Infection in a Mouse Model</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">155</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2014.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1016%2Fj.antiviral.2014.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=24462697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVOjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2014&pages=153-155&author=S.+J.+Smitherauthor=L.+S.+Eastaughauthor=J.+A.+Stewardauthor=M.+Nelsonauthor=R.+P.+Lenkauthor=M.+S.+Lever&title=Post-exposure+Efficacy+of+Oral+T-705+%28Favipiravir%29+Against+Inhalational+Ebola+Virus+Infection+in+a+Mouse+Model&doi=10.1016%2Fj.antiviral.2014.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Post-exposure efficacy of Oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model</span></div><div class="casAuthors">Smither, Sophie J.; Eastaugh, Lin S.; Steward, Jackie A.; Nelson, Michelle; Lenk, Robert P.; Lever, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">153-155</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Filoviruses cause disease with high case fatality rates and are considered biol. threat agents.  Licensed post-exposure therapies that can be administered by the oral route are desired for safe and rapid distribution and uptake in the event of exposure or outbreaks.  Favipiravir or T-705 has broad antiviral activity and has already undergone phase II and is undergoing phase III clin. trials for influenza.  Here we report the first use of T-705 against Ebola virus.  T-705 gave 100% protection against aerosol Ebola virus E718 infection; protection was shown in immune-deficient mice after 14 days of twice-daily dosing.  T-705 was also shown to inhibit Ebola virus infection in cell culture.  T-705 is likely to be licensed for use against influenza in the near future and could also be used with a new indication for filovirus infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4fn813ywvgLVg90H21EOLACvtfcHk0liuiO3I3LeC9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVOjt7s%253D&md5=ed50722557680051ddef5684978f24bc</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2014.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2014.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DSmither%26aufirst%3DS.%2BJ.%26aulast%3DEastaugh%26aufirst%3DL.%2BS.%26aulast%3DSteward%26aufirst%3DJ.%2BA.%26aulast%3DNelson%26aufirst%3DM.%26aulast%3DLenk%26aufirst%3DR.%2BP.%26aulast%3DLever%26aufirst%3DM.%2BS.%26atitle%3DPost-exposure%2520Efficacy%2520of%2520Oral%2520T-705%2520%2528Favipiravir%2529%2520Against%2520Inhalational%2520Ebola%2520Virus%2520Infection%2520in%2520a%2520Mouse%2520Model%26jtitle%3DAntiviral%2520Res.%26date%3D2014%26volume%3D104%26spage%3D153%26epage%3D155%26doi%3D10.1016%2Fj.antiviral.2014.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sissoko, D.</span>; <span class="NLM_string-name">Folkesson, E.</span>; <span class="NLM_string-name">Abdoul, M.</span>; <span class="NLM_string-name">Beavogui, A. H.</span>; <span class="NLM_string-name">Gunther, S.</span>; <span class="NLM_string-name">Shepherd, S.</span>; <span class="NLM_string-name">Danel, C.</span>; <span class="NLM_string-name">Mentre, F.</span>; <span class="NLM_string-name">Anglaret, X.</span>; <span class="NLM_string-name">Malvy, D.</span></span> <span> </span><span class="NLM_article-title">Favipiravir in Patients With Ebola Virus Disease: Early Results of the JIKI Trial in Guinea</span>.  <i>Conference on Retroviruses and Opportunistic Infections</i>, Seattle, WA, USA, Feb. 23–26, 2015, Abstract 103-ALB; <span class="NLM_publisher-name">CROI Foundation/IAS-USA</span>: <span class="NLM_publisher-loc">San Francisco, CA, USA</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=D.+Sissoko&author=E.+Folkesson&author=M.+Abdoul&author=A.+H.+Beavogui&author=S.+Gunther&author=S.+Shepherd&author=C.+Danel&author=F.+Mentre&author=X.+Anglaret&author=D.+Malvy&title=Favipiravir+in+Patients+With+Ebola+Virus+Disease%3A+Early+Results+of+the+JIKI+Trial+in+Guinea"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DSissoko%26aufirst%3DD.%26atitle%3DFavipiravir%2520in%2520Patients%2520With%2520Ebola%2520Virus%2520Disease%253A%2520Early%2520Results%2520of%2520the%2520JIKI%2520Trial%2520in%2520Guinea%26jtitle%3DConference%2520on%2520Retroviruses%2520and%2520Opportunistic%2520Infections%26pub%3DCROI%2520Foundation%252FIAS-USA%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McMullan, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flint, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albariño, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olinger, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethna, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hensley, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichol, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanier, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiropoulou, C. F.</span></span> <span> </span><span class="NLM_article-title">The Lipid Moiety of Brincidofovir is Required For In Vitro Antiviral Activity Against Ebola Virus</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">78</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2015.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1016%2Fj.antiviral.2015.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=26526586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVyqurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2016&pages=71-78&author=L.+K.+McMullanauthor=M.+Flintauthor=J.+Dyallauthor=C.+Albari%C3%B1oauthor=G.+G.+Olingerauthor=S.+Fosterauthor=P.+Sethnaauthor=L.+E.+Hensleyauthor=S.+T.+Nicholauthor=E.+R.+Lanierauthor=C.+F.+Spiropoulou&title=The+Lipid+Moiety+of+Brincidofovir+is+Required+For+In+Vitro+Antiviral+Activity+Against+Ebola+Virus&doi=10.1016%2Fj.antiviral.2015.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus</span></div><div class="casAuthors">McMullan, Laura K.; Flint, Mike; Dyall, Julie; Albarino, Cesar; Olinger, Gene G.; Foster, Scott; Sethna, Phiroze; Hensley, Lisa E.; Nichol, Stuart T.; Lanier, E. Randall; Spiropoulou, Christina F.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">71-78</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Brincidofovir (BCV) is the 3-hexadecyloxy-1-propanol (HDP) lipid conjugate of the acyclic nucleoside phosphonate cidofovir (CDV).  BCV has established broad-spectrum activity against double-stranded DNA (dsDNA) viruses; however, its activity against RNA viruses has been less thoroughly evaluated.  Here, we report that BCV inhibited infection of Ebola virus in multiple human cell lines.  Unlike the mechanism of action for BCV against cytomegalovirus and other dsDNA viruses, phosphorylation of CDV to the diphosphate form appeared unnecessary.  Instead, antiviral activity required the lipid moiety and in vitro activity against EBOV was obsd. for several HDP-nucleotide conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL5O09ZNdpmrVg90H21EOLACvtfcHk0lgDwBq4I2N13Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVyqurjI&md5=3b771401ef41f83a9b6f0d0ec4712f81</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2015.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2015.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DMcMullan%26aufirst%3DL.%2BK.%26aulast%3DFlint%26aufirst%3DM.%26aulast%3DDyall%26aufirst%3DJ.%26aulast%3DAlbari%25C3%25B1o%26aufirst%3DC.%26aulast%3DOlinger%26aufirst%3DG.%2BG.%26aulast%3DFoster%26aufirst%3DS.%26aulast%3DSethna%26aufirst%3DP.%26aulast%3DHensley%26aufirst%3DL.%2BE.%26aulast%3DNichol%26aufirst%3DS.%2BT.%26aulast%3DLanier%26aufirst%3DE.%2BR.%26aulast%3DSpiropoulou%26aufirst%3DC.%2BF.%26atitle%3DThe%2520Lipid%2520Moiety%2520of%2520Brincidofovir%2520is%2520Required%2520For%2520In%2520Vitro%2520Antiviral%2520Activity%2520Against%2520Ebola%2520Virus%26jtitle%3DAntiviral%2520Res.%26date%3D2016%26volume%3D125%26spage%3D71%26epage%3D78%26doi%3D10.1016%2Fj.antiviral.2015.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warren, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panchal, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuthman, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garza, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Tongeren, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Retterer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pegoraro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honnold, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotian, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taubenheim, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minning, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheridan, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavari, S.</span></span> <span> </span><span class="NLM_article-title">Protection Against Filovirus Disease by a Novel Broad-Spectrum Nucleoside Analogue BCX4430</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>508</i></span>,  <span class="NLM_fpage">402</span>– <span class="NLM_lpage">405</span>, <span class="refDoi"> DOI: 10.1038/nature13027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1038%2Fnature13027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=24590073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtlWhu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=508&publication_year=2014&pages=402-405&author=T.+K.+Warrenauthor=J.+Wellsauthor=R.+G.+Panchalauthor=K.+S.+Stuthmanauthor=N.+L.+Garzaauthor=S.+A.+Van+Tongerenauthor=L.+Dongauthor=C.+J.+Rettererauthor=B.+P.+Eatonauthor=G.+Pegoraroauthor=S.+Honnoldauthor=S.+Bantiaauthor=P.+Kotianauthor=X.+Chenauthor=B.+R.+Taubenheimauthor=L.+S.+Welchauthor=D.+M.+Minningauthor=Y.+S.+Babuauthor=W.+P.+Sheridanauthor=S.+Bavari&title=Protection+Against+Filovirus+Disease+by+a+Novel+Broad-Spectrum+Nucleoside+Analogue+BCX4430&doi=10.1038%2Fnature13027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430</span></div><div class="casAuthors">Warren, Travis K.; Wells, Jay; Panchal, Rekha G.; Stuthman, Kelly S.; Garza, Nicole L.; Van Tongeren, Sean A.; Dong, Lian; Retterer, Cary J.; Eaton, Brett P.; Pegoraro, Gianluca; Honnold, Shelley; Bantia, Shanta; Kotian, Pravin; Chen, Xilin; Taubenheim, Brian R.; Welch, Lisa S.; Minning, Dena M.; Babu, Yarlagadda S.; Sheridan, William P.; Bavari, Sina</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">508</span>
        (<span class="NLM_cas:issue">7496</span>),
    <span class="NLM_cas:pages">402-405</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Filoviruses are emerging pathogens and causative agents of viral haemorrhagic fever.  Case fatality rates of filovirus disease outbreaks are among the highest reported for any human pathogen, exceeding 90% (ref. 1).  Licensed therapeutic or vaccine products are not available to treat filovirus diseases.  Candidate therapeutics previously shown to be efficacious in non-human primate disease models are based on virus-specific designs and have limited broad-spectrum antiviral potential.  Here we show that BCX4430, a novel synthetic adenosine analog, inhibits infection of distinct filoviruses in human cells.  Biochem., reporter-based and primer-extension assays indicate that BCX4430 inhibits viral RNA polymerase function, acting as a non-obligate RNA chain terminator.  Post-exposure i.m. administration of BCX4430 protects against Ebola virus and Marburg virus disease in rodent models.  Most importantly, BCX4430 completely protects cynomolgus macaques from Marburg virus infection when administered as late as 48 h after infection.  In addn., BCX4430 exhibits broad-spectrum antiviral activity against numerous viruses, including bunyaviruses, arenaviruses, paramyxoviruses, coronaviruses and flaviviruses.  This is the first report, to our knowledge, of non-human primate protection from filovirus disease by a synthetic drug-like small mol.  We provide addnl. pharmacol. characterizations supporting the potential development of BCX4430 as a countermeasure against human filovirus diseases and other viral diseases representing major public health threats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpev8c7g-X43rVg90H21EOLACvtfcHk0lgDwBq4I2N13Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtlWhu7w%253D&md5=dc7d390055ecf253e4b21c95b4e9e1a2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature13027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13027%26sid%3Dliteratum%253Aachs%26aulast%3DWarren%26aufirst%3DT.%2BK.%26aulast%3DWells%26aufirst%3DJ.%26aulast%3DPanchal%26aufirst%3DR.%2BG.%26aulast%3DStuthman%26aufirst%3DK.%2BS.%26aulast%3DGarza%26aufirst%3DN.%2BL.%26aulast%3DVan%2BTongeren%26aufirst%3DS.%2BA.%26aulast%3DDong%26aufirst%3DL.%26aulast%3DRetterer%26aufirst%3DC.%2BJ.%26aulast%3DEaton%26aufirst%3DB.%2BP.%26aulast%3DPegoraro%26aufirst%3DG.%26aulast%3DHonnold%26aufirst%3DS.%26aulast%3DBantia%26aufirst%3DS.%26aulast%3DKotian%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DTaubenheim%26aufirst%3DB.%2BR.%26aulast%3DWelch%26aufirst%3DL.%2BS.%26aulast%3DMinning%26aufirst%3DD.%2BM.%26aulast%3DBabu%26aufirst%3DY.%2BS.%26aulast%3DSheridan%26aufirst%3DW.%2BP.%26aulast%3DBavari%26aufirst%3DS.%26atitle%3DProtection%2520Against%2520Filovirus%2520Disease%2520by%2520a%2520Novel%2520Broad-Spectrum%2520Nucleoside%2520Analogue%2520BCX4430%26jtitle%3DNature%26date%3D2014%26volume%3D508%26spage%3D402%26epage%3D405%26doi%3D10.1038%2Fnature13027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Henao-Restrepo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longini, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmunds, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camacho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doumbia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draguez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duraffour, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enwere, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hossmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondé, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuisma, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norheim, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riveros, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soumah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trelle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicari, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kéïta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieny, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Røttingen, J.-A.</span></span> <span> </span><span class="NLM_article-title">Efficacy and Effectiveness of an rVSV-Vectored Vaccine Expressing Ebola, Surface Glycoprotein: Interim Results From the Guinea Ring Vaccination Cluster-Randomised Trial</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>386</i></span>,  <span class="NLM_fpage">857</span>– <span class="NLM_lpage">866</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(15)61117-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1016%2FS0140-6736%2815%2961117-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=26248676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1yjsrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=386&publication_year=2015&pages=857-866&author=A.+M.+Henao-Restrepoauthor=I.+M.+Longiniauthor=M.+Eggerauthor=N.+E.+Deanauthor=W.+J.+Edmundsauthor=A.+Camachoauthor=M.+W.+Carrollauthor=M.+Doumbiaauthor=B.+Draguezauthor=S.+Duraffourauthor=G.+Enwereauthor=R.+Graisauthor=S.+Guntherauthor=S.+Hossmannauthor=M.+K.+Kond%C3%A9author=S.+Koneauthor=E.+Kuismaauthor=M.+M.+Levineauthor=S.+Mandalauthor=G.+Norheimauthor=X.+Riverosauthor=A.+Soumahauthor=S.+Trelleauthor=A.+S.+Vicariauthor=C.+H.+Watsonauthor=S.+K%C3%A9%C3%AFtaauthor=M.+P.+Kienyauthor=J.-A.+R%C3%B8ttingen&title=Efficacy+and+Effectiveness+of+an+rVSV-Vectored+Vaccine+Expressing+Ebola%2C+Surface+Glycoprotein%3A+Interim+Results+From+the+Guinea+Ring+Vaccination+Cluster-Randomised+Trial&doi=10.1016%2FS0140-6736%2815%2961117-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial</span></div><div class="casAuthors">Henao-Restrepo, Ana Maria; Longini, Ira M.; Egger, Matthias; Dean, Natalie E.; Edmunds, W. John; Camacho, Anton; Carroll, Miles W.; Doumbia, Moussa; Draguez, Bertrand; Duraffour, Sophie; Enwere, Godwin; Grais, Rebecca; Gunther, Stephan; Hossmann, Stefanie; Konde, Mandy Kader; Kone, Souleymane; Kuisma, Eeva; Levine, Myron M.; Mandal, Sema; Norheim, Gunnstein; Riveros, Ximena; Soumah, Aboubacar; Trelle, Sven; Vicari, Andrea S.; Watson, Conall H.; Keita, Sakoba; Kieny, Marie Paule; Roettingen, John-Arne</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">386</span>
        (<span class="NLM_cas:issue">9996</span>),
    <span class="NLM_cas:pages">857-866</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A recombinant, replication-competent vesicular stomatitis virus-based vaccine expressing a surface glycoprotein of Zaire Ebolavirus (rVSV-ZEBOV) is a promising Ebola vaccine candidate.  We report the results of an interim anal. of a trial of rVSV-ZEBOV in Guinea, west Africa.  For this open-label, cluster-randomised ring vaccination trial, suspected cases of Ebola virus disease (Guinea, west Africa) were independently ascertained by Ebola response teams as part of a national surveillance system.  After lab. confirmation of a new case, clusters of all contacts and contacts of contacts were defined and randomly allocated 1:1 to immediate vaccination or delayed (21 days later) vaccination with rVSV-ZEBOV (one dose of 2 × 107 plaque-forming units, administered i.m. in the deltoid muscle).  Adults (age ≥18 years) who were not pregnant or breastfeeding were eligible for vaccination.  Block randomisation was used, with randomly varying blocks, stratified by location (urban vs rural) and size of rings (≤20 vs >20 individuals).  The study is open label and masking of participants and field teams to the time of vaccination is not possible, but Ebola response teams and lab. workers were unaware of allocation to immediate or delayed vaccination.  Taking into account the incubation period of the virus of about 10 days, the prespecified primary outcome was lab.-confirmed Ebola virus disease with onset of symptoms at least 10 days after randomisation.  The primary anal. was per protocol and compared the incidence of Ebola virus disease in eligible and vaccinated individuals in immediate vaccination clusters with the incidence in eligible individuals in delayed vaccination clusters.  This trial is registered with the Pan African Clin. Trials Registry, no. PACTR201503001057193.  Between Apr. 1, 2015, and July 20, 2015, 90 clusters, with a total population of 7651 people were included in the planned interim anal. 48 of these clusters (4123 people) were randomly assigned to immediate vaccination with rVSV-ZEBOV, and 42 clusters (3528 people) were randomly assigned to delayed vaccination with rVSV-ZEBOV.  In the immediate vaccination group, there were no cases of Ebola virus disease with symptom onset at least 10 days after randomisation, whereas in the delayed vaccination group there were 16 cases of Ebola virus disease from seven clusters, showing a vaccine efficacy of 100% (95% CI 74·7-100·0; p=0·0036).  No new cases of Ebola virus disease were diagnosed in vaccinees from the immediate or delayed groups from 6 days post-vaccination.  At the cluster level, with the inclusion of all eligible adults, vaccine effectiveness was 75·1% (95% CI -7·1 to 94·2; p=0·1791), and 76·3% (95% CI -15·5 to 95·1; p=0·3351) with the inclusion of everyone (eligible or not eligible for vaccination). 43 serious adverse events were reported; one serious adverse event was judged to be causally related to vaccination (a febrile episode in a vaccinated participant, which resolved without sequelae).  Assessment of serious adverse events is ongoing.  The results of this interim anal. indicate that rVSV-ZEBOV might be highly efficacious and safe in preventing Ebola virus disease, and is most likely effective at the population level when delivered during an Ebola virus disease outbreak via a ring vaccination strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW0EdaKSJSF7Vg90H21EOLACvtfcHk0lgDwBq4I2N13Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1yjsrzM&md5=26bdabce63d3b06a7bbe2ba63b7de984</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2815%2961117-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252815%252961117-5%26sid%3Dliteratum%253Aachs%26aulast%3DHenao-Restrepo%26aufirst%3DA.%2BM.%26aulast%3DLongini%26aufirst%3DI.%2BM.%26aulast%3DEgger%26aufirst%3DM.%26aulast%3DDean%26aufirst%3DN.%2BE.%26aulast%3DEdmunds%26aufirst%3DW.%2BJ.%26aulast%3DCamacho%26aufirst%3DA.%26aulast%3DCarroll%26aufirst%3DM.%2BW.%26aulast%3DDoumbia%26aufirst%3DM.%26aulast%3DDraguez%26aufirst%3DB.%26aulast%3DDuraffour%26aufirst%3DS.%26aulast%3DEnwere%26aufirst%3DG.%26aulast%3DGrais%26aufirst%3DR.%26aulast%3DGunther%26aufirst%3DS.%26aulast%3DHossmann%26aufirst%3DS.%26aulast%3DKond%25C3%25A9%26aufirst%3DM.%2BK.%26aulast%3DKone%26aufirst%3DS.%26aulast%3DKuisma%26aufirst%3DE.%26aulast%3DLevine%26aufirst%3DM.%2BM.%26aulast%3DMandal%26aufirst%3DS.%26aulast%3DNorheim%26aufirst%3DG.%26aulast%3DRiveros%26aufirst%3DX.%26aulast%3DSoumah%26aufirst%3DA.%26aulast%3DTrelle%26aufirst%3DS.%26aulast%3DVicari%26aufirst%3DA.%2BS.%26aulast%3DWatson%26aufirst%3DC.%2BH.%26aulast%3DK%25C3%25A9%25C3%25AFta%26aufirst%3DS.%26aulast%3DKieny%26aufirst%3DM.%2BP.%26aulast%3DR%25C3%25B8ttingen%26aufirst%3DJ.-A.%26atitle%3DEfficacy%2520and%2520Effectiveness%2520of%2520an%2520rVSV-Vectored%2520Vaccine%2520Expressing%2520Ebola%252C%2520Surface%2520Glycoprotein%253A%2520Interim%2520Results%2520From%2520the%2520Guinea%2520Ring%2520Vaccination%2520Cluster-Randomised%2520Trial%26jtitle%3DLancet%26date%3D2015%26volume%3D386%26spage%3D857%26epage%3D866%26doi%3D10.1016%2FS0140-6736%2815%2961117-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warren, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloveva, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuthman, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Tongeren, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garza, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shurtleff, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Retterer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharaibeh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomba, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelmsen, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuss, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugelman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacios, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerffler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neville, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carra, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lew, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babusis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stray, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trancheva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barauskas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flint, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMullan, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fearns, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayers, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiropoulou, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichol, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavari, S.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Efficacy of The Small Molecule GS-5734 Against Ebola Virus in Rhesus Monkeys</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>531</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">385</span>, <span class="refDoi"> DOI: 10.1038/nature17180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1038%2Fnature17180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=26934220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC28XjvVGnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=531&publication_year=2016&pages=381-385&author=T.+K.+Warrenauthor=R.+Jordanauthor=M.+K.+Loauthor=A.+S.+Rayauthor=R.+L.+Mackmanauthor=V.+Solovevaauthor=D.+Siegelauthor=M.+Perronauthor=R.+Bannisterauthor=H.+C.+Huiauthor=N.+Larsonauthor=R.+Strickleyauthor=J.+Wellsauthor=K.+S.+Stuthmanauthor=S.+A.+Van+Tongerenauthor=N.+L.+Garzaauthor=G.+Donnellyauthor=A.+C.+Shurtleffauthor=C.+J.+Rettererauthor=D.+Gharaibehauthor=R.+Zamaniauthor=T.+Kennyauthor=B.+P.+Eatonauthor=E.+Grimesauthor=L.+S.+Welchauthor=L.+Gombaauthor=C.+L.+Wilhelmsenauthor=D.+K.+Nicholsauthor=J.+E.+Nussauthor=E.+R.+Nagleauthor=J.+R.+Kugelmanauthor=G.+Palaciosauthor=E.+Doerfflerauthor=S.+Nevilleauthor=E.+Carraauthor=M.+O.+Clarkeauthor=L.+Zhangauthor=W.+Lewauthor=B.+Rossauthor=Q.+Wangauthor=K.+Chunauthor=L.+Wolfeauthor=D.+Babusisauthor=Y.+Parkauthor=K.+M.+Strayauthor=I.+Tranchevaauthor=J.+Y.+Fengauthor=O.+Barauskasauthor=Y.+Xuauthor=P.+Wongauthor=M.+R.+Braunauthor=M.+Flintauthor=L.+K.+McMullanauthor=S.+S.+Chenauthor=R.+Fearnsauthor=S.+Swaminathanauthor=D.+L.+Mayersauthor=C.+F.+Spiropoulouauthor=W.+A.+Leeauthor=S.+T.+Nicholauthor=T.+Cihlarauthor=S.+Bavari&title=Therapeutic+Efficacy+of+The+Small+Molecule+GS-5734+Against+Ebola+Virus+in+Rhesus+Monkeys&doi=10.1038%2Fnature17180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys</span></div><div class="casAuthors">Warren, Travis K.; Jordan, Robert; Lo, Michael K.; Ray, Adrian S.; Mackman, Richard L.; Soloveva, Veronica; Siegel, Dustin; Perron, Michel; Bannister, Roy; Hui, Hon C.; Larson, Nate; Strickley, Robert; Wells, Jay; Stuthman, Kelly S.; Van Tongeren, Sean A.; Garza, Nicole L.; Donnelly, Ginger; Shurtleff, Amy C.; Retterer, Cary J.; Gharaibeh, Dima; Zamani, Rouzbeh; Kenny, Tara; Eaton, Brett P.; Grimes, Elizabeth; Welch, Lisa S.; Gomba, Laura; Wilhelmsen, Catherine L.; Nichols, Donald K.; Nuss, Jonathan E.; Nagle, Elyse R.; Kugelman, Jeffrey R.; Palacios, Gustavo; Doerffler, Edward; Neville, Sean; Carra, Ernest; Clarke, Michael O.; Zhang, Lijun; Lew, Willard; Ross, Bruce; Wang, Queenie; Chun, Kwon; Wolfe, Lydia; Babusis, Darius; Park, Yeojin; Stray, Kirsten M.; Trancheva, Iva; Feng, Joy Y.; Barauskas, Ona; Xu, Yili; Wong, Pamela; Braun, Molly R.; Flint, Mike; McMullan, Laura K.; Chen, Shan-Shan; Fearns, Rachel; Swaminathan, Swami; Mayers, Douglas L.; Spiropoulou, Christina F.; Lee, William A.; Nichol, Stuart T.; Cihlar, Tomas; Bavari, Sina</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">531</span>
        (<span class="NLM_cas:issue">7594</span>),
    <span class="NLM_cas:pages">381-385</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The most recent Ebola virus outbreak in West Africa, which was unprecedented in the no. of cases and fatalities, geog. distribution, and no. of nations affected, highlights the need for safe, effective, and readily available antiviral agents for treatment and prevention of acute Ebola virus (EBOV) disease (EVD) or sequelae.  No antiviral therapeutics have yet received regulatory approval or demonstrated clin. efficacy.  Here we report the discovery of a novel small mol. GS-5734, a monophosphoramidate prodrug of an adenosine analog, with antiviral activity against EBOV.  GS-5734 exhibits antiviral activity against multiple variants of EBOV and other filoviruses in cell-based assays.  The pharmacol. active nucleoside triphosphate (NTP) is efficiently formed in multiple human cell types incubated with GS-5734 in vitro, and the NTP acts as an alternative substrate and RNA-chain terminator in primer-extension assays using a surrogate respiratory syncytial virus RNA polymerase.  I.v. administration of GS-5734 to nonhuman primates resulted in persistent NTP levels in peripheral blood mononuclear cells (half-life, 14 h) and distribution to sanctuary sites for viral replication including testes, eyes, and brain.  In a rhesus monkey model of EVD, once-daily i.v. administration of 10 mg kg-1 GS-5734 for 12 days resulted in profound suppression of EBOV replication and protected 100% of EBOV-infected animals against lethal disease, ameliorating clin. disease signs and pathophysiol. markers, even when treatments were initiated three days after virus exposure when systemic viral RNA was detected in two out of six treated animals.  These results show the first substantive post-exposure protection by a small-mol. antiviral compd. against EBOV in nonhuman primates.  The broad-spectrum antiviral activity of GS-5734 in vitro against other pathogenic RNA viruses, including filoviruses, arenaviruses, and coronaviruses, suggests the potential for wider medical use.  GS-5734 is amenable to large-scale manufg., and clin. studies investigating the drug safety and pharmacokinetics are ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX4QsyLVjgHLVg90H21EOLACvtfcHk0ljjSib-8iZEDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjvVGnu70%253D&md5=ab121d827ac0a40cc1fed3dd1df905b6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnature17180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17180%26sid%3Dliteratum%253Aachs%26aulast%3DWarren%26aufirst%3DT.%2BK.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DLo%26aufirst%3DM.%2BK.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DSoloveva%26aufirst%3DV.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DPerron%26aufirst%3DM.%26aulast%3DBannister%26aufirst%3DR.%26aulast%3DHui%26aufirst%3DH.%2BC.%26aulast%3DLarson%26aufirst%3DN.%26aulast%3DStrickley%26aufirst%3DR.%26aulast%3DWells%26aufirst%3DJ.%26aulast%3DStuthman%26aufirst%3DK.%2BS.%26aulast%3DVan%2BTongeren%26aufirst%3DS.%2BA.%26aulast%3DGarza%26aufirst%3DN.%2BL.%26aulast%3DDonnelly%26aufirst%3DG.%26aulast%3DShurtleff%26aufirst%3DA.%2BC.%26aulast%3DRetterer%26aufirst%3DC.%2BJ.%26aulast%3DGharaibeh%26aufirst%3DD.%26aulast%3DZamani%26aufirst%3DR.%26aulast%3DKenny%26aufirst%3DT.%26aulast%3DEaton%26aufirst%3DB.%2BP.%26aulast%3DGrimes%26aufirst%3DE.%26aulast%3DWelch%26aufirst%3DL.%2BS.%26aulast%3DGomba%26aufirst%3DL.%26aulast%3DWilhelmsen%26aufirst%3DC.%2BL.%26aulast%3DNichols%26aufirst%3DD.%2BK.%26aulast%3DNuss%26aufirst%3DJ.%2BE.%26aulast%3DNagle%26aufirst%3DE.%2BR.%26aulast%3DKugelman%26aufirst%3DJ.%2BR.%26aulast%3DPalacios%26aufirst%3DG.%26aulast%3DDoerffler%26aufirst%3DE.%26aulast%3DNeville%26aufirst%3DS.%26aulast%3DCarra%26aufirst%3DE.%26aulast%3DClarke%26aufirst%3DM.%2BO.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLew%26aufirst%3DW.%26aulast%3DRoss%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DChun%26aufirst%3DK.%26aulast%3DWolfe%26aufirst%3DL.%26aulast%3DBabusis%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DStray%26aufirst%3DK.%2BM.%26aulast%3DTrancheva%26aufirst%3DI.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DBarauskas%26aufirst%3DO.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DWong%26aufirst%3DP.%26aulast%3DBraun%26aufirst%3DM.%2BR.%26aulast%3DFlint%26aufirst%3DM.%26aulast%3DMcMullan%26aufirst%3DL.%2BK.%26aulast%3DChen%26aufirst%3DS.%2BS.%26aulast%3DFearns%26aufirst%3DR.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DMayers%26aufirst%3DD.%2BL.%26aulast%3DSpiropoulou%26aufirst%3DC.%2BF.%26aulast%3DLee%26aufirst%3DW.%2BA.%26aulast%3DNichol%26aufirst%3DS.%2BT.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DBavari%26aufirst%3DS.%26atitle%3DTherapeutic%2520Efficacy%2520of%2520The%2520Small%2520Molecule%2520GS-5734%2520Against%2520Ebola%2520Virus%2520in%2520Rhesus%2520Monkeys%26jtitle%3DNature%26date%3D2016%26volume%3D531%26spage%3D381%26epage%3D385%26doi%3D10.1038%2Fnature17180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mehellou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuigan, C.</span></span> <span> </span><span class="NLM_article-title">Aryloxy Phosphoramidate Triesters: A Technology For Delivering Monophosphorylated Nucleosides and Sugars Into Cells</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1779</span>– <span class="NLM_lpage">1791</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200900289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1002%2Fcmdc.200900289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=19760699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlagurbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1779-1791&author=Y.+Mehellouauthor=J.+Balzariniauthor=C.+McGuigan&title=Aryloxy+Phosphoramidate+Triesters%3A+A+Technology+For+Delivering+Monophosphorylated+Nucleosides+and+Sugars+Into+Cells&doi=10.1002%2Fcmdc.200900289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Aryloxy Phosphoramidate Triesters: a Technology for Delivering Monophosphorylated Nucleosides and Sugars into Cells</span></div><div class="casAuthors">Mehellou, Youcef; Balzarini, Jan; McGuigan, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1779-1791</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Prodrug technologies aimed at delivering nucleoside monophosphates into cells (protides) have proved to be effective in improving the therapeutic potential of antiviral and anticancer nucleosides.  In these cases, the nucleoside monophosphates are delivered into the cell, where they may then be further converted (phosphorylated) to their active species.  Herein, we describe one of these technologies developed in our labs., known as the phosphoramidate protide method.  In this approach, the charges of the phosphate group are fully masked to provide efficient passive cell-membrane penetration.  Upon entering the cell, the masking groups are enzymically cleaved to release the phosphorylated biomol.  The application of this technol. to various therapeutic nucleosides has resulted in improved antiviral and anticancer activities, and in some cases it has transformed inactive nucleosides to active ones.  Addnl., the phosphoramidate technol. has also been applied to numerous antiviral nucleoside phosphonates, and has resulted in at least three phosphoramidate-based nucleotides progressing to clin. investigations.  Furthermore, the phosphoramidate technol. has been recently applied to sugars (mainly glucosamine) in order to improve their therapeutic potential.  The development of the phosphoramidate technol., mechanism of action and the application of the technol. to various monophosphorylated nucleosides and sugars will be reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzsccB6GOugbVg90H21EOLACvtfcHk0ljjSib-8iZEDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlagurbI&md5=ccffcc4d9db89b5f1d0aa13e6daf2100</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900289%26sid%3Dliteratum%253Aachs%26aulast%3DMehellou%26aufirst%3DY.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DMcGuigan%26aufirst%3DC.%26atitle%3DAryloxy%2520Phosphoramidate%2520Triesters%253A%2520A%2520Technology%2520For%2520Delivering%2520Monophosphorylated%2520Nucleosides%2520and%2520Sugars%2520Into%2520Cells%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1779%26epage%3D1791%26doi%3D10.1002%2Fcmdc.200900289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sofia, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagarathnam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rachakonda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espiritu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keilman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steuer, H. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furman, P. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of a β-D-2′-Deoxy-2′-α-Fluoro-2′-β-<i>C</i>-Methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7202</span>– <span class="NLM_lpage">7218</span>, <span class="refDoi"> DOI: 10.1021/jm100863x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100863x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7202-7218&author=M.+J.+Sofiaauthor=D.+Baoauthor=W.+Changauthor=J.+Duauthor=D.+Nagarathnamauthor=S.+Rachakondaauthor=P.+G.+Reddyauthor=B.+S.+Rossauthor=P.+Wangauthor=H.-R.+Zhangauthor=S.+Bansalauthor=C.+Espirituauthor=M.+Keilmanauthor=A.+M.+Lamauthor=H.+M.+M.+Steuerauthor=C.+Niuauthor=M.+J.+Ottoauthor=P.+A.+Furman&title=Discovery+of+a+%CE%B2-D-2%E2%80%B2-Deoxy-2%E2%80%B2-%CE%B1-Fluoro-2%E2%80%B2-%CE%B2-C-Methyluridine+Nucleotide+Prodrug+%28PSI-7977%29+for+the+Treatment+of+Hepatitis+C+Virus&doi=10.1021%2Fjm100863x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a β-D-2'-Deoxy-2'-α-fluoro-2'-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus</span></div><div class="casAuthors">Sofia, Michael J.; Bao, Donghui; Chang, Wonsuk; Du, Jinfa; Nagarathnam, Dhanapalan; Rachakonda, Suguna; Reddy, P. Ganapati; Ross, Bruce S.; Wang, Peiyuan; Zhang, Hai-Ren; Bansal, Shalini; Espiritu, Christine; Keilman, Meg; Lam, Angela M.; Steuer, Holly M. Micolochick; Niu, Congrong; Otto, Michael J.; Furman, Phillip A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7202-7218</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) is a global health problem requiring novel approaches for effective treatment of this disease.  The HCV NS5B polymerase has been demonstrated to be a viable target for the development of HCV therapies.  β-D-2'-Deoxy-2'-α-fluoro-2'-β-C-Me nucleosides are selective inhibitors of the HCV NS5B polymerase and have demonstrated potent activity in the clinic.  Phosphoramidate prodrugs of the 5'-phosphate deriv. of the β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine nucleoside were prepd. and showed significant potency in the HCV subgenomic replicon assay (<1 μM) and produced high levels of triphosphate 6 in primary hepatocytes and in the livers of rats, dogs, and monkeys when administered in vivo.  The single diastereomer 51 of diastereomeric mixt. 14 was crystd., and an X-ray structure was detd. establishing the phosphoramidate stereochem. as Sp, thus correlating for the first time the stereochem. of a phosphoramidate prodrug with biol. activity.  51 (PSI-7977) was selected as a clin. development candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWAkLi9-odWbVg90H21EOLACvtfcHk0lik88WvF25NpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtb%252FO&md5=33d371e557e9d70562a326f97798f45c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm100863x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100863x%26sid%3Dliteratum%253Aachs%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DBao%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DNagarathnam%26aufirst%3DD.%26aulast%3DRachakonda%26aufirst%3DS.%26aulast%3DReddy%26aufirst%3DP.%2BG.%26aulast%3DRoss%26aufirst%3DB.%2BS.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DH.-R.%26aulast%3DBansal%26aufirst%3DS.%26aulast%3DEspiritu%26aufirst%3DC.%26aulast%3DKeilman%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DSteuer%26aufirst%3DH.%2BM.%2BM.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DDiscovery%2520of%2520a%2520%25CE%25B2-D-2%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-%25CE%25B1-Fluoro-2%25E2%2580%25B2-%25CE%25B2-C-Methyluridine%2520Nucleotide%2520Prodrug%2520%2528PSI-7977%2529%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C%2520Virus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7202%26epage%3D7218%26doi%3D10.1021%2Fjm100863x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, G.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cundy, K. C.</span></span> <span> </span><span class="NLM_article-title">Selective Intracellular Activation of a Novel Prodrug of the Human Immunodeficiency Virus Reverse Transcriptase Inhibitor Tenofovir Leads to Preferential Distribution and Accumulation in Lymphatic Tissue</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1898</span>– <span class="NLM_lpage">1906</span>, <span class="refDoi"> DOI: 10.1128/AAC.49.5.1898-1906.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1128%2FAAC.49.5.1898-1906.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=15855512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFSntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=1898-1906&author=A.+W.+Leeauthor=G.-X.+Heauthor=E.+Eisenbergauthor=T.+Cihlarauthor=S.+Swaminathanauthor=A.+Mulatoauthor=K.+C.+Cundy&title=Selective+Intracellular+Activation+of+a+Novel+Prodrug+of+the+Human+Immunodeficiency+Virus+Reverse+Transcriptase+Inhibitor+Tenofovir+Leads+to+Preferential+Distribution+and+Accumulation+in+Lymphatic+Tissue&doi=10.1128%2FAAC.49.5.1898-1906.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue</span></div><div class="casAuthors">Lee, William A.; He, Gong-Xin; Eisenberg, Eugene; Cihlar, Tomas; Swaminathan, Swami; Mulato, Andrew; Cundy, Kenneth C.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1898-1906</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">An isopropylalaninyl monoamidate Ph monoester prodrug of tenofovir (GS 7340) was prepd., and its in vitro antiviral activity, metab., and pharmacokinetics in dogs were detd.  The 50% effective concn. (EC50) of GS 7340 against human immunodeficiency virus type 1 in MT-2 cells was 0.005 μM compared to an EC50 of 5 μM for the parent drug, tenofovir.  The (L)-alaninyl analog (GS 7340) was >1000-fold more active than the (D)-alaninyl analog.  GS 7340 has a half-life of 90 min in human plasma at 37° and a half-life of 28.3 min in an MT-2 cell ext. at 37°.  The antiviral activity (>10× the EC50) and the metabolic stability in MT-2 cell exts. (>35×) and plasma (>2.5×) were also sensitive to the stereochem. at the phosphorus.  After a single oral dose of GS 7340 (10 mg-eq/kg tenofovir) to male beagle dogs, the plasma bioavailability of tenofovir compared to an i.v. dose of tenofovir was 17%.  The total intracellular concn. of all tenofovir species in isolated peripheral blood mononuclear cells at 24 h was 63 μg-eq/mL compared to 0.2 μg-eq/mL in plasma.  A radiolabeled distribution study with dogs resulted in an increased distribution of tenofovir to tissues of lymphatic origin compared to the com. available prodrug tenofovir DF (Viread).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbOoU4rGP0xrVg90H21EOLACvtfcHk0lik88WvF25NpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFSntL0%253D&md5=b5e724620a1cafa4b473a84aea841282</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1128%2FAAC.49.5.1898-1906.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.49.5.1898-1906.2005%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DA.%2BW.%26aulast%3DHe%26aufirst%3DG.-X.%26aulast%3DEisenberg%26aufirst%3DE.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DMulato%26aufirst%3DA.%26aulast%3DCundy%26aufirst%3DK.%2BC.%26atitle%3DSelective%2520Intracellular%2520Activation%2520of%2520a%2520Novel%2520Prodrug%2520of%2520the%2520Human%2520Immunodeficiency%2520Virus%2520Reverse%2520Transcriptase%2520Inhibitor%2520Tenofovir%2520Leads%2520to%2520Preferential%2520Distribution%2520and%2520Accumulation%2520in%2520Lymphatic%2520Tissue%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26volume%3D49%26spage%3D1898%26epage%3D1906%26doi%3D10.1128%2FAAC.49.5.1898-1906.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steuer, H. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitaker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sofia, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furman, P. A.</span></span> <span> </span><span class="NLM_article-title">The Mechanism of Action of β-D-2′-Deoxy-2′-Fluoro-2′-<i>C</i>-Methylcytidine Involves a Second Metabolic Pathway Leading to β-D-2′-Deoxy-2′-Fluoro-2′-<i>C</i>-Methyluridine 5′-Triphosphate, A Potent Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">458</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1128/AAC.01184-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1128%2FAAC.01184-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=17999967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=458-464&author=E.+Murakamiauthor=C.+Niuauthor=H.+Baoauthor=H.+M.+M.+Steuerauthor=T.+Whitakerauthor=T.+Nachmanauthor=M.+A.+Sofiaauthor=P.+Wangauthor=M.+J.+Ottoauthor=P.+A.+Furman&title=The+Mechanism+of+Action+of+%CE%B2-D-2%E2%80%B2-Deoxy-2%E2%80%B2-Fluoro-2%E2%80%B2-C-Methylcytidine+Involves+a+Second+Metabolic+Pathway+Leading+to+%CE%B2-D-2%E2%80%B2-Deoxy-2%E2%80%B2-Fluoro-2%E2%80%B2-C-Methyluridine+5%E2%80%B2-Triphosphate%2C+A+Potent+Inhibitor+of+the+Hepatitis+C+Virus+RNA-Dependent+RNA+Polymerase&doi=10.1128%2FAAC.01184-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanism of action of β-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine involves a second metabolic pathway leading to β-D-2'-deoxy-2'-fluoro-2'-C-methyluridine 5'-triphosphate, a potent inhibitor of the hepatitis C virus RNA-dependent RNA polymerase</span></div><div class="casAuthors">Murakami, Eisuke; Niu, Congrong; Bao, Haiying; Micolochick Steuer, Holly M.; Whitaker, Tony; Nachman, Tammy; Sofia, Michael A.; Wang, Peiyuan; Otto, Michael J.; Furman, Phillip A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">458-464</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">β-D-2'-Deoxy-2'-fluoro-2'-C-methylcytidine (PSI-6130) is a potent inhibitor of hepatitis C virus (HCV) RNA replication in an HCV replicon assay.  The 5'-triphosphate of PSI-6130 is a competitive inhibitor of the HCV RNA-dependent RNA polymerase (RdRp) and acts as a nonobligate chain terminator.  Recently, it has been shown that the metab. of PSI-6130 also results in the formation of the 5'-triphosphate of the uridine congener, β-D-2'-deoxy-2'-fluoro-2'-C-methyluridine (PSI-6206; RO2433).  Here we show that the formation of the 5'-triphosphate of RO2433 (RO2433-TP) requires the deamination of PSI-6130 monophosphate and that RO2433 monophosphate is subsequently phosphorylated to the corresponding di- and triphosphates by cellular UMP-CMP kinase and nucleoside diphosphate kinase, resp.  RO2433-TP is a potent inhibitor of the HCV RdRp; however, both enzymic and cell-based assays show that PSI-6130 triphosphate is a more potent inhibitor of the HCV RdRp than RO2433-TP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdrOmmMbGQNrVg90H21EOLACvtfcHk0ljsg8u8P8e3fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSqtbc%253D&md5=9215a7a0363bc79295269f560d2597ef</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1128%2FAAC.01184-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01184-07%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DE.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DBao%26aufirst%3DH.%26aulast%3DSteuer%26aufirst%3DH.%2BM.%2BM.%26aulast%3DWhitaker%26aufirst%3DT.%26aulast%3DNachman%26aufirst%3DT.%26aulast%3DSofia%26aufirst%3DM.%2BA.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DThe%2520Mechanism%2520of%2520Action%2520of%2520%25CE%25B2-D-2%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-Fluoro-2%25E2%2580%25B2-C-Methylcytidine%2520Involves%2520a%2520Second%2520Metabolic%2520Pathway%2520Leading%2520to%2520%25CE%25B2-D-2%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-Fluoro-2%25E2%2580%25B2-C-Methyluridine%25205%25E2%2580%25B2-Triphosphate%252C%2520A%2520Potent%2520Inhibitor%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520RNA-Dependent%2520RNA%2520Polymerase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D458%26epage%3D464%26doi%3D10.1128%2FAAC.01184-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, O. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. U.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Antiviral Activity of a Series of 1′-Substituted 4-Aza-7,9-Dideazaadenosine <i>C</i>-Nucleosides</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2705</span>– <span class="NLM_lpage">2707</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1016%2Fj.bmcl.2012.02.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=22446091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVGqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2705-2707&author=A.+Choauthor=O.+L.+Saundersauthor=T.+Butlerauthor=L.+Zhangauthor=J.+Xuauthor=J.+E.+Velaauthor=J.+Y.+Fengauthor=A.+S.+Rayauthor=C.+U.+Kim&title=Synthesis+and+Antiviral+Activity+of+a+Series+of+1%E2%80%B2-Substituted+4-Aza-7%2C9-Dideazaadenosine+C-Nucleosides&doi=10.1016%2Fj.bmcl.2012.02.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides</span></div><div class="casAuthors">Cho, Aesop; Saunders, Oliver L.; Butler, Thomas; Zhang, Lijun; Xu, Jie; Vela, Jennifer E.; Feng, Joy Y.; Ray, Adrian S.; Kim, Choung U.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2705-2707</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 1'-substituted analogs of 4-aza-7,9-dideazaadenosine C-nucleoside, e.g. I, were prepd. and evaluated for the potential as antiviral agents.  These compds. showed a broad range of inhibitory activity against various RNA viruses.  In particular, the whole cell potency against HCV when R = CN was attributed to inhibition of HCV NS5B polymerase and intracellular concn. of the corresponding nucleoside triphosphate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAj_ComFGJ9LVg90H21EOLACvtfcHk0ljsg8u8P8e3fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVGqt7Y%253D&md5=b7576da7b34ae7b3862d80b52645465a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.105%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DA.%26aulast%3DSaunders%26aufirst%3DO.%2BL.%26aulast%3DButler%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DVela%26aufirst%3DJ.%2BE.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DKim%26aufirst%3DC.%2BU.%26atitle%3DSynthesis%2520and%2520Antiviral%2520Activity%2520of%2520a%2520Series%2520of%25201%25E2%2580%25B2-Substituted%25204-Aza-7%252C9-Dideazaadenosine%2520C-Nucleosides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2705%26epage%3D2707%26doi%3D10.1016%2Fj.bmcl.2012.02.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span>; <span class="NLM_string-name">Parrish, J. P.</span>; <span class="NLM_string-name">Ray, A. S.</span>; <span class="NLM_string-name">Theodore, D. A.</span></span> <span> </span><span class="NLM_article-title">Methods and Compounds for Treating Paramyxoviridae Virus Infections</span>. U.S. Patent <span class="NLM_patent">2011045102</span> July, 22, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=R.+L.+Mackman&author=J.+P.+Parrish&author=A.+S.+Ray&author=D.+A.+Theodore&title=Methods+and+Compounds+for+Treating+Paramyxoviridae+Virus+Infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMackman%26aufirst%3DR.%2BL.%26atitle%3DMethods%2520and%2520Compounds%2520for%2520Treating%2520Paramyxoviridae%2520Virus%2520Infections%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patil, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otter, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R. S.</span></span> <span> </span><span class="NLM_article-title">4-Aza-7,9-Dideazaadenosine, A New Cytotoxic Synthetic <i>C</i>-Nucleoside Analogue of Adenosine</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">5339</span>– <span class="NLM_lpage">5342</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)73494-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1016%2FS0040-4039%2800%2973494-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADyaK2cXmtlWht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1994&pages=5339-5342&author=S.+A.+Patilauthor=P.+B.+Otterauthor=R.+S.+Klein&title=4-Aza-7%2C9-Dideazaadenosine%2C+A+New+Cytotoxic+Synthetic+C-Nucleoside+Analogue+of+Adenosine&doi=10.1016%2FS0040-4039%2800%2973494-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">4-Aza-7,9-dideazaadenosine, a new cytotoxic synthetic C-nucleoside analog of adenosine</span></div><div class="casAuthors">Patil, Shirish A.; Otter, Brian A.; Klein, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">5339-42</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">The first synthesis of I, the pyrrolo[2,1-f]triazine C-nucleoside congener of adenosine is described.  The key intermediate ribofuranosyl pyrrole is obtained by the direct C-ribosylation of pyrrolemagnesium bromide followed by an acid-catalyzed dehydration, Vilsmeier formylation, and N-amination.  In vitro growth inhibitory activities of I against leukemic cell lines (0.8-15 nM) are comparable to those of 9-deazaadenosine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1bQfZLO2B8bVg90H21EOLACvtfcHk0ljsg8u8P8e3fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmtlWht7o%253D&md5=5331a09cb66b387fd153ad1d8f69d6c7</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2973494-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252973494-0%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DS.%2BA.%26aulast%3DOtter%26aufirst%3DP.%2BB.%26aulast%3DKlein%26aufirst%3DR.%2BS.%26atitle%3D4-Aza-7%252C9-Dideazaadenosine%252C%2520A%2520New%2520Cytotoxic%2520Synthetic%2520C-Nucleoside%2520Analogue%2520of%2520Adenosine%26jtitle%3DTetrahedron%2520Lett.%26date%3D1994%26volume%3D35%26spage%3D5339%26epage%3D5342%26doi%3D10.1016%2FS0040-4039%2800%2973494-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lou, Z.</span>; <span class="NLM_string-name">Chen, G.</span>; <span class="NLM_string-name">Xie, Y.</span></span> <span> </span><span class="NLM_article-title">Cyanoribofuranoside Compound and a Preparation Method Thereof</span>. Chinese Patent <span class="NLM_patent">CN 1137132 C</span> Feb., 4, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=Z.+Lou&author=G.+Chen&author=Y.+Xie&title=Cyanoribofuranoside+Compound+and+a+Preparation+Method+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLou%26aufirst%3DZ.%26atitle%3DCyanoribofuranoside%2520Compound%2520and%2520a%2520Preparation%2520Method%2520Thereof%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kano, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashida, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haraguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyasaka, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of 1′-<i>C</i>-Cyano-Pyrimidine Nucleosides</span>. <i>Nucleosides, Nucleotides Nucleic Acids</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">324</span>, <span class="refDoi"> DOI: 10.1080/07328319608002386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1080%2F07328319608002386" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1996&pages=305-324&author=Y.+Yoshimuraauthor=F.+Kanoauthor=S.+Miyazakiauthor=N.+Ashidaauthor=S.+Sakataauthor=K.+Haraguchiauthor=Y.+Itohauthor=H.+Tanakaauthor=T.+Miyasaka&title=Synthesis+and+Biological+Evaluation+of+1%E2%80%B2-C-Cyano-Pyrimidine+Nucleosides&doi=10.1080%2F07328319608002386"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1080%2F07328319608002386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07328319608002386%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimura%26aufirst%3DY.%26aulast%3DKano%26aufirst%3DF.%26aulast%3DMiyazaki%26aufirst%3DS.%26aulast%3DAshida%26aufirst%3DN.%26aulast%3DSakata%26aufirst%3DS.%26aulast%3DHaraguchi%26aufirst%3DK.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DMiyasaka%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%25201%25E2%2580%25B2-C-Cyano-Pyrimidine%2520Nucleosides%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D1996%26volume%3D15%26spage%3D305%26epage%3D324%26doi%3D10.1080%2F07328319608002386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kirschberg, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squires, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zonte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aktoudianakis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metobo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. U.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 1′-<i>C</i>-Cyano Pyrimidine Nucleosides and Characterization as HCV Polymerase Inhibitors</span>. <i>Nucleosides, Nucleotides Nucleic Acids</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">763</span>– <span class="NLM_lpage">785</span>, <span class="refDoi"> DOI: 10.1080/15257770.2015.1075550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1080%2F15257770.2015.1075550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=26398773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFKhsrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=763-785&author=T.+A.+Kirschbergauthor=M.+Mishauthor=N.+H.+Squiresauthor=S.+Zonteauthor=E.+Aktoudianakisauthor=S.+Metoboauthor=T.+Butlerauthor=X.+Juauthor=A.+Choauthor=A.+S.+Rayauthor=C.+U.+Kim&title=Synthesis+of+1%E2%80%B2-C-Cyano+Pyrimidine+Nucleosides+and+Characterization+as+HCV+Polymerase+Inhibitors&doi=10.1080%2F15257770.2015.1075550"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 1'-C-Cyano Pyrimidine Nucleosides and Characterization as HCV Polymerase Inhibitors</span></div><div class="casAuthors">Kirschberg, Thorsten A.; Mish, Michael; Squires, Neil H.; Zonte, Sebastian; Aktoudianakis, Evangelos; Metobo, Sammy; Butler, Thomas; Ju, Xie; Cho, Aesop; Ray, Adrian S.; Kim, Choung U.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">763-785</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Ribose modified 1'-C-cyano pyrimidine nucleosides were synthesized.  A silver triflate mediated Vorbruggen reaction was used to generate the nucleoside scaffold and follow-up chem. provided specific ribose modified analogs.  Nucleosides and phosphoramidate prodrugs were tested for their anti-HCV activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo25OTpf7cL67Vg90H21EOLACvtfcHk0lhLmDdRkRBJWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFKhsrfI&md5=172176a9fd3b10fdc4d64a8630b68763</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1080%2F15257770.2015.1075550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15257770.2015.1075550%26sid%3Dliteratum%253Aachs%26aulast%3DKirschberg%26aufirst%3DT.%2BA.%26aulast%3DMish%26aufirst%3DM.%26aulast%3DSquires%26aufirst%3DN.%2BH.%26aulast%3DZonte%26aufirst%3DS.%26aulast%3DAktoudianakis%26aufirst%3DE.%26aulast%3DMetobo%26aufirst%3DS.%26aulast%3DButler%26aufirst%3DT.%26aulast%3DJu%26aufirst%3DX.%26aulast%3DCho%26aufirst%3DA.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DKim%26aufirst%3DC.%2BU.%26atitle%3DSynthesis%2520of%25201%25E2%2580%25B2-C-Cyano%2520Pyrimidine%2520Nucleosides%2520and%2520Characterization%2520as%2520HCV%2520Polymerase%2520Inhibitors%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2015%26volume%3D34%26spage%3D763%26epage%3D785%26doi%3D10.1080%2F15257770.2015.1075550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metobo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aktoudianakis, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lew, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerffler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babusis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carey, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">German, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenaux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHutchison, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. U.</span></span> <span> </span><span class="NLM_article-title">Discovery of the First <i>C</i>-nucleoside HCV Polymerase Inhibitor (GS-6620) with Demonstrated Antiviral Response in HCV Infected Patients</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1812</span>– <span class="NLM_lpage">1825</span>, <span class="refDoi"> DOI: 10.1021/jm400201a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400201a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2nt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1812-1825&author=A.+Choauthor=L.+Zhangauthor=J.+Xuauthor=R.+Leeauthor=T.+Butlerauthor=S.+Metoboauthor=V.+Aktoudianakisauthor=W.+Lewauthor=H.+Yeauthor=M.+Clarkeauthor=E.+Doerfflerauthor=D.+Byunauthor=T.+Wangauthor=D.+Babusisauthor=A.+C.+Careyauthor=P.+Germanauthor=D.+Sauerauthor=W.+Zhongauthor=S.+Rossiauthor=M.+Fenauxauthor=J.+G.+McHutchisonauthor=J.+Perryauthor=J.+Fengauthor=A.+S.+Rayauthor=C.+U.+Kim&title=Discovery+of+the+First+C-nucleoside+HCV+Polymerase+Inhibitor+%28GS-6620%29+with+Demonstrated+Antiviral+Response+in+HCV+Infected+Patients&doi=10.1021%2Fjm400201a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the First C-Nucleoside HCV Polymerase Inhibitor (GS-6620) with Demonstrated Antiviral Response in HCV Infected Patients</span></div><div class="casAuthors">Cho, Aesop; Zhang, Lijun; Xu, Jie; Lee, Rick; Butler, Thomas; Metobo, Sammy; Aktoudianakis, Vangelis; Lew, Willard; Ye, Hong; Clarke, Michael; Doerffler, Edward; Byun, Daniel; Wang, Ting; Babusis, Darius; Carey, Anne C.; German, Polina; Sauer, Dorothea; Zhong, Weidong; Rossi, Stephen; Fenaux, Martijn; McHutchison, John G.; Perry, Jason; Feng, Joy; Ray, Adrian S.; Kim, Choung U.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1812-1825</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection presents an unmet medical need requiring more effective treatment options.  Nucleoside inhibitors (NI) of HCV polymerase (NS5B) have demonstrated pan-genotypic activity and durable antiviral response in the clinic, and they are likely to become a key component of future treatment regimens.  NI candidates that have entered clin. development thus far have all been N-nucleoside derivs.  Herein, we report the discovery of a C-nucleoside class of NS5B inhibitors.  Exploration of adenosine analogs in this class identified 1'-cyano-2'-C-Me 4-aza-7,9-dideaza adenosine as a potent and selective inhibitor of NS5B.  A monophosphate prodrug approach afforded a series of compds. showing submicromolar activity in HCV replicon assays.  Further pharmacokinetic optimization for sufficient oral absorption and liver triphosphate loading led to identification of a clin. development candidate GS-6620 (I).  In a phase I clin. study, the potential for potent activity was demonstrated but with high intra- and interpatient pharmacokinetic and pharmacodynamic variability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro0DWejYRAB7Vg90H21EOLACvtfcHk0lhLmDdRkRBJWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2nt7c%253D&md5=60cb14dcd3d500933bcf4e55e9257fc6</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm400201a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400201a%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DR.%26aulast%3DButler%26aufirst%3DT.%26aulast%3DMetobo%26aufirst%3DS.%26aulast%3DAktoudianakis%26aufirst%3DV.%26aulast%3DLew%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DClarke%26aufirst%3DM.%26aulast%3DDoerffler%26aufirst%3DE.%26aulast%3DByun%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DBabusis%26aufirst%3DD.%26aulast%3DCarey%26aufirst%3DA.%2BC.%26aulast%3DGerman%26aufirst%3DP.%26aulast%3DSauer%26aufirst%3DD.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DRossi%26aufirst%3DS.%26aulast%3DFenaux%26aufirst%3DM.%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DKim%26aufirst%3DC.%2BU.%26atitle%3DDiscovery%2520of%2520the%2520First%2520C-nucleoside%2520HCV%2520Polymerase%2520Inhibitor%2520%2528GS-6620%2529%2520with%2520Demonstrated%2520Antiviral%2520Response%2520in%2520HCV%2520Infected%2520Patients%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1812%26epage%3D1825%26doi%3D10.1021%2Fjm400201a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkin, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichert, W. M.</span></span> <span> </span><span class="NLM_article-title">Directed Cell Migration on Fibronectin Gradients: Effect of Gradient Slope</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>312</i></span>,  <span class="NLM_fpage">2424</span>– <span class="NLM_lpage">2432</span>, <span class="refDoi"> DOI: 10.1016/j.yexcr.2006.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1016%2Fj.yexcr.2006.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=16730349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmsl2ju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2006&pages=2424-2432&author=J.+T.+Smithauthor=J.+T.+Elkinauthor=W.+M.+Reichert&title=Directed+Cell+Migration+on+Fibronectin+Gradients%3A+Effect+of+Gradient+Slope&doi=10.1016%2Fj.yexcr.2006.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">Directed cell migration on fibronectin gradients: Effect of gradient slope</span></div><div class="casAuthors">Smith, Jason T.; Elkin, James T.; Reichert, W. Monty</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">312</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2424-2432</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The migration of human microvascular endothelial cells (hMEC) was measured on a range of fibronectin gradient slopes. hMEC drift speed increased with increasing gradient slope with no concurrent change in cellular persistence time or random cell speed.  The frequency of discrete cellular motion in the gradient direction increased with gradient slope.  Morphol. polarization of cells on the gradients is also characterized and correlated with cellular drift speed.  These expts. present the first demonstration of cellular response to changing haptotactic gradient slope using an in vitro system for the quant. study of cell migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2O0Yz433V77Vg90H21EOLACvtfcHk0lhLmDdRkRBJWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xmsl2ju70%253D&md5=8bb11aee1a1b2ec1f34f116ee2ba94d4</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2006.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2006.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DJ.%2BT.%26aulast%3DElkin%26aufirst%3DJ.%2BT.%26aulast%3DReichert%26aufirst%3DW.%2BM.%26atitle%3DDirected%2520Cell%2520Migration%2520on%2520Fibronectin%2520Gradients%253A%2520Effect%2520of%2520Gradient%2520Slope%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2006%26volume%3D312%26spage%3D2424%26epage%3D2432%26doi%3D10.1016%2Fj.yexcr.2006.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroenke, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piwnica-Worms, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackerman, J. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neil, J. J.</span></span> <span> </span><span class="NLM_article-title">Intracellular Water Specific MR of Microbead-Adherent Cells: The HeLa Cell Intracellular Water Exchange Lifetime</span>. <i>NMR Biomed.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1002/nbm.1173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1002%2Fnbm.1173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=17461436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkt1Sku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=159-164&author=L.+Zhaoauthor=C.+D.+Kroenkeauthor=J.+Songauthor=D.+Piwnica-Wormsauthor=J.+J.+H.+Ackermanauthor=J.+J.+Neil&title=Intracellular+Water+Specific+MR+of+Microbead-Adherent+Cells%3A+The+HeLa+Cell+Intracellular+Water+Exchange+Lifetime&doi=10.1002%2Fnbm.1173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular water-specific MR of microbead-adherent cells: the HeLa cell intracellular water exchange lifetime</span></div><div class="casAuthors">Zhao, L.; Kroenke, C. D.; Song, J.; Piwnica-Worms, D.; Ackerman, J. J. H.; Neil, J. J.</div><div class="citationInfo"><span class="NLM_cas:title">NMR in Biomedicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-164</span>CODEN:
                <span class="NLM_cas:coden">NMRBEF</span>;
        ISSN:<span class="NLM_cas:issn">0952-3480</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Quant. characterization of the intracellular water 1H MR signal from cultured cells will provide crit. biophys. insight into the MR signal from tissues in vivo.  Microbeads provide a robust immobilization substrate for the m any mammalian cell lines that adhere to surfaces and also provide sufficient cell d. for observation of the intracellular water MR signal.  However, selective observation of the intracellular water MR signal from perfused, microbead-adherent mammalian cells requires highly effective suppression of the extracellular water MR signal.  We describe how high-velocity perfusion of microbead-adherent cells results in short apparent 1H MR longitudinal and transverse relaxation times for the extracellular water in a thin slice selected orthogonal to the direction of flow.  When combined with a spin-echo pulse sequence, this phenomenon provides highly effective suppression of the extracellular water MR signal.  This new method is exploited here to quantify the kinetics of water exchange from the intracellular to extracellular spaces of HeLa cells.  The time const. describing water exchange from intracellular to extracellular spaces, also known as the exchange lifetime for intracellular water, is 119 ± 14 ms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRk0icA4x2Z7Vg90H21EOLACvtfcHk0lhS2UrArt8P0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkt1Sku7s%253D&md5=b2c8be705f1dede292ae732c61cd85f4</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1002%2Fnbm.1173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fnbm.1173%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DKroenke%26aufirst%3DC.%2BD.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DPiwnica-Worms%26aufirst%3DD.%26aulast%3DAckerman%26aufirst%3DJ.%2BJ.%2BH.%26aulast%3DNeil%26aufirst%3DJ.%2BJ.%26atitle%3DIntracellular%2520Water%2520Specific%2520MR%2520of%2520Microbead-Adherent%2520Cells%253A%2520The%2520HeLa%2520Cell%2520Intracellular%2520Water%2520Exchange%2520Lifetime%26jtitle%3DNMR%2520Biomed.%26date%3D2008%26volume%3D21%26spage%3D159%26epage%3D164%26doi%3D10.1002%2Fnbm.1173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barauskas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkus, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, B.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerffler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W.</span></span> <span> </span><span class="NLM_article-title">Discovery of β-D-2′-α-Fluoro-4′-α-Cyano-5-Aza-7,9-Dideaza Adenosine as a Potent Nucleoside Inhibitor of Respiratory Syncytial Virus With Excellent Selectivity Over Mitochondrial RNA and DNA Polymerases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2484</span>– <span class="NLM_lpage">2487</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.04.073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1016%2Fj.bmcl.2015.04.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=25978965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsFyisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2484-2487&author=M.+O.+Clarkeauthor=R.+Mackmanauthor=D.+Byunauthor=H.+Huiauthor=O.+Barauskasauthor=G.+Birkusauthor=B.-K.+Chunauthor=E.+Doerfflerauthor=J.+Fengauthor=K.+Karkiauthor=G.+Leeauthor=M.+Perronauthor=D.+Siegelauthor=S.+Swaminathanauthor=W.+Lee&title=Discovery+of+%CE%B2-D-2%E2%80%B2-%CE%B1-Fluoro-4%E2%80%B2-%CE%B1-Cyano-5-Aza-7%2C9-Dideaza+Adenosine+as+a+Potent+Nucleoside+Inhibitor+of+Respiratory+Syncytial+Virus+With+Excellent+Selectivity+Over+Mitochondrial+RNA+and+DNA+Polymerases&doi=10.1016%2Fj.bmcl.2015.04.073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of β-D-2'-deoxy-2'-α-fluoro-4'-α-cyano-5-aza-7,9-dideaza adenosine as a potent nucleoside inhibitor of respiratory syncytial virus with excellent selectivity over mitochondrial RNA and DNA polymerases</span></div><div class="casAuthors">Clarke, Michael O.; Mackman, Richard; Byun, Daniel; Hui, Hon; Barauskas, Ona; Birkus, Gabriel; Chun, Byoung-Kwon; Doerffler, Edward; Feng, Joy; Karki, Kapil; Lee, Gary; Perron, Michel; Siegel, Dustin; Swaminathan, Swami; Lee, William</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2484-2487</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Novel 4'-substituted β-D-2'-deoxy-2'-α-fluoro (2'd2'F) nucleoside inhibitors of respiratory syncytial virus (RSV) are reported.  The introduction of 4'-substitution onto 2'd2'F nucleoside analogs resulted in compds. demonstrating potent cell based RSV inhibition, improved inhibition of the RSV polymerase by the nucleoside triphosphate metabolites, and enhanced selectivity over incorporation by mitochondrial RNA and DNA polymerases.  Selectivity over the mitochondrial polymerases was found to be extremely sensitive to the specific 4'-substitution and not readily predictable.  Combining the most potent and selective 4'-groups from N-nucleoside analogs onto a 2'd2'F C-nucleoside analog resulted in the identification of I as a promising nucleoside lead for RSV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkr67PvLBml7Vg90H21EOLACvtfcHk0lhS2UrArt8P0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnsFyisr0%253D&md5=744a3a2680ef899fcd84258c386471d2</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.073%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DM.%2BO.%26aulast%3DMackman%26aufirst%3DR.%26aulast%3DByun%26aufirst%3DD.%26aulast%3DHui%26aufirst%3DH.%26aulast%3DBarauskas%26aufirst%3DO.%26aulast%3DBirkus%26aufirst%3DG.%26aulast%3DChun%26aufirst%3DB.-K.%26aulast%3DDoerffler%26aufirst%3DE.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DPerron%26aufirst%3DM.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520%25CE%25B2-D-2%25E2%2580%25B2-%25CE%25B1-Fluoro-4%25E2%2580%25B2-%25CE%25B1-Cyano-5-Aza-7%252C9-Dideaza%2520Adenosine%2520as%2520a%2520Potent%2520Nucleoside%2520Inhibitor%2520of%2520Respiratory%2520Syncytial%2520Virus%2520With%2520Excellent%2520Selectivity%2520Over%2520Mitochondrial%2520RNA%2520and%2520DNA%2520Polymerases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2484%26epage%3D2487%26doi%3D10.1016%2Fj.bmcl.2015.04.073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barauskas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmadyar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babusis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCutcheon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakowicz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span> <span> </span><span class="NLM_article-title">Role of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C Virus</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">806</span>– <span class="NLM_lpage">817</span>, <span class="refDoi"> DOI: 10.1128/AAC.01922-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1128%2FAAC.01922-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=26596942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsFKit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=806-817&author=J.+Fengauthor=Y.+Xuauthor=O.+Barauskasauthor=J.+K.+Perryauthor=S.+Ahmadyarauthor=G.+Stepanauthor=H.+Yuauthor=D.+Babusisauthor=Y.+Parkauthor=K.+McCutcheonauthor=M.+Perronauthor=B.+E.+Schultzauthor=R.+Sakowiczauthor=A.+S.+Ray&title=Role+of+Mitochondrial+RNA+Polymerase+in+the+Toxicity+of+Nucleotide+Inhibitors+of+Hepatitis+C+Virus&doi=10.1128%2FAAC.01922-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Role of mitochondrial RNA polymerase in the toxicity of nucleotide inhibitors of hepatitis C virus</span></div><div class="casAuthors">Feng, Joy Y.; Xu, Yili; Barauskas, Ona; Perry, Jason K.; Ahmadyar, Shekeba; Stepan, George; Yu, Helen; Babusis, Darius; Park, Yeojin; McCutcheon, Krista; Perron, Michel; Schultz, Brian E.; Sakowicz, Roman; Ray, Adrian S.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">806-817</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Toxicity has emerged during the clin. development of many but not all nucleotide inhibitors (NI) of hepatitis C virus (HCV).  To better understand the mechanism for adverse events, clin. relevant HCV NI were characterized in biochem. and cellular assays, including assays of decreased viability in multiple cell lines and primary cells, interaction with human DNA and RNA polymerases, and inhibition of mitochondrial protein synthesis and respiration.  NI that were incorporated by the mitochondrial RNA polymerase (PolRMT) inhibited mitochondrial protein synthesis and showed a corresponding decrease in mitochondrial oxygen consumption in cells.  The nucleoside released by the prodrug balapiravir (R1626), 4'-azido cytidine, was a highly selective inhibitor of mitochondrial RNA transcription.  The nucleotide prodrug of 2'-C-Me guanosine, BMS-986094, showed a primary effect on mitochondrial function at submicromolar concns., followed by general cytotoxicity.  In contrast, NI contg. multiple ribose modifications, including the active forms of mericitabine and sofosbuvir, were poor substrates for PolRMT and did not show mitochondrial toxicity in cells.  In general, these studies identified the prostate cell line PC-3 as more than an order of magnitude more sensitive to mitochondrial toxicity than the commonly used HepG2 cells.  In conclusion, analogous to the role of mitochondrial DNA polymerase gamma in toxicity caused by some 2'-deoxynucleotide analogs, there is an assocn. between HCV NI that interact with PolRMT and the observation of adverse events.  More broadly applied, the sensitive methods for detecting mitochondrial toxicity described here may help in the identification of mitochondrial toxicity prior to clin. testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJLNn7rQbeOrVg90H21EOLACvtfcHk0lhS2UrArt8P0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsFKit70%253D&md5=7cc35537b70729a9de882d2ac4b18a98</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1128%2FAAC.01922-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01922-15%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DBarauskas%26aufirst%3DO.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DAhmadyar%26aufirst%3DS.%26aulast%3DStepan%26aufirst%3DG.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DBabusis%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DMcCutcheon%26aufirst%3DK.%26aulast%3DPerron%26aufirst%3DM.%26aulast%3DSchultz%26aufirst%3DB.%2BE.%26aulast%3DSakowicz%26aufirst%3DR.%26aulast%3DRay%26aufirst%3DA.%2BS.%26atitle%3DRole%2520of%2520Mitochondrial%2520RNA%2520Polymerase%2520in%2520the%2520Toxicity%2520of%2520Nucleotide%2520Inhibitors%2520of%2520Hepatitis%2520C%2520Virus%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D806%26epage%3D817%26doi%3D10.1128%2FAAC.01922-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poch, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delarue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, D. H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouloy, M.</span></span> <span> </span><span class="NLM_article-title">Rift Valley Fever Virus L Segment: Correction of the Sequence and Possible Functional Role of Newly Identified Regions Conserved in RNA-Dependent Polymerases</span>. <i>J. Gen. Virol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">1345</span>– <span class="NLM_lpage">1352</span>, <span class="refDoi"> DOI: 10.1099/0022-1317-75-6-1345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1099%2F0022-1317-75-6-1345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=7515937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADyaK2cXlt1Kmsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1994&pages=1345-1352&author=R.+M%C3%BCllerauthor=O.+Pochauthor=M.+Delarueauthor=D.+H.+L.+Bishopauthor=M.+Bouloy&title=Rift+Valley+Fever+Virus+L+Segment%3A+Correction+of+the+Sequence+and+Possible+Functional+Role+of+Newly+Identified+Regions+Conserved+in+RNA-Dependent+Polymerases&doi=10.1099%2F0022-1317-75-6-1345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">Rift valley fever virus L segment: correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases</span></div><div class="casAuthors">Mueller, R.; Poch, O.; Delarue, M.; Bishop, D. H. L.; Bouloy, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1345-52</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    </div><div class="casAbstract">The sequence of Rift Valley fever virus L segment that the authors published in a previous paper was erroneous in the 3'-terminal region of the antigenomic RNA mol.  Here, the authors have shown that the L segment is in fact 6404 nucleotides long and encodes a polypeptide of 237.7 K in the viral complementary sense.  Sequence comparisons performed between the RNA-dependent RNA polymerases of 22 neg.-stranded RNA viruses revealed the existence of two novel regions located at the amino termini of the proteins and conserved only in the polymerases of bunya- and arenaviruses.  In the region conserved in all RNA-dependent polymerases, corresponding to the so-called polymerase module, the authors identified a new motif, designated premotif A, common to all RNA-dependent polymerases, as well as amino acids located in the region between motifs preA and A which are strictly conserved for segmented neg.-stranded RNA viruses.  Using the recently released coordinates of human immunodeficiency virus reverse transcriptase and the alignment between all RNA-dependent polymerases in the polymerase module, the authors have detd. the position of the conserved residues in these polymerases and discuss their possible functions in light of the variable structural information.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq518GlOdLiaLVg90H21EOLACvtfcHk0lg0F_LvVtKPAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlt1Kmsb0%253D&md5=9c15f982bafd2de7fbae61e347c8d967</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1099%2F0022-1317-75-6-1345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252F0022-1317-75-6-1345%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DR.%26aulast%3DPoch%26aufirst%3DO.%26aulast%3DDelarue%26aufirst%3DM.%26aulast%3DBishop%26aufirst%3DD.%2BH.%2BL.%26aulast%3DBouloy%26aufirst%3DM.%26atitle%3DRift%2520Valley%2520Fever%2520Virus%2520L%2520Segment%253A%2520Correction%2520of%2520the%2520Sequence%2520and%2520Possible%2520Functional%2520Role%2520of%2520Newly%2520Identified%2520Regions%2520Conserved%2520in%2520RNA-Dependent%2520Polymerases%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D1994%26volume%3D75%26spage%3D1345%26epage%3D1352%26doi%3D10.1099%2F0022-1317-75-6-1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chopra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdine, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, S. C.</span></span> <span> </span><span class="NLM_article-title">Structure of a Covalently Trapped Catalytic Complex of HIV-1 Reverse Transcriptase: Implications for Drug Resistance</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">1669</span>– <span class="NLM_lpage">1675</span>, <span class="refDoi"> DOI: 10.1126/science.282.5394.1669</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1126%2Fscience.282.5394.1669" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=9831551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADyaK1cXnslGhtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1998&pages=1669-1675&author=H.+Huangauthor=R.+Chopraauthor=G.+L.+Verdineauthor=S.+C.+Harrison&title=Structure+of+a+Covalently+Trapped+Catalytic+Complex+of+HIV-1+Reverse+Transcriptase%3A+Implications+for+Drug+Resistance&doi=10.1126%2Fscience.282.5394.1669"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance</span></div><div class="casAuthors">Huang, Huifang; Chopra, Rajiv; Verdine, Gregory L.; Harrison, Stephen C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">5394</span>),
    <span class="NLM_cas:pages">1669-1675</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A combinatorial disulfide crosslinking strategy was used to prep. a stalled complex of human immunodeficiency virus-type 1 (HIV-1) reverse transcriptase with a DNA template:primer and a deoxynucleoside triphosphate (dNTP), and the crystal structure of the complex was detd. at a resoln. of 3.2 angstroms.  The presence of a dideoxynucleotide at the 3'-primer terminus allows capture of a state in which the substrates are poised for attack on the dNTP.  Conformational changes that accompany formation of the catalytic complex produce distinct clusters of the residues that are altered in viruses resistant to nucleoside analog drugs.  The positioning of these residues in the neighborhood of the dNTP helps to resolve some long-standing puzzles about the mol. basis of resistance.  The resistance mutations are likely to influence binding or reactivity of the inhibitors, relative to normal dNTPs, and the clustering of the mutations correlates with the chem. structure of the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV_rP3C5B_N7Vg90H21EOLACvtfcHk0lg0F_LvVtKPAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnslGhtr4%253D&md5=e97c3a69e2aa084beff2ec8dd88af3b4</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1126%2Fscience.282.5394.1669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.282.5394.1669%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DVerdine%26aufirst%3DG.%2BL.%26aulast%3DHarrison%26aufirst%3DS.%2BC.%26atitle%3DStructure%2520of%2520a%2520Covalently%2520Trapped%2520Catalytic%2520Complex%2520of%2520HIV-1%2520Reverse%2520Transcriptase%253A%2520Implications%2520for%2520Drug%2520Resistance%26jtitle%3DScience%26date%3D1998%26volume%3D282%26spage%3D1669%26epage%3D1675%26doi%3D10.1126%2Fscience.282.5394.1669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit32c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Appleby, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barauskas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetmore, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sofia, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, T. E.</span></span> <span> </span><span class="NLM_article-title">Structural Basis For RNA Replication by the Hepatitis C Virus Polymerase</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">771</span>– <span class="NLM_lpage">775</span>, <span class="refDoi"> DOI: 10.1126/science.1259210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1126%2Fscience.1259210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=25678663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitlKktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2015&pages=771-775&author=T.+C.+Applebyauthor=J.+K.+Perryauthor=E.+Murakamiauthor=O.+Barauskasauthor=J.+Fengauthor=A.+Choauthor=D.+Foxauthor=D.+R.+Wetmoreauthor=M.+E.+McGrathauthor=A.+S.+Rayauthor=M.+J.+Sofiaauthor=S.+Swaminathanauthor=T.+E.+Edwards&title=Structural+Basis+For+RNA+Replication+by+the+Hepatitis+C+Virus+Polymerase&doi=10.1126%2Fscience.1259210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32cR"><div class="casContent"><span class="casTitleNuber">32c</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for RNA replication by the hepatitis C virus polymerase</span></div><div class="casAuthors">Appleby, Todd C.; Perry, Jason K.; Murakami, Eisuke; Barauskas, Ona; Feng, Joy; Cho, Aesop; Fox, David, III; Wetmore, Diana R.; McGrath, Mary E.; Ray, Adrian S.; Sofia, Michael J.; Swaminathan, S.; Edwards, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6223</span>),
    <span class="NLM_cas:pages">771-775</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Nucleotide analog inhibitors have shown clin. success in the treatment of hepatitis C virus (HCV) infection, despite an incomplete mechanistic understanding of NS5B, the viral RNA-dependent RNA polymerase.  Here we study the details of HCV RNA replication by detg. crystal structures of stalled polymerase ternary complexes with enzymes, RNA templates, RNA primers, incoming nucleotides, and catalytic metal ions during both primed initiation and elongation of RNA synthesis.  Our anal. revealed that highly conserved active-site residues in NS5B position the primer for in-line attack on the incoming nucleotide.  A β loop and a C-terminal membrane-anchoring linker occlude the active-site cavity in the apo state, retract in the primed initiation assembly to enforce replication of the HCV genome from the 3' terminus, and vacate the active-site cavity during elongation.  We investigated the incorporation of nucleotide analog inhibitors, including the clin. active metabolite formed by sofosbuvir, to elucidate key mol. interactions in the active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvMC7Wt9bjr7Vg90H21EOLACvtfcHk0lg0F_LvVtKPAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitlKktrk%253D&md5=aeebcacedf36a44ae80c972100c80c24</span></div><a href="/servlet/linkout?suffix=cit32c&amp;dbid=16384&amp;doi=10.1126%2Fscience.1259210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1259210%26sid%3Dliteratum%253Aachs%26aulast%3DAppleby%26aufirst%3DT.%2BC.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DMurakami%26aufirst%3DE.%26aulast%3DBarauskas%26aufirst%3DO.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DCho%26aufirst%3DA.%26aulast%3DFox%26aufirst%3DD.%26aulast%3DWetmore%26aufirst%3DD.%2BR.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DEdwards%26aufirst%3DT.%2BE.%26atitle%3DStructural%2520Basis%2520For%2520RNA%2520Replication%2520by%2520the%2520Hepatitis%2520C%2520Virus%2520Polymerase%26jtitle%3DScience%26date%3D2015%26volume%3D347%26spage%3D771%26epage%3D775%26doi%3D10.1126%2Fscience.1259210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="note"><p class="first last">For active site models of other filovirus polymerases see the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01594/suppl_file/jm6b01594_si_001.pdb" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barauskas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenaux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirunagari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagpacan, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ku, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitrinos, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkus, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Hepatitis C Virus Replication by GS-6620, a Potent <i>C</i>-Nucleoside Monophosphate Prodrug</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1930</span>– <span class="NLM_lpage">1942</span>, <span class="refDoi"> DOI: 10.1128/AAC.02351-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1128%2FAAC.02351-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=24419349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVSlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=1930-1942&author=J.+Y.+Fengauthor=G.+Chengauthor=J.+Perryauthor=O.+Barauskasauthor=Y.+Xuauthor=M.+Fenauxauthor=S.+Engauthor=N.+Tirunagariauthor=B.+Pengauthor=M.+Yuauthor=Y.+Tianauthor=Y.-J.+Leeauthor=G.+Stepanauthor=L.+L.+Lagpacanauthor=D.+Jinauthor=M.+Hungauthor=K.+S.+Kuauthor=B.+Hanauthor=K.+Kitrinosauthor=M.+Perronauthor=G.+Birkusauthor=K.+A.+Wongauthor=W.+Zhongauthor=C.+U.+Kimauthor=A.+Careyauthor=A.+Choauthor=A.+S.+Ray&title=Inhibition+of+Hepatitis+C+Virus+Replication+by+GS-6620%2C+a+Potent+C-Nucleoside+Monophosphate+Prodrug&doi=10.1128%2FAAC.02351-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of hepatitis C virus replication by GS-6620, a potent C-nucleoside monophosphate prodrug</span></div><div class="casAuthors">Feng, Joy Y.; Cheng, Guofeng; Perry, Jason; Barauskas, Ona; Xu, Yili; Fenaux, Martijn; Eng, Stacey; Tirunagari, Neeraj; Peng, Betty; Yu, Mei; Tian, Yang; Lee, Yu-Jen; Stepan, George; Lagpacan, Leanna L.; Jin, Debi; Hung, Magdeleine; Ku, Karin S.; Han, Bin; Kitrinos, Kathryn; Perron, Michel; Birkus, Gabriel; Wong, Kelly A.; Zhong, Weidong; Kim, Choung U.; Carey, Anne; Cho, Aesop; Ray, Adrian S.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1930-1942, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">As a class, nucleotide inhibitors (NIs) of the hepatitis C virus (HCV) nonstructural protein 5B (NS5B) RNA-dependent RNA polymerase offer advantages over other direct-acting antivirals, including properties, such as pangenotype activity, a high barrier to resistance, and reduced potential for drug-drug interactions.  We studied the in vitro pharmacol. of a novel C-nucleoside adenosine analog monophosphate prodrug, GS-6620.  It was found to be a potent and selective HCV inhibitor against HCV replicons of genotypes 1 to 6 and against an infectious genotype 2a virus (50% effective concn. [EC50], 0.048 to 0.68 μM).  GS-6620 showed limited activities against other viruses, maintaining only some of its activity against the closely related bovine viral diarrhea virus (EC50, 1.5 μM).  The active 5'-triphosphate metabolite of GS-6620 is a chain terminator of viral RNA synthesis and a competitive inhibitor of NS5B-catalyzed ATP incorporation, with Ki/Km values of 0.23 and 0.18 for HCV NS5B genotypes 1b and 2a, resp.  With its unique dual substitutions of 1'-CN and 2'-C-Me on the ribose ring, the active triphosphate metabolite was found to have enhanced selectivity for the HCV NS5B polymerase over host RNA polymerases.  GS-6620 demonstrated a high barrier to resistance in vitro.  Prolonged passaging resulted in the selection of the S282T mutation in NS5B that was found to be resistant in both cellular and enzymic assays (>30-fold).  Consistent with its in vitro profile, GS-6620 exhibited the potential for potent anti-HCV activity in a proof-of-concept clin. trial, but its utility was limited by the requirement of high dose levels and pharmacokinetic and pharmacodynamic variability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvNp6xp0zrdrVg90H21EOLACvtfcHk0lgxkqc5Veagxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVSlsLs%253D&md5=43e83867f11918c5499dd6a993386260</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1128%2FAAC.02351-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02351-13%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DBarauskas%26aufirst%3DO.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DFenaux%26aufirst%3DM.%26aulast%3DEng%26aufirst%3DS.%26aulast%3DTirunagari%26aufirst%3DN.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DY.-J.%26aulast%3DStepan%26aufirst%3DG.%26aulast%3DLagpacan%26aufirst%3DL.%2BL.%26aulast%3DJin%26aufirst%3DD.%26aulast%3DHung%26aufirst%3DM.%26aulast%3DKu%26aufirst%3DK.%2BS.%26aulast%3DHan%26aufirst%3DB.%26aulast%3DKitrinos%26aufirst%3DK.%26aulast%3DPerron%26aufirst%3DM.%26aulast%3DBirkus%26aufirst%3DG.%26aulast%3DWong%26aufirst%3DK.%2BA.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DKim%26aufirst%3DC.%2BU.%26aulast%3DCarey%26aufirst%3DA.%26aulast%3DCho%26aufirst%3DA.%26aulast%3DRay%26aufirst%3DA.%2BS.%26atitle%3DInhibition%2520of%2520Hepatitis%2520C%2520Virus%2520Replication%2520by%2520GS-6620%252C%2520a%2520Potent%2520C-Nucleoside%2520Monophosphate%2520Prodrug%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D1930%26epage%3D1942%26doi%3D10.1128%2FAAC.02351-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T.</span>; <span class="NLM_string-name">Cho, A.</span>; <span class="NLM_string-name">Kim, C. U.</span>; <span class="NLM_string-name">Saunders, O. L.</span>; <span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">1′-Substituted Carba-Nucleoside Analogs for Antiviral Treatment</span>. U.S. Patent <span class="NLM_patent">2009041447</span> Apr., 22, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=T.+Butler&author=A.+Cho&author=C.+U.+Kim&author=O.+L.+Saunders&author=L.+Zhang&title=1%E2%80%B2-Substituted+Carba-Nucleoside+Analogs+for+Antiviral+Treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DT.%26atitle%3D1%25E2%2580%25B2-Substituted%2520Carba-Nucleoside%2520Analogs%2520for%2520Antiviral%2520Treatment%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T.</span>; <span class="NLM_string-name">Cho, A.</span>; <span class="NLM_string-name">Graetz, B. R.</span>; <span class="NLM_string-name">Kim, C. U.</span>; <span class="NLM_string-name">Metobo, S. E.</span>; <span class="NLM_string-name">Saunders, O. L.</span>; <span class="NLM_string-name">Waltman, A. W.</span>; <span class="NLM_string-name">Xu, J.</span>; <span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">Processes and Intermediates for the Preparation of 1′-Substituted Carba-Nucleoside Analogs</span>. U.S. Patent<span class="NLM_patent">20100459508</span> Sep., 20, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+Butler&author=A.+Cho&author=B.+R.+Graetz&author=C.+U.+Kim&author=S.+E.+Metobo&author=O.+L.+Saunders&author=A.+W.+Waltman&author=J.+Xu&author=L.+Zhang&title=Processes+and+Intermediates+for+the+Preparation+of+1%E2%80%B2-Substituted+Carba-Nucleoside+Analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DT.%26atitle%3DProcesses%2520and%2520Intermediates%2520for%2520the%2520Preparation%2520of%25201%25E2%2580%25B2-Substituted%2520Carba-Nucleoside%2520Analogs%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Metobo, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, O. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aktoudianakis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. U.</span></span> <span> </span><span class="NLM_article-title">Practical Synthesis of 1′-Substituted Tubercidin <i>C</i>-Nucleoside Analogs</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2011.11.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1016%2Fj.tetlet.2011.11.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Ols7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=484-486&author=S.+E.+Metoboauthor=J.+Xuauthor=O.+L.+Saundersauthor=T.+Butlerauthor=E.+Aktoudianakisauthor=A.+Choauthor=C.+U.+Kim&title=Practical+Synthesis+of+1%E2%80%B2-Substituted+Tubercidin+C-Nucleoside+Analogs&doi=10.1016%2Fj.tetlet.2011.11.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Practical synthesis of 1'-substituted Tubercidin C-nucleoside analogs</span></div><div class="casAuthors">Metobo, Sammy E.; Xu, Jie; Saunders, Oliver L.; Butler, Thomas; Aktoudianakis, Evangelos; Cho, Aesop; Kim, Choung U.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">484-486</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Several 1'-substituted analogs of Tubercidin C-nucleosides were prepd. using a highly convergent synthesis.  Good to high diastereoselectivity was achieved using a variety of nucleophiles targeting the 1'-position.  The source for this stereoselectivity is herein proposed.  It is thought to be attributed to a temp.-dependent chelation of the incoming nucleophile to either the 2'- or 3'-benzyloxy ether of the ribose core.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzYtnu5F19ibVg90H21EOLACvtfcHk0lgxkqc5Veagxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Ols7fN&md5=14adad9cdf925cecfa238f7ef2330902</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2011.11.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2011.11.055%26sid%3Dliteratum%253Aachs%26aulast%3DMetobo%26aufirst%3DS.%2BE.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DSaunders%26aufirst%3DO.%2BL.%26aulast%3DButler%26aufirst%3DT.%26aulast%3DAktoudianakis%26aufirst%3DE.%26aulast%3DCho%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DC.%2BU.%26atitle%3DPractical%2520Synthesis%2520of%25201%25E2%2580%25B2-Substituted%2520Tubercidin%2520C-Nucleoside%2520Analogs%26jtitle%3DTetrahedron%2520Lett.%26date%3D2012%26volume%3D53%26spage%3D484%26epage%3D486%26doi%3D10.1016%2Fj.tetlet.2011.11.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Axt, S. D.</span>; <span class="NLM_string-name">Badalov, P. R.</span>; <span class="NLM_string-name">Brak, K.</span>; <span class="NLM_string-name">Campagna, S.</span>; <span class="NLM_string-name">Chtchemelinine, A.</span>; <span class="NLM_string-name">Chun, B. K.</span>; <span class="NLM_string-name">Clarke, M. O. H.</span>; <span class="NLM_string-name">Doerffler, E.</span>; <span class="NLM_string-name">Frick, M. M.</span>; <span class="NLM_string-name">Gao, D.</span>; <span class="NLM_string-name">Heumann, L. V.</span>; <span class="NLM_string-name">Hoang, B.</span>; <span class="NLM_string-name">Hui, H. C.</span>; <span class="NLM_string-name">Jordan, R.</span>; <span class="NLM_string-name">Lew, W.</span>; <span class="NLM_string-name">Mackman, R. L.</span>; <span class="NLM_string-name">Milburn, R. R.</span>; <span class="NLM_string-name">Neville, S. T.</span>; <span class="NLM_string-name">Parrish, J. P.</span>; <span class="NLM_string-name">Ray, A. S.</span>; <span class="NLM_string-name">Ross, B.</span>; <span class="NLM_string-name">Rueden, E.</span>; <span class="NLM_string-name">Scott, R. W.</span>; <span class="NLM_string-name">Siegel, D.</span>; <span class="NLM_string-name">Stevens, A. C.</span>; <span class="NLM_string-name">Tadeus, C.</span>; <span class="NLM_string-name">Vieira, T.</span>; <span class="NLM_string-name">Waltman, A. W.</span>; <span class="NLM_string-name">Wang, X.</span>; <span class="NLM_string-name">Whitcomb, M. C.</span>; <span class="NLM_string-name">Wolfe, L.</span>; <span class="NLM_string-name">Yu, C.-Y.</span></span> <span> </span><span class="NLM_article-title">Methods For Treating Filoviridae Virus Infections</span>. U.S. Patent <span class="NLM_patent">2015017934</span>, Oct. 29, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+D.+Axt&author=P.+R.+Badalov&author=K.+Brak&author=S.+Campagna&author=A.+Chtchemelinine&author=B.+K.+Chun&author=M.+O.+H.+Clarke&author=E.+Doerffler&author=M.+M.+Frick&author=D.+Gao&author=L.+V.+Heumann&author=B.+Hoang&author=H.+C.+Hui&author=R.+Jordan&author=W.+Lew&author=R.+L.+Mackman&author=R.+R.+Milburn&author=S.+T.+Neville&author=J.+P.+Parrish&author=A.+S.+Ray&author=B.+Ross&author=E.+Rueden&author=R.+W.+Scott&author=D.+Siegel&author=A.+C.+Stevens&author=C.+Tadeus&author=T.+Vieira&author=A.+W.+Waltman&author=X.+Wang&author=M.+C.+Whitcomb&author=L.+Wolfe&author=C.-Y.+Yu&title=Methods+For+Treating+Filoviridae+Virus+Infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAxt%26aufirst%3DS.%2BD.%26atitle%3DMethods%2520For%2520Treating%2520Filoviridae%2520Virus%2520Infections%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krasovskiy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knochel, P.</span></span> <span> </span><span class="NLM_article-title">A LiCl-Mediated Br/Mg Exchange Reaction For the Preparation of Functionalized Aryl- and Heteroarylmagnesium Compounds From Organic Bromides</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">3333</span>– <span class="NLM_lpage">3336</span>, <span class="refDoi"> DOI: 10.1002/anie.200454084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1002%2Fanie.200454084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsF2gu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=3333-3336&author=A.+Krasovskiyauthor=P.+Knochel&title=A+LiCl-Mediated+Br%2FMg+Exchange+Reaction+For+the+Preparation+of+Functionalized+Aryl-+and+Heteroarylmagnesium+Compounds+From+Organic+Bromides&doi=10.1002%2Fanie.200454084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A LiCl-mediated Br/Mg exchange reaction for the preparation of functionalized aryl- and heteroarylmagnesium compounds from organic bromides</span></div><div class="casAuthors">Krasovskiy, Arkady; Knochel, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3333-3336</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A wide range of aryl and heteroaryl bromides, which are usually sluggish in exchange reactions, are readily converted into the corresponding Grignard reagents by means of a Br/Mg exchange reaction triggered by iPrMgCl·LiCl.  These Grignard intermediates react with electrophiles in good yields.  For example, 4-MeOC6H4MgCl·LiCl was prepd. from iPrMgCl·LiCl and 4-MeOC6H4Br and reacted with PhCHO giving 4-MeOC6H4CH(OH)Ph (70% yield).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPoDY5Id67ErVg90H21EOLACvtfcHk0lgfl-JyDz_pgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsF2gu7s%253D&md5=aabf3ff877c31da0dd84f3a5be883580</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fanie.200454084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200454084%26sid%3Dliteratum%253Aachs%26aulast%3DKrasovskiy%26aufirst%3DA.%26aulast%3DKnochel%26aufirst%3DP.%26atitle%3DA%2520LiCl-Mediated%2520Br%252FMg%2520Exchange%2520Reaction%2520For%2520the%2520Preparation%2520of%2520Functionalized%2520Aryl-%2520and%2520Heteroarylmagnesium%2520Compounds%2520From%2520Organic%2520Bromides%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2004%26volume%3D43%26spage%3D3333%26epage%3D3336%26doi%3D10.1002%2Fanie.200454084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span>For a separate account
describing the crystallization induced resolution of <i>p</i>-nitrophenolate 2-ethylbutyl-L-alaninate phosphoramidate see: <span class="NLM_contrib-group"><span class="NLM_string-name">Klasson, B.</span>; <span class="NLM_string-name">Eneroth, A.</span>; <span class="NLM_string-name">Nilson, M.</span>; <span class="NLM_string-name">Pinho, P.</span>; <span class="NLM_string-name">Samuelsson, B.</span>; <span class="NLM_string-name">Sund, C.</span></span> <span> </span><span class="NLM_article-title">HCV Polymerase Inhibitors</span>. European Patent <span class="NLM_patent">IB2012056994</span> Dec. 5, <span class="NLM_year">2012</span>. The conditions in this patent were identified independently/concurrently with this report.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=B.+Klasson&author=A.+Eneroth&author=M.+Nilson&author=P.+Pinho&author=B.+Samuelsson&author=C.+Sund&title=HCV+Polymerase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKlasson%26aufirst%3DB.%26atitle%3DHCV%2520Polymerase%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bahar, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogihara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, T.</span></span> <span> </span><span class="NLM_article-title">Species Difference of Esterase Expression and Hydrolase Activity in Plasma</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">3979</span>– <span class="NLM_lpage">3988</span>, <span class="refDoi"> DOI: 10.1002/jps.23258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1002%2Fjps.23258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=22833171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVyksb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2012&pages=3979-3988&author=F.+G.+Baharauthor=K.+Ohuraauthor=T.+Ogiharaauthor=T.+Imai&title=Species+Difference+of+Esterase+Expression+and+Hydrolase+Activity+in+Plasma&doi=10.1002%2Fjps.23258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Species difference of esterase expression and hydrolase activity in plasma</span></div><div class="casAuthors">Bahar, Fatma Goksin; Ohura, Kayoko; Ogihara, Takuo; Imai, Teruko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3979-3988</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Differences in esterase expression among human, rhesus monkey, cynomolgus monkey, dog, minipig, rabbit, rat, and mouse plasma were identified using native polyacrylamide gel electrophoresis.  Paraoxonase (PON) and butyrylcholinesterase (BChE) were ubiquitous in all species, but were highly expressed in primates and dogs, whereas carboxylesterase (CES) was only abundant in rabbits, mice, and rats.  Several unknown esterases were obsd. in minipig and mouse plasma.  These differences in plasma esterases and their expression levels result in species differences with respect to hydrolase activity.  These differences were characterized using several different substrates.  In contrast to the high hydrolase activity found for p-nitrophenylacetate (PNPA), a substrate of several hydrolase enzymes, irinotecan, a carbamate compd., was resistant to all plasma esterases.  Oseltamivir, temocapril, and propranolol (PL) derivs. were rapidly hydrolyzed in mouse and rat plasma by their highly active CES enzyme, but rabbit plasma CES hydrolyzed only the PL derivs.  Interestingly, PL derivs. were highly hydrolyzed by monkey plasma BChE, whereas BChE from human, dog, and minipig plasma showed negligible activity.  In conclusion, the esterase expression and hydrolyzing pattern of dog plasma were found to be closest to that of human plasma.  These differences should be considered when selecting model animals for preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIjepKzp5aYLVg90H21EOLACvtfcHk0lgfl-JyDz_pgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVyksb7L&md5=6ec3b10b30a3ab7071a426eadb993a11</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fjps.23258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23258%26sid%3Dliteratum%253Aachs%26aulast%3DBahar%26aufirst%3DF.%2BG.%26aulast%3DOhura%26aufirst%3DK.%26aulast%3DOgihara%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DT.%26atitle%3DSpecies%2520Difference%2520of%2520Esterase%2520Expression%2520and%2520Hydrolase%2520Activity%2520in%2520Plasma%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D101%26spage%3D3979%26epage%3D3988%26doi%3D10.1002%2Fjps.23258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhagani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cropley, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filipe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gifford, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabeen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannessen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karageorgopoulos, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lackenby, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lester, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R. S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacConnachie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahungu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mepham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmarini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seaton, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sreenu, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Templeton, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkie, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, E. C.</span></span> <span> </span><span class="NLM_article-title">Late Ebola Virus Relapse Causing Meningoencephalitis: A Case Report</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>388</i></span>,  <span class="NLM_fpage">498</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(16)30386-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=10.1016%2FS0140-6736%2816%2930386-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=27209148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FitV2ksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2016&pages=498-503&author=M.+Jacobsauthor=A.+Rodgerauthor=D.+D.+Bellauthor=S.+Bhaganiauthor=I.+Cropleyauthor=A.+Filipeauthor=R.+J.+Giffordauthor=S.+Hopkinsauthor=J.+Hughesauthor=F.+Jabeenauthor=I.+Johannessenauthor=D.+Karageorgopoulosauthor=A.+Lackenbyauthor=R.+Lesterauthor=R.+S.+N.+Liuauthor=A.+MacConnachieauthor=T.+Mahunguauthor=D.+Martinauthor=N.+Marshallauthor=S.+Mephamauthor=R.+Ortonauthor=M.+Palmariniauthor=M.+Patelauthor=C.+Perryauthor=S.+E.+Petersauthor=D.+Porterauthor=D.+Ritchieauthor=N.+D.+Ritchieauthor=R.+A.+Seatonauthor=V.+B.+Sreenuauthor=K.+Templetonauthor=S.+Warrenauthor=G.+S.+Wilkieauthor=M.+Zambonauthor=R.+Gopalauthor=E.+C.+Thomson&title=Late+Ebola+Virus+Relapse+Causing+Meningoencephalitis%3A+A+Case+Report&doi=10.1016%2FS0140-6736%2816%2930386-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Late Ebola virus relapse causing meningoencephalitis: a case report</span></div><div class="casAuthors">Jacobs Michael; Rodger Alison; Bell David J; MacConnachie Alisdair; Perry Colin; Peters S Erica; Porter Duncan; Ritchie David; Ritchie Neil D; Seaton R Andrew; Bhagani Sanjay; Cropley Ian; Hopkins Susan; Karageorgopoulos Drosos; Lester Rebecca; Mahungu Tabitha; Mepham Stephen; Warren Simon; Filipe Ana; Gifford Robert J; Hughes Joseph; Orton Richard; Palmarini Massimo; Sreenu Vattipally B; Wilkie Gavin S; Jabeen Farrah; Johannessen Ingolfur; Templeton Kate; Lackenby Angie; Zambon Maria; Liu Rebecca S N; Martin Daniel; Marshall Neal; Patel Monika; Gopal Robin; Thomson Emma C</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">10043</span>),
    <span class="NLM_cas:pages">498-503</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  There are thousands of survivors of the 2014 Ebola outbreak in west Africa.  Ebola virus can persist in survivors for months in immune-privileged sites; however, viral relapse causing life-threatening and potentially transmissible disease has not been described.  We report a case of late relapse in a patient who had been treated for severe Ebola virus disease with high viral load (peak cycle threshold value 13.2).  METHODS:  A 39-year-old female nurse from Scotland, who had assisted the humanitarian effort in Sierra Leone, had received intensive supportive treatment and experimental antiviral therapies, and had been discharged with undetectable Ebola virus RNA in peripheral blood.  The patient was readmitted to hospital 9 months after discharge with symptoms of acute meningitis, and was found to have Ebola virus in cerebrospinal fluid (CSF).  She was treated with supportive therapy and experimental antiviral drug GS-5734 (Gilead Sciences, San Francisco, Foster City, CA, USA).  We monitored Ebola virus RNA in CSF and plasma, and sequenced the viral genome using an unbiased metagenomic approach.  FINDINGS:  On admission, reverse transcriptase PCR identified Ebola virus RNA at a higher level in CSF (cycle threshold value 23.7) than plasma (31.3); infectious virus was only recovered from CSF.  The patient developed progressive meningoencephalitis with cranial neuropathies and radiculopathy.  Clinical recovery was associated with addition of high-dose corticosteroids during GS-5734 treatment.  CSF Ebola virus RNA slowly declined and was undetectable following 14 days of treatment with GS-5734.  Sequencing of plasma and CSF viral genome revealed only two non-coding changes compared with the original infecting virus.  INTERPRETATION:  Our report shows that previously unanticipated, late, severe relapses of Ebola virus can occur, in this case in the CNS.  This finding fundamentally redefines what is known about the natural history of Ebola virus infection.  Vigilance should be maintained in the thousands of Ebola survivors for cases of relapsed infection.  The potential for these cases to initiate new transmission chains is a serious public health concern.  FUNDING:  Royal Free London NHS Foundation Trust.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRYRsrOSKHcwJQHPYJuLg8TfW6udTcc2eb0opmkVflV0bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FitV2ksg%253D%253D&md5=c2cb4099c19a6603874e120d53a7c8b4</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2816%2930386-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252816%252930386-5%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DRodger%26aufirst%3DA.%26aulast%3DBell%26aufirst%3DD.%2BD.%26aulast%3DBhagani%26aufirst%3DS.%26aulast%3DCropley%26aufirst%3DI.%26aulast%3DFilipe%26aufirst%3DA.%26aulast%3DGifford%26aufirst%3DR.%2BJ.%26aulast%3DHopkins%26aufirst%3DS.%26aulast%3DHughes%26aufirst%3DJ.%26aulast%3DJabeen%26aufirst%3DF.%26aulast%3DJohannessen%26aufirst%3DI.%26aulast%3DKarageorgopoulos%26aufirst%3DD.%26aulast%3DLackenby%26aufirst%3DA.%26aulast%3DLester%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DR.%2BS.%2BN.%26aulast%3DMacConnachie%26aufirst%3DA.%26aulast%3DMahungu%26aufirst%3DT.%26aulast%3DMartin%26aufirst%3DD.%26aulast%3DMarshall%26aufirst%3DN.%26aulast%3DMepham%26aufirst%3DS.%26aulast%3DOrton%26aufirst%3DR.%26aulast%3DPalmarini%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DC.%26aulast%3DPeters%26aufirst%3DS.%2BE.%26aulast%3DPorter%26aufirst%3DD.%26aulast%3DRitchie%26aufirst%3DD.%26aulast%3DRitchie%26aufirst%3DN.%2BD.%26aulast%3DSeaton%26aufirst%3DR.%2BA.%26aulast%3DSreenu%26aufirst%3DV.%2BB.%26aulast%3DTempleton%26aufirst%3DK.%26aulast%3DWarren%26aufirst%3DS.%26aulast%3DWilkie%26aufirst%3DG.%2BS.%26aulast%3DZambon%26aufirst%3DM.%26aulast%3DGopal%26aufirst%3DR.%26aulast%3DThomson%26aufirst%3DE.%2BC.%26atitle%3DLate%2520Ebola%2520Virus%2520Relapse%2520Causing%2520Meningoencephalitis%253A%2520A%2520Case%2520Report%26jtitle%3DLancet%26date%3D2016%26volume%3D388%26spage%3D498%26epage%3D503%26doi%3D10.1016%2FS0140-6736%2816%2930386-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schnirring, L.</span></span> <span> </span><span class="NLM_article-title">Youngest Ebola Survivor Leaves Guinea Hospital</span>; <span class="NLM_publisher-name">Center For Infectious Disease Research and Policy</span>, <span class="NLM_publisher-loc">Minneapolis, MN, USA</span>, Nov. 30, <span class="NLM_year">2015</span>; <a href="http://www.cidrap.umn.edu/news-perspective/2015/11/youngest-ebola-survivor-leaves-guinea-hospital" class="extLink">http://www.cidrap.umn.edu/news-perspective/2015/11/youngest-ebola-survivor-leaves-guinea-hospital</a> (accessed Jul. 22, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=L.+Schnirring&title=Youngest+Ebola+Survivor+Leaves+Guinea+Hospital"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DSchnirring%26aufirst%3DL.%26atitle%3DYoungest%2520Ebola%2520Survivor%2520Leaves%2520Guinea%2520Hospital%26pub%3DCenter%2520For%2520Infectious%2520Disease%2520Research%2520and%2520Policy%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">National Institues of Health</span>. <span> </span><span class="NLM_article-title">PREVAIL Treatment
Trial For Men With Persistent Ebola Viral RNA in Semen Opens in Liberia</span>, Jul. 5, <span class="NLM_year">2016</span>; <a href="https://www.nih.gov/news-events/news-releases/prevail-treatment-trial-men-persistent-ebola-viral-rna-semen-opens-liberia" class="extLink">https://www.nih.gov/news-events/news-releases/prevail-treatment-trial-men-persistent-ebola-viral-rna-semen-opens-liberia</a> (accessed, Jul., 22, <span class="NLM_year">2016</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=National+Institues+of+Health&title=PREVAIL+Treatment%0ATrial+For+Men+With+Persistent+Ebola+Viral+RNA+in+Semen+Opens+in+Liberia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DPREVAIL%2520Treatment%250ATrial%2520For%2520Men%2520With%2520Persistent%2520Ebola%2520Viral%2520RNA%2520in%2520Semen%2520Opens%2520in%2520Liberia%26date%3D2016%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RTD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RTD','PDB','1RTD'); return false;">PDB: 1RTD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WTG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WTG','PDB','4WTG'); return false;">PDB: 4WTG</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i27"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01594">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_56154"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01594">10.1021/acs.jmedchem.6b01594</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Homology model of HIV (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RTD">1RTD</a><a class="ref cit32b" href="javascript:void(0);">(32b)</a>) X-ray structure used to generate the EBOV model for <b>4tp</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01594/suppl_file/jm6b01594_si_001.pdb">PDB</a>)</p></li><li><p class="inline">Homology model of HCV (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WTG">4WTG</a><a class="ref cit32c" href="javascript:void(0);">(32c)</a>) X-ray structure used to generate the EBOV model for <b>13tp</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01594/suppl_file/jm6b01594_si_002.pdb">PDB</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01594/suppl_file/jm6b01594_si_003.csv">CSV</a>)</p></li><li><p class="inline">Assay methods, molecular modeling with RSV, Marburg and Sudan viruses, compound synthesis, and single crystal X-ray structure information(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01594/suppl_file/jm6b01594_si_004.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01594/suppl_file/jm6b01594_si_001.pdb">jm6b01594_si_001.pdb (326.04 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01594/suppl_file/jm6b01594_si_002.pdb">jm6b01594_si_002.pdb (326.34 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01594/suppl_file/jm6b01594_si_003.csv">jm6b01594_si_003.csv (4.16 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01594/suppl_file/jm6b01594_si_004.pdf">jm6b01594_si_004.pdf (782.06 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The Cambridge Crystallographic Data Center (CCDC) numbers for the X-ray structures of compound <b>22b</b> and <b>4b</b> are 1445315 and 1525480, respectively.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-5%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01594" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01594" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998f89edac3d18","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
